defm14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Rule 14a-101)
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
|
o |
|
Preliminary Proxy Statement |
|
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
þ |
|
Definitive Proxy Statement |
|
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to §240.14a-12 |
Altiris, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
o |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
|
|
|
þ |
|
Fee paid previously with preliminary materials. |
|
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
SPECIAL MEETING OF
STOCKHOLDERS
MERGER PROPOSAL
YOUR VOTE IS VERY IMPORTANT
To the Stockholders of Altiris, Inc.:
On January 26, 2007, we entered into an agreement and plan
of merger with Symantec Corporation and Atlas Merger Corp., a
wholly owned subsidiary of Symantec. If the merger is completed,
Altiris will become a wholly owned subsidiary of Symantec and
holders of Altiris common stock will receive $33.00 in cash,
without interest, for each share of Altiris common stock they
own at the effective time of the merger.
In connection with our merger agreement with Symantec, we will
hold a special meeting of Altiris stockholders on Wednesday,
April 4, 2007 at 2:00 p.m., local time, at our
corporate headquarters located at 588 West 400 South,
Lindon, Utah 84042. Stockholders of Altiris will be asked, at
the special meeting, to consider and vote upon the adoption of
the merger agreement. After careful consideration, the board of
directors of Altiris has unanimously approved and has declared
the merger, the merger agreement and the transactions
contemplated by the merger agreement advisable, and has
determined that it is in the best interests of Altiris
stockholders that Altiris enter into the merger agreement and
consummate the merger on the terms and conditions set forth in
the merger agreement. Accordingly, the board of directors of
Altiris unanimously recommends that Altiris stockholders vote
FOR the adoption of the merger agreement. We are
also asking you to vote FOR any proposal by
Altiris board of directors to adjourn the special meeting,
if necessary, to solicit additional proxies if there are not
sufficient votes in favor of adoption of the merger agreement.
The merger cannot be completed unless stockholders holding a
majority of the outstanding shares of Altiris common stock at
the close of business on the record date for the special meeting
vote FOR the adoption of the merger agreement. The
completion of the merger is also subject to the satisfaction or
waiver of other specified closing conditions. More information
about the merger is contained in the accompanying proxy
statement. We encourage you to read the accompanying proxy
statement carefully and in its entirety, because it explains the
proposed merger, the documents related to the merger and other
related matters.
Your vote is very important, regardless of the number of
shares you hold. Whether or not you plan to
attend the special meeting, please take the time to submit a
proxy by following the instructions on your proxy card as soon
as possible. If your shares are held in an account at a
brokerage firm, bank or other nominee, you should instruct your
broker, bank or nominee how to vote in accordance with the
voting instructions furnished by your broker, bank or nominee.
If you sign, date and send us your proxy card but do not
indicate how you want to vote, your proxy will be voted
FOR the adoption of the merger agreement and
FOR any proposal by our board of directors to
adjourn the special meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of adoption
of the merger agreement. If you do not vote or do not instruct
your broker, bank or nominee how to vote, it will have the same
effect as voting against the proposal to adopt the merger
agreement.
We are very excited about the merger and I join the other
members of our board of directors in recommending that you vote
FOR the adoption of the merger agreement. After you
have reviewed the enclosed materials, please vote by one of the
means specified in the proxy statement as soon as you can. Thank
you in advance for your continued support.
Sincerely,
Gregory S. Butterfield
Chairman of the Board of Directors,
President and Chief Executive Officer of Altiris, Inc.
The proxy statement is dated March 7, 2007, and is first
being mailed to stockholders of Altiris on or about
March 9, 2007.
588 West 400 South
Lindon, Utah 84042
(801) 805-2400
NOTICE OF SPECIAL MEETING OF
STOCKHOLDERS
TO BE HELD ON APRIL 4,
2007
To the Stockholders of Altiris,
Inc.:
NOTICE IS HEREBY GIVEN THAT a special meeting of stockholders of
Altiris, Inc., a Delaware corporation, will be held on
Wednesday, April 4, 2007 at 2:00 p.m., local time, at
our corporate headquarters located at 588 West 400 South,
Lindon, Utah 84042, for the following purposes:
1. To consider and vote upon a proposal to adopt the
Agreement and Plan of Merger, dated as of January 26, 2007,
among Symantec Corporation, Atlas Merger Corp. and Altiris,
Inc.; and
2. To consider and vote upon any proposal by Altiris
board of directors to adjourn the special meeting, if necessary,
to solicit additional proxies if there are not sufficient votes
in favor of adoption of the merger agreement.
The board of directors of Altiris has unanimously approved
the merger agreement and recommends that Altiris stockholders
vote FOR the adoption of the merger
agreement. The board of directors of Altiris also
recommends that Altiris stockholders vote FOR any
proposal by Altiris board of directors to adjourn the
special meeting, if necessary, to solicit additional proxies if
there are not sufficient votes in favor of adoption of the
merger agreement.
The board of directors of Altiris has fixed the close of
business on February 28, 2007 as the record date for the
determination of stockholders entitled to notice of, and to vote
at, the special meeting and any adjournment or postponement of
the special meeting. Only holders of record of shares of Altiris
common stock at the close of business on the record date are
entitled to notice of, and to vote at, the special meeting or
any adjournment or postponement of the special meeting. At the
close of business on the record date, Altiris had outstanding
and entitled to vote 29,832,752 shares of common stock.
Altiris stockholders who do not wish to accept the merger
consideration for their shares and who do not vote in favor of
the adoption of the merger agreement may have appraisal rights
under the Delaware General Corporation Law in connection with
the merger if they meet specified conditions. See the section of
this proxy statement entitled The Merger
Appraisal Rights beginning on page 41.
Your vote is very important, regardless of the number of
shares you hold. The affirmative vote of the
holders of a majority of the outstanding shares of Altiris
common stock at the close of business on the record date is
required to adopt the merger agreement. Provided a quorum is
present, the affirmative vote of the holders of a majority of
the outstanding shares of Altiris common stock present in person
or represented by proxy at the special meeting and entitled to
vote is required to approve any proposal by Altiris board
of directors to adjourn the special meeting, if necessary, to
solicit additional proxies if there are not sufficient votes in
favor of adoption of the merger agreement. Even if you plan to
attend the special meeting in person, we request that you
complete, sign, date and return the enclosed proxy card to
ensure that your shares will be represented at the special
meeting if you are unable to attend. If you sign, date and
mail your proxy card without indicating how you wish to vote,
your proxy will be counted as a vote FOR the
adoption of the merger agreement and FOR any
proposal by Altiris board of directors to adjourn the
special meeting, if necessary, to solicit additional proxies if
there are not sufficient votes in favor of adoption of the
merger agreement. If you do not vote, it will have the same
effect as a vote against the proposal to adopt the merger
agreement and make it more difficult for Altiris to achieve a
quorum at the special meeting. If you do not
vote, it will not affect the outcome of any proposal to adjourn
the special meeting, but will reduce the number of votes
required to approve such a proposal. If you do attend the
special meeting and wish to vote in person, you may withdraw
your proxy and vote in person.
This proxy statement contains detailed information about the
merger and the other transactions contemplated by the merger
agreement. Please read this proxy statement and the merger
agreement attached to it as Annex A carefully and in
their entirety. For specific instructions on how to vote your
shares, please refer to the section of this proxy statement
entitled The Special Meeting beginning on
page 13.
By Order of the Board of Directors,
Gregory S. Butterfield
Chairman of the Board of
Directors,
President and Chief Executive
Officer of Altiris, Inc.
Lindon, Utah
March 7, 2007
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
Q-1
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
4
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
5
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
9
|
|
|
|
|
10
|
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
14
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
15
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
17
|
|
|
|
|
17
|
|
|
|
|
25
|
|
|
|
|
28
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
40
|
|
|
|
|
41
|
|
|
|
|
41
|
|
|
|
|
43
|
|
|
|
|
43
|
|
|
|
|
44
|
|
|
|
|
|
|
|
|
|
45
|
|
|
|
|
45
|
|
|
|
|
45
|
|
|
|
|
45
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
46
|
|
|
|
|
47
|
|
|
|
|
49
|
|
|
|
|
52
|
|
|
|
|
52
|
|
|
|
|
53
|
|
|
|
|
56
|
|
|
|
|
56
|
|
|
|
|
58
|
|
|
|
|
59
|
|
|
|
|
59
|
|
|
|
|
60
|
|
|
|
|
60
|
|
|
|
|
61
|
|
|
|
|
61
|
|
|
|
|
62
|
|
|
|
|
64
|
|
|
|
|
64
|
|
|
|
|
64
|
|
|
|
|
64
|
|
|
|
|
65
|
|
QUESTIONS
AND ANSWERS ABOUT THE MERGER AND THE SPECIAL MEETING
The following are some questions that you, as a stockholder
of Altiris, may have regarding the merger and the special
meeting of Altiris stockholders, and brief answers to such
questions. We urge you to read carefully the entirety of this
proxy statement, because the information in this section does
not provide all the information that may be important to you
with respect to the adoption of the merger agreement. Additional
important information is also contained in the annexes to this
proxy statement.
|
|
|
Q: |
|
When and where is the special meeting of our stockholders? |
|
|
|
A: |
|
The special meeting of Altiris stockholders will take
place on Wednesday, April 4, 2007, at 2:00 p.m. local
time, at our corporate headquarters, located at 588 West
400 South, Lindon, Utah 84042. |
|
|
|
Q: |
|
What matters will be voted on at the special meeting? |
|
A: |
|
We have entered into an agreement and plan of merger with
Symantec Corporation, a Delaware corporation, and its wholly
owned subsidiary, Atlas Merger Corp., a Delaware corporation.
Under the terms of the merger agreement, Atlas Merger Corp., or
Merger Sub, will merge with and into Altiris, and Altiris will
thereby become a wholly owned subsidiary of Symantec. |
|
|
|
|
|
In order to complete the merger, our stockholders holding at
least a majority of our outstanding common stock on the record
date must vote FOR the adoption of the merger
agreement. A special meeting of our stockholders will be held on
April 4, 2007 to obtain this vote of our stockholders. At
that meeting, you will be asked to consider and vote on the
adoption of the merger agreement. In addition, you may be asked
to consider and vote on a proposal by our board of directors to
adjourn the special meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of adoption
of the merger agreement. This proxy statement contains important
information about the merger and the special meeting, and you
should read it carefully in its entirety. |
|
|
|
|
|
Your vote is very important, regardless of the number of
shares you hold. We encourage you to vote as soon as possible.
The enclosed voting materials allow you to vote your shares
without attending the special meeting of Altiris stockholders.
For more specific information on how to vote, please see the
questions and answers below and the section entitled The
Special Meeting beginning on page 13 of this proxy
statement. |
|
Q: |
|
As an Altiris stockholder, what will I receive upon
completion of the merger? |
|
A: |
|
If the merger is completed, you will receive $33.00 in cash,
without interest, for each share of our common stock that you
own immediately prior to the effective time of the merger unless
you exercise and perfect your appraisal rights under Delaware
law. |
|
Q: |
|
What do I need to do now? |
|
A: |
|
After you carefully read this proxy statement in its entirety,
including its annexes, consider how the merger affects you and
then vote or provide voting instructions as described in this
proxy statement. |
|
Q: |
|
Who can vote and attend the special meeting? |
|
A: |
|
All stockholders of record as of the close of business on
February 28, 2007, the record date set by our board of
directors for the special meeting, are entitled to receive
notice of and to attend and vote at the special meeting, or any
postponement or adjournment thereof. If you want to attend the
special meeting and your shares are held in an account at a
brokerage firm, bank or other nominee, you must bring to the
special meeting a proxy from the record holder (your broker,
bank or nominee) of the shares authorizing you to vote at the
special meeting. |
|
Q: |
|
What constitutes a quorum at the special meeting? |
|
A: |
|
In order to constitute a quorum and to transact business at the
special meeting, a majority of the outstanding shares of Altiris
common stock on the record date must be represented at the
special meeting, either in person or by proxy. Shares
represented by proxies that reflect abstentions will be counted
as shares that are present and entitled to vote for purposes of
determining the presence of a quorum. |
Q-1
|
|
|
Q: |
|
What vote of our stockholders is required to adopt the merger
agreement? |
|
|
|
A: |
|
The affirmative vote of at least a majority of the shares of our
common stock outstanding at the close of business on the record
date is required to adopt the merger agreement. Because the vote
is based on the number of shares outstanding rather than the
number of votes cast, failure to vote your shares and
abstentions will have the same effect as voting against the
adoption of the merger agreement. In connection with the merger
agreement, some of our stockholders, and all of our directors
and some of our officers in their capacities as our
stockholders, entered into voting agreements with Symantec
pursuant to which each of those stockholders agreed, among other
things, to vote the shares of our common stock over which that
stockholder exercises voting control in favor of adoption of the
merger agreement. These stockholders exercise voting control
over an aggregate of 3,515,258 shares of our common stock as
of the close of business on February 28, 2007, the record
date set by our board of directors for the special meeting,
which constitutes approximately 11.8% of the shares of our
common stock outstanding on that date. See the section entitled
The Merger Voting Agreements beginning
on page 36. |
|
|
|
Q: |
|
What vote of our stockholders is required to approve any
proposal by our board of directors to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement? |
|
A: |
|
Provided a quorum is present, the affirmative vote of the
holders of a majority of the outstanding shares of Altiris
common stock present in person or represented by proxy at the
special meeting and entitled to vote is required to approve any
proposal by our board of directors to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement. Failure to vote your shares will not affect the
outcome of any proposal to adjourn the special meeting, but will
reduce the number of votes required to approve such a proposal.
Abstentions will have the same effect as voting against any
proposal by our board of directors to adjourn the special
meeting. |
|
Q: |
|
How many votes do Altiris stockholders have? |
|
A: |
|
Each holder of record of Altiris common stock as of the close of
business on February 28, 2007 will be entitled to one vote
for each share of common stock held on that date. |
|
Q: |
|
How does Altiris board of directors recommend I
vote? |
|
A: |
|
At a meeting held on January 26, 2007, Altiris board
of directors unanimously approved and declared the merger, the
merger agreement and the transactions contemplated by the merger
agreement advisable, and determined that it is in the best
interests of Altiris stockholders that Altiris enter into the
merger agreement and consummate the merger on the terms and
conditions set forth in the merger agreement. Accordingly,
the board of directors of Altiris unanimously recommends that
you vote FOR the adoption of the merger
agreement. The board of directors of Altiris also recommends
that Altiris stockholders vote FOR any proposal by
Altiris board of directors to adjourn the special meeting,
if necessary, to solicit additional proxies if there are not
sufficient votes in favor of adoption of the merger agreement. |
|
Q: |
|
May I vote in person? |
|
A: |
|
Yes. If your shares are not held in street name
through a broker, bank or nominee, you may attend the special
meeting of our stockholders and vote your shares in person,
rather than signing and returning your proxy card. If your
shares are held in street name, you must request a
legal proxy from the broker, bank or nominee that holds your
shares and present that proxy and proof of identification at the
special meeting to vote your shares. |
|
Q: |
|
May I vote via the Internet or telephone? |
|
|
|
A: |
|
If your shares are registered in your name, you may only vote by
returning a signed proxy card or voting in person at the
meeting. If your shares are held in street name
through a broker, bank or nominee, you may vote by completing
and returning the voting form provided by your broker, bank or
nominee or via the Internet or by telephone through your broker,
bank or nominee, if such a service is provided. To vote via the
Internet or telephone, you should follow the instructions on the
voting form provided by your broker, bank or nominee. Votes
submitted electronically via the Internet or by telephone must
be received by 11:59 p.m. EST on Tuesday, April 3,
2007. |
Q-2
|
|
|
Q: |
|
May I change my vote after I have mailed my signed proxy
card? |
|
A: |
|
Yes. You may change your vote at any time before your proxy card
is voted at the special meeting. You can do this in one of three
ways. First, you can send a written, later-dated notice to the
Secretary of Altiris stating that you would like to revoke your
proxy. Second, you can complete and submit a new proxy card
bearing a later date. Third, you can attend the special meeting
and vote in person. Your attendance alone will not revoke your
proxy; you must vote at the special meeting in order to revoke
your earlier proxy. If you have instructed a broker, bank or
nominee to vote your shares, you must follow directions received
from your broker, bank or nominee to change those instructions. |
|
Q: |
|
If my broker, bank or nominee holds my shares in street
name, will they vote my shares for me? |
|
A: |
|
Your broker, bank or nominee will not be able to vote your
shares without instructions from you. You should instruct your
broker, bank or nominee to vote your shares following the
procedure provided by your broker, bank or nominee. Without
instructions, your shares will not be voted, which will have the
effect of a vote against the adoption of the merger agreement. |
|
Q: |
|
What happens if I do not vote, whether by attending the
special meeting in person, returning a proxy card or through
Internet or telephone voting procedures? |
|
A: |
|
The failure to vote will have the same effect as voting against
adoption of the merger agreement. The failure to vote will not
affect the outcome of any proposal by our board of directors to
adjourn the special meeting, but will reduce the number of votes
required to approve such a proposal. |
|
Q: |
|
Is the merger expected to be taxable to me for United States
federal income tax purposes? |
|
A: |
|
Generally, yes. The receipt of $33.00 in cash for each share of
our common stock pursuant to the merger will be a taxable
transaction for United States federal income tax purposes. For
United States federal income tax purposes, generally you will
recognize gain or loss as a result of the merger measured by the
difference, if any, between $33.00 per share and your
adjusted tax basis in that share. |
|
|
|
You should read the section entitled The
Merger Material United States Federal Income Tax
Consequences beginning on page 43 for a more complete
discussion of the United States federal income tax consequences
of the merger. Tax matters can be complicated, and the tax
consequences of the merger to you will depend on your particular
tax situation. You should consult your own tax advisor as to
the tax consequences of the merger to you. |
|
Q: |
|
Should I send in my Altiris stock certificates now? |
|
A: |
|
No. Promptly after the merger is completed, each holder of
record immediately prior to the effective time of the merger
will be sent a letter of transmittal, together with written
instructions for exchanging share certificates for the cash
merger consideration. These instructions will tell you how and
where to send in your certificates for the cash merger
consideration. You will receive your cash payment, without
interest, after the exchange agent receives your stock
certificates and any other documents requested in the
instructions. |
|
Q: |
|
What happens if I sell my shares before the special
meeting? |
|
A: |
|
The record date of the special meeting is earlier than the
special meeting and the date that the merger is expected to be
completed. If you transfer your shares of Altiris common stock
after the record date but before the special meeting, you will
retain your right to vote at the special meeting, but will have
transferred the right to receive $33.00 per share in cash,
without interest, to be received by our stockholders in the
merger. In order to receive the $33.00 per share in cash,
without interest, you must hold your shares through completion
of the merger. |
|
Q: |
|
When do you expect the merger to be completed? |
|
A: |
|
We are working toward completing the merger promptly. In
addition to obtaining stockholder approval, we must satisfy all
other closing conditions contained in the merger agreement,
including the expiration or termination of applicable regulatory
waiting periods under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, or the HSR
Act, and receipt of antitrust approvals under the laws of the
Federal Republic of Germany. |
Q-3
|
|
|
Q: |
|
Am I entitled to appraisal rights? |
|
A: |
|
Under the General Corporation Law of the State of Delaware,
holders of Altiris common stock who do not vote in favor of
adoption of the merger agreement will have the right to seek
appraisal of the fair value of their shares as determined by the
Delaware Court of Chancery if the merger is completed, but only
if they submit a written demand for an appraisal prior to the
vote on the adoption of the merger agreement and they comply
with the Delaware law procedures explained in this proxy
statement. For additional information about appraisal rights,
see the section entitled The Merger Appraisal
Rights beginning on page 41. |
|
Q: |
|
Do any of Altiris directors or officers have interests
in the merger that may differ from those of Altiris
stockholders? |
|
A: |
|
Yes. Symantec has entered into employment offer letters with
some of Altiris officers, effective upon completion of the
merger, which provide that the executives will be employed by
Symantec following closing. The employment offer letters provide
for a base salary and target bonus, grant of options and
restricted stock units, payment of a retention bonus and other
payments and benefits. See The Merger
Interests of Our Directors and Executive Officers in the
Merger beginning on page 37 for a description of
these agreements as well as a description of other rights of our
directors and executive officers that come into effect in
connection with the merger. |
|
Q: |
|
How will the merger affect my stock options and restricted
stock units to acquire Altiris common stock? |
|
A: |
|
At the effective time of the merger, each outstanding option to
purchase Altiris common stock will be assumed by Symantec and
converted into an option to purchase Symantec common stock. Each
outstanding Altiris restricted stock unit, or RSU, will be
assumed by Symantec and converted into a right to receive shares
of Symantec common stock. The number of shares of Symantec
common stock subject to each assumed option and RSU will be
determined by multiplying the number of shares of Altiris common
stock that were subject to the option or RSU immediately prior
to the completion of the merger by an exchange ratio and then
rounding the result down to the nearest whole share. The
exchange ratio used for this purpose will be calculated
immediately prior to the completion of the merger by dividing
$33.00 by the average of the closing sale prices of Symantec
common stock as quoted on the Nasdaq Global Select Market for
the ten consecutive trading days ending with the trading day
that is one trading day prior to the completion of the merger.
The per share exercise price for each share of Symantec common
stock issuable upon exercise of each assumed Altiris option will
be adjusted to a price determined by dividing the per share
exercise price applicable to the Altiris option immediately
prior to the completion of the merger by the same exchange ratio
and rounding up to the nearest whole cent. The other terms of
the assumed stock options and RSUs will remain unchanged. Some
holders of options to purchase Altiris common stock and Altiris
RSUs will be entitled to full or partial acceleration of vesting
in connection with the merger. For more information as it
relates to some of Altiris directors and executive
officers, see The Merger Interests of Our
Directors and Executive Officers in the Merger beginning
on page 37. |
|
Q: |
|
Who is paying for this proxy solicitation? |
|
A: |
|
Altiris is conducting this proxy solicitation and will bear the
cost of soliciting proxies, including the preparation, assembly,
printing and mailing of this proxy statement, the proxy card and
any additional information furnished to stockholders. Altiris
estimates that its proxy solicitor fees will be approximately
$5,500. We also reimburse brokerage houses and other custodians,
nominees and fiduciaries for their costs of forwarding proxy and
solicitation materials to beneficial owners. If you choose to
access the proxy materials
and/or
submit your proxy over the Internet, you are responsible for any
related Internet access charges you may incur. If you choose to
submit your proxy by telephone, you are responsible for any
related telephone charges you may incur. |
Q-4
|
|
|
Q: |
|
Who can help answer my questions? |
|
A: |
|
If you would like additional copies, without charge, of this
proxy statement or if you have questions about the merger,
including the procedures for voting your shares, you should
contact: |
Altiris, Inc.
588 West 400 South
Lindon, Utah 84042
Telephone:
(801) 805-2400
Attention: Craig H. Christensen
E-mail:
craig.christensen@altiris.com
or our proxy solicitor,
The Altman Group, Inc.
1200 Wall Street West, 3rd Floor
Lyndhurst, New Jersey 07071
Call toll-free:
(800) 217-0538
Q-5
SUMMARY
This summary highlights selected information from this proxy
statement relating to the merger. This summary may not contain
all of the information that is important to you. To understand
the merger fully and for a more complete description of the
legal terms of the merger, you should carefully read this entire
proxy statement and the documents to which we have referred you.
In particular, you should read the annexes attached to this
proxy statement, including the agreement and plan of merger,
dated as of January 26, 2007, among Symantec, Altiris and
Merger Sub, which is attached as Annex A to this
proxy statement. We have included page references in parentheses
to direct you to a more complete description of the topics
presented in this summary. See the section entitled Where
You Can Find More Information beginning on
page 64.
The
Companies
Altiris, Inc.
588 West 400 South
Lindon, UT 84042
Telephone:
(801) 805-2400
We are a leading provider of service-oriented management
software products and services that enable organizations to
manage information technology, or IT, assets throughout their
lifecycles. Our comprehensive integrated lifecycle management
solutions are designed to address the challenges that IT
professionals face in deploying, migrating, backing up and
restoring software settings on multiple hardware devices;
provisioning and managing servers; tracking performance and
diagnostic metrics for hardware and software; taking inventory
of existing IT assets; accessing security compliance and
vulnerabilities; managing patches and updates; and facilitating
problem resolution for hardware or software failures. We have
designed our software for use by organizations of all sizes to
manage the efficiency and ensure the reliability and
availability of complex and distributed IT environments. We
believe that the comprehensive functionality of our products,
combined with their ease of installation and use, allows an
organization to lower its total cost of IT ownership. Our
products are used by businesses in a wide variety of industries
and computing environments. We were incorporated in Utah in
August 1998 and reincorporated in Delaware in February 2002. We
are quoted on the Nasdaq Global Select Market under the symbol
ATRS. Our principal executive offices are located at
588 West 400 South, Lindon, Utah 84042, and our telephone
number is
(801) 805-2400.
Additional information regarding us is contained in our filings
with the Securities and Exchange Commission, or the SEC. See
Where You Can Find More Information beginning on
page 64.
Symantec Corporation
20330 Stevens Creek Blvd.
Cupertino, CA 95014
Telephone:
(408) 517-8000
Symantec is the world leader in providing solutions to help
individuals and enterprises assure the security, availability,
and integrity of their information. With innovative technology
solutions and services, Symantec helps individuals and
enterprises protect and manage their digital assets. Symantec
provides a wide range of solutions including enterprise and
consumer security, data management, application and
infrastructure management, security management, storage and
service management, and response and managed security services.
Symantec was founded in 1982, and has operations in more than 40
countries worldwide. Symantec is quoted on the Nasdaq Global
Select Market under the symbol SYMC. Symantecs
principal executive offices are located at 20330 Stevens Creek
Boulevard, Cupertino, California 95014 and its telephone number
is
(408) 517-8000.
Additional information regarding Symantec is contained in
Symantecs filings with the SEC.
1
Atlas Merger Corp.
20330 Stevens Creek Blvd.
Cupertino, CA 95014
Telephone:
(408) 517-8000
Merger Sub is a Delaware corporation and a wholly owned
subsidiary of Symantec. Merger Sub exists solely to facilitate
the merger and has not engaged in any operations other than in
connection with its formation and the negotiation and execution
of the merger agreement. Merger Subs principal executive
offices and telephone number are the same as those of Symantec.
The
Merger (Page 45)
Symantec has agreed to acquire Altiris under the terms of the
merger agreement that is described in this proxy statement and
attached as Annex A. We encourage you to read the
merger agreement carefully and in its entirety. It is the
principal document governing the merger.
If the merger is completed, you will receive $33.00 in cash,
without interest, in exchange for each share of our common stock
that you own immediately before the effective time of the merger
unless you do not vote in favor of adoption of the merger
agreement and properly perfect your appraisal rights under
Delaware law.
After the merger is completed, your shares of our common stock
will be converted into the right to receive the merger
consideration, without interest, but you will no longer have any
rights as an Altiris stockholder. As an Altiris stockholder, you
will receive the merger consideration, without interest, after
exchanging your Altiris stock certificates in accordance with
the instructions contained in the letter of transmittal to be
sent to you shortly after completion of the merger.
See the section entitled The Merger Agreement
Merger Consideration beginning on page 45.
Treatment
of Awards Outstanding under Altiris Stock Plans
Stock
Options (Page 46)
Symantec will assume all Altiris options outstanding immediately
prior to the effective time of the merger, and the assumed
options will be converted into options to purchase shares of
Symantec common stock. Generally, each option will continue to
be subject to the terms and conditions, including the vesting
schedule, set forth in the Altiris stock plan under which the
option was granted and the individual stock option agreements
governing that option. However, following the completion of the
merger, Altiris options will become options to purchase Symantec
common stock with the exercise price and number of shares
underlying the option will be adjusted in accordance with the
terms of the merger agreement. The exercise price and the number
of shares of Symantec common stock subject to Altiris options
after completion of the merger will be determined pursuant to
the merger agreement, which provides that the number of shares
of Symantec common stock subject to Altiris options will be
determined by multiplying the number of shares that were subject
to the Altiris option immediately prior to the completion of the
merger by an exchange ratio and then rounding the result down to
the nearest whole share. The exchange ratio used for this
purpose will be calculated immediately prior to the completion
of the merger by dividing $33.00 by the average of the closing
sales prices of Symantec common stock as quoted on the Nasdaq
Global Select Market for the ten consecutive trading days ending
with the trading day that is one trading day prior to the
completion of the merger. The per share exercise price for each
share issuable upon exercise of the Altiris options will be
adjusted to a price determined by dividing the per share
exercise price applicable to the Altiris option immediately
prior to the completion of the merger by the same exchange ratio
and rounding up to the nearest whole cent.
RSUs
(Page 46)
Symantec will also assume all outstanding Altiris RSUs in the
merger, and these assumed RSUs will be converted into rights to
receive shares of Symantec common stock. Generally, each RSU
will continue to be subject to the terms and conditions,
including the vesting schedule, set forth in the Altiris stock
plan under which the RSUs were granted and the related
restricted stock unit award agreement, except that the RSUs will
become rights to receive Symantec common stock at vesting with
the number of shares subject to the RSUs adjusted in accordance
2
with the terms of the merger agreement. The number of shares of
Symantec common stock deliverable at vesting will be adjusted by
multiplying the number of shares of Altiris common stock subject
to the RSU immediately prior to the completion of the merger by
the exchange ratio described under the heading
Stock Options above and rounding down to
the nearest whole share.
Restricted
Stock (Page 47)
Any restricted shares of Altiris common stock held as of
immediately prior to the effective time of the merger will be
converted into the right to receive $33.00 in cash, without
interest (less applicable tax withholding), subject to the
vesting schedule applicable to such restricted shares. In
general, holders of restricted shares will receive this cash
consideration with respect to unvested shares in accordance with
the applicable vesting schedule, provided that the holders of
the restricted stock awards satisfy the applicable vesting
requirements, and reduced by applicable tax withholding. Until
vested, such cash consideration will be held by Symantec. Any
cash payments made for vesting of unvested shares will be made
by Symantec according to its normal payroll procedures following
the date within a month upon which such cash payments vested.
Reasons
for the Merger (Page 25)
In the course of reaching its decision to approve the merger and
enter into the merger agreement, our board of directors
consulted with our senior management, outside legal counsel and
our financial advisor, and reviewed a significant amount of
information and considered a number of factors, including, among
others, the following factors:
|
|
|
|
|
the possible alternatives to the merger, including the
possibility of continuing to operate as an independent entity
and the perceived risks thereof; managements dealings with
other possible business combination partners both in the past
and during the course of the negotiations with Symantec; and the
likelihood that a third party would offer a higher price than
the $33.00 in cash per share offered by Symantec;
|
|
|
|
the current and prospective environment in which we operate,
including national and local economic conditions, the
competitive environment, the trend toward consolidation in the
software and systems management markets; and the likely effect
of these factors on our potential growth, development,
productivity, profitability and strategic options;
|
|
|
|
historical financial information concerning our business,
management, financial performance and conditions, technology,
operations, prospects and competitive position;
|
|
|
|
the size of Altiris and related economies of scale, and that the
diversification of our product offerings beyond the level that
may be reasonably achievable on an independent basis was
becoming increasingly important to continued success in the
current software and systems management environment;
|
|
|
|
the likelihood that the merger will be completed, including the
likelihood that the regulatory and stockholder approvals needed
to complete the merger will be obtained;
|
|
|
|
current financial market conditions and historical market
prices, volatility and trading information with respect to our
common stock; and
|
|
|
|
the consideration to be received by our stockholders in the
merger, including the form of such consideration.
|
See the section entitled The Merger
Recommendation of our Board of Directors beginning on
page 25 for additional factors that our board of directors
considered.
Recommendation
of our Board of Directors (Page 25)
After careful consideration of the factors described in the
section entitled The Merger Recommendation of
our Board of Directors beginning on page 25, our
board of directors unanimously:
|
|
|
|
|
approved and declared the merger, the merger agreement and the
transactions contemplated by the merger agreement advisable;
|
3
|
|
|
|
|
determined that it is in the best interests of our stockholders
that Altiris enter into the merger agreement and consummate the
merger on the terms and conditions set forth in the merger
agreement; and
|
|
|
|
recommends that our stockholders adopt the merger agreement.
|
Our board of directors also recommends that Altiris stockholders
vote FOR any proposal by our board of directors to
adjourn the special meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of adoption
of the merger agreement.
See the section entitled The Merger
Recommendation of our Board of Directors beginning on
page 25.
The
Special Meeting (Page 13)
Time, Date and Place. A special meeting of our
stockholders will be held on Wednesday, April 4, 2007, at
our corporate headquarters located at 588 West
400 South, Lindon, Utah 84042 at 2:00 p.m., local
time, to consider and vote upon a proposal to adopt the merger
agreement and consider and vote upon a proposal to adjourn the
special meeting, if necessary, to solicit additional proxies if
there are not sufficient votes in favor of adoption of the
merger agreement.
Record Date and Voting Power. You are entitled
to vote at the special meeting if you owned shares of our common
stock at the close of business on February 28, 2007, the
record date set by our board of directors for the special
meeting. You will have one vote at the special meeting for each
share of our common stock you owned at the close of business on
the record date. As of the record date, there were
29,832,752 shares of our common stock outstanding and
entitled to be voted at the special meeting.
Required Vote. The adoption of the merger
agreement requires the affirmative vote of at least a majority
of the shares of our common stock outstanding at the close of
business on the record date. Provided a quorum is present, the
affirmative vote of the holders of a majority of the outstanding
shares of our common stock present in person or represented by
proxy at the special meeting and entitled to vote is required to
approve any proposal by our board of directors to adjourn the
special meeting, if necessary, to solicit additional proxies if
there are not sufficient votes in favor of adoption of the
merger agreement. In connection with the merger agreement, some
of our stockholders, and all of our directors and some of our
officers in their capacities as our stockholders, entered into
voting agreements with Symantec pursuant to which each of those
stockholders agreed, among other things, to vote the shares of
our common stock over which that stockholder exercises voting
control in favor of adoption of the merger agreement. These
stockholders exercise voting control over an aggregate of
3,515,258 shares of our common stock as of
February 28, 2007, the record date for the special meeting,
which constitutes approximately 11.8% of the shares of our
common stock outstanding on that date. See the section entitled
The Merger Voting Agreements beginning
on page 36.
Share Ownership of Directors and
Management. As of the record date, our directors
and executive officers and their affiliates owned
approximately 11.9% of the shares entitled to vote at
the special meeting.
See the section entitled The Special Meeting
beginning on page 13.
Opinion
of Altiris Financial Advisor (Page 28)
Goldman, Sachs & Co., or Goldman Sachs, rendered its
oral opinion, which was subsequently confirmed in writing, to
the Altiris board of directors that, as of January 26,
2007, and based upon and subject to the factors and assumptions
set forth in its written opinion, the $33.00 per share in
cash to be received by the holders of shares of our common stock
pursuant to the merger agreement was fair from a financial point
of view to such holders.
The full text of the written opinion of Goldman Sachs, dated
January 26, 2007, which sets forth the assumptions made,
procedures followed, matters considered and limitations on the
review undertaken in connection with the opinion, is attached as
Annex B to this proxy statement. Goldman Sachs
provided its opinion for the information and assistance of our
board of directors in connection with its consideration of the
merger. The Goldman Sachs opinion is not a recommendation as to
how any holder of shares of our common stock should vote with
respect to the merger. Pursuant to an engagement letter between
Altiris and
4
Goldman Sachs, Altiris has agreed to pay Goldman Sachs a
customary transaction fee, all of which is payable upon
consummation of the merger.
See the section entitled The Merger Opinion of
Goldman, Sachs & Co. beginning on page 28.
Interests
of our Directors and Executive Officers in the Merger
(Page 37)
When considering the recommendation by our board of directors in
favor of the adoption of the merger agreement, you should be
aware that a number of our officers and directors have interests
in the merger that are different from yours, including, among
others:
|
|
|
|
|
some of our executive officers have entered into employment
offer letters with, or received retention packages from,
Symantec;
|
|
|
|
some of our officers will be entitled to severance payments in
connection with the merger (and, in some cases, a tax
gross-up
relating to such severance payments);
|
|
|
|
some of our officers will receive acceleration of the vesting of
their options, restricted stock and RSUs in connection with the
merger; and
|
|
|
|
indemnification arrangements for our current and former
directors and officers will be continued if the merger is
completed.
|
See the section entitled The Merger Interests
of our Directors and Executive Officers in the Merger
beginning on page 37.
Voting
Agreements (Page 36)
In connection with the merger agreement, some of our
stockholders, and all of our directors and some of our officers
in their capacities as our stockholders, entered into voting
agreements with Symantec pursuant to which each of those
stockholders agreed, among other things, to vote the shares of
our common stock over which that stockholder exercises voting
control in favor of adoption of the merger agreement. These
stockholders exercise voting control over an aggregate of
3,515,258 shares of our common stock as of
February 28, 2007, the record date for the special meeting,
which constitutes approximately 11.8% of the shares of our
common stock outstanding on that date. See the section entitled
The Merger Voting Agreements beginning
on page 36.
Market
Price and Dividend Data (Page 40)
Our common stock is listed on the Nasdaq Global Select Market
under the symbol ATRS. On January 26, 2007, the
last full trading day prior to the public announcement of the
proposed merger, our common stock closed at a price of $27.14.
On March 6, 2007, the last full trading day prior to the
date of this proxy statement, our common stock closed at a price
of $32.64. See the section entitled The Merger
Market Price and Dividend Data beginning on page 40.
Delisting
and Deregistration of Altiris Common Stock
If the merger is completed, our common stock will no longer be
traded on the Nasdaq Global Select Market and will be
deregistered under the Securities Exchange Act of 1934, as
amended, and we will no longer be required to file periodic
reports with the SEC with respect to our shares of common stock.
The
Merger Agreement (Page 45)
Conditions
to the Consummation of the Merger (Page 56)
The obligations of each of us, Symantec and Merger Sub to
complete the merger are subject to the satisfaction or waiver of
each of the following conditions:
|
|
|
|
|
the adoption of the merger agreement by our stockholders in
accordance with Delaware law and our certificate of
incorporation and bylaws;
|
5
|
|
|
|
|
all applicable waiting periods (and any extensions thereof)
applicable to the merger under the HSR Act have expired or early
termination of such waiting periods have been granted, and the
approvals under antitrust, competition or similar laws of the
Federal Republic of Germany have been obtained, in each case
without any condition or requirements requiring or calling for
any antitrust restraint (as described in the section entitled
The Merger Agreement Conditions to the
Consummation of the Merger); and
|
|
|
|
no judgment, order, injunction, decree, statute, law, ordinance,
rule or regulation, or other legal restraint or prohibition
(whether temporary, preliminary or permanent), entered, enacted,
promulgated, enforced or issued by any court or other
governmental authority of competent jurisdiction, is in effect
prohibiting, making illegal or enjoining the merger.
|
We will not be obligated to effect the merger unless each of the
following conditions is satisfied or waived:
|
|
|
|
|
Symantecs representations and warranties in the merger
agreement (other than those described in the round bullet point
below)
|
|
|
|
|
|
that are qualified as to material adverse effect are true and
correct, and
|
|
|
|
that are not qualified as to material adverse effect are true
and correct
|
in each case both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except to the extent that
the failure of any such representations and warranties referred
to in the second dash point above to be true and correct does
not have, and would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
Symantec or a material adverse effect on Symantecs ability
to consummate the merger;
|
|
|
|
|
Symantecs representations and warranties relating to
Symantecs power and authority to enter into the merger
agreement and enforceability of the merger agreement against
Symantec are true and correct both when made and at and as of
the closing date of the merger (except to the extent expressly
made as of an earlier date, in which case as of such
date); and
|
|
|
|
Symantec must have performed and complied in all material
respects with those covenants required to be performed by
Symantec under the merger agreement on or before the closing
date of the merger.
|
Neither Symantec nor Merger Sub will be obligated to effect the
merger unless each of the following conditions is satisfied or
waived:
|
|
|
|
|
our representations and warranties in the merger agreement
(other than those described in the two round bullet points
immediately below)
|
|
|
|
|
|
that are qualified as to material adverse effect are true and
correct, and
|
|
|
|
that are not qualified as to material adverse effect are true
and correct
|
in each case both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except to the extent that
the failure of any such representations and warranties referred
to in the second dash point above to be true and correct does
not have, and would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
Altiris;
|
|
|
|
|
our representations relating to our power and authority to enter
into the merger agreement, the enforceability of the merger
agreement against us and certain takeover laws are true and
correct both when made and at and as of the closing date of the
merger (except to the extent expressly made as of an earlier
date, in which case as of such date);
|
|
|
|
our representations relating to our capital structure are true
and correct both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except with respect to
deviations in our actual fully diluted capitalization (including
outstanding capital stock, stock options and warrants) from our
fully diluted capitalization as set forth in the corresponding
representation by an amount that does not exceed one percent of
such fully diluted capitalization;
|
6
|
|
|
|
|
we must have performed and complied in all material respects
with those covenants required to be performed by us under the
merger agreement on or before the closing date of the merger;
|
|
|
|
no material adverse change (as described in the section entitled
The Merger Agreement Representations and
Warranties Material Adverse Effect) on Altiris
is continuing, whether or not resulting from a breach of any
representation, warranty or covenant in the merger agreement;
|
|
|
|
there are no suits, actions, proceedings, applications or
counterclaims pending by any governmental authority wherein an
unfavorable injunction, judgment, order, decree, ruling or
charge would:
|
|
|
|
|
|
prevent, restrain or prohibit the completion of the merger;
|
|
|
|
cause the merger to be rescinded; or
|
|
|
|
result in any antitrust restraint; and
|
|
|
|
|
|
there are no injunctions, judgments, orders, decrees, rulings or
charges described in the round bullet point immediately above in
effect, or any applicable law having any such effect, or any
notification by a governmental authority of an intention to seek
such a remedy that has not subsequently been withdrawn.
|
See the section entitled The Merger Agreement
Conditions to the Consummation of the Merger beginning on
page 56.
Termination
of the Merger Agreement (Page 58)
Symantec or we can terminate the merger agreement by written
notice under specified circumstances, including:
|
|
|
|
|
by mutual written consent of Symantec and us, if the board of
directors of each so determines;
|
|
|
|
by either us or Symantec (as authorized by the board of
directors of Altiris or Symantec, as applicable):
|
|
|
|
|
|
if the merger has not been completed by July 31, 2007,
which date will be extended to October 31, 2007 if on
July 31, 2007 all of the closing conditions have been
satisfied or waived (other than conditions that by their nature
are only to be satisfied as of the closing of the merger and
other than the condition relating to antitrust approvals);
provided, however, that this right to terminate the merger
agreement will not be available to a party whose failure to
comply with, or breach of, any provision of the merger agreement
was a proximate cause of or resulted in the failure of the
merger to be completed by such date;
|
|
|
|
if a governmental authority of competent jurisdiction issues an
order, decree or ruling or takes any other action (including the
failure to have taken an action), in any case having the effect
of permanently restraining, enjoining or otherwise prohibiting
the consummation of the merger, which order, decree, ruling or
other action is final and nonappealable; or
|
|
|
|
if the approval of our stockholders to adopt the merger
agreement is not obtained at our special meeting, or at any
adjournment or postponement of such meeting, at which the vote
on that matter was taken;
|
|
|
|
|
|
by us (as authorized by our board of directors):
|
|
|
|
|
|
following a breach of any representation, warranty, covenant or
agreement on the part of Symantec, such that the corresponding
closing conditions relating to the accuracy of representations
and warranties and compliance with covenants cannot be met, and
such breach is incapable of being cured or is not cured in all
material respects within 20 business days after Symantec
receives written notice from us of such breach; or
|
|
|
|
if our board of directors makes a change in recommendation (as
described in the section entitled The Merger
Agreement No Solicitation Covenant
Change in Recommendation) in response to a superior
proposal in compliance with the merger agreement, we publicly
announce our intention to accept or enter into the superior
proposal that is the subject of the change in recommendation,
and we pay Symantec the termination fee of $37.5 million as
described under the heading Expenses and
Termination Fees below;
|
7
|
|
|
|
|
by Symantec (as authorized by its board of directors):
|
|
|
|
|
|
following a breach of any representation, warranty, covenant or
agreement by us, such that the corresponding closing conditions
relating to the accuracy of representations and warranties and
compliance with covenants cannot be met, and such breach is
incapable of being cured or is not cured in all material
respects within 20 business days after we receive written notice
from Symantec of such breach; or
|
|
|
|
if we materially breach our obligation to give notice of,
convene and hold the special meeting of our stockholders as
required by the merger agreement;
|
|
|
|
if we fail to include in this proxy statement that our board of
directors recommends that our stockholders adopt the merger
agreement;
|
|
|
|
if we effect a change in recommendation;
|
|
|
|
if we approve any alternative transaction (as described in the
section entitled The Merger Agreement No
Solicitation Covenant) or recommend that our stockholders
approve or accept any alternative transaction without the prior
written consent of Symantec;
|
|
|
|
if we enter into a letter of intent in violation of the merger
agreement or any contract accepting any alternative transaction
proposal (as described in the section entitled The Merger
Agreement No Solicitation Covenant) without
the prior written consent of Symantec;
|
|
|
|
if we fail to reconfirm the recommendation of our board of
directors that our stockholders adopt the merger agreement
within ten business days of receipt of a written request from
Symantec to do so following the occurrence of any alternative
transaction proposal; or
|
|
|
|
if, within ten business days of a third person or party
publishing, sending or giving to our stockholders a tender or
exchange offer relating to our common stock pursuant to
Rule 14e-2
promulgated under the Securities Exchange Act of 1934, as
amended, we fail to send a statement to our stockholders
disclosing that our board of directors recommends rejection of
that tender or exchange offer.
|
See the section entitled The Merger Agreement
Termination of the Merger Agreement beginning on
page 58.
No
Solicitation Covenant (Page 53)
We have agreed with Symantec that we will not, and will cause
our subsidiaries not to, permit any of our or our
subsidiaries officers, directors, attorneys or financial
advisors (or our or our subsidiaries other employees,
agents or representatives who have the authority to act on
behalf of Altiris or its subsidiaries regarding any alternative
transaction, as described below), which persons we sometimes
refer to herein as our representatives, to, directly or
indirectly:
|
|
|
|
|
solicit, initiate, seek, endorse, recommend or support, or
knowingly encourage or facilitate, any inquiry, proposal or
offer from, furnish any non-public information to, or
participate in any discussions or negotiations with, or enter
into any agreement with, any party or group regarding any
alternative transaction;
|
|
|
|
approve, endorse or recommend any alternative transaction (as
described in the section entitled The Merger
Agreement No Solicitation Covenant
Change in Recommendation) except to the extent
specifically permitted by the merger agreement; or
|
|
|
|
enter into any letter of intent or similar document or any
contract, agreement or commitment (whether binding or not)
contemplating or otherwise relating to any alternative
transaction proposal.
|
See the section entitled The Merger Agreement
No Solicitation Covenant beginning on page 53.
8
Expenses
and Termination Fees
(Page 59)
The merger agreement requires that we pay Symantec a termination
fee of $37,500,000 if, among other things:
|
|
|
|
|
the merger agreement is terminated by us after any change in
recommendation by our board of directors in response to a
superior proposal in compliance with the merger agreement and
the subsequent public announcement of our intention to accept or
enter into the superior proposal that was the subject of the
change in recommendation, in which case the termination fee
would be payable prior to such termination as a precondition to
such termination;
|
|
|
|
the merger agreement is terminated by Symantec based upon any of
the circumstances set forth in the last round bullet point under
the heading The Merger Agreement Termination
of the Merger Agreement above, in which case the
termination fee would be payable promptly but in no event later
than two business days after such termination;
|
|
|
|
the merger agreement is terminated by either us or Symantec
following the failure to obtain the approval of our stockholders
to adopt the merger and the following conditions are also met:
|
|
|
|
|
|
following January 26, 2007 and prior to the termination of
the merger agreement, an alternative transaction proposal with
respect to Altiris has been publicly announced, made to our
stockholders or made to Altiris and subsequently publicly
announced or disclosed and, in each case, not withdrawn; and
|
|
|
|
within 12 months following the termination of the merger
agreement, any company acquisition (as described in the section
entitled The Merger Agreement Termination of
the Merger Agreement) is consummated or we enter into a
contract providing for any company acquisition;
|
in which case the termination fee would be payable concurrently
with the earlier of the consummation of that company acquisition
or the execution of a contract relating to that company
acquisition.
See the section entitled The Merger Agreement
Termination Fee beginning on page 59.
Material
United States Federal Income Tax Consequences
(Page 43)
The exchange of shares of our common stock for the cash merger
consideration will be a taxable transaction to our stockholders
for United States federal income tax purposes.
You should read the section entitled The
Merger Material United States Federal Income Tax
Consequences beginning on page 43 for a more complete
discussion of the federal income tax consequences of the merger.
Tax matters can be complicated, and the tax consequences of
the merger to you will depend on the facts of your own
situation. You should consult your own tax advisor to fully
understand the tax consequences of the merger to you.
Regulatory
Matters (Page 41)
The
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, or the HSR Act,
prohibits us from completing the merger until we have furnished
required information and materials to the Antitrust Division of
the Department of Justice and the Federal Trade Commission and
the required waiting period has ended. Symantec and we have
filed the required notification and report forms, but the
waiting period has not yet ended and we may receive requests for
additional information. The merger is also subject to
notification and a required waiting period in the Federal
Republic of Germany, which Symantec has filed. The merger may
also be subject to review and required waiting periods by the
governmental authorities of various other jurisdictions, under
the antitrust laws of those jurisdictions. See the section
entitled The Merger Regulatory Matters
beginning on page 41.
Appraisal
Rights (Page 41)
Under Delaware law, Altiris stockholders who do not wish
to accept the $33.00 per share cash consideration, without
interest, payable pursuant to the merger may seek, under
Section 262 of the General Corporation Law of the
9
State of Delaware, judicial appraisal of the fair value of their
shares by the Delaware Court of Chancery. This value could be
more than, less than or equal to the merger consideration of
$33.00 per share in cash. This right to appraisal is
subject to a number of restrictions and technical requirements.
Generally, in order to properly demand appraisal, among other
things:
|
|
|
|
|
you must not vote in favor of the proposal to adopt the merger
agreement;
|
|
|
|
you must make a written demand on us for appraisal in compliance
with the General Corporation Law of the State of Delaware before
the vote on the proposal to adopt the merger agreement occurs at
the special meeting; and
|
|
|
|
you must hold your shares of record continuously from the time
of making a written demand for appraisal through the effective
time of the merger; a stockholder who is the record holder of
shares of Altiris common stock on the date the written demand
for appraisal is made, but who thereafter transfers those shares
prior to the effective time of the merger, will lose any right
to appraisal for those shares.
|
Merely voting against the adoption of the merger agreement will
not preserve your right to appraisal under Delaware law. Also,
because a submitted proxy not marked AGAINST or
ABSTAIN will be voted FOR the proposal
to adopt the merger agreement, the submission of a proxy not
marked against or abstain will result in
the waiver of appraisal rights. If you hold shares in the name
of a broker, bank or other nominee, you must instruct your
nominee to take the steps necessary to enable you to demand
appraisal for your shares. If you or your nominee fails to
follow all of the steps required by Section 262 of the
General Corporation Law of the State of Delaware, you will lose
your right of appraisal. See the section entitled The
Merger Appraisal Rights beginning on
page 41 for a description of the procedures that you must
follow in order to exercise your appraisal rights.
Annex C to this proxy statement contains the full
text of Section 262 of the General Corporation Law of the
State of Delaware, which relates to your right to appraisal. We
encourage you to read these provisions carefully and in their
entirety.
Exchange
Agent
Computershare Trust Company, Inc. will act as the exchange agent
in connection with the merger.
10
CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This proxy statement contains forward-looking statements within
the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words such as
estimate, project, intend,
anticipate, believe, will,
may, should, would, and
similar expressions are intended to identify forward-looking
statements. These statements are based on the current
expectations and beliefs of our management and are subject to a
number of factors and uncertainties that could cause actual
results to differ materially from those described in the
forward-looking statements. These statements are not guarantees
of future performance, involve risks, uncertainties and
assumptions that are difficult to predict, and are based upon
assumptions as to future events that may not prove accurate.
Therefore, actual outcomes and results may differ materially
from what is expressed in the forward-looking statements.
In any forward-looking statement in which we express an
expectation or belief as to future results, that expectation or
belief is expressed in good faith and believed to have a
reasonable basis, but there can be no assurance that the
statement or expectation or belief will result or be achieved or
accomplished. Risks and uncertainties pertaining to the
following factors, among others, could cause actual results to
differ materially from those described in the forward-looking
statements:
|
|
|
|
|
the occurrence of any event, change or circumstance that could
give rise to the ability on the part of Symantec to terminate
the merger agreement;
|
|
|
|
our ability to obtain the stockholder and regulatory approvals
required for the merger, including the expiration of the waiting
period under the HSR Act;
|
|
|
|
the timing of the closing of the merger and receipt by
stockholders of the merger consideration;
|
|
|
|
whether or not the conditions to the completion of the merger
are satisfied and the possibility that the merger will not be
completed for any other reason;
|
|
|
|
risks that the proposed transaction disrupts current plans and
operations, and the potential difficulties in employee retention
as a result of the announcement or pendency of the merger;
|
|
|
|
the effect of the announcement or pendency of the merger on our
customer relationships, operating results and business
generally, including any deterioration of our relationships with
Dell, Hewlett-Packard, Fujitsu Siemens Computers, Microsoft and
other original equipment manufacturers, or OEMs, and strategic
partners;
|
|
|
|
the ability to recognize the benefits of the merger;
|
|
|
|
the amount of the costs, fees and expenses and charges related
to the merger, including the possibility that the merger
agreement may be terminated under circumstances that require us
to pay Symantec a termination fee of $37,500,000;
|
|
|
|
changes in the demand for our products;
|
|
|
|
changes in economic conditions generally or technology spending
in particular;
|
|
|
|
market conditions and specific financial market conditions
affecting our common stock;
|
|
|
|
changes in the competitive dynamics of our markets, including
strategic alliances and consolidation among our competitors or
strategic partners; and
|
|
|
|
other risks related to our business that are described in our
public filings (see the section entitled Where You Can
Find More Information beginning on page 64).
|
11
These and other important factors are detailed in various SEC
filings made periodically by us, particularly our latest report
on
Form 10-K
and subsequent reports on
Form 10-Q,
copies of which are available from us without charge or online
at http://www.altiris.com. Please review such filings and do not
place undue reliance on these forward-looking statements.
You should carefully consider the cautionary statements
contained or referred to in this section in connection with any
subsequent written or oral forward-looking statements that may
be issued by us or persons acting on our behalf. We do not
undertake any obligation to release publicly any revisions to
any forward-looking statements contained herein to reflect
events or circumstances that occur after the date of this proxy
statement or to reflect the occurrence of unanticipated events.
12
THE
SPECIAL MEETING
We are furnishing this proxy statement to our stockholders as
part of the solicitation of proxies by our board of directors
for use at the special meeting.
Date,
Time and Place
We will hold the special meeting at our corporate headquarters
located at 588 West 400 South, Lindon, Utah 84042, at
2:00 p.m., local time, on Wednesday, April 4, 2007.
Purpose
of Special Meeting
At the special meeting, we are asking holders of record of
Altiris common stock to consider and vote on the following
proposals:
|
|
|
|
|
the adoption of the Agreement and Plan of Merger, dated
January 26, 2007, among Altiris, Symantec and Merger Sub
(see the sections entitled The Merger beginning on
page 17 and The Merger Agreement beginning on
page 45); and
|
|
|
|
any proposal by our board of directors to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement.
|
No other business will be presented at the special meeting.
Recommendation
of our Board of Directors
After careful consideration, our board of directors determined
that it is advisable, fair to and in the best interests of
Altiris and its stockholders for Altiris to enter into the
merger agreement and consummate the merger and the other
transactions contemplated by the merger agreement.
Our board of directors unanimously recommends that our
stockholders vote FOR the proposal to adopt the
merger agreement. Our board of directors also
recommends that Altiris stockholders vote FOR any
proposal by our board of directors to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement. Our board of directors will determine whether to make
such a proposal to adjourn the special meeting in accordance
with its obligations under the merger agreement and its
fiduciary duties to our stockholders.
In considering such recommendation, you should be aware that
some of our directors and officers have interests in the merger
that are different from, or in addition to, those of our
stockholders generally. See the section entitled The
Merger Interests of our Directors and Executive
Officers in the Merger beginning on page 37.
If your submitted proxy card does not specify how you want to
vote your shares, your shares will be voted FOR the
proposal to adopt the merger agreement and FOR any
proposal by our board of directors to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement.
Record
Date; Stock Entitled to Vote; Quorum
Only holders of record of our common stock at the close of
business on February 28, 2007, the record date set by our
board of directors, are entitled to notice of and to vote at the
special meeting. At the close of business on the record date,
29,832,752 shares of our common stock were issued and
outstanding and held by approximately 48 holders of record.
A quorum is present at the special meeting if a majority of the
shares of our common stock issued and outstanding and entitled
to vote at the close of business on the record date are
represented in person or by proxy. In the event that a quorum is
not present at the special meeting, it is expected that the
meeting will be postponed to solicit additional proxies. Holders
of record of our common stock at the close of business on the
record date are entitled to one vote per share at the special
meeting on the proposals to adopt the merger agreement and
adjourn the special meeting.
13
Votes
Required
The adoption of the merger agreement requires the affirmative
vote of the holders of a majority of the shares of our common
stock outstanding at the close of business on the record date.
If an Altiris stockholder abstains from voting or does not vote,
either in person or by proxy, it will count as a vote against
the adoption of the merger agreement.
Provided a quorum is present, the affirmative vote of the
holders of a majority of the outstanding shares of our common
stock present in person or represented by proxy at the special
meeting and entitled to vote is required to adjourn the special
meeting, if necessary, to solicit additional proxies if there
are not sufficient votes in favor of adoption of the merger
agreement. If an Altiris stockholder does not vote, either in
person or by proxy, such failure will not affect the outcome of
any proposal to adjourn the special meeting, but will reduce the
number of votes required to approve such a proposal. If an
Altiris stockholder abstains from voting, either in person or by
proxy, it will count as a vote against any proposal to adjourn
the special meeting.
Voting by
Altiris Directors, Executive Officers and Certain
Stockholders
At the close of business on the record date, our directors and
executive officers and their affiliates owned and were entitled
to vote 3,550,941 shares of our common stock, which
represented approximately 11.9% of the shares of our common
stock outstanding on that date.
In connection with the parties entry into the merger
agreement, all of our directors and some of our executive
officers, and Technology Crossover Management IV, L.L.C. on
behalf of TCV IV Strategic Partners L.P. and TCV IV, L.P.,
together one of our major stockholders, have each entered into
voting agreements with Symantec pursuant to which they have
agreed, among other things, to vote all of their shares of our
common stock as of the record date, representing in the
aggregate approximately 11.8% of our outstanding common
stock as of such date, in favor of the adoption of the merger
agreement. See the section entitled The Merger
Voting Agreements beginning on page 36.
Voting of
Proxies
All shares represented by properly executed proxies received in
time for the special meeting will be voted at the special
meeting in the manner specified by the holders. Properly
executed proxies that do not contain voting instructions will be
voted FOR the adoption of the merger agreement and
FOR any proposal by our board of directors to
adjourn the special meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of adoption
of the merger agreement.
Shares of our common stock represented at the special meeting
but not voting, including shares of our common stock for which
proxies have been received but for which stockholders have
abstained, will be treated as present at the special meeting for
purposes of determining the presence or absence of a quorum for
the transaction of all business.
Only shares affirmatively voted for the adoption of the merger
agreement, including properly executed proxies that do not
contain voting instructions, will be counted as favorable votes
for that proposal. Only shares affirmatively voted for any
proposal by our board of directors to adjourn the special
meeting, including properly executed proxies that do not contain
voting instructions, will be counted as favorable votes for such
a proposal. If an Altiris stockholder abstains from voting,
it will effectively count as a vote against the adoption of the
merger agreement and a vote against the adjournment of the
special meeting. If an Altiris stockholder does not vote, either
in person or by proxy, it will effectively count as a vote
against the adoption of the merger agreement and it will not
affect the outcome of any proposal to adjourn the special
meeting, but will reduce the number of votes required to approve
any such proposal.
Brokers who hold shares of our common stock in street
name for customers who are the beneficial owners of such
shares may not give a proxy to vote those customers shares
in the absence of specific instructions from those customers.
Any broker non-votes would be considered present for
purposes of determining whether or not a quorum is present, but
would not be considered entitled to vote on a particular
proposal. Failing to instruct your broker on how to vote your
shares on the proposal to adopt the merger agreement will have
the same effect as a vote
14
against such proposal. Failing to instruct your broker on how to
vote your shares on any proposal to adjourn the special meeting
will have no effect on the outcome of such a proposal, but will
reduce the number of votes required to approve that proposal.
Revocability
of Proxies
The grant of a proxy on the enclosed form of proxy does not
preclude a stockholder from voting in person at the special
meeting. A stockholder may revoke a proxy at any time prior to
its exercise by:
|
|
|
|
|
filing with the Secretary of Altiris a duly executed revocation
of proxy;
|
|
|
|
submitting a duly completed and executed proxy to the Secretary
of Altiris bearing a later date; or
|
|
|
|
appearing at the special meeting and voting in person;
attendance at the special meeting will not in and of itself
constitute revocation of a proxy you must vote your
shares at the meeting in order to revoke your earlier proxy.
|
If you have instructed your broker to vote your shares, you must
follow directions received from your broker to change these
instructions.
Solicitation
of Proxies
All costs of solicitation of proxies will be borne by us. We
have retained The Altman Group to aid in the solicitation of
proxies and to verify records relating to the solicitation. The
Altman Group will receive customary fees for these services,
which we estimate to be approximately $5,500. The extent to
which these proxy soliciting efforts will be necessary depends
entirely upon how promptly proxies are received. You should send
in your proxy by mail without delay. We also reimburse brokers
and other custodians, nominees and fiduciaries for their
expenses in sending these materials to you and getting your
voting instructions.
Stockholders should not send stock certificates with their
proxies. A letter of transmittal with instructions for the
surrender of our common stock certificates will be mailed to our
stockholders as soon as practicable after completion of the
merger. The instructions will provide that, at the election of
the stockholder, certificates may be surrendered, and the merger
consideration in exchange for the certificates may be collected,
by hand delivery.
Appraisal
Rights
Under the General Corporation Law of the State of Delaware,
holders of Altiris common stock who do not vote in favor of
adoption of the merger agreement will have the right to seek
appraisal of the fair value of their shares as determined by the
Delaware Court of Chancery if the merger is completed, but only
if they submit a written demand for appraisal prior to the vote
on the adoption of the merger agreement, and they comply with
the provisions of Section 262 of the General Corporation
Law of the State of Delaware set forth in full at
Annex C to this proxy statement. See the section
entitled The Merger Appraisal Rights
beginning on page 41.
15
Assistance
If you need assistance in completing your proxy card or have
questions regarding the Altiris special meeting, please contact:
Altiris, Inc.
588 West 400 South
Lindon, Utah 84042
Telephone:
(801) 805-2400
Attention: Craig H. Christensen
E-mail:
craig.christense@altiris.com
or our proxy solicitor,
The Altman Group, Inc.
1200 Wall Street West, 3rd Floor
Lyndhurst, New Jersey 07071
Call toll-free:
(800) 217-0538
16
THE
MERGER
The following discussion summarizes the material terms of the
merger. Stockholders should read the merger agreement, which is
attached as Annex A to this proxy statement,
carefully and in its entirety.
General
Description of the Merger
Under the merger agreement, Merger Sub will merge with and into
Altiris, with Altiris surviving as a wholly owned subsidiary of
Symantec. Pursuant to the merger agreement, at the effective
time of the merger each outstanding share of Altiris common
stock, par value $0.0001 per share, will be converted into
the right to receive $33.00 in cash, without interest.
Symantec will assume all Altiris options outstanding immediately
prior to the effective time of the merger and the assumed
options will be converted into options to purchase shares of
Symantec common stock. Generally, each option will continue to
be subject to the terms and conditions, including the vesting
schedule, set forth in the Altiris stock plan under which the
option was granted and the individual stock option agreements
governing that option. However, following the completion of the
merger, Altiris options will become options to purchase Symantec
common stock with the exercise price and number of shares
underlying the option adjusted in accordance with the terms of
the merger agreement. The exercise price and the number of
shares of Symantec common stock subject to Altiris options after
the completion of the merger will be determined pursuant to the
merger agreement, which provides that the number of shares of
Symantec common stock subject to Altiris options will be
determined by multiplying the number of shares that were subject
to the Altiris option immediately prior to the completion of the
merger by an exchange ratio and then rounding the result down to
the nearest whole share. The exchange ratio used for this
purpose will be calculated immediately prior to the completion
of the merger by dividing $33.00 by the average of the closing
sales prices of Symantec common stock as quoted on the Nasdaq
Global Select Market for the ten consecutive trading days ending
with the trading day that is one trading day prior to the
completion of the merger. The per share exercise price for each
share issuable upon exercise of the Altiris options will be
adjusted to a price determined by dividing the per share
exercise price applicable to the Altiris option immediately
prior to the completion of the merger by the same exchange ratio
and rounding up to the nearest whole cent.
Symantec will also assume all outstanding Altiris RSUs in the
merger, and these assumed RSUs will be converted into rights to
receive shares of Symantec common stock. Generally, each RSU
will continue to be subject to the terms and conditions,
including the vesting schedule, set forth in the Altiris stock
plan under which the RSUs were granted and the related
restricted stock unit award agreement, except that the RSUs will
become rights to receive Symantec common stock at vesting with
the number of shares subject to the RSUs adjusted in accordance
with the terms of the merger agreement. The number of shares of
Symantec common stock deliverable at vesting will be adjusted by
multiplying the number of shares of Altiris common stock subject
to the RSU immediately prior to the completion of the merger by
the exchange ratio described above and rounding down to the
nearest whole share.
Any restricted shares of Altiris common stock held immediately
prior to the effective time of the merger will be converted into
the right to receive $33.00 cash, without interest, less
applicable tax withholding, subject to the vesting schedule
applicable to such restricted shares. In general, holders of
restricted shares will receive this cash consideration with
respect to unvested shares in accordance with the applicable
vesting schedule, provided that the holders of the restricted
stock awards satisfy the applicable vesting requirements, and
reduced by applicable tax withholding. Until vested, such
consideration will be held by Symantec. Any cash payments made
for vesting of unvested shares will be made by Symantec
according to its normal payroll procedures following the date
within a month upon which such cash payments vested.
Background
to the Merger
Altiris was incorporated in Utah in August 1998 and
reincorporated in Delaware in February 2002. We operate in a
highly competitive industry that is subject to cyclicality,
constant and rapid technological change, software obsolescence
and fluctuations in supply and demand. Despite these challenges,
and following a period of rapid growth, we completed our initial
public offering in May 2002.
17
Since our initial public offering, our board of directors and
management team have periodically discussed and reviewed
Altiris business, strategic direction, long-term goals,
performance and prospects in the context of developments in the
systems management software market, including consolidation
among Altiris competitors and convergence of technology
offerings in the highly competitive systems management market in
which Altiris operates. In the course of these discussions, our
board of directors and senior management have also discussed and
reviewed various potential strategic alternatives involving
possible acquisitions or business combinations that could
complement and enhance Altiris competitive strengths and
strategic position, as well as regularly reviewed our prospects
as an independent company. In this regard, the senior management
of Altiris has from time to time communicated informally with,
and has been approached by, representatives of other software
and high-technology companies regarding industry and market
trends and issues, their respective companys strategic
direction and the potential benefits and issues surrounding
possible business combinations or other strategic and commercial
transactions. These other companies include Symantec and three
other companies we refer to in this section as Company A,
Company B and Company C.
On July 22, 2005, our board of directors held a meeting at
which our board, together with our senior management, conducted
its regular periodic review of Altiris near- and long-term
challenges and opportunities. This review included, among other
things, a discussion of Altiris current and potential
future markets, the status of Altiris relationships with
key strategic partners, Altiris major competitors and its
competitive advantages and threats, managements current
acquisition strategies, Altiris overall financial and
operational strengths and weaknesses, and future potential
strategic opportunities for our company. At the conclusion of
this meeting, our board of directors and senior management
determined that they should dedicate more time in future
meetings to review potential alternative business strategies,
including potential strategic business combinations.
In mid-October, 2005, our chairman, president and chief
executive officer, Gregory S. Butterfield, was approached by a
representative of Company A, a company with which members of our
management team had informal conversations in the past about
potential strategic transactions, regarding a potential
acquisition of Altiris by Company A. Initial meetings between
our senior management and representatives of Company A were held
at Company As headquarters and at our headquarters in
Lindon, Utah, during the latter half of October and early
November, 2005, at which certain high-level management and
technology diligence discussions were held with Company A. A
mutual confidentiality agreement was executed by Company A on
November 1, 2005, with effect from October 18, 2005,
to enable the parties to share information regarding a potential
transaction. An additional meeting between senior management of
Altiris and senior management of Company A was held in late
January 2006. Following this series of meetings, Company A
conveyed that it had determined to discontinue discussions with
us for the time being due to other priorities.
During this period, at our board of directors regularly
scheduled meeting on October 20, 2005, Mr. Butterfield
proposed that Altiris consider engaging an investment banking
firm to assist in identifying and evaluating future potential
strategic opportunities, as well as advising our board of
directors and management with respect to such opportunities. At
its next regularly scheduled meeting on February 2, 2006,
our board of directors requested that our management interview
certain investment banking firms for this purpose.
As a result of the selection process carried out by our senior
management at the request of Altiris board of directors,
on February 7, 2006, representatives of Goldman Sachs met
with members of our senior management to discuss Altiris
strategic alternatives and acquisition opportunities, as well as
Altiris stand-alone business strategy.
Shortly after that meeting, Mr. Butterfield was contacted
by Company Bs chief executive officer regarding a
potential business combination transaction with Company B.
During the month of February, 2006, Mr. Butterfield held
meetings with Company Bs chief executive officer to
discuss the terms of such a potential transaction. However,
after such meetings, we and Company B were not able to reach an
agreement on mutually acceptable terms.
As a follow up to their initial meeting with our senior
management, representatives from Goldman Sachs met with our
board of directors and senior management during a special
meeting of our board held on May 26, 2006. During that
meeting, representatives of Goldman Sachs, our senior management
and our board of directors reviewed and discussed, among other
things, the systems management software market, Altiris
key business and technology strengths and challenges as a
stand-alone company, and various alternative strategic
opportunities. Our
18
directors discussed Goldman Sachs presentation and asked
questions of management regarding their confidence in
Altiris plans, forecasts and presentations. With our
boards approval, over the next several months,
Altiris senior management, in consultation from time to
time with Goldman Sachs on an informal basis, continued to
review potential strategic options with respect to the company.
During this period, our board of directors and senior management
noted, among other things, that the systems management software
market was experiencing new competitive challenges from both
incumbent market participants and heightened levels of
consolidation activity. Our board of directors also reviewed the
various approaches made by Company A and Company B, and other
informal discussions with certain other parties on various
occasions in the past, regarding the possibility of a strategic
business combination transaction with Altiris.
During the month of June 2006, Company C approached us
expressing an interest in acquiring Altiris. In addition,
Company A also contacted Mr. Butterfield requesting that
discussions be resumed regarding a combination between the two
companies and, in this respect, meetings were scheduled with
representatives of Company A for the end of the following month.
On July 13, 2006, we entered into a mutual confidentiality
agreement with Company C. After the execution of such
confidentiality agreement, certain meetings were held with
representatives of Company C during which initial management
presentations were made. Following the approval of Company
Cs board of directors, further discussions and meetings
took place during the second half of July and into the first
half of August of 2006, which included preliminary due diligence
sessions with representatives of Company C. The Altiris board of
directors and senior management reviewed the potential strategic
opportunities with Company A and Company C at the boards
regularly scheduled meeting on July 26, 2006. During the
same period, our management team had three days of scheduled
meetings between members of our management team and Company
As management team regarding our technology, financial
position and customers. Our senior management continued to
consult with Goldman Sachs during the course of these
discussions.
In light of these meetings and discussions with Company A and
Company C, and various other factors, including continuing
strategic discussions between our board of directors and senior
management regarding the long-term prospects for Altiris and the
potential for significant long-term growth and competitive
positioning (other than through larger acquisitions), and the
risks associated with integration, our board of directors on
August 24, 2006, after discussing various alternatives for
Altiris and reviewing Altiris existing strategic
opportunities, authorized and directed our senior management to
formally engage Goldman Sachs as Altiris financial advisor
in connection with its consideration of various financial
alternatives. Subsequently, we entered into an engagement letter
with Goldman Sachs dated as of August 8, 2006.
During the month of August 2006, we experienced a significant
increase in the price of our common stock. At the end of August
2006, Mr. Butterfield was informed by a representative of
Company C that, following internal discussions, Company C was
not able to get comfortable with Altiris then current
valuation and, therefore, did not feel that it would be able at
that time to propose a price that it felt would be compelling to
our board of directors. During this time, and into the month of
September 2006, our senior management continued to communicate
with senior management of Company A on an occasional basis by
phone and in person.
On October 26, 2006, at a regularly scheduled meeting of
our board of directors, Mr. Butterfield reported to our
board on the potential strategic business combination
opportunities with Company A and Company C then under
consideration by management, and the history and status of the
discussions with each company, and discussed the likelihood and
potential timing to complete strategic transactions with such
companies. He also outlined our managements view of the
advantages and disadvantages of each potential transaction from
a business and strategy perspective. He also led a discussion by
our board of directors and senior management regarding
alternative strategic opportunities and business strategies that
included a detailed review of the evolution of Altiris
product offerings and technology direction in the context of the
systems management software market and market trends, including
the increasing convergence and consolidation of relevant market
segments and product solutions, and analyzed Altiris
product and technology position relative to its major
competitors. At the conclusion of this meeting, our board of
directors and senior management determined that Altiris should
continue to view potential business combination opportunities
opportunistically, but that, in light of the recent
communications from Company C and the relatively slow-moving
process with Company A, management should pursue certain
alternative strategic opportunities and initiatives approved by
our board of directors.
19
On October 31, 2006, members of Symantecs senior
technical staff met with their counterparts at Altiris to
explore potential strategic technology relationships.
At the end of November 2006, the chief executive officer of
Company C once again approached Mr. Butterfield asking to
resume discussions regarding a potential acquisition of Altiris
citing renewed interest based on, among other things,
Altiris recently announced five-year agreement with Dell
Products L.P., or Dell. On November 27, 2006, senior
management of Company C held meetings with our senior management
at our corporate headquarters in Lindon, Utah, at which our
relationship with Dell and other customers, as well as
organizational issues, were discussed. Altiris did not
immediately hear back from Company C after those meetings.
During the week of December 4, 2006, Mr. Butterfield
placed a phone call to Symantecs chairman and chief
executive officer, John W. Thompson, to discuss our new
agreement with Dell, pursuant to which we agreed with Dell to
jointly develop an open unified server and desktop management
architecture, and to explore whether any potential partnership
opportunities might exist between Altiris and Symantec in light
of this open architecture. The intent of our agreement with Dell
was to expose this new open architecture to other software
companies, providing customers with the ability to automate and
integrate multiple solutions from different software and
hardware manufacturers on a common platform.
During the week of December 11, 2006, Mr. Thompson
returned Mr. Butterfields call and they discussed
Altiris new relationship with Dell and other business and
strategic issues, as well as industry trends, market conditions
and customer needs in general. At the end of that conversation,
they concluded that they should have a
face-to-face
meeting to explore potential opportunities and synergies between
the two companies beyond potential partnership opportunities. On
December 21, 2006, Mr. Thompson, together with other
key executives from Symantec, met with Mr. Butterfield and
our chief financial officer, chief technology officer and
worldwide vice president of sales at Altiris corporate
headquarters in Lindon, Utah. Each company presented its
respective technology vision and philosophies,
go-to-market
and overall sales and marketing strategy, and global services
and commitments to customers and partners. Altiris also
presented a high-level overview of its financials results.
Mr. Butterfield once again had a telephone conversation
with Mr. Thompson on December 26, 2006, during which
Mr. Thompson indicated that he wanted to proceed with more
in-depth discussions concerning potential business combination
opportunities between Symantec and Altiris. Mr. Butterfield
arranged several
one-on-one
meetings between representatives of Symantec and different
members of our senior management to discuss more specifically
and in detail these potential opportunities. In the period that
followed, Altiris management began to compile
comprehensive data room materials to ensure that the company
would be in a position to quickly respond to information
requests from prospective business combination partners.
In the meantime, Company As chief executive officer once
again contacted Mr. Butterfield on December 27, 2006,
during which Company A expressed a desire to renew and update
their diligence efforts with a view to moving forward with a
transaction. Following this conversation, a due diligence
session was planned for January 3, 2007, which would be
attended by senior management of the two companies and their
financial advisors.
On December 28, 2006, we held a special meeting of our
board of directors to, among other things, provide our board
with an update on the ongoing strategic discussions with Company
A and Company C, and on the status of certain other strategic
projects in which Altiris was engaged, and to brief the board on
the initial discussions and meetings with Symantec. After a
discussion concerning these matters, our board of directors
authorized Mr. Butterfield and our senior management to
continue pursuing discussions with each of these companies.
On the evening of January 2, 2007, Mr. Thompson placed
a telephone call to Mr. Butterfield to discuss a proposed
transaction whereby Symantec would acquire all of the
outstanding capital stock of Altiris. During this call,
Mr. Thompson discussed in detail with Mr. Butterfield
his overall vision and strategy for the two companies, the
proposed integration of Altiris into the Symantec organization
(including the idea of keeping Altiris as a separate business
unit of Symantec, with Mr. Butterfield as the head of this
business unit reporting directly to Mr. Thompson) and other
acquisition-related topics. Mr. Thompson then proposed a
price per share of Altiris common stock of $31.00 in cash, for
which he presented various supporting data, and indicated that
Symantec would expect that Altiris work swiftly with Symantec to
negotiate and enter into definitive documentation for the
proposed acquisition. Mr. Thompson requested a response to
his proposal by January 5, 2007. The next day, on
20
January 3, 2007, Symantec submitted a non-binding letter of
interest signed by Mr. Thompson and addressed to
Mr. Butterfield outlining the principal terms discussed
during the telephone call between Mr. Thompson and
Mr. Butterfield. Included in this letter of interest, was a
proposed binding exclusivity clause that would be effective
until January 26, 2007, during which time Altiris would be
required to negotiate exclusively with Symantec towards an
acquisition as proposed in the letter, and discontinue
discussions with and not solicit alternative proposals from any
other parties.
That same day, on January 3, 2007, members of our senior
management and representatives of Goldman Sachs met with
representatives of Company A and their financial advisors for a
previously scheduled
all-day due
diligence session. At those meetings, at the direction of our
board of directors, representatives of Goldman Sachs indicated
to Company As financial advisors that Company A needed to
move quickly if it were seriously considering delivering a
formal proposal to Altiris, which proposal should be as detailed
as possible. After those meetings, Company A indicated to us
that we should expect to hear from them shortly with respect to
a proposal.
In order to update our board of directors on the proposal made
by Mr. Thompson and the ongoing discussions with Company A
and Company C, a special meeting of our board of directors was
held on the evening of January 4, 2007. Representatives of
Goldman Sachs and Altiris regular outside legal counsel,
Wilson Sonsini Goodrich & Rosati, Professional
Corporation, were invited to attend and were briefed regarding
the proposal prior to the meeting. Our board of directors
engaged in a preliminary discussion with our senior management
and representatives of Goldman Sachs and Wilson Sonsini
regarding Symantecs proposal (including the price proposed
by Symantec) and Symantecs request for binding exclusivity
(and certain alternatives to agreeing to binding exclusivity). A
representative of Goldman Sachs then discussed with our board of
directors, among other things, the Symantec proposal, an initial
analysis of the proposal outlined by Mr. Thompson and
certain other relevant data for the boards consideration,
during which our board of directors discussed and considered the
proposal and facts presented, as well as the status of the
discussions with Company A and Company C. At
Mr. Butterfields request, a representative of Wilson
Sonsini then reviewed with the board of directors their
fiduciary duties associated with their evaluation of strategic
alternatives for the company and their consideration of
Symantecs proposal, and in particular the application of
those fiduciary duties in the context of a decision to sell
control of the company. In addition, our board of directors
considered Altiris ongoing strategic acquisition projects
in light of the proposals made by Symantec and others. At the
end of that meeting, our board of directors determined that they
needed to further consider Symantecs proposal and
authorized management to instruct Goldman Sachs to conduct
further preliminary financial analysis and Wilson Sonsini to
request additional information regarding the non-financial terms
and conditions of the Symantec proposal, scheduling a further
special meeting of our board of directors for January 8,
2007.
Following that special meeting, Wilson Sonsini conveyed to
Fenwick & West LLP, Symantecs regular outside
legal counsel, that our board of directors had requested
additional information regarding the non-financial terms and
conditions of the Symantec proposal, in response to which
Fenwick & West indicated that they would provide a
draft definitive agreement. On January 5, 2007, Wilson
Sonsini received from Fenwick & West a draft agreement
and plan of merger containing the proposed terms of the proposed
acquisition of Altiris by Symantec and was instructed to begin
their review of the merger agreement. On that same day,
Mr. Butterfield received a phone call from Company Cs
chief executive officer indicating that they were not prepared
to make a formal proposal to acquire Altiris at that time. Close
in time to this call, representatives of Goldman Sachs received
a similar message from Company Cs chief financial officer,
who indicated that Company C did not feel that it would be able
to pay any meaningful premium to the then current share price.
Over that weekend, Wilson Sonsini reviewed and summarized
certain principal issues raised by the merger agreement for our
senior management and assisted Altiris in compiling
comprehensive data room materials.
A special meeting of our board of directors was held on
January 8, 2007, during which Mr. Butterfield further
reported on the status of the discussions with Symantec, as well
as the communications from Company C and its advisors.
Representatives from Goldman Sachs also updated our board of
directors on their discussions with Symantecs financial
advisor and reviewed, among other things, certain historical
information regarding our financial performance, and financial
analyses and operating results of Symantec and other potential
strategic partners, as well as a more detailed analysis of the
Symantec proposal. Following questions from our directors
regarding these matters, the discussion then turned to the draft
merger agreement submitted by Symantec and a
21
representative of Wilson Sonsini reviewed various issues arising
from the draft, with specific focus on non-solicitation (or
no-shop) and related provisions, closing conditions,
termination rights and obligations of the parties regarding
antitrust and regulatory approvals. In addition, our directors
discussed again the rationale for a combination with Symantec,
certain alternative business strategies considered by Altiris,
Symantecs ability to close such a transaction (including
any antitrust concerns) and certain other pertinent factors
regarding a combination with Symantec, as well as the status and
likelihood of any potential transaction with Company A or
Company C and the benefits and risks of approaching other
potential business combination partners. At the end of the
meeting, our board of directors concluded that given our
discussions with Symantec, it was not in the companys best
interests to approach other potential business combination
partners, but that the board should remain open to proposals
from Company A or Company C. Our board then directed our senior
management to continue discussions with Symantec, to allow
Symantec access to on-line data room materials on condition that
a confidentiality agreement first was entered into by Symantec,
and to work with Wilson Sonsini to negotiate the terms of the
merger agreement, with particular instructions to maintain
appropriate flexibility in the event of competing strategic
opportunities and achieve the highest degree of deal certainty
that Symantec would be willing to agree to. Our board of
directors also concluded, among other things, that senior
management should pursue the Symantec proposal, in priority to
any other strategic acquisitions currently under consideration
by the company, as it currently presented the best opportunity
for maximizing stockholder value and was in the best interests
of Altiris stockholders. However, based on its analyses,
our board of directors determined that it was appropriate to
convey to Symantec its willingness to negotiate a sale of
Altiris at a price of at least $33.00 per share in cash,
but on a non-exclusive basis prior to the execution of a
definitive merger agreement, and instructed Mr. Butterfield
and a representative of Goldman Sachs to convey this message to
their counterparts.
After the conclusion of the Altiris board meeting,
Mr. Butterfield contacted Mr. Thompson and conveyed to
him that our board of directors had authorized our senior
management to proceed with discussions with Symantec and that
Altiris would be willing to move quickly towards the negotiation
and execution of definitive documentation, but that Altiris
would not grant exclusivity to Symantec. Mr. Butterfield
also proposed a price of $33.00 in cash per share of
Altiris common stock. The two chief executive officers
also discussed the importance to Altiris board of
directors of deal certainty, Symantecs ability to close a
transaction and its financial and market strength and the
benefits that would be provided to our stockholders, customer
and partners from a merger. Mr. Thompson indicated that he
would contact the members of his board of directors and provide
a response to Altiris counter-proposal. Around the same
time, at the direction of our board of directors, a
representative of Goldman Sachs also conveyed a similar message
to representatives of Symantecs financial advisor.
On January 9, 2007, Mr. Thompson contacted
Mr. Butterfield to inform him that Altiris proposed
$33.00 per share price in cash was acceptable to Symantec,
subject to the satisfactory completion of due diligence and
negotiation of the terms and conditions of a definitive merger
agreement, and discussed next steps. Mr. Thompson also
expressed his desire to complete the due diligence and
negotiation process as quickly as practicable and proposed a
timeline for doing so, and Mr. Butterfield expressed to
Mr. Thompson that he, together with management and
Altiris advisors, were willing to work towards meeting
that timeline. Later that day, Fenwick & West and
Wilson Sonsini completed negotiations on a mutual
confidentiality agreement that was previously provided by
Altiris to Symantec on January 2, 2007, and the two
companies entered into that agreement. On January 10, 2007,
representatives of Symantec were given access to an on-line data
room to commence their due diligence investigation of Altiris.
Mr. Butterfield updated each of our board members
individually with respect to this news and the timing discussed
with Mr. Thompson.
During the period that followed, Symantec began to conduct
extensive due diligence on Altiris and representatives of Wilson
Sonsini began to engage with representatives of
Fenwick & West on the merger agreement. Drafts of the
merger agreement were exchanged by the two law firms during the
later part of the week of January 8, 2007 and detailed
discussions on the merger agreement were held among
representatives of the two law firms over the long weekend of
January
13-15, 2007.
In the meantime, our management team began preparing the
disclosure schedules contemplated by the merger agreement.
During the afternoon of January 15, 2007, we held a special
meeting of our board of directors, during which
Mr. Butterfield reported that Altiris senior
management and advisors had been making good progress on the
merger agreement with Symantec and related documentation. A
representative of Wilson Sonsini then updated the board as
22
to the outstanding issues on the merger agreement. In addition,
representatives of Goldman Sachs updated our board of directors
on further discussions they had had with financial advisors for
Company A, which, during this period, had continued to express
an interest in pursuing a strategic transaction with Altiris.
Our management also indicated that they had continued to respond
to the occasional due diligence request from Company A. However,
representatives of Goldman Sachs also indicated that Company
As financial advisors did not indicate that a formal
proposal would be forthcoming. Our board of directors considered
these new developments and its prior decision not to approach
other potential business combination partners, and at the
conclusion of that meeting, our board of directors re-affirmed
its earlier direction to our senior management and advisors to
continue to move forward in their efforts to negotiate
definitive documentation with Symantec relating to the proposed
acquisition. Our directors also requested that they be kept
apprised of any further developments with respect to
communications with Company A.
Later that same day, Mr. Thompson contacted
Mr. Butterfield to inform him that Symantec would be
pre-announcing their third quarter results prior to the opening
of the markets the following day. Following this conversation,
Mr. Butterfield immediately called a conference call of
Altiris senior management and outside advisors to discuss
the potential timing and other implications of the pending
Symantec pre-announcement. Later that night,
Mr. Butterfield updated certain members of our board of
directors regarding these developments.
Symantec issued a press release on January 16, 2007,
announcing that its third quarter results were expected to miss
its previously issued guidance. That same day, Mr. Thompson
called Mr. Butterfield to inform him that, during a meeting
of Symantecs board of directors held the day before, the
Symantec board had re-affirmed their commitment to the proposed
acquisition of Altiris at the agreed price, and to schedule a
face-to-face
meeting for January 17, 2007 to review outstanding issues
and to discuss the overall transaction. During that meeting,
Mr. Thompson and Mr. Butterfield again reviewed the
timing of the transaction and Mr. Thompson proposed
continuing to work towards reaching agreement on definitive
documentation by the end of the following week, the week of
January 22, 2007. The two chief executives also discussed
high-level integration plans and certain employee-related
matters.
On January 17, 2007, our board of directors held another
special meeting during which Mr. Thompsons
conversation with Mr. Butterfield was conveyed to the
board. Wilson Sonsini had provided in advance of the meeting a
memorandum summarizing the principal terms of the merger
agreement and requested voting agreements, together with a
current draft of the merger agreement. During the meeting,
representatives of Wilson Sonsini reported that there remained
outstanding a relatively small number of material issues on the
merger agreement which included, among others, the formulation
of the material adverse effect / material
adverse change definition, the process by which our board
of directors could consider alternative proposals, certain
conditions to closing, the obligations of Symantec to agree to
limitations on either Symantecs or our business in order
to obtain antitrust approvals, the amount of the termination fee
under the merger agreement and the treatment of Altiris
stock options and other equity awards. The board was given the
opportunity to ask questions and express their views on these
issues throughout and following this presentation. Our directors
then expressed certain views on the remaining issues and
instructed Wilson Sonsini accordingly. Mr. Butterfield then
scheduled a subsequent meeting of our board of directors for
January 23, 2007, at which time it was anticipated that
negotiations on the merger agreement and related documentation
would be substantially completed.
During the next week, Wilson Sonsini and Fenwick &
West, together with each of their respective clients and their
other advisors, continued to work to finalize the merger
agreement, the disclosure schedules to the merger agreement and
the voting agreements requested by Symantec to be entered into
in connection with the proposed merger.
On the morning of January 19, 2007, Mr. Butterfield
received a faxed copy of a non-binding indication of interest
letter from Company A outlining in general terms a proposed
acquisition of all of the outstanding equity securities of
Altiris by Company A for a price per Altiris share of $31.00 in
cash, subject to the negotiation of definitive documentation,
which would be financed by cash on Company As balance
sheet and would not be subject to a financing condition. The
letter also indicated that, in order for Company A to commit to
the proposed valuation, it needed to, among other things,
complete business, legal, financial and integration due
diligence to its sole satisfaction, and that Company A requested
a response from Altiris by 5:00 p.m. EST on
January 26, 2007. Shortly
23
after receipt of the letter, Mr. Butterfield received a
previously scheduled telephone call from Company As chief
executive officer to walk him through Company As
non-binding indication of interest. During the same day,
representatives of Goldman Sachs were contacted by
representatives of Company As financial advisors to
discuss the proposed transaction and brief discussions were had
on valuation, the financial position and ability of Company A to
offer a higher price and Company As view of the timing to
complete it due diligence, which was indicated to be up to four
weeks.
Over the weekend of January
20-21, 2007,
Mr. Butterfield had a telephone conversation with
Mr. Thompson, during which they discussed in more detail a
proposed timeline for the finalization of the merger agreement
and related documentation and the announcement of the
transaction. Mr. Thompson indicated that, in light of
Symantecs earnings conference call on January 24,
2007, as well as the remaining contract negotiations to be
completed and work on communications plans, Symantec anticipated
finalizing the merger agreement by January 26, 2007, with
an announcement of the transaction on January 29, 2007.
Our previously scheduled special meeting of our board of
directors was held on January 23, 2007 to discuss the
latest developments with respect to Company A, as well as
provide an update to the board on the proposed transaction with
Symantec. In advance of the meeting, our directors were provided
with copies of the current draft of the merger agreement, an
updated summary of the merger agreement and a set of slides on
their fiduciary duties prepared by Wilson Sonsini, and a
presentation prepared by Goldman Sachs reviewing the proposal by
Company A. Mr. Butterfield began by updating our board of
directors on the timing discussed with Mr. Thompson over
the weekend. Our board of directors asked questions, as well as
solicited the views of Goldman Sachs and Wilson Sonsini
regarding the timeline. A representative of Wilson Sonsini
reported to our board of directors that the terms and conditions
of the merger agreement and the voting agreement were nearly
complete and that there were very few material issues remaining.
Following a discussion on matters concerning the Symantec
process, Mr. Butterfield summarized for the board the
proposal made by Company A and his discussions with Company
As chief executive officer in light of the status of
negotiations with Symantec, and a representative of Wilson
Sonsini then reviewed with our board of directors their
fiduciary duties, including what our board should consider when
evaluating the proposal by Company A. In addition, a
representative of Goldman Sachs then discussed with our
directors, among other things, the Company A proposal and the
Symantec proposal, and certain other data relating to each
proposal. Throughout these presentations, our board of directors
asked a number of detailed questions of senior management and
the companys advisors regarding both proposals (including
questions regarding the timing to complete a diligence process
and reach definitive agreements with Company A, and Company
As financial ability to increase its offer price), and
carefully considered the information provided and alternative
strategic responses to Company As proposal. At the
conclusion of the meeting, our board of directors determined
that, due to the greater relative certainty of the transaction
with Symantec at this stage, the review of Company As
financial position, resources and perceived ability to increase
its proposed $31.00 per share price beyond the
$33.00 per share price offered by Symantec, the significant
amount of additional time and resources that any negotiations
with Company A were likely to require and the likelihood that
any such strategy would be likely to create significant
additional uncertainty to the current proposed merger with
Symantec, it was in the best interests of Altiris and its
stockholders to focus its efforts to completing the negotiations
with Symantec and entering into a definitive merger agreement
within the timeframe discussed with Mr. Thompson. A further
special meeting of our board of directors was scheduled for
January 26, 2007 in anticipation of final approval of the
transaction with Symantec at that time.
Following that special meeting of our board of directors held on
January 23, 2007, Mr. Butterfield had several
telephone conversations with Mr. Thompson, during which
certain remaining issues regarding the merger agreement, as well
as certain employment and employee benefit issues were
discussed. In addition, Mr. Butterfield was informed that
Symantec would also hold a special meeting of their board of
directors on January 26, 2007, to seek final approvals for
the proposed transaction. In addition, our senior management
worked with Wilson Sonsini to reach resolution on the
outstanding issues on the merger agreement and the voting
agreements, including among them final negotiations on the
amount of the termination fee. In addition, draft employment
agreement for certain Altiris employees (including
Mr. Butterfield) were received from Symantec on
January 25, 2007.
On January 26, 2007, a special meeting of our board of
directors was held. Members of our senior management and
representatives from Goldman Sachs and Wilson Sonsini were in
attendance. Mr. Butterfield reviewed the history of the
discussions with Symantec, together with a history of
discussions with certain other potential business
24
combination counterparties including Company A and Company C,
and led our board of directors in a detailed discussion of
various key factors relating to the proposed transaction with
Symantec, including those discussed below under the heading
Recommendation of our Board of
Directors Reasons for the Merger, which
factors our board of directors, during this meeting and at
various other meetings, have taken into careful consideration.
Representatives of Goldman Sachs also reported that they had
engaged in additional discussions with Company As
financial advisors and were unable to obtain additional
information regarding Company As ability or willingness to
materially improve its proposed valuation. A representative of
Wilson Sonsini then reviewed again with our board of directors
their fiduciary duties, following which a representative of
Goldman Sachs reviewed again with our board of directors the
financial analyses relating to the proposed transaction
including, among other things, a summary of the transaction
economics, a financial review of both Altiris and Symantec and
an analysis of the proposed transaction. In addition, Goldman
Sachs indicated to our board of directors that, upon completion
of the final merger agreement and subject to its review thereof
and based upon and subject to the factors and assumptions to be
set forth in its written opinion, it believed it would be in a
position to render its opinion as to the fairness from a
financial point of view to the holders of shares of our common
stock of the $33.00 per share in cash to be received by
such holders pursuant to the merger agreement. Following all of
these discussions, and after careful consideration, our board of
directors determined that it was advisable, fair and in the best
interests of Altiris and its stockholders for the board of
directors to approve the merger and enter into the merger
agreement, as subsequently finalized by certain authorized
officers of Altiris. Our board of directors then, among other
things, unanimously adopted and approved the merger agreement,
the merger and the related transactions, and unanimously
resolved to recommend that Altiris stockholders vote in
favor of the adoption of the merger agreement, in each case,
subject to the receipt of the opinion from Goldman Sachs (for
which they designated Mr. Butterfield as authorized
recipient on their behalf) and resolution of all final issues on
the merger agreement and related documentation.
Later that day, Mr. Butterfield was informed by
Mr. Thompson that Symantecs board of directors had
also unanimously approved the merger agreement, the merger and
the related transactions and agreements. Throughout the day, the
draft employment agreements between Symantec and certain members
of our senior management were negotiated and finalized. That
evening, Goldman Sachs delivered to Mr. Butterfield, on
behalf of our board of directors, its oral opinion (subsequently
confirmed in writing) that, as of January 26, 2007, and
based upon and subject to the factors and assumptions set forth
in its written opinion, the $33.00 per share in cash to be
received by the holders of shares of our common stock pursuant
to the merger agreement was fair from a financial point of view
to such holders.
Late in the evening of January 26, 2007, the parties
determined that only immaterial issues on the disclosure
schedules to the merger agreement remained and authorized the
release of their respective signature pages to the merger
agreement and related agreements. Following resolution of these
remaining issues, the merger agreement was completed and the
executed agreement dated as of January 26, 2007.
Over the weekend, Altiris and Symantec coordinated their various
press announcements, filings and communications materials and
the proposed merger was announced by press release the morning
of January 29, 2007 prior to the opening of market trading.
Recommendation
of our Board of Directors
Reasons for the Merger. In the course of
reaching its decision to approve the merger and enter into the
merger agreement, our board of directors consulted with our
senior management, outside legal counsel and our financial
advisor, and reviewed a significant amount of information and
considered a number of factors, including, among others, the
following factors:
|
|
|
|
|
the possible alternatives to the merger, including the
possibility of continuing to operate as an independent entity
and the perceived risks thereof; managements dealings with
other possible business combination partners both in the past
and during the course of the negotiations with Symantec; and the
likelihood that a third party would offer a higher price than
the $33.00 in cash per share offered by Symantec;
|
|
|
|
the current and prospective environment in which we operate,
including national and local economic conditions, the
competitive environment, the trend toward consolidation in the
software and systems
|
25
|
|
|
|
|
management markets; and the likely effect of these factors on
our potential growth, development, productivity, profitability
and strategic options;
|
|
|
|
|
|
historical financial information concerning our business,
management, financial performance and conditions, technology,
operations, prospects and competitive position;
|
|
|
|
the size of Altiris and related economies of scale, and that the
diversification of our product offerings beyond the level that
may be reasonably achievable on an independent basis was
becoming increasingly important to continued success in the
current software and systems management environment;
|
|
|
|
the likelihood that the merger will be completed, including the
likelihood that the regulatory and stockholder approvals needed
to complete the merger will be obtained;
|
|
|
|
current financial market conditions and historical market
prices, volatility and trading information with respect to our
common stock; and
|
|
|
|
the consideration to be received by our stockholders in the
merger, including the form of such consideration.
|
Our board of directors also identified and considered a number
of positive factors supporting its decision to approve the
merger and enter into the merger agreement, including, but not
limited to:
|
|
|
|
|
discussions with our management team regarding our business,
financial performance and condition, technology, operations,
competitive position, business strategy, strategic objectives
and options and prospects, as well as risks involved in
achieving these prospects; the nature of our business and the
industry in which we compete; and current industry, economic and
global market conditions, both on a historical and on a
prospective basis, all of which led our board of directors to
conclude that the merger presented an opportunity for our
stockholders to realize greater value than the value likely to
be realized by stockholders in the event we remained independent;
|
|
|
|
a review of the possible alternatives to a sale of Altiris,
including remaining independent and growing our business
organically, pursuing a strategy of growth through acquisitions
or pursuing corporate alliances; the value to our stockholders
of such alternatives; the timing and likelihood of actually
achieving additional value from these alternatives; and our
board of directors assessment that none of these
alternatives was reasonably likely to result in value for our
stockholders greater than the consideration to be received by
our stockholders in the merger;
|
|
|
|
the risks associated with Altiris remaining an independent
company, including the increased competition, the significant
and increasing cost of complying with our obligations as a
publicly traded company, our anticipated operating performance
and a review of ongoing product development initiatives;
|
|
|
|
the belief by our management that the merger would allow for
enhanced products and opportunities for our partners, clients
and customers, and our managements view that the
relatively limited overlap between us and Symantec would
minimize the impact of the merger on our customers and employees;
|
|
|
|
the current and historical market prices of our common stock,
and the current and historical market prices of our common stock
relative to those of other industry participants and general
market indices, including the fact that the $33.00 per
share in cash, without interest, to be paid as the consideration
in the merger represented an approximate 22% premium over the
closing price of our common stock on January 26, 2007 (the
last trading day prior to the public announcement of the
merger); an approximate 27% premium over the average closing
price of our common stock from December 27, 2006 to
January 26, 2007 (the
30-day
trading period prior to the public announcement of the merger);
and an approximate 34% premium over the average closing price of
our common stock from October 27, 2006 to January 26,
2007 (the
90-day
trading period prior to the public announcement of the merger);
|
|
|
|
the opinion of Goldman Sachs to our board of directors that, as
of January 26, 2007, and based upon and subject to the
factors and assumptions set forth therein, the $33.00 per
share in cash to be received by the holders of shares of our
common stock was fair from a financial point of view to such
holders, as more fully described under the heading The
Merger Opinion of Goldman, Sachs &
Co. beginning on page 28. The full text of the
written opinion of Goldman Sachs, dated January 26, 2007,
which sets forth the
|
26
|
|
|
|
|
assumptions made, procedures followed, matters considered and
limitations on the review undertaken in connection with the
opinion is attached as Annex B to this proxy
statement;
|
|
|
|
|
|
the belief by our board of directors that we had obtained the
highest price per share that Symantec was willing to pay, taking
into account the terms resulting from extensive negotiations
between the parties;
|
|
|
|
the assessment, based on our managements dealings with
other possible buyers both in the past and during the course of
negotiations with Symantec, as to the low likelihood that a
third party (including the party referred to in the section
entitled Background to the Merger above as Company A
that submitted a non-binding indication of interest to our board
of directors on January 19, 2007) would offer a higher
price than Symantec;
|
|
|
|
the fact that the merger consideration is all cash, which
provides certainty of value to our stockholders compared to a
transaction in which our stockholders would receive stock;
|
|
|
|
the fact that the merger would be subject to the approval of our
stockholders and that if a higher priced offer were to be made
to the stockholders prior to the completion of the merger, the
stockholders could elect not to adopt the merger agreement;
|
|
|
|
the availability of appraisal rights for Altiris stockholders
who properly exercise their statutory appraisal rights under
Delaware law; and
|
|
|
|
the terms of the merger agreement, as reviewed by our board of
directors with our outside legal advisors, including:
|
|
|
|
|
|
the structure of the merger;
|
|
|
|
the representations and warranties contained in the merger
agreement;
|
|
|
|
the conditions to our and Symantecs respective obligations
contained in the merger agreement;
|
|
|
|
the ability of our board of directors, under specified
circumstances, to furnish information to and conduct
negotiations with a third party and, upon the payment to
Symantec of a termination fee of $37,500,000, to terminate the
merger agreement to accept a superior proposal;
|
|
|
|
our board of directors belief that the $37,500,000 maximum
aggregate termination fees and expenses payable to Symantec was
reasonable in the context of termination fees that were payable
in other comparable transactions and would not be likely to
preclude another party from making a superior proposal;
|
|
|
|
the likelihood that the merger will be consummated in light of
the conditions to Symantecs obligation to complete the
merger, Symantecs financial capability and the absence of
any financing condition to Symantecs obligation to
complete the merger; and
|
|
|
|
the negotiated exclusions to the definition of a material
adverse change and material adverse effect in
the merger agreement, including changes in general economic
conditions or changes affecting the industry generally in which
we operate; changes in the trading volume or trading prices of
our common stock in and of itself; acts of war or terrorism;
changes in applicable law or United States generally accepted
accounting principles, or GAAP; any failure to meet analysts
estimates or expectations as to revenue, earnings or other
financial performance in and of itself; and the announcement or
the execution of the merger agreement or the pendency or
completion of the merger. See the section entitled The
Merger Agreement Representations and
Warranties beginning on page 47.
|
In the course of its deliberations, our board of directors also
identified and considered a variety of risks and other
countervailing factors, including:
|
|
|
|
|
the fact that our stockholders will not participate in any
future growth potential of Altiris or Symantec or any synergies
resulting from the merger;
|
|
|
|
the possibility that the merger might not be completed and the
potential effects of the public announcement and pendency of the
merger on our management attention, our ability to retain
employees, our relationship
|
27
|
|
|
|
|
with customers and suppliers, and our sales, operating results
and stock price and our ability to attract and retain key
management and sales, marketing and technical personnel;
|
|
|
|
|
|
the restrictions the merger agreement imposes on soliciting
competing bids and the fact that we may be obligated to pay to
Symantec the $37,500,000 termination fee under specified
circumstances or reimburse expenses of Symantec up to a maximum
of $2,000,000 in the event that our stockholders do not adopt
the merger agreement and the possibility that this termination
fee could discourage a competing proposal to acquire us or
reduce the price in an alternative transaction;
|
|
|
|
the restrictions the merger agreement imposes on our operations
during the period between the signing of the merger agreement
and the completion of the merger and the fact that, should the
merger not occur, such restrictions could have had an adverse
effect on our operations during such time;
|
|
|
|
the challenges associated with seeking the regulatory approvals
required to complete the merger in a timely manner;
|
|
|
|
the fact that the merger agreement precludes us from actively
soliciting alternative proposals;
|
|
|
|
the fact that certain of our directors and officers may have
conflicts of interest in connection with the merger, as they may
receive certain benefits that are different from, and in
addition to, those of our other stockholders;
|
|
|
|
the fact that gains from a cash transaction would be taxable to
our stockholders for United States federal income tax
purposes; and
|
|
|
|
that, while the merger is expected to be completed, there can be
no assurance that all conditions to the parties
obligations to complete the merger will be satisfied, and as a
result, it is possible that the merger may not be completed,
even if the merger agreement is adopted by our stockholders (See
the section entitled The Merger Agreement
Conditions to the Consummation of the Merger beginning on
page 56).
|
The preceding discussion is not meant to be an exhaustive
description of the information and factors considered by our
board of directors, but is believed to address the material
information and factors considered. In view of the wide variety
of factors considered in connection with its evaluation of the
merger and the complexity of these matters, our board of
directors did not find it practicable to, and did not, quantify
or otherwise attempt to assign relative weights to the various
factors considered in reaching its determination. In considering
the factors described above, individual members of the board may
have given different weight to different factors.
Board of Directors Recommendation. After
careful consideration, and taking into account all of the
factors outlined above, our board of directors unanimously
recommends that our stockholders vote FOR the
adoption of the merger agreement. Our board of
directors also recommends that Altiris stockholders vote
FOR any proposal by our board of directors to
adjourn the special meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of adoption
of the merger agreement.
Opinion
of Goldman, Sachs & Co.
Goldman Sachs rendered its oral opinion, which was subsequently
confirmed in writing, to the Altiris board of directors that, as
of January 26, 2007 and based upon and subject to the
factors and assumptions set forth in its written opinion, the
$33.00 per share in cash to be received by the holders of
shares of our common stock pursuant to the merger agreement was
fair from a financial point of view to such holders.
The full text of the written opinion of Goldman Sachs, dated
January 26, 2007, which sets forth the assumptions made,
procedures followed, matters considered and limitations on the
review undertaken in connection with the opinion, is attached as
Annex B to this proxy statement. Goldman Sachs
provided its opinion for the information and assistance of
Altiris board of directors in connection with its
consideration of the merger. The Goldman Sachs opinion is not a
recommendation as to how any holder of shares of our common
stock should vote with respect to the merger.
28
In connection with rendering the opinion described above and
performing its related financial analyses, Goldman Sachs
reviewed, among other things:
|
|
|
|
|
the merger agreement;
|
|
|
|
annual reports to stockholders and Annual Reports on
Form 10-K
of Altiris for the four years ended December 31, 2005;
|
|
|
|
certain interim reports to stockholders and Quarterly Reports on
Form 10-Q
of Altiris;
|
|
|
|
certain other communications from Altiris to its
stockholders; and
|
|
|
|
certain internal financial analyses and forecasts for Altiris
prepared by its management.
|
Goldman Sachs also held discussions with members of our senior
management regarding their assessment of the past and current
business operations, financial condition, and future prospects
of Altiris. In addition, Goldman Sachs reviewed the reported
price and trading activity for our common stock, compared
certain financial and stock market information for Altiris with
similar information for certain other companies, the securities
of which are publicly traded, reviewed the financial terms of
certain recent business combinations in the software industry
specifically and in other industries generally and performed
such other studies and analyses, and considered such other
factors, as it considered appropriate.
Goldman Sachs relied upon the accuracy and completeness of all
of the financial, legal, accounting, tax and other information
discussed with or reviewed by it and assumed such accuracy and
completeness for purposes of rendering the opinion described
above. In that regard, Goldman Sachs assumed with the consent of
our board of directors that the internal financial forecasts
prepared by our management have been reasonably prepared on a
basis reflecting the best currently available estimates and
judgments of Altiris. In addition, Goldman Sachs did not make an
independent evaluation or appraisal of the assets and
liabilities (including any contingent, derivative or
off-balance-sheet assets and liabilities) of Altiris or any of
our subsidiaries, nor was any evaluation or appraisal of the
assets or liabilities of Altiris or any of our subsidiaries
furnished to Goldman Sachs. The Goldman Sachs opinion does not
address the underlying business decision of Altiris to engage in
the transaction contemplated by the merger agreement. The
Goldman Sachs opinion is necessarily based on economic,
monetary, market and other conditions as in effect on, and the
information made available to it as of, the date of the opinion.
The following is a summary of the material financial analyses
delivered by Goldman Sachs to our board of directors in
connection with rendering the opinion described above. The
following summary, however, does not purport to be a complete
description of the financial analyses performed by Goldman
Sachs, nor does the order of analyses described represent
relative importance or weight given to those analyses by Goldman
Sachs. Some of the summaries of the financial analyses include
information presented in tabular format. The tables must be read
together with the full text of each summary and are alone not a
complete description of Goldman Sachs financial analyses.
Except as otherwise noted, the following quantitative
information, to the extent that it is based on market data, is
based on market data as it existed on or before January 25,
2007 and is not necessarily indicative of current market
conditions.
Historical Stock Trading Analysis. Goldman
Sachs reviewed the historical trading prices and volumes for our
common stock for the one-year period ending January 25,
2007. In addition, Goldman Sachs analyzed the consideration to
be received by holders of our common stock pursuant to the
merger agreement in relation to the closing prices of our common
stock on January 3, 2007, the date of Symantecs
initial written acquisition proposal, January 25, 2007, and
the average market price over the
30-day,
60-day,
90-day,
180-day and
one-year periods ending January 25, 2007.
This analysis indicated that the $33.00 per share in cash
to be received by the holders of our common stock pursuant to
the merger agreement represented:
|
|
|
|
|
a premium of 23% based on the closing market price of
$26.80 per share on January 25, 2007;
|
|
|
|
a premium of 30% based on the closing market price of
$25.47 per share on January 3, 2007;
|
29
|
|
|
|
|
a premium of 28% based on the average market price of $25.75 per
share for the
30-day
period ended January 25, 2007;
|
|
|
|
a premium of 34% based on the average market price of $24.54 per
share for the
60-day
period ended January 25, 2007;
|
|
|
|
a premium of 40% based on the average market price of $23.64 per
share for the
90-day
period ended January 25, 2007;
|
|
|
|
a premium of 55% based on the average market price of $21.33 per
share for the
180-day
period ended January 25, 2007;
|
|
|
|
a premium of 57% based on the average market price of $21.05 per
share for the one-year period ended January 25,
2007; and
|
|
|
|
a premium of 33% to Altiris enterprise value based on the
closing market price of $26.80 per share on
January 25, 2007.
|
Selected Companies Analysis. Goldman Sachs
reviewed and compared certain financial information for Altiris
to corresponding financial information, ratios and public market
multiples for the following publicly traded corporations in the
systems management software and security software industries.
|
|
|
Selected Systems Management Software Companies
|
|
Selected Security Software Companies
|
|
BMC Software, Inc.
|
|
Blue Coat Systems, Inc.
|
CA, Inc.
|
|
Check Point Software Technologies
Ltd.
|
Compuware Corporation
|
|
Citrix Systems, Inc.
|
EMC Corporation
|
|
Entrust, Inc.
|
Novell, Inc.
|
|
McAfee, Inc.
|
Opsware Inc.
|
|
SafeNet, Inc.
|
Quest Software, Inc.
|
|
Secure Computing Corporation
|
|
|
SonicWALL, Inc.
|
|
|
Symantec
|
|
|
Trend Micro Incorporated
|
|
|
VeriSign, Inc.
|
|
|
Websense, Inc.
|
Although none of the selected companies is directly comparable
to Altiris, the companies included were chosen because they are
publicly traded companies with operations that for purposes of
analysis may be considered similar to certain operations of
Altiris.
Goldman Sachs calculated and compared the
|
|
|
|
|
enterprise value to the estimated calendar year 2007 and 2008
revenue;
|
|
|
|
enterprise value to the estimated calendar year 2007 and 2008
earnings before interest, tax, depreciation and amortization, or
EBITDA;
|
|
|
|
price per share of common stock to estimated calendar year 2007
and 2008 earnings per share of common stock;
|
|
|
|
ratio of the price per share of common stock and estimated
calendar year 2007 earnings per share to the long-term
forecasted compound annual growth rate of earnings per
share; and
|
|
|
|
price per share of common stock to estimated calendar year 2007
and 2008 free cash flow (which is defined as operating cash flow
less capital expenditures) ratios of Altiris and the selected
companies listed above that Goldman Sachs selected based on
financial data and share prices as of January 25, 2007,
information obtained from SEC filings, estimates provided by the
Institutional Brokers Estimate System, or IBES, and
|
30
|
|
|
|
|
selected, publicly-available securities analysts
estimates, or Street, for the selected companies and Altiris,
and information and forecasts for Altiris provided by our
management.
|
The results of these analyses are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
Enterprise Value Multiples(1)
|
|
|
|
|
|
|
|
|
Price/Earnings/5-Year
|
|
|
Price/Free Cash
|
|
|
|
Sales
|
|
|
EBITDA
|
|
|
Price/Earnings Multiples
|
|
|
EPS Compound
|
|
|
Flow Multiples
|
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
Annual Growth Rate
|
|
|
2007
|
|
|
2008
|
|
|
Altiris closing market price*
(IBES/Street estimates)
|
|
|
2.6
|
x
|
|
|
2.4
|
x
|
|
|
13.8
|
x
|
|
|
11.8
|
x
|
|
|
25.0
|
x
|
|
|
22.6
|
x
|
|
|
1.9
|
x
|
|
|
18.3
|
x
|
|
|
17.9x
|
|
Altiris closing market price*
(Altiris management estimates)
|
|
|
2.3
|
|
|
|
2.0
|
|
|
|
13.2
|
|
|
|
10.4
|
|
|
|
24.1
|
|
|
|
19.6
|
|
|
|
NA(2
|
)
|
|
|
22.3
|
|
|
|
18.4
|
|
Transaction price** (IBES/Street
estimates)
|
|
|
3.4
|
|
|
|
3.1
|
|
|
|
18.3
|
|
|
|
15.6
|
|
|
|
30.8
|
|
|
|
27.8
|
|
|
|
2.3
|
|
|
|
22.9
|
|
|
|
22.4
|
|
Transaction price** (Altiris
management estimates)
|
|
|
3.1
|
|
|
|
2.7
|
|
|
|
17.4
|
|
|
|
13.7
|
|
|
|
29.7
|
|
|
|
24.2
|
|
|
|
NA(2
|
)
|
|
|
27.9
|
|
|
|
23.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selected Systems Management
Companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BMC Software, Inc.
|
|
|
3.7
|
x
|
|
|
3.6
|
x
|
|
|
13.5
|
x
|
|
|
12.3
|
x
|
|
|
21.2
|
x
|
|
|
19.1
|
x
|
|
|
2.0
|
x
|
|
|
13.5
|
x
|
|
|
NA(2
|
)
|
CA, Inc.
|
|
|
4.1
|
|
|
|
4.0
|
|
|
|
14.0
|
|
|
|
NA(2
|
)
|
|
|
NM(3
|
)
|
|
|
27.7
|
|
|
|
NM(3
|
)
|
|
|
21.4
|
|
|
|
13.3
|
|
Compuware Corporation
|
|
|
1.9
|
|
|
|
1.9
|
|
|
|
9.7
|
|
|
|
8.5
|
|
|
|
19.6
|
|
|
|
16.8
|
|
|
|
1.7
|
|
|
|
NA(2
|
)
|
|
|
NA(2
|
)
|
EMC Corporation
|
|
|
2.3
|
|
|
|
2.1
|
|
|
|
10.2
|
|
|
|
9.0
|
|
|
|
21.8
|
|
|
|
18.4
|
|
|
|
1.5
|
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
Novell, Inc.
|
|
|
1.6
|
|
|
|
1.5
|
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
32.7
|
|
|
|
NM(3
|
)
|
|
|
NA(2
|
)
|
|
|
NA(2
|
)
|
Opsware Inc.
|
|
|
5.0
|
|
|
|
3.8
|
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
27.3
|
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
Quest Software, Inc.
|
|
|
2.1
|
|
|
|
1.9
|
|
|
|
10.4
|
|
|
|
9.1
|
|
|
|
19.0
|
|
|
|
16.8
|
|
|
|
1.3
|
|
|
|
12.3
|
|
|
|
11.0
|
|
Mean
|
|
|
3.0
|
x
|
|
|
2.7
|
x
|
|
|
11.6
|
x
|
|
|
9.7
|
x
|
|
|
20.4
|
x
|
|
|
22.7
|
x
|
|
|
1.6
|
x
|
|
|
15.7
|
x
|
|
|
12.2x
|
|
Median
|
|
|
2.3
|
|
|
|
2.1
|
|
|
|
10.4
|
|
|
|
9.0
|
|
|
|
20.4
|
|
|
|
19.1
|
|
|
|
1.6
|
|
|
|
13.5
|
|
|
|
12.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selected Security
Companies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Blue Coat Systems, Inc.
|
|
|
1.6
|
x
|
|
|
1.4
|
x
|
|
|
21.1
|
x
|
|
|
14.7
|
x
|
|
|
33.1
|
x
|
|
|
22.6
|
x
|
|
|
1.5
|
x
|
|
|
NA(2
|
)
|
|
|
NA(2
|
)
|
Check Point Software Technologies
Ltd.
|
|
|
6.3
|
|
|
|
5.9
|
|
|
|
11.6
|
|
|
|
11.5
|
|
|
|
16.2
|
|
|
|
14.5
|
|
|
|
1.6
|
|
|
|
15.1
|
|
|
|
NA(2
|
)
|
Citrix Systems, Inc.
|
|
|
4.1
|
|
|
|
3.6
|
|
|
|
13.8
|
|
|
|
10.0
|
|
|
|
20.5
|
|
|
|
18.4
|
|
|
|
1.4
|
|
|
|
17.5
|
|
|
|
15.6
|
|
Entrust, Inc.
|
|
|
1.8
|
|
|
|
1.5
|
|
|
|
NA(2
|
)
|
|
|
NA(2
|
)
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
NM(3
|
)
|
|
|
15.1
|
|
|
|
NA(2
|
)
|
McAfee, Inc.
|
|
|
2.9
|
|
|
|
2.7
|
|
|
|
11.5
|
|
|
|
10.6
|
|
|
|
19.2
|
|
|
|
17.3
|
|
|
|
1.3
|
|
|
|
11.4
|
|
|
|
11.3
|
|
SafeNet, Inc.
|
|
|
0.9
|
|
|
|
0.9
|
|
|
|
5.7
|
|
|
|
5.2
|
|
|
|
17.6
|
|
|
|
15.5
|
|
|
|
1.0
|
|
|
|
21.5
|
|
|
|
NA(2
|
)
|
Secure Computing Corporation
|
|
|
2.3
|
|
|
|
2.0
|
|
|
|
23.4
|
|
|
|
11.7
|
|
|
|
27.0
|
|
|
|
14.1
|
|
|
|
2.0
|
|
|
|
11.1
|
|
|
|
8.6
|
|
SonicWALL, Inc.
|
|
|
1.8
|
|
|
|
1.6
|
|
|
|
15.8
|
|
|
|
11.4
|
|
|
|
27.9
|
|
|
|
24.3
|
|
|
|
1.9
|
|
|
|
NA(2
|
)
|
|
|
NA(2
|
)
|
Symantec
|
|
|
3.1
|
|
|
|
2.9
|
|
|
|
9.0
|
|
|
|
8.0
|
|
|
|
16.9
|
|
|
|
14.8
|
|
|
|
1.4
|
|
|
|
12.7
|
|
|
|
11.0
|
|
Trend Micro Incorporated
|
|
|
3.9
|
|
|
|
3.5
|
|
|
|
11.1
|
|
|
|
10.0
|
|
|
|
24.7
|
|
|
|
21.5
|
|
|
|
4.9
|
|
|
|
17.8
|
|
|
|
NA(2
|
)
|
VeriSign, Inc.
|
|
|
3.4
|
|
|
|
3.0
|
|
|
|
11.7
|
|
|
|
9.7
|
|
|
|
20.8
|
|
|
|
17.0
|
|
|
|
1.4
|
|
|
|
20.6
|
|
|
|
18.1
|
|
Websense, Inc.
|
|
|
3.7
|
|
|
|
3.2
|
|
|
|
11.1
|
|
|
|
8.6
|
|
|
|
23.3
|
|
|
|
19.4
|
|
|
|
1.6
|
|
|
|
12.6
|
|
|
|
NA(2
|
)
|
Mean
|
|
|
3.0
|
x
|
|
|
2.7
|
x
|
|
|
13.2
|
x
|
|
|
10.2
|
x
|
|
|
22.5
|
x
|
|
|
18.1
|
x
|
|
|
1.8
|
x
|
|
|
15.6
|
x
|
|
|
12.9x
|
|
Median
|
|
|
3.0
|
|
|
|
2.8
|
|
|
|
11.6
|
|
|
|
10.0
|
|
|
|
20.8
|
|
|
|
17.3
|
|
|
|
1.5
|
|
|
|
15.1
|
|
|
|
11.3
|
|
|
|
|
(1) |
|
Projected sales, EBITDA and earnings per share estimates have
been calendarized. |
|
(2) |
|
Not available. |
|
(3) |
|
Not meaningful. |
|
|
|
* |
|
Based on Altiris closing market price of $26.80 per
share as of January 25, 2007. |
** Based on transaction price of $33.00 per share.
Present Value of Future Share Price
Analysis. Goldman Sachs performed an illustrative
analysis of the implied present value of the future price per
share of our common stock, which is designed to provide an
indication of the present value of a theoretical future value of
a companys equity as a function of such companys
estimated future earnings per share and its assumed price to
future earnings per share multiple. For this analysis, Goldman
Sachs used the financial projections for Altiris prepared by our
management for each of the calendar years 2007 and 2008 and the
median estimates provided by IBES for each of the calendar years
2007 and 2008 and derived
31
illustrative calendar year 2007 and 2008 ranges of earnings per
share. Goldman Sachs also derived illustrative calendar year
2009 implied earnings per share estimates based on an
illustrative range of
year-over-year
earnings per share growth of between 0.0% and 20.0%, based on
historical results and managements earnings per share
estimates for calendar years 2007 and 2008.
Goldman Sachs first calculated the implied values per share of
our common stock as of January 25th for each of the
calendar years 2007 to 2009, by applying price to forward
earnings per share multiples of 19.0x to 27.0x to earnings per
share of common stock estimates for each of the calendar years
2007 to 2009, and then discounted 2008 and 2009 values back one
year and two years, respectively, using a discount rate of
12.0%. This analysis resulted in a range of implied present
values of $18.83 to $35.25 per share of common stock.
Discounted Cash Flow Analysis. Goldman Sachs
performed an illustrative discounted cash flow analysis using
our management forecasts to determine a range of implied present
values per share of Altiris common stock. All unlevered cash
flows were discounted to the present, and illustrative terminal
values were based upon hypothetical forward free cash flow
multiples ranging from 11.0x to 19.0x for 2012 free cash flows.
In performing the illustrative discounted cash flow analysis,
Goldman Sachs applied discount rates ranging from 10.0% to 14.0%
to the projected unlevered free cash flows of Altiris for
calendar years 2007 to 2011 and to illustrative terminal values.
This analysis resulted in a range of implied present values of
$23.83 to $36.42 per share of our common stock.
Using the same forecasts and a discount rate of 12.0%, Goldman
Sachs performed an illustrative sensitivity analysis to
determine a range of implied present values per share of our
common stock based on a range of operating margins and five-year
compound annual revenue growth rates. In performing the
illustrative cash flow sensitivity analysis, Goldman Sachs
varied the annual operating margins over the forecast period by
plus and minus 4% from managements forecasts of operating
margins. Goldman Sachs also varied the five-year compound annual
revenue growth rates from 8% to 16%. This analysis resulted in a
range of implied present values of $22.38 to $39.01 per
share of our common stock.
Selected Transactions Analysis. Goldman Sachs
reviewed publicly available information relating to the
following announced transactions involving companies in the
software industry (Acquiror/Target Announcement
Date):
|
|
|
|
|
Investor consortium consisting of Silver Lake Partners and Texas
Pacific Group / Sabre Holdings Corporation
December 12, 2006;
|
|
|
|
Trimble Navigation Limited / @Road, Inc.
December 12, 2006;
|
|
|
|
Check Point Software Technologies Ltd. / Protect Data
AB November 20, 2006;
|
|
|
|
Oracle Corporation / Stellent, Inc. November 2,
2006;
|
|
|
|
Vista Equity Partners / Indus International, Inc.
October 23, 2006;
|
|
|
|
Oracle Corporation / MetaSolv, Inc. October 23,
2006;
|
|
|
|
Investor consortium consisting of The Carlyle Group and
Providence Equity Partners / Open Solutions Inc.
October 16, 2006;
|
|
|
|
Innovation Technology Group, Inc. / Vitria Technology,
Inc. September 21, 2006;
|
|
|
|
Investor consortium consisting of Hellman & Friedman
LLC and Texas Pacific Group / Intergraph Corporation
August 31, 2006;
|
|
|
|
Corel Corporation / Intervideo, Inc. August 26,
2006;
|
|
|
|
International Business Machines Corp./ Internet Security
Systems, Inc. August 23, 2006;
|
|
|
|
International Business Machines Corp./ FileNet
Corporation August 9, 2006;
|
|
|
|
Open Text Corp./Hummingbird Ltd. August 4, 2006;
|
|
|
|
International Business Machines Corp./MRO Software,
Inc. August 3, 2006;
|
32
|
|
|
|
|
Hewlett-Packard Company / Mercury Interactive
Corporation July 25, 2006;
|
|
|
|
EMC Corporation / RSA Security Inc. June 29,
2006;
|
|
|
|
Investor consortium consisting of Battery Ventures VI, L.P. and
Thoma Cressey Equity Partners / Onyx Software
Corporation June 6, 2006;
|
|
|
|
AttachmateWRQ / NetIQ Corporation April 27,
2006;
|
|
|
|
JDA Software Group, Inc. / Manugistics Group, Inc.
April 24, 2006;
|
|
|
|
Engel Holding AS / Visma ASA April 18, 2006;
|
|
|
|
Oracle Corporation / Portal Software, Inc.
April 12, 2006;
|
|
|
|
Dassault Systèmes SA / MatrixOne, Inc.
March 2, 2006;
|
|
|
|
Borland Software Corporation / Segue Software Inc.
February 8, 2006;
|
|
|
|
International Business Machines Corp./Micromuse,
Inc. December 21, 2005;
|
|
|
|
Progress Software Corporation / NEON Systems, Inc.
December 19, 2005;
|
|
|
|
Silver Lake Partners / Serena Software, Inc.
November 10, 2005;
|
|
|
|
Golden Gate Capital / Geac Computer Corporation
November 7, 2005;
|
|
|
|
Francisco Partners / FrontRange Solutions, Inc.
November 4, 2005;
|
|
|
|
Autonomy Corporation plc / Verity, Inc.
November 4, 2005;
|
|
|
|
EMC Corporation / Captiva Software Corporation
October 20, 2005;
|
|
|
|
Symantec Corp./BindView Development Corporation
October 3, 2005;
|
|
|
|
Syntellect Inc. / Apropos Technology, Inc.
September 26, 2005;
|
|
|
|
Hewlett-Packard Company / Peregrine Systems, Inc.
September 19, 2005;
|
|
|
|
Oracle Corporation / Siebel Systems, Inc.
September 12, 2006;
|
|
|
|
BEA Systems, Inc. / Plumtree Software
August 22, 2005;
|
|
|
|
SSA Global Technologies, Inc. / Epiphany, Inc.
August 4, 2005;
|
|
|
|
Oracle Corporation / i-flex Solutions Limited
August 3, 2005;
|
|
|
|
The Carlyle Group / SS&C Technologies, Inc.
July 28, 2005;
|
|
|
|
Sun Microsystems, Inc. / SeeBeyond Technology
Corporation June 28, 2005;
|
|
|
|
CA, Inc. / Niku Corporation June 9, 2005;
|
|
|
|
Lawson Software, Inc. / Intentia International AB
June 2, 2005;
|
|
|
|
Sun Microsystems, Inc. / Storage Technology Corp.
June 2, 2005;
|
|
|
|
ScanSoft, Inc. / Nuance Communications, Inc.
May 9, 2005;
|
|
|
|
Adobe Systems Incorporated / Macromedia, Inc.
April 18, 2005;
|
|
|
|
CA, Inc. / Concord Communications, Inc.
April 7, 2005;
|
|
|
|
Investor consortium consisting of Silver Lake Partners, Bain
Capital, Kohlberg Kravis Roberts & Co., The Blackstone
Group, Texas Pacific Group, Providence Equity Partners and
Goldman Sachs Capital Partners / SunGard Data Systems
Inc. March 28, 2005;
|
|
|
|
Avid Technology, Inc. / Pinnacle Systems, Inc.
March 21, 2005;
|
33
|
|
|
|
|
International Business Machines Corporation / Ascential Software
Corporation March 14, 2005;
|
|
|
|
Oracle Corporation / Retek Inc. March 8, 2005;
|
|
|
|
International Business Machines Corporation / Corio,
Inc. January 25, 2005;
|
|
|
|
Cadence Design Systems, Inc. / Verisity Ltd.
January 12, 2005;
|
|
|
|
UGS Corp. / Tecnomatix Technologies Ltd.
January 4, 2005;
|
|
|
|
Symantec Corporation / VERITAS Software Corporation
December 16, 2004;
|
|
|
|
Oracle Corporation / PeopleSoft, Inc.
December 13, 2004;
|
|
|
|
Synopsys, Inc. / Nassda Corporation December 1,
2004;
|
|
|
|
CA, Inc./ Netegrity, Inc. October 6, 2004;
|
|
|
|
Cognos Incorporated / Frango AB August 24, 2004;
|
|
|
|
Tektronix, Inc. / INet Technologies, Inc.
June 29, 2004;
|
|
|
|
BMC Software, Inc. / Marimba, Inc. April 29,
2004;
|
|
|
|
Hewlett-Packard Company / Novadigm, Inc.
February 4, 2004; and
|
|
|
|
Ariba, Inc. / Free-Markets News Network, Corp.
January 23, 2004.
|
While none of the companies that participated in the selected
transactions is directly comparable to Altiris, the companies
that participated in the selected transactions are companies
with operations that, for the purposes of analysis, may be
considered similar to certain of our operations.
For each of the selected transactions, Goldman Sachs calculated
and compared
|
|
|
|
|
the premium paid in relation to the market value of the acquired
companys stock for the one, five, ten and 20 trading day
period prior to announcement;
|
|
|
|
aggregate consideration (defined as equity consideration plus
debt minus cash and cash equivalents) as a multiple of the
target companys publicly reported revenues for the latest
twelve months, or LTM;
|
|
|
|
aggregate consideration as a multiple of the target
companys publicly available analyst estimates for revenues
for the next twelve months, or NTM; and
|
|
|
|
equity consideration as a multiple of the NTM earnings based on
IBES median estimates.
|
The following table presents the results of this analysis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium Over Target Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
Price Prior to Announcement
|
|
|
|
|
|
|
|
|
|
|
|
|
1-Day
|
|
|
5-Days
|
|
|
10-Days
|
|
|
20-Days
|
|
|
LTM
|
|
|
NTM
|
|
|
NTM
|
|
|
|
Prior
|
|
|
Prior
|
|
|
Prior
|
|
|
Prior
|
|
|
Revenues
|
|
|
Revenues
|
|
|
Price/Earnings
|
|
|
Mean
|
|
|
28.4
|
%
|
|
|
28.8
|
%
|
|
|
31.0
|
%
|
|
|
35.4
|
%
|
|
|
3.1
|
x
|
|
|
2.6
|
x
|
|
|
33.9x
|
|
Median
|
|
|
24.5
|
%
|
|
|
26.3
|
%
|
|
|
28.8
|
%
|
|
|
31.9
|
%
|
|
|
2.5
|
x
|
|
|
2.3
|
x
|
|
|
28.7x
|
|
Symantec/Altiris(1)(3)
|
|
|
22.3
|
%
|
|
|
25.6
|
%
|
|
|
26.3
|
%
|
|
|
28.1
|
%
|
|
|
3.7
|
x
|
|
|
3.4
|
x
|
|
|
30.8x
|
|
Symantec/Altiris(2)(3)
|
|
|
22.3
|
%
|
|
|
25.6
|
%
|
|
|
26.3
|
%
|
|
|
28.1
|
%
|
|
|
3.7
|
x
|
|
|
3.1
|
x
|
|
|
29.7x
|
|
|
|
|
(1) |
|
Based on IBES estimates. |
|
(2) |
|
Based on Altiris management forecasts. |
|
(3) |
|
For illustrative purposes, based on market data as of
January 25, 2007. |
The preparation of a fairness opinion is a complex process and
is not necessarily susceptible to partial analysis or summary
description. Selecting portions of the analyses or of the
summary set forth above, without considering the analyses as a
whole, could create an incomplete view of the processes
underlying Goldman Sachs opinion. In arriving at its
fairness determination, Goldman Sachs considered the results of
all of its analyses and did not
34
attribute any particular weight to any factor or analysis
considered by it. Rather, Goldman Sachs made its determination
as to fairness on the basis of its experience and professional
judgment after considering the results of all of its analyses.
No company or transaction used in the above analyses as a
comparison is directly comparable to Altiris or the contemplated
transaction.
Goldman Sachs prepared these analyses for purposes of Goldman
Sachs providing its opinion to our board of directors as to the
fairness, from a financial point of view, of the $33.00 per
share in cash to be received by the holders of the outstanding
shares of our common stock pursuant to the merger agreement.
These analyses do not purport to be appraisals nor do they
necessarily reflect the prices at which businesses or securities
actually may be sold. Analyses based upon forecasts of future
results are not necessarily indicative of actual future results,
which may be significantly more or less favorable than suggested
by these analyses. Because these analyses are inherently subject
to uncertainty, being based upon numerous factors or events
beyond the control of the parties or their respective advisors,
none of Altiris, Goldman Sachs or any other person assumes
responsibility if future results are materially different from
those forecast.
The merger consideration was determined through arms-length
negotiations between Altiris and Symantec and was unanimously
approved by our board of directors. Goldman Sachs provided
advice to our board of directors during these negotiations.
Goldman Sachs did not, however, recommend any specific amount of
consideration to Altiris or our board of directors or that any
specific amount of consideration constituted the only
appropriate consideration for the merger.
As described above, the Goldman Sachs opinion to our board of
directors was one of many factors taken into consideration by
our board of directors in making its determination to approve
the merger agreement. The foregoing summary does not purport to
be a complete description of the analyses performed by Goldman
Sachs in connection with the fairness opinion and is qualified
in its entirety by reference to the written opinion of Goldman
Sachs attached as Annex B to this proxy statement.
Goldman Sachs and its affiliates, as part of their investment
banking business, are continually engaged in performing
financial analyses with respect to businesses and their
securities in connection with mergers and acquisitions,
negotiated underwritings, competitive biddings, secondary
distributions of listed and unlisted securities, private
placements and other transactions as well as for estate,
corporate and other purposes. Goldman Sachs has acted as
financial advisor to Altiris in connection with, and has
participated in certain of the negotiations leading to, the
transaction contemplated by the merger agreement. In addition,
Goldman Sachs has provided certain investment banking services
to Symantec from time to time, including having acted as an
agent in connection with its share repurchase program in March
2004. Goldman Sachs also may provide investment banking services
to Altiris and Symantec in the future. In connection with the
above-described investment banking services Goldman Sachs has
received, and may receive in the future, compensation.
Goldman Sachs is a full service securities firm engaged, either
directly or through its affiliates, in securities trading,
investment management, financial planning and benefits
counseling, risk management, hedging, financing and brokerage
activities for both companies and individuals. In the ordinary
course of these activities, Goldman Sachs and its affiliates may
provide such services to Altiris, Symantec and their respective
affiliates, may actively trade the debt and equity securities
(or related derivative securities) of Altiris and Symantec for
their own account and for the accounts of their customers and
may at any time hold long and short positions of such securities.
Our board of directors selected Goldman Sachs as its financial
advisor because it is an internationally recognized investment
banking firm that has substantial experience in transactions
similar to the merger. Pursuant to a letter agreement dated
August 8, 2006, we engaged Goldman Sachs to act as our
financial advisor in connection with our consideration of
various financial alternatives. Pursuant to the terms of this
engagement letter, we have agreed to pay Goldman Sachs a
customary transaction fee, all of which is payable upon
consummation of the transaction. In addition, we have agreed to
reimburse Goldman Sachs for its expenses, including
attorneys fees and disbursements, and to indemnify Goldman
Sachs and related persons against various liabilities, including
certain liabilities under the federal securities laws.
35
Voting
Agreements
Concurrently with the execution and delivery of the merger
agreement, Symantec entered into voting agreements with the
following individuals and entities: each of the members of our
board of directors, Gregory S. Butterfield, our Chairman,
President and Chief Executive Officer, Dwain A. Kinghorn, our
Vice President, Chief Technology Officer, Michael R. Samuelian,
Vice President, Worldwide Sales, and Technology Crossover
Management IV, L.L.C. on behalf of TCV IV Strategic Partners
L.P. and TCV IV, L.P., together one of our major stockholders.
As of the record date for the Altiris special meeting, an
aggregate of 3,515,258 shares of Altiris common stock were
subject to the voting agreements, representing approximately
11.8% of the outstanding shares of Altiris common stock.
Pursuant to the voting agreements, the parties described above
have agreed, among other things, to vote all of their shares of
Altiris common stock:
|
|
|
|
|
in favor of the adoption of the merger agreement and any matter
proposed in connection with the merger that is reasonably
necessary to facilitate the merger; and
|
|
|
|
against any acquisition proposal other than the merger and any
other matter that would reasonably be expected to prevent,
delay, postpone or frustrate the purposes of the merger.
|
In addition, each of these parties has given representatives of
Symantec an irrevocable proxy to vote their shares of Altiris
common stock in this manner.
The voting agreements prohibit each of the parties described
above from transferring any shares of Altiris common stock at
any time prior to the termination of the voting agreement,
except that each of those parties will be able to:
|
|
|
|
|
exercise any options held by each such party;
|
|
|
|
transfer or otherwise dispose of shares of common stock to a
charitable organization qualified under Section 501(c)(3)
of the Internal Revenue Code of 1986, as amended;
|
|
|
|
with respect to an individual Altiris stockholder, transfer or
otherwise dispose of shares of common stock to any member of
such stockholders immediate family, or to a trust for the
benefit of such stockholder or any member of such
stockholders immediate family;
|
|
|
|
with respect to an entity Altiris stockholder, transfer any
shares of common stock to any affiliated fund; or
|
|
|
|
with respect to an entity Altiris stockholder, transfer, by way
of a distribution in kind following the record date set for the
Altiris special meeting, any shares of common stock to its
limited partners or general partner in accordance with the terms
of its limited partnership agreement; provided that any transfer
referred to above other than exercise any options held by
each such party above is permitted only if the transferee
agrees to be bound by the terms of the voting agreement, and if
requested by Symantec, to execute an irrevocable proxy.
|
Additionally, each of Gregory S. Butterfield, Dwain A. Kinghorn,
and Michael R. Samuelian may transfer up to 10,000, 21,800 and
4,024 shares of our common stock, respectively, to a
charitable organization qualified under Section 501(c)(3)
of the Internal Revenue Code of 1986, as amended, without such
charitable organization agreeing to be bound by the voting
agreement.
Each of the parties described above also has agreed not to
exercise any appraisal or similar rights under Section 262
of the Delaware General Corporation Law, as amended, in
connection with the merger. Those parties also agreed not to
deposit any shares of Altiris common stock in a voting trust or
subject any shares of Altiris common stock to any arrangement
with any person with respect to the voting of such shares of
Altiris common stock, except as permitted by the voting
agreement.
Each voting agreement terminates upon the earlier of the
completion of the merger or any termination of the merger
agreement, including a termination by Altiris in order to enter
into a written agreement for a superior proposal in accordance
with the terms of the merger agreement.
36
Interests
of our Directors and Executive Officers in the Merger
In considering the recommendation of our board of directors in
favor of the adoption of the merger agreement, you should be
aware that members of our board of directors and our executive
officers have interests in the merger that are different from,
or in addition to, yours.
All such additional interests are described below, to the extent
material, and except as described below, such persons have, to
our knowledge, no material interest in the merger apart from
those of stockholders generally. Our board of directors was
aware of, and considered the interests of, our directors and
executive officers in approving the merger agreement and the
merger.
Senior
Management Severance Plan
On October 20, 2005, Altiris implemented a Senior
Management Severance Plan, or the Severance Plan. Pursuant to
the Severance Plan, each of the employees that participate in
the Severance Plan, which are Stephen C. Erickson, Michael R.
Samuelian, Dwain A. Kinghorn, Stephen M. Madigan, Craig H.
Christensen, Carine Clark, Chad Latimer and Edward A. Reilly,
whose employment is terminated as a result of an involuntary
termination (as defined in the Severance Plan) within six months
following the date of the effective time of the merger will
receive the following benefits, provided, among other things,
that the employee executes a general release of claims:
|
|
|
|
|
a lump sum severance payment equal to twelve months base
salary in effect immediately prior to the effective time of the
merger, less applicable tax withholding;
|
|
|
|
100% of such employees target bonus for the year in which
the effective time of the merger occurs, less applicable tax
withholding;
|
|
|
|
full vesting of any unvested stock options;
|
|
|
|
a release of any right of Altiris to repurchase our common stock
owned by such employee; and
|
|
|
|
twelve months paid health, dental, vision and life
insurance benefits.
|
In addition, any such employee who remains continuously employed
by Altiris or a successor through the six month anniversary
following the effective time of the merger is also entitled to
receive the payments and benefits listed above as a retention
payment.
Messrs. Butterfield, Samuelian and Kinghorn will not
receive the benefits as set forth in the Severance Plan, as
their employment offer letters with Symantec discussed below
supersede the Severance Plan in the event that the merger is
completed.
Employment
Agreement between Altiris and Gregory S.
Butterfield
On July 28, 2006, we entered into an employment agreement
with Gregory S. Butterfield, referred to herein as his Altiris
Employment Agreement, which provides for specified benefits to
Mr. Butterfield in connection with the merger and the
transactions contemplated by the merger agreement. In the event
Mr. Butterfields employment with us terminates other
than for cause (as defined in the Altiris Employment Agreement),
death, or disability at any time between the period beginning on
the earlier of the execution of the merger agreement on
January 26, 2007 and ending 12 months after the
effective time of the merger, Mr. Butterfield will be
entitled to the following benefits, provided, among other
things, that he executes a general release:
|
|
|
|
|
two years of base salary as in effect as of the date of such
termination, less applicable tax withholding;
|
|
|
|
two times Mr. Butterfields annual bonus at 100% of
budget achievement, less applicable tax withholding;
|
|
|
|
full vesting of Mr. Butterfields equity awards
granted by Altiris; and
|
|
|
|
reimbursement for Mr. Butterfields and his
dependents Consolidated Omnibus Budget Reconciliation Act
(COBRA) premiums, provided that Mr. Butterfield elects such
COBRA coverage, until the earlier of
|
|
|
|
|
|
the date Mr. Butterfield is no longer eligible to receive
coverage pursuant to COBRA;
|
37
|
|
|
|
|
18 months from the termination date; or
|
|
|
|
until Mr. Butterfield obtains substantially similar
coverage from another employer.
|
Mr. Butterfield will also receive a
gross-up for
IRS Code Section 280G golden parachute taxes, if such taxes
are triggered. Mr. Butterfields Altiris Employment
Agreement will be superseded by his employment offer letter with
Symantec in the event that the merger is completed.
Indemnification
and Insurance
The merger agreement provides that for a period of six years
from and after the effective time of the merger, Symantec will
and will cause the surviving corporation in the merger to
fulfill and honor the obligations of Altiris to our directors
and officers as of immediately prior to the effective time of
the merger pursuant to any indemnification provisions under our
certificate of incorporation or bylaws in effect on the
January 26, 2007, and pursuant to the terms of any
indemnification agreements between us or any of our subsidiaries
and our directors and officers existing as of January 26,
2007 with respect to claims arising out of acts or omissions
occurring at or prior to the effective time of the merger.
The merger agreement also provides that for a period of six
years from and after the effective time of the merger, Symantec
and the surviving corporation in the merger will maintain in
effect, to the extent available, directors and
officers liability insurance covering those persons who
are currently covered by our directors and officers
liability insurance policy in an amount and on terms no less
advantageous, when taken as a whole, to those applicable to our
current directors and officers.
See section entitled The Merger Agreement
Indemnification and Insurance beginning on page 60.
Employment
Offer Letter between Symantec and Gregory S.
Butterfield
On January 26, 2007, Symantec entered into an employment
offer letter with Gregory S. Butterfield, the effectiveness of
which is contingent upon the completion of the merger. Pursuant
to such agreement, Mr. Butterfields position will be
Group President of the Altiris Division with an annual base
salary of $450,000, an annual target bonus of 80% of his annual
base salary, a non-qualified stock option to purchase
115,000 shares of common stock of Symantec and a grant of
50,000 restricted stock units, both under the Symantec 2004
Equity Incentive Plan. Additionally, Mr. Butterfield is
entitled to a $900,000 retention payment following two years of
active employment with Symantec. Upon completion of the merger,
subject to the execution of a standard release of claims, 50% of
Mr. Butterfields Altiris equity awards and Altiris
cash severance (as set forth in his Altiris Employment
Agreement) will vest or be paid, with another 25% vesting or
being paid six months after completion of the merger and the
remaining 25% vesting or being paid 12 months after
completion of the merger.
Subject to execution of a standard release of claims,
Mr. Butterfield will be entitled to the following benefits
if Symantec terminates his employment other than for cause (as
defined in the employment offer letter), Mr. Butterfield
resigns for good reason (as defined in the employment offer
letter) or upon his death or disability, within two years
following completion of the merger:
|
|
|
|
|
each equity award granted by Altiris will fully vest and become
exercisable;
|
|
|
|
he will become entitled to severance payments pursuant to the
Altiris Employment Agreement (less any payments of such
severance payments on the completion of the merger and the
six-month and
12-month
anniversaries of completion of the merger as described above);
|
|
|
|
he will become entitled to the payment of COBRA premiums for
Mr. Butterfield and his dependents for 18 months of
continuation coverage or until the earlier of
|
|
|
|
|
|
the date on which Mr. Butterfield is no longer eligible to
maintain COBRA coverage, or
|
|
|
|
until Mr. Butterfield is able to obtain similar coverage
under another employers group insurance plan;
|
|
|
|
|
|
25% of the equity awards granted by Symantec pursuant to the
employment offer letter will fully vest; and
|
|
|
|
he will become entitled to a $900,000 retention payment, less
applicable tax withholding.
|
38
Mr. Butterfield will also receive a
gross-up for
Internal Revenue Code Section 280G golden parachute taxes,
if such taxes are triggered.
Employment
Offer Letter between Symantec and Michael R.
Samuelian
On January 26, 2007, Symantec entered into an employment
offer letter with Michael R. Samuelian, the effectiveness of
which is contingent upon the completion of the merger. Pursuant
to such agreement, Mr. Samuelians position will be
Vice President of Sales of the Altiris Division with an annual
base salary of $280,000, an annual targeted commission of
$120,000, a non-qualified stock option to purchase
30,000 shares of common stock of Symantec and a grant of
22,500 restricted stock units, both under the Symantec 2004
Equity Incentive Plan. Additionally, Mr. Samuelian is
entitled to a $264,000 retention payment following two years of
active employment with Symantec. The agreement sets forth that
acceptance of the position with Symantec will not constitute a
triggering event under the Severance Plan. Subject to the
execution of a standard release of claims, 50% of
Mr. Samuelians Altiris equity awards and Altiris cash
severance (as set forth in the Severance Plan) will vest or be
paid six months after completion of the merger and the remaining
50% vesting or being paid 12 months after completion of the
merger.
Subject to execution of a standard release of claims,
Mr. Samuelian will be entitled to the following benefits if
Symantec terminates his employment other than for cause (as
defined in the employment agreement), Mr. Samuelian resigns
for good reason (as defined in the employment agreement) or upon
his death or disability, within two years following completion
of the merger:
|
|
|
|
|
each equity award granted by Altiris will fully vest and become
exercisable;
|
|
|
|
he will become entitled to severance payments pursuant to the
Severance Plan (less any payments of such severance payments on
the six-month and
12-month
anniversaries of completion of the merger as described above);
|
|
|
|
he will become entitled to the payment of COBRA premiums for
Mr. Samuelian and his dependents for 18 months of
continuation coverage or until the earlier of
|
|
|
|
|
|
the date on which Mr. Samuelian is no longer eligible to
maintain COBRA coverage; or
|
|
|
|
until Mr. Samuelian is able to obtain similar coverage
under another employers group insurance plan;
|
|
|
|
|
|
life insurance benefits for 12 months;
|
|
|
|
25% of the equity awards granted by Symantec pursuant to the
employment offer letter will fully vest; and
|
|
|
|
he will become entitled to a $264,000 retention payment, less
applicable tax withholding.
|
Employment
Offer Letter between Symantec and Dwain A.
Kinghorn
On January 26, 2007, Symantec entered into an employment
offer letter with Dwain A. Kinghorn, the effectiveness of which
is contingent upon the completion of the merger. Pursuant to
such agreement, Mr. Kinghorns position will be Vice
President, Engineering of the Altiris Division with an annual
base salary of $265,000, an annual target bonus of 40% of his
annual base salary, a non-qualified stock option to purchase
35,000 shares of common stock of Symantec and a grant of
22,500 restricted stock units, both under the Symantec 2004
Equity Incentive Plan. Additionally, Mr. Kinghorn is
entitled to a $264,000 retention payment following two years of
active employment with Symantec. The agreement sets forth that
acceptance of the position with Symantec will not constitute a
triggering event under the Severance Plan. Subject to the
execution of a standard release of claims, 50% of
Mr. Kinghorns Altiris equity awards and Altiris cash
severance (as set forth in the Severance Plan) will vest or be
paid six months after completion of the merger with the
remaining 50% vesting or being paid 12 months after
completion of the merger.
Subject to execution of a standard release of claims,
Mr. Kinghorn will be entitled to the following benefits if
Symantec terminates his employment other than for cause (as
defined in the employment agreement), Mr. Kinghorn
39
resigns for good reason (as defined in the employment agreement)
or upon his death or disability, within two years following
completion of the merger:
|
|
|
|
|
each equity award granted by Altiris will fully vest and become
exercisable;
|
|
|
|
he will become entitled to severance payments pursuant to the
Severance Plan (less any payments of such severance payments on
the six-month and
12-month
anniversaries of completion of the merger as described above);
|
|
|
|
he will become entitled to the payment of COBRA premiums for
Mr. Kinghorn and his dependents for 18 months of
continuation coverage or until the earlier of
|
|
|
|
|
|
the date on which Mr. Kinghorn is no longer eligible to
maintain COBRA coverage; or
|
|
|
|
until Mr. Kinghorn is able to obtain similar coverage under
another employers group insurance plan;
|
|
|
|
|
|
life insurance benefits for 12 months;
|
|
|
|
25% of the equity awards granted by Symantec pursuant to the
employment offer letter will fully vest; and
|
|
|
|
he will become entitled to a $264,000 retention payment, less
applicable tax withholding.
|
Acceleration
of RSUs
We have granted to Stephen C. Erickson, Michael R. Samuelian,
Dwain A. Kinghorn, Craig H. Christensen, Carine Clark, Chad
Latimer and Edward A. Reilly an aggregate of 110,000 RSUs that
are subject to vesting. In the event that the merger is
completed, all such RSUs will become fully vested and
immediately exercisable in connection with the merger.
Market
Price and Dividend Data
Our common stock is included in the Nasdaq Global Select Market
under the symbol ATRS. This table shows, for the
periods indicated, the range of high and low bids for our common
stock as quoted on the Nasdaq Global Select Market.
|
|
|
|
|
|
|
|
|
|
|
Altiris
|
|
|
|
Common Stock
|
|
|
|
Low
|
|
|
High
|
|
|
Year ended December 31,
2006
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
16.68
|
|
|
$
|
22.17
|
|
Second Quarter
|
|
$
|
16.34
|
|
|
$
|
22.20
|
|
Third Quarter
|
|
$
|
16.06
|
|
|
$
|
23.28
|
|
Fourth Quarter
|
|
$
|
20.28
|
|
|
$
|
25.92
|
|
Year ended December 31,
2005
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
23.85
|
|
|
$
|
34.39
|
|
Second Quarter
|
|
$
|
14.17
|
|
|
$
|
23.97
|
|
Third Quarter
|
|
$
|
12.89
|
|
|
$
|
15.29
|
|
Fourth Quarter
|
|
$
|
15.04
|
|
|
$
|
17.65
|
|
The following table sets forth the closing per share sales price
of our common stock, as reported on the Nasdaq Global Select
Market on January 26, 2007, the last full trading day
before the public announcement of the proposed merger, and on
March 6, 2007, the latest practicable trading day before the
date of this proxy statement:
|
|
|
|
|
|
|
Altiris Common Stock
|
|
|
|
Closing Price
|
|
|
January 26, 2007
|
|
$
|
27.14
|
|
March 6, 2007
|
|
$
|
32.64
|
|
40
We have never declared or paid cash dividends on our common
stock. Our current policy is to retain earnings for use in our
business. Following the completion of the merger, there will be
no further market for our common stock.
Regulatory
Matters
United States Antitrust. Under the HSR Act and
the rules thereunder, certain transactions, including the
merger, may not be completed unless certain waiting period
requirements have been satisfied. Symantec and we have each
filed a notification and report form pursuant to the HSR Act
with the Antitrust Division of the Department of Justice and the
Federal Trade Commission, but the waiting period has not yet
ended and we may each receive additional requests for
information. The requirements of the HSR Act will be satisfied
if the merger is completed within one year from the termination
of the waiting period. Even if the waiting period is terminated,
the Antitrust Division, the Federal Trade Commission or others
could take action under the antitrust laws with respect to the
merger, including seeking to enjoin the completion of the
merger, to rescind the merger or to conditionally approve the
merger. There can be no assurance that a challenge to the merger
on antitrust grounds will not be made or, if such a challenge is
made, that it would not be successful.
General. Comparable notifications and
antitrust review is required in the Federal Republic of Germany
and may be required in one or more additional jurisdictions.
Symantec has filed the required notification in the Federal
Republic of Germany, but the waiting period has not yet ended
and additional requests for information may be received. The
parties are currently evaluating the need for other such
notifications. All such filings will be effected as soon as
possible. It is possible that any of the governmental entities
with which filings are made may seek, as conditions for granting
approval of the merger, various regulatory concessions. There
can be no assurance that Symantec or we will be able to satisfy
or comply with these conditions or be able to cause our
respective subsidiaries to satisfy or comply with these
conditions, or that compliance or noncompliance will not have
adverse consequences for Symantec after completion of the
merger, or that the required regulatory approvals will be
obtained within the time frame contemplated by Symantec and us
or on terms that will be satisfactory to Symantec and us. In
addition, the merger agreement provides that Symantec is not
required to accept or agree to any such concession or conditions
under specified circumstances. See the section entitled
The Merger Agreement Conditions to the
Consummation of the Merger beginning on page 56.
Appraisal
Rights
The discussion of the provisions set forth below is not a
complete summary regarding your appraisal rights under Delaware
law and is qualified in its entirety by reference to the text of
the relevant provisions of Delaware law, which are attached to
this proxy statement as Annex C. Stockholders
intending to exercise appraisal rights should carefully review
Annex C. Failure to follow precisely any of the
statutory procedures set forth in Annex C may result
in a termination or waiver of these rights.
If the merger is consummated, dissenting holders of our common
stock who follow the procedures specified in Section 262 of
the Delaware General Corporate Law
(Section 262) within the appropriate time periods will
be entitled to have their shares of our common stock appraised
by a court and to receive the fair value of such
shares in cash as determined by the Delaware Court of Chancery
in lieu of the consideration that such stockholder would
otherwise be entitled to receive pursuant to the merger
agreement.
The following is a brief summary of Section 262, which sets
forth the procedures for dissenting from the merger and
demanding statutory appraisal rights. Failure to follow the
procedures set forth in Section 262 precisely could result
in the loss of appraisal rights. This proxy statement
constitutes notice to holders of our common stock concerning the
availability of appraisal rights under Section 262. A
stockholder of record wishing to assert appraisal rights must
hold the shares of stock on the date of making a demand for
appraisal rights with respect to such shares and must
continuously hold such shares through the effective time of the
merger.
Stockholders who desire to exercise their appraisal rights must
satisfy all of the conditions of Section 262. A written
demand for appraisal of shares must be filed with us before the
special meeting on April 4, 2007. This written demand for
appraisal of shares must be in addition to and separate from a
vote against the merger. Stockholders electing to exercise their
appraisal rights must not vote FOR adoption of the
merger agreement. Any proxy or vote against adoption of the
merger agreement will not in and of itself constitute a demand
for appraisal within the meaning of Section 262.
41
A demand for appraisal must be executed by or for the
stockholder of record, fully and correctly, as such
stockholders name appears on the share certificate. If the
shares are owned of record in a fiduciary capacity, such as by a
trustee, guardian or custodian, this demand must be executed by
or for the fiduciary. If the shares are owned by or for more
than one person, as in a joint tenancy or tenancy in common,
such demand must be executed by or for all joint owners. An
authorized agent, including an agent for two or more joint
owners, may execute the demand for appraisal for a stockholder
of record; however, the agent must identify the record owner and
expressly disclose the fact that, in exercising the demand, he
is acting as agent for the record owner. A person having a
beneficial interest in our common stock held of record in the
name of another person, such as a broker or nominee, must act
promptly to cause the record holder to follow the steps
summarized below and in a timely manner to perfect whatever
appraisal rights the beneficial owners may have.
Any of our stockholders who elects to exercise appraisal rights
should mail or deliver his, her or its written demand to us at
our address at 588 West 400 South, Lindon, Utah 84042,
Attention: Secretary. The written demand for appraisal should
specify the stockholders name and mailing address, and
that the stockholder is thereby demanding appraisal of his, her
or its Altiris common stock. Within ten days after the effective
time of the merger, we must provide notice of the effective time
of the merger to all of our stockholders who have complied with
Section 262 and have not voted for adoption of the merger
agreement.
Within 120 days after the effective time of the merger, but
not thereafter, any stockholder who has satisfied the
requirements of Section 262 may deliver to us a written
demand for a statement listing the aggregate number of shares
not voted in favor of adoption of the merger agreement and with
respect to which demands for appraisal have been received and
the aggregate number of holders of such shares. We, as the
surviving corporation in the merger, must mail such written
statement to the stockholder no later than the later of ten days
after the stockholders request is received by us or ten
days after the latest date for delivery of a demand for
appraisal under Section 262.
Within 120 days after the effective time of the merger, but
not thereafter, either we or any stockholder who has complied
with the required conditions of Section 262 and who is
otherwise entitled to appraisal rights may file a petition in
the Delaware Court of Chancery demanding a determination of the
fair value of the Altiris shares of stockholders entitled to
appraisal rights. We have no obligation or present intention to
file such a petition if demand for appraisal is made.
Upon the filing of any petition by a stockholder in accordance
with Section 262, service of a copy must be made upon us,
which we must, within 20 days after service, file in the
office of the Register in Chancery in which the petition was
filed, a duly verified list containing the names and addresses
of all stockholders who have demanded payment for their shares
and with whom agreements as to the value of their shares have
not been reached by us. If we file a petition, the petition must
be accompanied by the verified list. The Register in Chancery,
if so ordered by the court, will give notice of the time and
place fixed for the hearing of such petition by registered or
certified mail to us and to the stockholders shown on the list
at the addresses therein stated, and notice will also be given
by publishing a notice at least one week before the day of the
hearing in a newspaper of general circulation published in the
City of Wilmington, Delaware, or such publication as the court
deems advisable. The forms of the notices by mail and by
publication must be approved by the court, and we will bear the
costs thereof. The Delaware Court of Chancery may require the
stockholders who have demanded an appraisal for their shares,
and who hold stock represented by certificates, to submit their
stock certificates to the Register in Chancery for notation of
the pendency of the appraisal proceedings and the Delaware Court
of Chancery may dismiss the proceedings as to any stockholder
that fails to comply with such direction.
If a petition for an appraisal is filed in a timely fashion,
after a hearing on the petition, the court will determine which
stockholders are entitled to appraisal rights and will appraise
the shares owned by these stockholders, determining the fair
value of such shares, exclusive of any element of value arising
from the accomplishment or expectation of the merger, together
with a fair rate of interest to be paid, if any, upon the amount
determined to be the fair value.
Altiris stockholders considering seeking appraisal of their
shares should note that the fair value of their shares
determined under Section 262 could be more, the same or
less than the consideration they would receive pursuant to the
merger agreement if they did not seek appraisal of their shares.
The costs of the appraisal proceeding may be determined by the
court and taxed against the parties as the court deems equitable
under the circumstances. Upon
42
application of a dissenting stockholder, the court may order
that all or a portion of the expenses incurred by any dissenting
stockholder in connection with the appraisal proceeding,
including reasonable attorneys fees and the fees and
expenses of experts, be charged pro rata against the value of
all shares entitled to appraisal. In the absence of a
determination or assessment, each party bears his, her or its
own expenses. The exchange of shares for cash pursuant to the
exercise of appraisal rights will be a taxable transaction for
United States federal income tax purposes and possibly state,
local and foreign income tax purposes as well. See the section
entitled The Merger Material United States
Federal Income Tax Consequences on beginning on
page 43.
Any stockholder who has duly demanded appraisal in compliance
with Section 262 will not, after the effective time of the
merger, be entitled to vote for any purpose the shares subject
to demand or to receive payment of dividends or other
distributions on such shares, except for dividends or
distributions payable to stockholders of record at a date prior
to the effective time of the merger.
At any time within 60 days after the effective time of the
merger, any stockholder will have the right to withdraw his
demand for appraisal and to accept the terms offered in the
merger agreement. After this period, a stockholder may withdraw
his demand for appraisal and receive payment for his shares as
provided in the merger agreement only with our consent. If no
petition for appraisal is filed with the court within
120 days after the effective time of the merger,
stockholders rights to appraisal (if available) will
cease. Inasmuch as we have no obligation to file such a
petition, any stockholder who desires a petition to be filed is
advised to file it on a timely basis. No petition timely filed
in the court demanding appraisal may be dismissed as to any
stockholder without the approval of the court, which approval
may be conditioned upon such terms as the court deems just.
Failure by any Altiris stockholder to comply fully with the
procedures described above and set forth in Annex C
to this proxy statement may result in termination of such
stockholders appraisal rights.
Accounting
Treatment
The merger will be accounted for as a purchase
transaction for financial accounting purposes.
Material
United States Federal Income Tax Consequences
This section discusses certain material United States federal
income tax consequences of the merger to Altiris stockholders
whose shares of our stock are surrendered in the merger in
exchange for cash. This discussion is included for general
information purposes only and does not constitute, and is not, a
tax opinion or tax advice to any particular holder of Altiris
stock. This summary is based on the provisions of the Internal
Revenue Code of 1986, as amended, or the Code, the Treasury
Regulations promulgated thereunder, judicial decisions,
administrative rulings and other legal authorities, all as of
the date hereof and all of which are subject to change, possibly
with retroactive effect. No ruling from the Internal Revenue
Service, or the IRS, nor an opinion of counsel will be requested
concerning the United States federal income tax consequences of
the merger. The tax consequences set forth in the following
discussion are not binding on the IRS or the courts, and no
assurance can be given that contrary positions will not be
successfully asserted by the IRS or adopted by a court.
The following discussion does not address all of the United
States federal income tax consequences that may be relevant to a
particular holder of our stock, including holders who, in light
of their particular circumstances, may be subject to special
rules, including, without limitation:
|
|
|
|
|
financial institutions, mutual funds, tax-exempt organizations,
insurance companies, dealers in securities, persons that
mark-to-market
their securities, or persons that hold our stock as part of a
straddle, hedge or synthetic
security transaction (including a conversion
transaction);
|
|
|
|
holders that are nonresident alien individuals, foreign
corporations, foreign partnerships, foreign trusts or foreign
estates;
|
|
|
|
holders who hold our stock through pass-through entities;
|
|
|
|
holders of our options or warrants;
|
43
|
|
|
|
|
holders who acquired our stock pursuant to the exercise of stock
options, pursuant to participation in an employee stock purchase
plan or otherwise as compensation;
|
|
|
|
holders who hold their our stock as qualified small business
stock; or
|
|
|
|
holders who exercise dissenters rights.
|
The discussion below applies only to our stockholders that hold
our stock as capital assets at the time of the completion of the
merger. The discussion does not include any description of the
tax laws of any state, local or foreign government that may be
applicable to our stockholders.
Taxable Sale. The exchange of shares of our
stock for cash in the merger will be a taxable transaction for
United States federal income tax purposes. A holder of our stock
generally will recognize capital gain or capital loss equal to
the difference, if any, between the amount of cash received by
the stockholder pursuant to the merger and the
stockholders adjusted tax basis in the shares of our stock
surrendered. Gain or loss will be calculated separately for each
block of shares (or shares acquired at the same cost in a single
transaction) exchanged in the merger. If at the time of the
merger a non-corporate stockholders holding period for the
shares of our stock is more than one year, any gain recognized
generally will be subject to United States federal income tax at
a maximum rate of 15%. If the non-corporate stockholders
holding period for the shares of our stock is one year or less
at the time of the merger, any gain will be subject to United
States federal income tax at the same graduated rates as
ordinary income. The deductibility of capital losses is subject
to limitations. For corporations, capital gain is taxed at the
same rates as ordinary income, and the use of capital losses is
subject to limitations.
Federal Backup Withholding. To prevent federal
backup income tax withholding with respect to cash received
pursuant to the merger, each holder of our stock must either
provide a correct taxpayer identification number and certify
that such holder is not subject to backup withholding of federal
income tax by completing the substitute
Form W-9
included in the letter of transmittal or establish a basis for
exemption from backup withholding. Holders of our stock who fail
to provide their correct taxpayer identification numbers and the
appropriate certifications or to establish an exemption will be
subject to backup withholding on cash paid in exchange for our
stock at a tax withholding rate of 28% and may be subject to a
penalties imposed by the IRS. If the amount withheld on a
payment to a holder of Altiris stock results in an overpayment
of taxes, a refund generally may be obtained from the IRS.
EACH HOLDER OF OUR STOCK SHOULD CONSULT HIS, HER OR ITS OWN
TAX ADVISORS TO DETERMINE THE UNITED STATES FEDERAL INCOME TAX
CONSEQUENCES APPLICABLE TO SUCH HOLDER AS A RESULT OF THE
MERGER, AND ANY STATE, LOCAL OR FOREIGN TAX CONSEQUENCES
RELEVANT TO SUCH HOLDER AS A RESULT OF THE MERGER.
Delisting
and Deregistration of our Common Stock
If the merger is completed, our common stock will no longer be
traded on the Nasdaq Global Select Market and will be
deregistered under the Securities Exchange Act of 1934, as
amended, as soon as practicable following the completion of the
merger. The delisting and deregistration will be accomplished by
filing a Form 25 and a Form 15 with the SEC.
44
THE
MERGER AGREEMENT
The following is a description of the material aspects of the
merger agreement but does not purport to describe all of the
terms of the merger agreement. While we believe that the
following description covers the material terms of the merger
agreement, the description may not contain all of the
information that is important to you. We encourage you to read
carefully this entire document, including the merger agreement
attached to this proxy statement as Annex A, for a
more complete understanding of the merger. The following
description is subject to, and is qualified in its entirety by
reference to, the merger agreement.
The merger agreement has been included to provide you with
information regarding its terms. It is not intended to provide
any other factual information about Altiris or its business.
Such information can be found elsewhere in this proxy statement
and in the other public filings we make with the SEC, which are
available without charge at www.sec.gov.
The
Merger
Pursuant to the merger agreement, Merger Sub will merge with and
into Altiris, with Altiris surviving as a wholly owned
subsidiary of Symantec, sometimes referred to in this proxy
statement as the surviving corporation. At the effective time of
the merger, all of Altiris property, rights, privileges,
immunities, powers and franchises before the merger will vest in
the surviving corporation and all of Altiris debts,
liabilities and duties before the merger will become the debts,
liabilities and duties of the surviving corporation. Following
the completion of the merger, the directors of Merger Sub at the
effective time of the merger will become the directors of the
surviving corporation, and the officers of Merger Sub at the
effective time will become the officers of the surviving
corporation.
Merger
Consideration
The merger agreement provides that each share of our common
stock outstanding immediately prior to the effective time of the
merger (other than shares of our common stock in respect of
which appraisal rights under Delaware law have been perfected,
or shares held by Altiris or any of our subsidiaries which will
be canceled in the merger), will be converted into the right to
receive $33.00 in cash, without interest.
Procedures
for Payment of Merger Consideration
Stockholders should not return share certificates with the
enclosed proxy card.
Computershare Trust Company, Inc. will act as the exchange agent
for the payment of the merger consideration. Promptly after the
completion of the merger, Symantec will instruct the exchange
agent to mail the following materials to each holder of record
of our common stock at the time the merger is consummated:
|
|
|
|
|
a letter of transmittal for the stockholders use in
submitting its shares to the exchange agent for payment of the
merger consideration, and
|
|
|
|
instructions explaining what a stockholder must do to effect the
surrender of its share certificates in exchange for the merger
consideration.
|
Upon receipt of a letter of transmittal from the exchange agent,
each stockholder should complete and sign the letter of
transmittal and return it to the exchange agent together with
the stockholders share certificates and any other
necessary documentation in accordance with the instructions.
Upon completion of the merger, each Altiris share certificate,
other than those representing shares of our common stock in
respect of which appraisal rights under Delaware law have been
perfected and shares of our common stock held by Altiris or any
of our subsidiaries (which will be canceled in the merger), will
represent only the right to receive $33.00 in cash, without
interest.
Promptly after completion of the merger, Symantec will deposit
cash sufficient to deliver the aggregate merger consideration in
trust with the exchange agent for the benefit of our former
stockholders.
45
Symantec and the surviving corporation are entitled to deduct
and withhold from the consideration otherwise payable such
amounts as are required by applicable law.
Transfers
of Ownership and Lost Stock Certificates
Following the effective time of the merger, there will be no
further registration of transfers of shares of Altiris common
stock and warrants. If, after such time, certificates
representing Altiris common stock are presented to the surviving
corporation, they will be cancelled and exchanged for the merger
consideration. If any portion of the merger consideration is to
be paid to a person other than the person in whose name the
surrendered share certificate is registered in our records, the
exchange agent will only issue such merger consideration if the
certificate representing such shares and presented to the
exchange agent is properly endorsed or is otherwise accompanied
by all documents required to evidence and effect such transfer
and the person surrendering the share certificate for payment
evidences that any applicable stock transfer taxes have been
paid.
In the event any share certificate has been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the
person claiming such share certificate to be lost, stolen or
destroyed and, if required by the Symantec or the exchange
agent, the posting by such person of a bond in such amount as
Symantec or the exchange agent may reasonably direct as
indemnity against any claim that may be made against Symantec,
the surviving corporation or the exchange agent with respect to
such share certificate, the exchange agent will issue, in
exchange for such lost, stolen or destroyed share certificate,
the merger consideration, the right into which shares
represented by such certificate have been converted pursuant to
the merger agreement.
Unclaimed
Amounts
Any portion of the merger consideration which remains
undistributed to our stockholders six months after the effective
time of the merger will be delivered by the exchange agent to
Symantec, on demand, and thereafter any of our stockholders who
have not previously exchanged shares for the merger
consideration will only be entitled to request payment of the
merger consideration from Symantec or the surviving corporation.
Effect on
Outstanding Altiris Stock Options and other Equity
Awards
Stock
Options
Symantec will assume all Altiris options outstanding immediately
prior to the effective time of the merger, and the assumed
options will be converted into options to purchase shares of
Symantec common stock. Generally, each option will continue to
be subject to the terms and conditions, including the vesting
schedule, set forth in the Altiris stock plan under which the
option was granted and the individual stock option agreements
governing that option. However, following the closing of the
merger, Altiris options will become options to purchase Symantec
common stock with the exercise price and number of shares
underlying the option adjusted to reflect the merger. The
exercise price and the number of shares of Symantec common stock
subject to Altiris options after the merger will be determined
pursuant to the merger agreement, which provides that the number
of shares of Symantec common stock subject to Altiris options
will be determined by multiplying the number of shares that were
subject to the Altiris option immediately prior to the merger by
an exchange ratio and then rounding the result down to the
nearest whole share. The exchange ratio used for this purpose
will be calculated immediately prior to the completion of the
merger by dividing $33.00 by the average of the closing sales
prices of Symantec common stock as quoted on the Nasdaq Global
Select Market for the 10 consecutive trading days ending with
the trading day that is one trading day prior to the completion
of the merger. The per share exercise price for each share
issuable upon exercise of the Altiris options will be adjusted
to a price determined by dividing the per share exercise price
applicable to the Altiris option immediately prior to completion
of the merger by the same exchange ratio and rounding up to the
nearest whole cent.
RSUs
Symantec will also assume all outstanding Altiris RSUs in the
merger, and these assumed RSUs will be converted into rights to
receive shares of Symantec common stock. Generally, each RSU
will continue to be subject to the terms and conditions,
including the vesting schedule, set forth in the Altiris stock
plan under which the RSUs
46
were granted and the related restricted stock unit award
agreement, except that the RSUs will become rights to receive
Symantec common stock at vesting with the number of shares
subject to the RSUs adjusted in accordance with the terms of the
merger agreement. The number of shares of Symantec common stock
deliverable at vesting will be adjusted by multiplying the
number of shares of Altiris common stock subject to the RSU
immediately prior to completion of the merger by the exchange
ratio described above and rounding down to the nearest whole
share.
Restricted
Stock
Any restricted shares of Altiris common stock held as of
immediately prior to the effective time of the merger will be
converted into the right to receive $33.00 cash, without
interest, less applicable tax withholding, subject to the
vesting schedule applicable to such restricted shares. In
general, holders of restricted shares will receive this cash
consideration with respect to unvested shares in accordance with
the applicable vesting schedule, provided that the holders of
the restricted stock awards satisfy the applicable vesting
requirements, and that the cash consideration will be reduced by
applicable tax withholding. Until vested, such cash
consideration will be held by Symantec. Any cash payments made
for vesting of unvested shares will be made by Symantec
according to its normal payroll procedures following the date
within a month upon which such cash payments vested.
Representations
and Warranties
The representations and warranties described below and
included in the merger agreement were made by Altiris and
Symantec solely for the benefit of each other for purposes of
the merger agreement. These representations and warranties were
made as of specific dates and are in some cases subject to
important qualifications, limitations and supplemental
information agreed to by Altiris and Symantec in connection with
negotiating the terms of the merger agreement. In addition, the
representations and warranties may have been included in the
merger agreement for the purpose of allocating risk between
Altiris and Symantec or establishing the circumstances in which
a party is not obligated to complete the merger if the
representations and warranties of the other party prove to be
untrue due to a change in circumstance or otherwise, rather than
to establish matters as facts. Moreover, the representations and
warranties may also be subject to a contractual standard of
materiality or material adverse effect different from those
generally applicable to stockholders, and information concerning
the subject matter of such representations and warranties may
change after the dates specified in the merger agreement, which
subsequent information may or may not be fully reflected in
public disclosures. Accordingly, you should not rely on the
representations and warranties as disclosures or
characterizations of the actual state of facts and circumstances
regarding Altiris or Symantec. The representations and
warranties and other provisions of the merger agreement should
not be read alone, and you should read the information provided
elsewhere in this document for information regarding the
parties. See the section entitled Where You Can Find More
Information beginning on page 64.
Altiris
We have made a number of representations and warranties to
Symantec regarding aspects of our business and other matters
pertinent to the merger. The topics covered by these
representations and warranties include the following:
|
|
|
|
|
our and our subsidiaries corporate organization, good
standing and qualification;
|
|
|
|
our ownership of our subsidiaries and our subsidiaries
capital structure;
|
|
|
|
our corporate power and authority to enter into the merger
agreement and consummate the merger and other transactions
contemplated by the merger agreement, and the approval by our
board of directors of the merger and the merger agreement;
|
|
|
|
governmental consents, approvals and filings required in
connection with the merger;
|
|
|
|
the enforceability of the merger agreement as a binding
agreement of Altiris;
|
|
|
|
required approvals under Delaware law and other state laws
governing takeovers;
|
47
|
|
|
|
|
our capital structure, including details regarding our stock
options and other equity incentive awards, and our debt
obligations;
|
|
|
|
no conflict resulting from the merger agreement or the merger
with our charter documents, applicable law or our material
contracts or privacy policies, and no creation or imposition of
any lien as a result of entering into the merger agreement or
completing the merger;
|
|
|
|
the filing of required reports, prospectuses and other documents
with the SEC, the compliance of such reports with the
requirements of applicable federal securities laws, rules and
regulations, the accuracy and completeness of the information
contained in such reports and the content of our financial
statements included in such reports, including the absence of
undisclosed liabilities;
|
|
|
|
our compliance with the Sarbanes-Oxley Act of 2002;
|
|
|
|
the accuracy and completeness of information in this proxy
statement and its compliance with applicable federal securities
laws;
|
|
|
|
the absence of pending or threatened litigation, the absence of
governmental orders, and the absence of any material internal
investigations since January 1, 2005;
|
|
|
|
our compliance with laws and governmental permits, including
laws with respect to export controls and corrupt practices;
|
|
|
|
our compliance with NASDAQ listing requirements and corporate
governance rules and regulations;
|
|
|
|
tax matters;
|
|
|
|
title to and condition of our and our subsidiaries
properties and assets;
|
|
|
|
absence of specified changes during the period from
September 30, 2006 to January 26, 2007;
|
|
|
|
disclosure of our material contracts, performance of our
obligations under those contracts and no defaults under those
contracts;
|
|
|
|
non-competition agreements and other restrictions on our
business;
|
|
|
|
intellectual property matters;
|
|
|
|
interested party agreements or transactions involving us and our
officers, directors or 10% stockholders;
|
|
|
|
employee benefits matters, including compliance with the
Employee Retirement Income Security Act, or ERISA;
|
|
|
|
agreements with bankers, brokers and finders;
|
|
|
|
insurance matters;
|
|
|
|
environmental matters;
|
|
|
|
our significant customers and suppliers;
|
|
|
|
our compliance with applicable privacy laws; and
|
|
|
|
the opinion of our financial advisor with respect to the
fairness of the merger consideration.
|
Symantec
Symantec has made a number of representations and warranties to
us regarding various matters pertinent to the merger. The topics
covered by these representations and warranties include the
following:
|
|
|
|
|
Symantecs and Merger Subs corporate organization,
good standing and qualification;
|
|
|
|
Symantecs and Merger Subs corporate power and
authority to enter into the merger agreement and consummate the
merger and the other transactions contemplated by the merger
agreement;
|
48
|
|
|
|
|
governmental consents, approvals and filings required in
connection with the merger;
|
|
|
|
the enforceability of the merger agreement as a binding
agreement of Symantec and Merger Sub;
|
|
|
|
no conflict resulting from the merger agreement or the merger
with Symantecs or Merger Subs charter documents,
applicable law or Symantecs or Merger Subs
contracts, and no creation or imposition of any lien as a result
of entering into the merger agreement or completing the merger;
|
|
|
|
availability to Symantec of sufficient funds to pay the merger
consideration;
|
|
|
|
ownership of our stock by Symantec or Merger Sub;
|
|
|
|
no prior Merger Sub operations; and
|
|
|
|
the accuracy and completeness of information provided by
Symantec for inclusion in this proxy statement.
|
Material
Adverse Effect
Several of the representations and warranties of Altiris and
Symantec are qualified by a material adverse effect or material
adverse change standard. As used in the merger agreement and
this proxy statement, a material adverse effect or
material adverse change means, with respect to
Altiris, Symantec or Merger Sub, any change, event,
circumstance, condition or effect, that is or is reasonably
likely to be, individually or in the aggregate, materially
adverse to the condition (financial or otherwise), assets
(including intangible assets), business, operations or results
of operations of such entity and its subsidiaries, taken as a
whole, except to the extent that any such effect is proximately
caused by:
|
|
|
|
|
changes in general economic conditions or changes affecting the
industry generally in which that entity operates (provided that
such changes do not affect that entity disproportionately as
compared to companies operating in the same industry in which
that entity operates);
|
|
|
|
changes in the trading volume or trading prices of such
entitys capital stock in and of themselves (provided that
this exclusion will not apply to any underlying effect that may
have caused such change in trading prices or volumes);
|
|
|
|
acts of war or terrorism (provided that such acts do not affect
that entity disproportionately as compared to companies
operating in the same industry in which that entity operates);
|
|
|
|
changes in applicable law or United States generally accepted
accounting principles, or GAAP;
|
|
|
|
any failure to meet analysts estimates or expectations as to
revenue, earnings or other financial performance (provided that
this exclusion will not apply to any underlying effect that may
have caused such failure); or
|
|
|
|
the announcement or the execution of the merger agreement or the
pendency or consummation of the merger.
|
References in this proxy statement to material adverse effect or
material adverse change have the same meaning as that which is
described above.
Interim
Operations of Altiris
We have agreed that, prior to the completion of the merger, each
of Altiris and our subsidiaries will use reasonable best efforts
to conduct our business in the ordinary course consistent with
past practices and
use reasonably diligent efforts to assure that contracts entered
into prior to the completion of the merger do not require
consents, waivers or novations as a result of the merger.
In addition, we have agreed that, prior to the completion of the
merger, unless otherwise approved in writing by Symantec,
neither Altiris nor any of its subsidiaries will:
|
|
|
|
|
incur any indebtedness or guarantee the indebtedness of another
person or entity, except for:
|
|
|
|
|
|
indebtedness for borrowed money under or guarantees with respect
to indebtedness under any existing debt obligation or existing
line of credit disclosed to Symantec;
|
49
|
|
|
|
|
indebtedness of, by and among Altiris and our
subsidiaries; or
|
|
|
|
guarantees of indebtedness under corporate credit cards held by
employees in the ordinary course of business, consistent with
past practices;
|
|
|
|
|
|
guarantee, assume or endorse the performance obligations of any
other entity or person;
|
|
|
|
lend any money other than reasonable and normal advances to
employees for ordinary expenses in the ordinary course of
business;
|
|
|
|
make any material investments in or material capital
contributions to any entity or person;
|
|
|
|
forgive or discharge any outstanding loans or advances;
|
|
|
|
prepay any indebtedness except in the ordinary course of
business consistent with past practices;
|
|
|
|
enter into specified types of material contracts described in
the merger agreement other than contracts providing for
commercial sales of our products or services in the ordinary
course of business;
|
|
|
|
materially breach, terminate, adversely amend, modify or waive
any of the material terms of, any of our material contracts,
except as otherwise permitted by this section of the merger
agreement;
|
|
|
|
make specified purchases, sales, pledges, dispositions of,
leases, licenses or transfers of our property or assets material
to our business, other than permitted encumbrances and sales or
non-exclusive licenses of our products or services in the
ordinary course of business;
|
|
|
|
except as permitted by this section of the merger agreement:
|
|
|
|
|
|
increase the base salary, incentive compensation, severance or
retention benefits or perquisites to our directors or executive
officers, (except increases pursuant to existing contracts
disclosed to Symantec and increases in the ordinary course of
business not in excess of 10% of base salary), nor provide any
severance, acceleration of vesting or other similar benefits to
any of such persons;
|
|
|
|
increase the compensation or benefits to our other employees
(except increases pursuant to existing contracts disclosed to
Symantec and increases in the ordinary course of business
consistent with past practice not in excess of 10% of base
salary), nor provide any severance, acceleration of vesting or
other similar benefits to any of such persons, except pursuant
to existing contracts disclosed to Symantec or as required by
applicable law;
|
|
|
|
amend or enter into any employment or consulting contract with
any officer or director (except in the ordinary course of
business pursuant to a standard offer letter with no severance,
retention or acceleration provisions);
|
|
|
|
adopt any plan or arrangement to provide compensation or
benefits to any employees, directors or consultants, or amend
any company benefit except as required by applicable law; or
|
|
|
|
materially amend any deferred compensation plan within the
meaning of Section 409A of the Code and Internal Revenue
Service Notice
2005-1 or
stock options except to the extent necessary to meet the good
faith compliance requirements of such Section or Notice;
|
|
|
|
|
|
make any material change in accounting policies or procedures,
except as required by GAAP or international accounting standards;
|
|
|
|
declare, set aside or pay any cash or stock dividend or other
distribution (whether in cash, stock or property) in respect to
its capital stock;
|
|
|
|
redeem, repurchase or otherwise acquire any of our capital stock
or other securities (except for certain repurchases from
employees and consultants in connection with the termination of
their services);
|
|
|
|
pay or distribute any cash or property to any of our
stockholders or security holders or make any other cash payment
to any of its stockholders or security holders;
|
50
|
|
|
|
|
terminate, waive or release any material right or claim, other
than any termination, waiver or release of any such right or
claim under customer contracts with respect to company products
or services that are immaterial to our business and do not
involve one of our significant customers;
|
|
|
|
issue, sell, create or authorize any shares of our capital stock
or grant any other securities other than:
|
|
|
|
|
|
the issuance of shares of stock pursuant to the exercise of our
options or warrants outstanding on January 26,
2007; and
|
|
|
|
the issuance of our options to newly hired employees in the
ordinary course of business, consistent with past practices,
subject to certain restrictions;
|
|
|
|
|
|
subdivide, split, combine or reverse split the outstanding
shares of any series of its stock or enter into any
recapitalization affecting the number of its outstanding shares
or affecting any other of its securities;
|
|
|
|
merge, consolidate or reorganize with, acquire, or enter into
any other business combination with any other entity or acquire
a substantial portion of the assets of any such entity;
|
|
|
|
amend its certificate of incorporation or bylaws or other
comparable charter documents except as required by applicable
law and except for immaterial amendments to an Altiris
subsidiarys charter documents;
|
|
|
|
license any of our technology or intellectual property except
for licenses for commercial sales of our products or services
made in the ordinary course of business;
|
|
|
|
acquire or license any intellectual property from a third party
under a contract that has cancellation penalties and requires
payments in excess of $1,000,000 per year or has other
materially restrictive terms, other than licenses of software
generally available to the public at a per copy license fee of
less than $10,000;
|
|
|
|
transfer or provide our source code to any person, other than to
our employees and consultants or as required under pre-existing
customer agreements;
|
|
|
|
materially change any insurance coverage;
|
|
|
|
agree to any audit assessment by any tax authority with respect
to income taxes or any material audit assessment with respect to
other taxes;
|
|
|
|
file or amend any income tax return or other material tax return
without providing copies to Symantec for review prior to filing;
|
|
|
|
make or change any material election in respect of taxes or
adopt or change any material accounting method in respect of
taxes, except as required by applicable law;
|
|
|
|
enter into any closing agreement, settle any claim or assessment
in respect of income taxes or other material taxes, surrender
any right to claim a refund of taxes, or consent to any
extension or waiver of the limitation period applicable to any
claim or assessment in respect of income taxes or other material
taxes;
|
|
|
|
subject to specified exceptions, modify or change the exercise
or conversion rights or exercise or purchase prices of any of
its capital stock, options, warrants or other securities, or
accelerate or otherwise modify the following:
|
|
|
|
|
|
the right to exercise any option, warrant or other right to
purchase any of its capital stock or other securities; or
|
|
|
|
the vesting or release of any shares of its capital stock or
other securities from any repurchase options or rights of
refusal held by it or any other party or any other restrictions;
|
51
|
|
|
|
|
except where the amount in controversy does not exceed $500,000
and does not involve injunctive or other equitable relief:
|
|
|
|
|
|
initiate any litigation, action, suit, proceeding, claim or
arbitration, other than exceptions for the routine collection of
bills, to enforce our rights under the merger agreement,
pre-existing litigation, and specified intellectual property
enforcement actions; or
|
|
|
|
settle or agree to settle any litigation, action, suit,
proceeding, claim or arbitration;
|
|
|
|
|
|
pay, discharge or satisfy any liability in an amount in excess
of $500,000 in any one case or $1,000,000 in the aggregate,
other than:
|
|
|
|
|
|
liabilities arising in the ordinary course of business;
|
|
|
|
liabilities already reflected or reserved against in our balance
sheet; and
|
|
|
|
the payment, discharge or satisfaction of transaction expenses
related to the merger;
|
|
|
|
|
|
make any capital expenditures or otherwise, apart from those
scheduled to be made prior to July 31, 2007 under our
capital expense budget for the 2007 fiscal year delivered to
Symantec;
|
|
|
|
materially change our warranties, discounts or credits to
customers, other than changes in the ordinary course of business
which are together immaterial to our business; or
|
|
|
|
agree to do any of the things described above.
|
Employee
Benefit Matters
Symantec will enroll Altiris employees who become Symantec
employees or who remain employees of the surviving corporation
as promptly as reasonably practicable after the completion of
the merger in Symantecs employee benefit plans for which
those employees are eligible (which may include, at
Symantecs sole discretion, Altiris benefit plans
continued by Symantec), including Symantecs medical plans,
dental plans, life insurance plans and disability plans, on
substantially similar terms as those applicable to employees of
Symantec who are similarly situated based on levels of
responsibility. Symantec will recognize the prior service with
us for each of our employees who becomes a Symantec employee:
|
|
|
|
|
for all purposes in connection with Symantecs paid time
off policy, severance policy, 401(k) plan, medical plans, dental
plans, life insurance plans and disability plans; and
|
|
|
|
for all purposes in connection with all other Symantec benefit
plans (to the extent permitted by the terms of the applicable
Symantec plans).
|
The benefit levels under such Symantec plans may nevertheless
depend in part on the grade or position our former employees
hold with Symantec as set forth under the terms of the
applicable Symantec plans. Symantec will have no obligation to
duplicate any benefit provided to any of our former employees or
to fund any benefit not previously funded or to continue in
effect any of our benefit programs, severance plans, or other
employee benefit plans of Symantec, and Symantec is free to
amend, modify, or terminate any Symantec employee benefit plans
following the completion of the merger. The employment of our
employees who become employees of Symantec is at-will and
terminable by Symantec at any time.
Stockholder
Meeting
We have agreed to take all action necessary in accordance with
our charter documents and applicable law to give notice of,
convene and hold a meeting of our stockholders as soon as
reasonably practicable after January 26, 2007 and, unless
there has been a change in our board of directors
recommendation of the merger, to obtain the required stockholder
adoption of the merger agreement, including by using reasonable
best efforts to solicit proxies from our stockholders in favor
of the adoption of the merger agreement. Subject to its ability
to change its recommendation under certain circumstances (see
the The Merger Agreement No Solicitation
Covenant below), our board of directors has agreed to
recommend the adoption of the merger agreement to our
stockholders.
52
No
Solicitation Covenant
We have agreed with Symantec that we will not, and will cause
our subsidiaries not to, permit any of our or our
subsidiaries officers, directors, attorneys or financial
advisor (or our or our subsidiaries other employees,
agents or representatives who have the authority to act on
behalf of Altiris or our subsidiaries regarding any alternative
transaction, as described below), which persons we sometimes
refer to herein as our representatives, to, directly or
indirectly:
|
|
|
|
|
solicit, initiate, seek, endorse, recommend or support, or
knowingly encourage or facilitate any inquiry, proposal or offer
from, furnish any non-public information to, or participate in
any discussions or negotiations with, or enter into any
agreement with, any party or group regarding any alternative
transaction
|
|
|
|
approve, endorse or recommend any alternative transaction,
except to the extent specifically permitted by the merger
agreement, as described below under the heading
No Solicitation Covenant Change in
Recommendation; or
|
|
|
|
enter into any letter of intent or similar document or any
contract, agreement or commitment (whether binding or not)
contemplating or otherwise relating to any alternative
transaction proposal, as described below.
|
As used in the merger agreement and in this proxy statement, the
term alternative transaction means any of the
following (other than the merger involving Symantec):
|
|
|
|
|
any acquisition or purchase by any person or group of more than
a 15% interest in the total outstanding voting securities of
Altiris;
|
|
|
|
any tender offer or exchange offer that, if consummated, would
result in any person or group beneficially owning securities
representing 15% or more of the total outstanding voting power
of Altiris;
|
|
|
|
any merger, consolidation, business combination, share exchange
or similar transaction involving Altiris pursuant to which our
stockholders immediately preceding such transaction hold
securities representing less than 85% of the total outstanding
voting power of the surviving or resulting entity of such
transaction (or parent entity of such surviving or resulting
entity);
|
|
|
|
any sale, lease, exchange, transfer, exclusive license or
disposition of assets (including capital stock or other
ownership interests in our subsidiaries) representing 15% or
more of the aggregate fair market value of the consolidated
assets of Altiris and our subsidiaries taken as a whole;
|
|
|
|
any liquidation or dissolution of Altiris; or
|
|
|
|
any extraordinary dividend, whether of cash or other property.
|
As used in the merger agreement and in this proxy statement, the
term alternative transaction proposal means any
offer, proposal or indication of interest (whether binding or
non-binding), or any public announcement of an intention to make
any offer, proposal or indication of interest, to Altiris or our
stockholders regarding an alternative transaction.
As used in the merger agreement and in this proxy statement, the
term superior proposal means, with respect to
Altiris, a bona fide written alternative transaction
proposal, which our board of directors has in good faith
determined:
|
|
|
|
|
to be more favorable, from a financial point of view, to our
stockholders (in their capacity as stockholders) than the terms
of the merger agreement;
|
|
|
|
provides for consideration consisting exclusively of cash or
publicly-traded equity securities; and
|
|
|
|
is reasonably capable of being consummated on the terms proposed.
|
For purposes of the term alternative transaction
proposal, referred to in the term superior
proposal, each reference to 15% or
85% in the definition of alternative
transaction will be deemed to be a reference to
53
50%. In addition, in making its determination as to
whether an alternative transaction proposal is a superior
proposal, our board of directors must do the following:
|
|
|
|
|
consult with its outside legal counsel and a financial advisor
of national standing;
|
|
|
|
take into account all legal, financial, regulatory, timing and
other aspects of the proposal (including the need for and
contingency of any financing); and
|
|
|
|
take into account the identity of the person or group making the
proposal.
|
We have also agreed with Symantec that we will, and will cause
our subsidiaries and representatives to, immediately cease any
and all activities, discussions or negotiations with any third
parties with respect to any alternative transaction proposal in
existence as of January 26, 2007. We have also agreed that
upon Symantecs request, we will request the prompt return
or destruction of all confidential information previously
furnished to any person with which we, our subsidiaries or
representatives have engaged in any such activities within the
12-month
period preceding January 26, 2007, as well as use
reasonable best efforts to enforce (and will not waive any
provisions of) any confidentiality or standstill agreement to
which we or any of our subsidiaries is a party relating to any
alternative transaction proposal.
Superior
Proposals
The merger agreement does provide that at any time prior to
obtaining stockholder adoption of the merger agreement, our
board of directors may, in response to a bona fide
written alternative transaction proposal that was not
solicited in, or submitted as a result of, a violation of our
covenant not to solicit alternative transaction proposals
described above that our board of directors determines in good
faith (after consultation with its outside legal counsel and
financial advisor) is or is reasonably likely to become a
superior proposal (as described above), take any of the actions
described below. We may only take these actions if our board of
directors determines in good faith, after consultation with its
outside legal counsel, that it is required to do so to comply
with its fiduciary duties to our stockholders under applicable
law, we have given Symantec prior written notice that our board
has made such a determination, and we have provided Symantec
with the information described in the two bullet points under
the heading No Solicitation
Covenant Notification Obligations below.
|
|
|
|
|
we may furnish non-public information to the person or group
making the alternative transaction proposal, provided that:
|
|
|
|
|
|
the person or group executes a confidentiality agreement in
substantially the same form as the confidentiality agreement
executed by Symantec and us;
|
|
|
|
that confidentiality agreement does not include any provision
having the actual or purported effect of restricting us from
fulfilling our obligations under the merger agreement or
confidentiality agreement with Symantec, and includes customary
employee non-solicitation provisions covering at least
12 months from execution of such confidentiality
agreement; and
|
|
|
|
we contemporaneously furnish to Symantec all non-public
information furnished to such person or group making the
alternative transaction proposal (to the extent not previously
provided to Symantec); and
|
|
|
|
|
|
we may engage in discussions or negotiations (including
negotiation of appropriate documentation) with the person or
group making the alternative transaction proposal.
|
Change
in Recommendation
The merger agreement provides that, subject to our termination
right in connection with a superior proposal as described under
the heading The Merger Agreement Termination
of the Merger Agreement below and except as described
below, our board of directors will recommend to our stockholders
that they vote in favor of the adoption of the merger agreement
at our special meeting and that neither our board of directors
nor any committee of our board will withdraw, amend or modify,
or propose or resolve to withdraw, amend or modify in a manner
adverse to Symantec, our board of directors recommendation
that our stockholders vote in favor of the adoption of the
merger
54
agreement. In other words, we are generally prohibited from
making a change in recommendation, which, as used in
the merger agreement and in this proxy statement, means any of
the following:
|
|
|
|
|
the withholding or withdrawal (or the amendment, qualification
or modification in a manner adverse to Symantec) of our board of
directors recommendation in favor of adoption of the
merger agreement, and
|
|
|
|
in the case of a tender or exchange offer made by a third party
directly to our stockholders, a failure to recommend (other than
a stop, look and listen letter or similar
communication of the type contemplated by
Rule 14d-9(f)
under the Securities Exchange Act of 1934, as amended, in place
of that recommendation) that our stockholders reject that tender
or exchange offer.
|
Notwithstanding the obligation described in the paragraph above,
solely in response to the receipt of a bona fide written
alternative transaction proposal that was not solicited in, or
submitted as a result of, a violation of our covenant not to
solicit alternative transaction proposals described at the
beginning of this section that our board of directors determines
in good faith (after consultation with its outside legal counsel
and financial advisor) to be a superior proposal, our board of
directors may make a change in recommendation if all of the
following conditions are met:
|
|
|
|
|
the superior proposal has been made and has not been withdrawn;
|
|
|
|
our stockholders have not yet adopted the merger agreement;
|
|
|
|
we have:
|
|
|
|
|
|
provided to Symantec three business days prior written
notice stating that we have received a superior proposal, the
material terms and conditions of, and the identity of the person
or group making, the superior proposal and a copy of all
negotiated draft agreements relating to that superior proposal,
and that our board of directors intends to effect a change in
recommendation and the manner in which it intends to do so;
|
|
|
|
provided to Symantec (to the extent not previously provided) a
copy of all non-public information made available to the person
or group making the superior proposal; and
|
|
|
|
during that three business day period, if requested by Symantec,
engaged in good faith negotiations with Symantec with respect to
any amendments Symantec proposes to make to the merger agreement
such that the superior proposal would no longer be a superior
proposal;
|
|
|
|
|
|
Symantec will not have, within that three business day period,
made, and not withdrawn, a bona fide written offer that
the our board of directors has in good faith determined (after
consultation with its outside legal counsel and its financial
advisor) results in the alternative transaction proposal that
had been determined to be a superior proposal no longer being a
superior proposal; and
|
|
|
|
our board of directors has determined in good faith, after
consultation with its outside legal counsel, that, in light of
such superior proposal and the results of any negotiations with
Symantec and any bona fide written offer from Symantec,
our board of directors is required to effect a change in
recommendation to comply with its fiduciary duties to our
stockholders under applicable law.
|
To the extent that our board has determined to effect a change
in recommendation in accordance with the merger agreement,
Altiris will have the ability to terminate the merger agreement
as described under the heading The Merger
Agreement Termination of the Merger Agreement
below on condition that we pay Symantec the termination fee also
described in that section. As described immediately above, our
board of directors may not make a change in recommendation if
Symantec makes an improved offer that results in the alternative
transaction proposal in question no longer being a superior
proposal.
Notification
Obligations
We have agreed to give Symantec 48 hours prior notice
(or such lesser prior notice as is provided to our board
members) of any of our boards meetings at which we are
reasonably expected to consider any alternative
55
transaction proposal or alternative transaction, including to
consider whether such alternative transaction proposal is a
superior proposal. In addition, we have agreed to:
|
|
|
|
|
as promptly as practicable (and in any event within
24 hours) after receipt by us, any of our subsidiaries or
any of our representatives of any alternative transaction
proposal or any request for non-public information relating in
any way to an alternative transaction proposal, give Symantec
oral and written notice of the material terms and conditions of
the alternative transaction proposal or request, the identity of
the person or group making that alternative transaction proposal
or request and a copy of material written materials provided to
it in connection with that alternative transaction
proposal; and
|
|
|
|
keep Symantec informed on a current basis in all material
respects regarding the status and details of any such
alternative transaction proposal or request (including
substantive modifications or proposed substantive
modifications), including by providing to Symantec a copy of
material written materials setting forth such modifications or
proposed modifications.
|
Tender
Offer Rules
The no solicitation covenant in the merger agreement does not
prevent us from complying with
Rules 14d-9
and 14e-2(a)
under the Securities Exchange Act of 1934, as amended, with
regard to an acquisition proposal, except that in order to
effect a change of recommendation, our board of directors must
first comply with the requirements outlined above under the
heading The Merger Agreement No Solicitation
Covenant Change in Recommendation.
Timing of
Closing
We intend to work towards closing the merger as promptly as
possible. In accordance with the merger agreement, the closing
of the merger will occur on a time and date specified by the
parties, but unless the parties agree otherwise, in no event
later than the third business day following the satisfaction or
waiver of all of the conditions set forth in the merger
agreement, other than those conditions that by their terms are
to be satisfied on the closing date of the merger, but subject
to the satisfaction or waiver of such conditions.
Conditions
to the Consummation of the Merger
The obligations of each of us, Symantec and Merger Sub to
consummate the merger are subject to the satisfaction or waiver
of each of the following conditions:
|
|
|
|
|
the adoption of the merger agreement by our stockholders in
accordance with Delaware law and our certificate of
incorporation and bylaws;
|
|
|
|
all applicable waiting periods (and any extensions thereof)
applicable to the merger under the HSR Act have expired or early
termination of such waiting periods have been granted, and the
approvals under antitrust, competition or similar laws of the
Federal Republic of Germany have been obtained, in each case
without any condition or requirements requiring or calling for
any antitrust restraint (as described below); and
|
|
|
|
no judgment, order, injunction, decree, statute, law, ordinance,
rule or regulation, or other legal restraint or prohibition
(whether temporary, preliminary or permanent), entered, enacted,
promulgated, enforced or issued by any court or other
governmental authority of competent jurisdiction, is in effect
prohibiting, making illegal or enjoining the merger.
|
As used in the merger agreement and in this proxy statement, the
term antitrust restraint means any of the following
to the extent any of them would be reasonably likely to either
adversely impact in any material respect the benefits expected
to be derived by Symantec from the merger, including with
respect to products, services or technologies of Altiris,
Symantec or their respective subsidiaries, including existing
products, services or technologies, or otherwise adversely
impact in any material respect any business line of Symantec or
its subsidiaries:
|
|
|
|
|
the sale, divestiture, license or other disposition or holding
separate (through the establishment of a trust or otherwise) of
any assets or categories of assets of Symantec or any of its
affiliates or Altiris or our subsidiaries;
|
56
|
|
|
|
|
the imposition of any limitation or regulation on the ability of
Symantec or any of its affiliates to freely conduct their
business or own such assets; or
|
|
|
|
the holding separate of the shares of our capital stock or any
limitation or regulation on the ability of Symantec or any of
its affiliates to exercise full rights of ownership of the
shares of our capital stock.
|
We will not be obligated to effect the merger unless each of
following conditions is satisfied or waived:
|
|
|
|
|
Symantecs representations and warranties in the merger
agreement (other than those described in the round bullet point
below)
|
|
|
|
|
|
that are qualified as to material adverse effect are true and
correct, and
|
|
|
|
that are not qualified as to material adverse effect are true
and correct
|
in each case both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except to the extent that
the failure of any such representations and warranties referred
to in the second dash point above to be true and correct does
not have, and would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
Symantec or a material adverse effect on Symantecs ability
to consummate the merger;
|
|
|
|
|
Symantecs representations and warranties relating to
Symantecs power and authority to enter into the merger
agreement and enforceability of the merger agreement against
Symantec are true and correct both when made and at and as of
the closing date of the merger (except to the extent expressly
made as of an earlier date, in which case as of such
date); and
|
|
|
|
Symantec must have performed and complied in all material
respects with those covenants required to be performed by
Symantec under the merger agreement on or before the closing
date of the merger.
|
Neither Symantec nor Merger Sub will be obligated to effect the
merger unless each of the following conditions is satisfied or
waived:
|
|
|
|
|
our representations and warranties in the merger agreement
(other than those described in the two round bullet points
immediately below)
|
|
|
|
|
|
that are qualified as to material adverse effect are true and
correct, and
|
|
|
|
that are not qualified as to material adverse effect are true
and correct
|
in each case both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except to the extent that
the failure of any such representations and warranties referred
to in the second dash point above to be true and correct does
not have, and would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on
Altiris;
|
|
|
|
|
our representations relating to our power and authority to enter
into the merger agreement, the enforceability of the merger
agreement against us and certain takeover laws are true and
correct both when made and at and as of the closing date of the
merger (except to the extent expressly made as of an earlier
date, in which case as of such date);
|
|
|
|
our representations relating to our capital structure are true
and correct both when made and at and as of the closing date of
the merger (except to the extent expressly made as of an earlier
date, in which case as of such date), except with respect to
deviations in the our actual fully diluted capitalization
(including outstanding capital stock, stock options and
warrants) from our fully diluted capitalization as set forth in
the corresponding representation by an amount that does not
exceed one percent of such fully diluted capitalization;
|
|
|
|
we must have performed and complied in all material respects
with those covenants required to be performed by us under the
merger agreement on or before the closing date of the merger;
|
|
|
|
no material adverse change on Altiris is continuing, whether or
not resulting from a breach of any representation, warranty or
covenant in the merger agreement;
|
57
|
|
|
|
|
there are no suits, actions, proceedings, applications or
counterclaims pending by any governmental authority wherein an
unfavorable injunction, judgment, order, decree, ruling or
charge would:
|
|
|
|
|
|
prevent, restrain or prohibit the completion of the merger;
|
|
|
|
cause the merger to be rescinded; or
|
|
|
|
result in any antitrust restraint; and
|
|
|
|
|
|
there are no injunctions, judgments, orders, decrees, rulings or
charges described in the round bullet point immediately above in
effect, or any applicable law having any such effect, or any
notification by a governmental authority of an intention to seek
such a remedy that has not subsequently been withdrawn.
|
Termination
of the Merger Agreement
Symantec or we can terminate the merger agreement by written
notice under certain circumstances, including:
|
|
|
|
|
by mutual written consent of Symantec and us, if the board of
directors of each so determines;
|
|
|
|
by either us or Symantec (as authorized by the board of
directors of Altiris or Symantec, as applicable):
|
|
|
|
|
|
if the merger has not been completed by July 31, 2007,
which date will be extended to October 31, 2007 if on
July 31, 2007 all of the closing conditions have been
satisfied or waived (other than conditions that by their nature
are only to be satisfied as of the closing of the merger and
other than the condition relating to antitrust approvals);
provided, however, that this right to terminate the merger
agreement will not be available to a party whose failure to
comply with, or breach of, any provision of the merger agreement
was a proximate cause of or resulted in the failure of the
merger to be completed by such date;
|
|
|
|
if a governmental authority of competent jurisdiction issues an
order, decree or ruling or takes any other action (including the
failure to have taken an action), in any case having the effect
of permanently restraining, enjoining or otherwise prohibiting
the consummation of the merger, which order, decree, ruling or
other action is final and nonappealable; or
|
|
|
|
if the approval of our stockholders to adopt the merger
agreement is not obtained at our special meeting, or at any
adjournment or postponement of such meeting, at which the vote
on that matter was taken;
|
|
|
|
|
|
by us (as authorized by our board of directors):
|
|
|
|
|
|
following a breach of any representation, warranty, covenant or
agreement on the part of Symantec, such that the corresponding
closing conditions relating to the accuracy of representations
and warranties and compliance with covenants cannot be met, and
such breach is incapable of being cured or is not cured in all
material respects within 20 business days after Symantec
receives written notice from us of such breach; or
|
|
|
|
if our board of directors makes a change in recommendation in
response to a superior proposal in compliance with the merger
agreement, we publicly announce our intention to accept or enter
into the superior proposal that is the subject of the change in
recommendation, and we pay Symantec the termination fee of
$37.5 million as described under the heading The
Merger Agreement Termination Fee below;
|
|
|
|
|
|
by Symantec (as authorized by its board of directors) following
a breach of any representation, warranty, covenant or agreement
by us, such that the corresponding closing conditions relating
to the accuracy of representations and warranties and compliance
with covenants cannot be met, and such breach is incapable of
being cured or is not cured in all material respects within 20
business days after we receive written notice from Symantec of
such breach; or
|
|
|
|
by Symantec (as authorized by its board of directors):
|
|
|
|
|
|
if we materially breach our obligation to give notice of,
convene and hold our stockholders meeting as required by
the merger agreement;
|
58
|
|
|
|
|
if we fail to include in this proxy statement that our board of
directors recommends that our stockholders adopt the merger
agreement;
|
|
|
|
if we effect a change in recommendation;
|
|
|
|
if we approve any alternative transaction (as previously
defined) or recommend that our stockholders approve or accept
any alternative transaction without the prior written consent of
Symantec;
|
|
|
|
if we enter into a letter of intent in violation of the merger
agreement or any contract accepting any alternative transaction
proposal without the prior written consent of Symantec;
|
|
|
|
if we fail to reconfirm the recommendation of our board of
directors that our stockholders adopt the merger agreement
within ten business days of receipt of a written request from
Symantec to do so following the occurrence of any alternative
transaction proposal; or
|
|
|
|
if, within ten business days of a third person or party
publishing, sending or giving to our stockholders a tender or
exchange offer relating to our common stock pursuant to
Rule 14e-2
promulgated under the Securities Exchange Act of 1934, as
amended, we fail to send a statement to our stockholders
disclosing that our board of directors recommends rejection of
that tender or exchange offer.
|
Termination
Fee
The merger agreement requires that we pay Symantec a termination
fee of $37,500,000 if, among other things:
|
|
|
|
|
the merger agreement is terminated by us after any change in
recommendation by our board of directors in response to a
superior proposal in compliance with the merger agreement and
the subsequent public announcement of our intention to accept or
enter into the superior proposal that was the subject of the
change in recommendation, in which case the termination fee
would be payable prior to such termination as a precondition to
such termination;
|
|
|
|
the merger agreement is terminated by Symantec based upon any of
the circumstances set forth in the last round bullet point under
The Merger Agreement Termination of the Merger
Agreement above, in which case the termination fee would
be payable promptly but in no event later than two business days
after such termination;
|
|
|
|
the merger agreement is terminated by either us or Symantec
following the failure to obtain the approval of our stockholders
to adopt the merger and the following conditions are also met:
|
|
|
|
|
|
following January 26, 2007 and prior to the termination of
the merger agreement, an alternative transaction proposal with
respect to us has been publicly announced, made to our
stockholders or made to Altiris and subsequently publicly
announced or disclosed and, in each case, not withdrawn; and
|
|
|
|
within 12 months following the termination of the merger
agreement, any company acquisition (as described below) is
consummated or we enter into a contract providing for any
company acquisition,
|
in which case the termination fee would be payable concurrently
with the earlier of the consummation of that company acquisition
or the execution of a contract relating to that company
acquisition.
As used in the merger agreement and in this proxy statement, the
term company acquisition means an alternative
transaction (as described under the heading The
Merger Agreement No Solicitation Covenant
above) except that each reference to 15% in the
definition of alternative transaction will be deemed
to be a reference to 40%; each reference to
85% in the definition of alternative
transaction will be deemed to be a reference to
60%; and the last bullet point in the definition of
alternative transaction is disregarded.
Other
Expenses
We have agreed to reimburse Symantecs
out-of-pocket
expenses incurred in connection with the merger agreement up to
$2,000,000, if the merger agreement is terminated following the
failure to obtain the approval of our stockholders to adopt the
merger agreement. This amount would be deducted from any
termination fee paid as described above.
59
Indemnification
and Insurance
The merger agreement provides that for a period of six years
from and after the effective time of the merger, Symantec will
and will cause the surviving corporation in the merger to
fulfill and honor the obligations of Altiris to our directors
and officers as of immediately prior to the effective time of
the merger pursuant to any indemnification provisions under our
certificate of incorporation or bylaws in effect on
January 26, 2007, and pursuant to the terms of any
indemnification agreements between us or any of our subsidiaries
and our directors and officers existing as of January 26,
2007 with respect to claims arising out of acts or omissions
occurring at or prior to the effective time of the merger.
In addition, the merger agreement provides that Symantec will
and will cause the surviving corporation in the merger to
maintain in effect, to the extent available, directors and
officers liability insurance covering those persons who
are currently covered by our directors and officers
liability insurance policy in an amount and on terms no less
advantageous, when taken as a whole, to those applicable to the
current directors and officers of Altiris. Symantec may fulfill
these obligations by purchasing a policy of directors and
officers insurance or a tail policy under our
existing directors and officers insurance policy, in
either case which:
|
|
|
|
|
has an effective term of six years from the effective time of
the merger;
|
|
|
|
covers only those persons who are currently covered by our
directors and officers insurance policy in effect as
of January 26, 2007, and only for actions and omissions
occurring on or prior to the effective time of the
merger; and
|
|
|
|
contains terms and conditions (including, without limitation,
coverage amounts) that are no less advantageous, when taken as a
whole, to those applicable to our current directors and officers.
|
However, in no event will Symantec or the surviving corporation
be required to expend an annual premium for any such coverage in
excess of 200% of the annual premium currently paid by us under
our directors and officers liability insurance
policy in effect as of January 26, 2007, and if the cost
for any such coverage is in excess of such amount, Symantec or
the surviving corporation will only be required to maintain such
coverage as is available for such amount. The merger agreement
provides that the obligations regarding indemnification and
directors and officers insurance described above
will survive the completion of the merger and that our directors
and officers are intended third-party beneficiaries under the
merger agreement of these obligations of Symantec and the
surviving corporation in the merger with respect to
indemnification and directors and officers insurance.
Additional
Covenants
The merger agreement provides a number of additional covenants
of the parties.
Each of Altiris and Symantec have agreed to use their respective
reasonable best efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations to
complete and make effective, in the most expeditious manner
practicable, the merger. Accordingly, Altiris and Symantec have
agreed to prepare and file as promptly as practicable with any
governmental authority or other third party all documentation to
effect all necessary filings, notices, petitions, statements,
registrations, submissions of information, applications and
other documents, and to obtain and maintain all approvals,
consents, registrations, permits, authorizations and other
confirmations required to be obtained from any governmental
authority or other third party that are necessary, proper or
advisable to complete the merger.
Altiris and Symantec have agreed to cooperate with one another
in determining whether any action by or in respect of, or filing
with, any governmental body, agency, official or authority is
required, or any actions, consents, approvals or waivers are
required to be obtained from parties to any material contracts
in connection with the merger agreement or the transactions
contemplated thereby, and in taking such actions or making such
filings, furnishing information required in connection therewith
and seeking timely to obtain any such actions, consents,
approvals or waivers.
60
Notwithstanding the covenants described above, if any
administrative or judicial action or proceeding is instituted
(or threatened to be instituted) by any governmental authority
challenging any transaction contemplated by the merger agreement
as violative of any antitrust laws, Symantec will have no
obligation to:
|
|
|
|
|
litigate or contest, or continue to litigate or contest, any
administrative or judicial action or proceeding brought by, or
any decree, judgment, injunction or other order, whether
temporary, preliminary or permanent issued in favor of, any
governmental authority asserting that the merger, or any aspect
thereof, is in violation of any antitrust law; or
|
|
|
|
make proposals, execute or carry out agreements, enter into
consent decrees or submit to orders providing for any antitrust
restraint.
|
Symantec has agreed to take such actions as are reasonably
necessary with respect to the assumption of Altiris stock
options and RSUs, including the reservation for issuance and
authorization for listing on the Nasdaq Global Select Market of
the shares of Symantec common stock subject to the assumed
options and assumed RSUs. Symantec has also agreed to file a
registration statement on
Form S-8
under the Securities Act of 1933, as amended, for the shares of
Symantec common stock issuable with respect to the assumed
options and assumed RSUs eligible for registration on such form
as soon as reasonably practicable (and no later than three
business days) after the effective time of the merger and shall
exercise reasonable best efforts to maintain the effectiveness
of such registration statement for so long as any of such
assumed options or assumed RSUs remain outstanding.
Certain
Additional Agreements
Voting Agreement. As a condition to Symantec
and Merger Sub entering into the merger agreement, each member
of our board of directors, including Gregory S. Butterfield, our
Chairman, President and Chief Executive Officer, Dwain A.
Kinghorn, our Vice President, Chief Technology Officer, Michael
R. Samuelian, our Vice President, Worldwide Sales, and
Technology Crossover Management IV, L.L.C. on behalf of TCV IV
Strategic Partners L.P. and TCV IV, L.P., together one our major
stockholders, entered into a voting agreement with Symantec,
pursuant to which each signatory agreed to vote his or its
shares of Altiris common stock in favor of adoption of the
merger agreement and any matter proposed in connection with the
merger that is reasonably necessary to facilitate the merger,
and against any alternative transaction proposal and any other
matter that would reasonably be expected to prevent, delay,
postpone or frustrate the purposes of the Merger. See the
section entitled The Merger Voting
Agreements beginning on page 36.
Amendment
and Waiver
At any time prior to the completion of the merger, any provision
of the merger agreement can be amended or waived, only if such
amendment or waiver is in writing and signed by us, Symantec and
Merger Sub, or, in the case of a waiver, by each party against
whom the waiver is to be effective. After the adoption of the
merger agreement by our stockholders, no such amendment or
waiver will reduce the amount or change the kind of
consideration to be received in exchange for shares of our
common stock without the further approval of our stockholders.
61
SECURITIES
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table shows the common stock beneficially owned as
of February 28, 2007 by:
|
|
|
|
|
each person who is known by us to beneficially own 5% or more of
our outstanding common stock;
|
|
|
|
each of our executive officers;
|
|
|
|
each of our directors; and
|
|
|
|
all our officers and directors as a group.
|
Beneficial ownership is determined in accordance with SEC rules.
In computing the number of shares beneficially owned by a
person, we have included shares for which the named person has
sole or shared power over voting or investment decisions. The
number of shares beneficially owned includes common stock which
the named person has the right to acquire, through conversion,
option or warrant exercise, or otherwise, within 60 days
after February 28, 2007. Percentage of beneficial ownership
is based on 29,832,752 shares outstanding as of
February 28, 2007. Beneficial ownership calculations for 5%
stockholders are based solely on publicly-filed
Schedule 13Ds or 13Gs, which 5% stockholders are required
to file with the SEC, and which generally set forth ownership
interests as of December 31, 2006. Except as otherwise
noted, the address of each person listed in the table is
c/o Altiris, Inc., 588 West 400 South, Lindon, UT
84042.
|
|
|
|
|
|
|
|
|
|
|
Shares Owned
|
|
|
|
|
|
|
Approximate
|
|
|
|
Number of
|
|
|
Percentage
|
|
|
|
Shares
|
|
|
Ownership
|
|
|
5% Stockholders
|
|
|
|
|
|
|
|
|
Entities affiliated with
Technology Crossover Ventures(1)(2)
|
|
|
3,068,827
|
|
|
|
10.29
|
|
528 Ramona Street
Palo Alto, California 94301
|
|
|
|
|
|
|
|
|
Directors and Executive
Officers
|
|
|
|
|
|
|
|
|
Gregory S. Butterfield(2)(3)
|
|
|
155,146
|
|
|
|
*
|
|
Craig H. Christensen(2)(4)
|
|
|
70,574
|
|
|
|
*
|
|
Stephen C. Erickson(2)(5)
|
|
|
43,236
|
|
|
|
*
|
|
Dwain A. Kinghorn(2)(6)
|
|
|
194,871
|
|
|
|
*
|
|
Stephen M. Madigan
|
|
|
0
|
|
|
|
*
|
|
Michael R. Samuelian(2)(7)
|
|
|
55,715
|
|
|
|
*
|
|
Gary B. Filler(2)(8)
|
|
|
16,666
|
|
|
|
*
|
|
Jay C. Hoag(2)(9)
|
|
|
3,089,659
|
|
|
|
10.35
|
|
Michael J. Levinthal(2)(10)
|
|
|
105,832
|
|
|
|
*
|
|
V. Eric Roach(2)(11)
|
|
|
204,165
|
|
|
|
*
|
|
Mark E. Sunday(2)(12)
|
|
|
20,832
|
|
|
|
*
|
|
All current directors and
executive officers as a group (11 people)
|
|
|
3,956,696
|
|
|
|
13.08
|
|
|
|
|
* |
|
Percentage is less than 1% of outstanding shares of common stock. |
|
(1) |
|
Consists of 2,958,508 shares held by TCV IV, L.P., and
110,319 shares held by TCV IV Strategic Partners, L.P.
(which are collectively referred to as the TCV
Funds). Jay C. Hoag, a director of Altiris, and Richard H.
Kimball are the Managing Members of Technology Crossover
Management IV, L.L.C. Mr. Hoag and Mr. Kimball each
disclaim beneficial ownership of these shares, except as to his
respective pecuniary interest therein. |
|
(2) |
|
Gregory S. Butterfield, Dwain A. Kinghorn, Michael R. Samuelian,
Gary B. Filler, Jay C. Hoag, Michael J. Levinthal, V. Eric
Roach, Mark E. Sunday and Technology Crossover Management IV,
L.L.C., on behalf of the TCV Funds have each entered into voting
agreements with Symantec pursuant to which they have agreed,
among other things, to vote all of their shares of our common
stock, representing in the aggregate |
62
|
|
|
|
|
approximately 11.8% of our common stock outstanding on
February 28, 2007, in favor of adopting the merger
agreement. |
|
|
|
(3) |
|
Mr. Butterfields shares include 122,001 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by
Mr. Butterfield. |
|
(4) |
|
Mr. Christensens shares include 51,876 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by
Mr. Christensen. |
|
(5) |
|
Mr. Ericksons shares include 26,251 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by Mr. Erickson. |
|
(6) |
|
Mr. Kinghorns shares include 27,500 shares held
by Computing Edge Corporation, or CEC, 83,155 shares held
by Computing Edge Limited, or CEL, 26,316 shares held in
Mr. Kinghorns name and 60,626 shares issuable
upon exercise of options exercisable within 60 days of
February 28, 2007 held by Mr. Kinghorn.
Mr. Kinghorn is the Chief Executive Officer and holds all
of the outstanding capital stock of CEC and he is a director of
CEL. Mr. Kinghorn disclaims beneficial ownership as to
CELs shares, except as to his pecuniary interest therein. |
|
(7) |
|
Mr. Samuelians shares include 32,501 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by
Mr. Samuelian. |
|
(8) |
|
Mr. Fillers shares include 12,500 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by Mr. Filler. |
|
(9) |
|
Mr. Hoags shares include 2,958,508 shares held
by TCV IV, L.P., 110,319 shares held by TCV IV Strategic
Partners, L.P., 8,322 shares held by Mr. Hoag and
12,500 shares issuable upon exercise of options exercisable
within 60 days of February 28, 2007 held by
Mr. Hoag. Mr. Hoag is a Managing Member of Technology
Crossover Management IV, L.L.C., which is the General Partner of
each of TCV IV Strategic Partners L.P. and TCV IV, L.P.
Mr. Hoag disclaims beneficial ownership of the shares held
by the TCV Funds, Technology Crossover Management IV,
L.L.C.,TCMI, Inc. and the Hoag Trust, except as to his
respective pecuniary interest in each of those entities. |
|
(10) |
|
Mr. Levinthals shares include 85,000 shares held
by a retirement trust for the benefit of Mr. Levinthal and
12,500 shares issuable upon exercise of options exercisable
within 60 days of February 28, 2007 held by
Mr. Levinthal. |
|
(11) |
|
Mr. Roachs shares include 133,333 shares held by
The Roach Family Trust, for which he serves as trustee, and
62,500 shares issuable upon exercise of options exercisable
within 60 days of February 28, 2007 held by
Mr. Roach. |
|
(12) |
|
Mr. Sundays shares include 12,500 shares
issuable upon exercise of options exercisable within
60 days of February 28, 2007 held by Mr. Sunday. |
63
STOCKHOLDER
PROPOSALS
If the merger is completed, we will not have public stockholders
and there will be no public participation in any future meeting
of Altiris stockholders. However, if the merger is not completed
or if we are otherwise required to do so under applicable law,
we will hold a 2007 annual meeting of our stockholders. Any
stockholder proposals to be considered timely for inclusion in
the proxy statement for our 2007 annual meeting of stockholders
must have been submitted in writing to Craig H. Christensen,
Secretary, Altiris, Inc., 588 West 400 South, Lindon, Utah
84042, and must have been received by February 25, 2007. If
the date of the 2007 annual meeting of stockholders is moved
more than 30 days before or after the anniversary date of
the 2006 annual meeting of stockholders, the deadline for
inclusion is instead the close of business on the tenth
(10th)
day following the day on which notice of the date of the annual
meeting of stockholders was mailed or the date of public
disclosure regarding the annual meeting of stockholders,
whichever occurs first. Such proposals must also comply with the
SECs rules concerning the inclusion of stockholder
proposals in company-sponsored proxy materials as set forth in
Rule 14a-8
promulgated under the Securities Exchange Act of 1934, as
amended, and our bylaws.
In accordance with our bylaws, stockholders who do not submit a
proposal for inclusion in the proxy statement for our 2007
annual meeting of stockholders, as described in the previous
paragraph, but who intend to present a proposal, nomination for
director or other business for consideration at the 2007 annual
meeting of stockholders, were required to have notified our
Secretary of their proposal, nomination or other business no
later than February 25, 2007. Our bylaws contain detailed
requirements that any such stockholders notice must
satisfy. Any stockholder notice and any request for a copy of
our bylaws should submitted in writing to Craig H. Christensen,
Secretary, Altiris, Inc., 588 West 400 South, Lindon, Utah
84042.
OTHER
MATTERS
As of the date of this proxy statement, our board of directors
knows of no matters that will be presented for consideration at
the special meeting other than as described in this proxy
statement.
WHERE YOU
CAN FIND MORE INFORMATION
Symantec and we file annual, quarterly and special reports,
proxy statements and other information with the SEC. You may
read and copy any reports, statements or other information that
Symantec and we file with the SEC at the SECs public
reference room at the following location:
Public Reference Room
100 F Street, N.E.
Washington, D.C. 20549
Please call the SEC at
1-800-SEC-0330
for further information on the public reference room. These SEC
filings are also available to the public from commercial
document retrieval services and at the Internet World Wide Web
site maintained by the SEC at http://www.sec.gov.
Reports, proxy statements and other information concerning us
may also be inspected at the offices of the Nasdaq Global Select
Market at 1735 K Street, N.W., Washington, D.C.
20006.
CERTAIN
INFORMATION CONCERNING ALTIRIS AND SYMANTEC
We have supplied all information contained in this proxy
statement relating to us, and Symantec has supplied all
information contained in this proxy statement relating to
Symantec.
64
MISCELLANEOUS
If you have any questions about this proxy statement, the
special meeting or the merger or need assistance with voting
procedures, you should contact:
Altiris, Inc.
588 West 400 South
Lindon, Utah 84042
Telephone:
(801) 805-2400
Attention: Craig H. Christensen
E-mail:
craig.christensen@altiris.com
or our proxy solicitor,
The Altman Group, Inc.
1200 Wall Street West, 3rd Floor
Lyndhurst, New Jersey 07071
Call toll-free:
(800) 217-0538
Our stockholders should not send in their Altiris stock
certificates until they receive the transmittal materials from
the exchange agent. Our stockholders of record who have further
questions about their share certificates or the exchange of our
common stock for cash should call the exchange agent.
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROXY
STATEMENT. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS
PROXY STATEMENT. THIS PROXY STATEMENT IS DATED MARCH 7,
2007. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN
THIS PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT
DATE. NEITHER THE MAILING OF THIS PROXY STATEMENT TO
STOCKHOLDERS NOR THE ISSUANCE OF CASH IN THE MERGER CREATES ANY
IMPLICATION TO THE CONTRARY. THIS PROXY STATEMENT DOES NOT
CONSTITUTE A SOLICITATION OF A PROXY IN ANY JURISDICTION WHERE,
OR TO OR FROM ANY PERSON TO WHOM, IT IS UNLAWFUL TO MAKE A PROXY
SOLICITATION.
65
Agreement
and Plan of Merger
This Agreement and Plan
of Merger (this Agreement) is made and
entered into as of January 26, 2007 (the Agreement
Date) by and among Symantec Corporation, a Delaware
corporation (Acquiror), Atlas Merger Corp., a
Delaware corporation and a wholly owned subsidiary of Acquiror
(Merger Sub), and Altiris, Inc., a Delaware
corporation (the Company).
Recitals
A. The parties intend that, subject to the terms and
conditions hereinafter set forth, Merger Sub shall merge with
and into the Company (the Merger), with the
Company to be the surviving corporation of the Merger (the
Surviving Corporation), on the terms and
subject to the conditions of this Agreement and pursuant to the
Certificate of Merger substantially in the form attached hereto
as Exhibit A (the Certificate of
Merger) and the applicable provisions of the laws of
the State of Delaware.
B. Subject to the terms and conditions set forth herein,
the Boards of Directors of Acquiror, Merger Sub and the Company
have determined that the Merger is in the best interests of
their respective companies and stockholders and have approved
and declared advisable the Merger, this Agreement and the other
transactions contemplated by this Agreement. Subject to the
terms and conditions set forth herein, the Board of Directors of
the Company has determined to recommend to its stockholders the
adoption of this Agreement.
C. Concurrently with the execution and delivery of this
Agreement, and as a material inducement to Acquirors
willingness to enter into this Agreement, each stockholder of
the Company listed on
Exhibit B-1
attached hereto is executing and delivering to Acquiror a Voting
Agreement substantially in the form attached hereto as
Exhibit B-2
(the Voting Agreement) pursuant to which,
subject to the terms and conditions set forth therein, such
stockholder has agreed to vote all shares of the Companys
capital stock owned by it in favor of adoption of this Agreement
and to give Acquiror an irrevocable proxy to do the same.
D. Concurrently with the execution and delivery of this
Agreement, and as a material inducement to Acquirors
willingness to enter into this Agreement, certain employees of
the Company are executing and delivering to Acquiror an
Employment Agreement (the Employment
Agreement), in each case to become effective upon the
Closing.
E. Acquiror, Merger Sub and the Company desire to make
certain representations, warranties, covenants and agreements in
connection with the Merger and to prescribe various conditions
to the Merger.
Now, Therefore, in
consideration of the foregoing and the mutual representations,
warranties, covenants and conditions contained herein, the
parties hereby agree as follows:
ARTICLE 1
Certain
Definitions
As used in this Agreement, the following terms shall have the
meanings set forth below.
Acquiror Common Stock means the Common Stock,
$0.01 par value per share, of Acquiror.
Acquiror Restricted Stock Unit means the
right to receive a share of Acquiror Common Stock on a future
date.
Affiliate means with respect to any Person,
another Person that directly, or indirectly through one or more
intermediaries, controls, is controlled by, or is under common
control with, such first Person, where control means
the possession, directly or indirectly, of the power to direct
or cause the direction of the management policies of a Person,
whether through the ownership of voting securities, by Contract,
as trustee or executor, or otherwise.
Alternative Transaction means, with respect
to the Company, any of the following transactions (other than
the Merger): (a) any acquisition or purchase from the
Company by any Person or Group of more than a 15% interest in
the total outstanding voting securities of the Company or any
tender offer or exchange offer that if consummated
A-5
would result in any Person or Group beneficially owning
securities representing 15% or more of the total outstanding
voting power of the Company, or any merger, consolidation,
business combination, share exchange or similar transaction
involving the Company pursuant to which the stockholders of the
Company immediately preceding such transaction hold securities
representing less than 85% of the total outstanding voting power
of the surviving or resulting entity of such transaction (or
parent entity of such surviving or resulting entity);
(b) any sale, lease, exchange, transfer, exclusive license
or disposition of assets (including capital stock or other
ownership interests in Subsidiaries) representing 15% or more of
the aggregate fair market value of the consolidated assets of
the Company and its Subsidiaries taken as a whole; (c) any
liquidation or dissolution of the Company; or (d) any
extraordinary dividend, whether of cash or other property.
Alternative Transaction Proposal means any
offer, proposal or indication of interest (whether binding or
non-binding), or any public announcement of an intention to make
any offer, proposal or indication of interest, to the Company or
Company Stockholders regarding an Alternative Transaction.
Antitrust Filings means notification and
report forms relating to the transactions contemplated by this
Agreement filed with the United States Federal Trade Commission
and the Antitrust Division of the United States Department of
Justice as required by the HSR Act, as well as comparable
pre-merger notification forms required by the merger
notification or control laws and regulations of any applicable
jurisdiction.
Antitrust Laws means federal, state or
foreign statutes, rules, regulations, orders or decrees that are
designed to prohibit, restrict or regulate actions having the
purpose or effect of monopolization or restraint of trade.
Applicable Law means with respect to any
Person, any federal, state, foreign, local, municipal or other
law, statute, ordinance, code, permit, rule or regulation
issued, enacted, adopted, promulgated, implemented or otherwise
put into effect by or under the authority of any Governmental
Authority and any orders, writs, injunctions, awards, judgments
and decrees applicable to such Person or its Subsidiaries, their
business or any of their respective assets or properties.
Balance Sheet Date means September 30,
2006, the date of the Company Balance Sheet.
Business Day shall mean a day (a) other
than Saturday or Sunday, and (b) on which commercial banks
are open for business in San Francisco, California.
Cash Amount Per Share means $33.00.
Change in Recommendation means the
withholding or withdrawal (or the amendment, qualification or
modification in a manner adverse to Acquiror) of the Company
Boards recommendation in favor of adoption of this
Agreement, and, in the case of a tender or exchange offer made
by a third party directly to the Company Stockholders, a failure
to recommend (other than a stop, look and listen
letter or similar communication of the type contemplated by
Rule 14d-9(f)
under the Exchange Act in place thereof) that Company
Stockholders reject such tender or exchange offer;
provided, however, that the delivery of any notice
from the Company to Acquiror specified in
Section 5.2(c) or Section 5.2(d)(iii)
will not be deemed to be or constitute a Change of
Recommendation.
Closing means the closing of the transactions
contemplated hereby.
Closing Date means a time and date to be
specified by the parties (but in no event later than three
Business Days unless otherwise agreed by the parties) after the
satisfaction or waiver of the conditions set forth in
Article 8 (excluding conditions that by their terms
are to be satisfied on the Closing Date, but subject to the
satisfaction or waiver of such conditions).
COBRA means the Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended.
Code means the Internal Revenue Code of 1986,
as amended.
Company Acquisition means, an Alternative
Transaction; provided that for purposes of this
definition of Company Acquisition, (a) each
reference to 15% in the definition of
Alternative Transaction shall be deemed to be a
reference to 40%, (b) each reference to
85% in the definition of Alternative
Transaction shall be
A-6
deemed to be a reference to 60%, and
(c) clause (d) of the definition of Alternative
Transaction shall be disregarded.
Company Balance Sheet means the
Companys unaudited balance sheet as of September 30,
2006 included in the Company Financial Statements.
Company Board means the board of directors of
the Company.
Company Business means the business of the
Company and the Company Subsidiaries as presently conducted.
Company Capital Stock means the capital stock
of the Company.
Company Charter Documents means the
Certificate of Incorporation (including any Certificates of
Designation) and Bylaws of the Company, each as amended to date.
Company Common Stock means the Common Stock,
$0.0001 par value per share, of the Company.
Company ESPP means the 2002 Employee Stock
Purchase Plan of the Company.
Company Option Plans means the 1998 Stock
Option Plan, 2002 Stock Plan and 2005 Stock Plan of the Company,
collectively.
Company Optionholders means the holders of
Company Options.
Company Options means options to purchase
shares of Company Common Stock, whether or not under the Company
Option Plans.
Company Preferred Stock means the Preferred
Stock, par value $0.0001 per share, of the Company.
Company Restricted Stock Unit means the right
to receive a share of Company Common Stock on a future date.
Company Securityholders means the Company
Stockholders, Company Optionholders and Company Warrantholders,
collectively.
Company Stockholders means the holders of
shares of Company Common Stock.
Company Subsidiary means a Subsidiary of the
Company.
Company Warrantholders means the holders of
Company Warrants.
Company Warrants means warrants to purchase
shares of Company Capital Stock.
Confidentiality Agreement means that certain
Confidentiality Agreement by and between Acquiror and the
Company dated as of January 9, 2007.
Contract means any written or oral legally
binding contract, agreement, instrument, commitment, obligation
or undertaking (including subcontracts, leases, subleases,
licenses, sublicenses, mortgages, notes, guarantees, indentures,
warranties, guarantees, insurance policies, benefit plans and
individual purchase orders).
Delaware Law means the Delaware General
Corporation Law.
Debt means the outstanding amount of
(a) indebtedness for borrowed money, (b) amounts owing
as deferred purchase price for the purchase of any property,
(c) indebtedness evidenced by any bond, debenture, note,
mortgage, indenture or other debt instrument or debt security,
(d) accounts payable to trade creditors and other accrued
expenses, in each case not arising in the ordinary course of
business, (e) amounts owing under any capitalized or
synthetic leases, (f) obligations secured by any
Encumbrances, (g) contingent reimbursement obligations
under letters of credit, and (h) guarantees or sureties
with respect to any indebtedness or obligation of a type
described in clauses (a) through (g) above of any
Person, of the Company and Company Subsidiaries.
Dissenting Shares shall mean any shares of
Company Capital Stock that are issued and outstanding
immediately prior to the Effective Time and in respect of which
appraisal rights shall have been perfected in accordance with
Delaware Law in connection with the Merger.
A-7
Documentation means, collectively,
programmers notes or logs, source code annotations, user
guides, manuals, instructions, software architecture designs,
layouts, any know-how, and any other designs, plans, drawings,
documentation, materials, supplier lists, software source code
and object code, net lists, photographs, development tools,
blueprints, media, memoranda and records that are primarily
related to or otherwise necessary for the use and exploitation
of any products of the Company or Company Subsidiaries, whether
in tangible or intangible form, whether owned by the Company or
Company Subsidiaries or held by the Company or Company
Subsidiaries under any licenses or sublicenses or similar grants
of rights.
Effective Time means the time of the filing
of the Certificate of Merger (or such later time as may be
mutually agreed in writing by the Company and Acquiror and
specified in the Certificate of Merger).
Encumbrance means, with respect to any asset,
any mortgage, deed of trust, lien, pledge, charge, security
interest, title retention device, collateral assignment,
restriction or other encumbrance of any kind in respect of such
asset (including any restriction on the voting of any security,
any restriction on the transfer of any security or other asset,
any restriction on the receipt of any income derived from any
asset, any restriction on the use of any asset and any
restriction on the possession, exercise or transfer of any other
attribute of ownership of any asset).
ERISA means the Employee Retirement Income
Security Act of 1974, as amended.
ERISA Affiliate means any entity which is a
member of: (a) a controlled group of
corporations, as defined in Section 414(b) of the
Code; (b) a group of entities under common
control, as defined in Section 414(c) of the Code; or
(c) an affiliated service group, as defined in
Section 414(m) of the Code, or treasury regulations
promulgated under Section 414(o) of the Code, any of which
includes the Company.
Exchange Act means the Securities Exchange
Act of 1934, as amended, including the rules and regulations
promulgated thereunder.
Exchange Ratio means the quotient obtained by
dividing (a) $33.00 by (b) the average of the closing
sale prices of Acquiror Common Stock as quoted on NASDAQ for the
ten consecutive trading days ending with the trading day that is
one trading day prior to the Closing Date.
Form Agreement means any Contract that
does not deviate in any material respect from the form
of such Contract made available by the Company to Acquiror
and labeled as the form of such Contract.
Freely Terminable Agreement means any
Contract that the Company or any Company Subsidiary has the
right to terminate, (a) without cause, (b) upon
30 days or less notice, and (c) without Liability to
the Company or any Company Subsidiaries.
GAAP means United States generally accepted
accounting principles applied on a consistent basis.
Governmental Authority shall mean any
supranational, national, state, municipal, local or foreign
government, any court, tribunal, arbitrator, administrative
agency, commission or other governmental official, authority or
instrumentality, in each case whether domestic or foreign, or
any quasi-governmental body exercising any regulatory, Taxing or
other governmental or quasi-governmental authority.
Group means the definition ascribed to such
term under Section 13(d) of the Exchange Act, the rules and
regulations thereunder and related case law.
HSR Act means the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended.
IAS means International Accounting Standards
applied on a consistent basis.
Immediate Family Member has the meaning
ascribed to such term under Item 404(a) of
Regulation S-K
promulgated under the Securities Act and Exchange Act.
Intellectual Property means, collectively,
all industrial and intellectual property rights, throughout the
world, including patents, patent applications, patent rights,
trademarks, trademark registrations and applications therefor,
trade dress rights, trade names, service marks, service mark
registrations and applications therefor, and any and all
goodwill associated with and symbolized by the foregoing items,
Internet domain name registrations, Internet and World Wide Web
URLs or addresses, copyrights, copyright registrations and
applications therefor,
A-8
mask work rights, mask work registrations and applications
therefor, franchises, licenses, inventions, trade secrets,
know-how, customer lists, supplier lists, proprietary processes
and formulae, technology, software source code and object code,
algorithms, net lists, architectures, structures, screen
displays, photographs, images, layouts, development tools,
designs, blueprints, specifications, technical drawings (or
similar information in electronic format) and all documentation
and media constituting, describing or relating to the foregoing,
including manuals, programmers notes, memoranda and
records.
knowledge means, with respect to any Person
that is an entity, the knowledge of such Persons executive
officers with respect to any fact, circumstance, event or other
matter in question after reasonable inquiry of the senior
employees of such entity who have administrative or operational
responsibility for the matter in question (it being understood
that such reasonable inquiry does not include circulation of
director and officer questionnaires for the current proxy season
since that process has not yet occurred as of the Agreement
Date).
Liabilities means debts, liabilities and
obligations, whether accrued or fixed, absolute or contingent,
matured or unmatured, determined or determinable, known or
unknown, including those arising under any law, action or
governmental order and those arising under any Contract.
Material Adverse Change and Material
Adverse Effect when used in connection with an entity,
means any change, event, circumstance, condition or effect,
(each, an Effect) that is or is reasonably
likely to be, individually or in the aggregate, materially
adverse to the condition (financial or otherwise), assets
(including intangible assets), business, operations or results
of operations of such entity and its subsidiaries, taken as a
whole, except to the extent that any such Effect is proximately
caused by: (a) changes in general economic conditions or
changes affecting the industry generally in which such entity
operates (provided that such changes do not affect such entity
disproportionately as compared to companies operating in the
same industry in which such entity operates); (b) changes
in the trading volume or trading prices of such entitys
capital stock in and of themselves (provided that such exclusion
shall not apply to any underlying Effect that may have caused
such change in trading prices or volumes); (c) acts of war
or terrorism (provided that such acts do not affect such entity
disproportionately as compared to companies operating in the
same industry in which such entity operates); (d) changes
in applicable law or GAAP; (e) any failure to meet analysts
estimates or expectations as to revenue, earnings or other
financial performance (provided that such exclusion shall not
apply to any underlying Effect that may have caused such
failure); or (f) the announcement or the execution of this
Agreement or the pendency or consummation of the Merger.
Merger Sub Common Stock means the Common
Stock, $0.001 par value per share, of Merger Sub.
NASDAQ means the Nasdaq Stock Market.
Permitted Encumbrances means:
(a) statutory liens for Taxes that are not yet due and
payable; (b) statutory liens to secure obligations to
landlords, lessors or renters under leases or rental agreements;
(c) deposits or pledges made in connection with, or to
secure payment of, workers compensation, unemployment
insurance or similar programs mandated by Applicable Law;
(d) statutory liens in favor of carriers, warehousemen,
mechanics and materialmen, to secure claims for labor, materials
or supplies and other like liens; (e) Encumbrances imposed
on the underlying fee interest in leased property; or
(f) Encumbrances that do not materially interfere with the
use or operation of the property subject thereto.
Person means any natural person, corporation,
company, limited liability company, general partnership, limited
liability partnership, trust, estate, proprietorship, joint
venture, association, organization, entity or Governmental
Authority.
Proxy Statement means the proxy statement to
be filed by the Company with the SEC in connection with the
solicitation of proxies from Company Stockholders for the
Company Stockholder Approval (as defined in
Section 3.3(a)), as amended or supplemented.
Sarbanes Act means the Sarbanes-Oxley Act of
2002.
SEC means the Securities and Exchange
Commission.
A-9
Securities Act means the Securities Act of
1933, as amended, including the rules and regulations
promulgated thereunder.
Subsidiary means any corporation,
association, business entity, partnership, limited liability
company or other Person of which the Company or Acquiror, as the
case may be, either alone or together with one or more
Subsidiaries or by one or more other Subsidiaries
(a) directly or indirectly owns or controls securities or
other interests representing more than 50% of the voting power
of such Person, or (b) is entitled, by Contract or
otherwise, to elect, appoint or designate directors constituting
a majority of the members of such Persons board of
directors or other governing body.
Superior Proposal means, with respect to the
Company, a bona fide written Alternative Transaction
Proposal, which the Company Board has in good faith determined
(after consultation with its outside legal counsel and a
financial advisor of national standing), taking into account all
legal, financial, regulatory, timing and other aspects of the
proposal (including the need for and contingency of any
financing) and the identity of the Person making the proposal,
(a) to be more favorable, from a financial point of view,
to the Company Stockholders (in their capacities as
stockholders) than the terms of this Agreement,
(b) provides for consideration consisting exclusively of
cash and/or
publicly-traded equity securities, and (c) is reasonably
capable of being consummated on the terms proposed;
provided that, for purposes of this definition of
Superior Proposal each reference to 15%
or 85% in the definition of Alternative
Transaction shall be deemed to be a reference to
50%.
Tax (and, with correlative meaning,
Taxes and Taxable) shall
mean (a) any income, alternative or add-on minimum tax,
gross income, estimated, gross receipts, sales, use, ad valorem,
value added, transfer, franchise, capital stock, profits,
license, registration, withholding, payroll, social security (or
equivalent), employment, unemployment, disability, excise,
severance, stamp, occupation, premium, property (real, tangible
or intangible), environmental or windfall profit tax, custom
duty or other tax, governmental fee or other like assessment or
charge of any kind whatsoever, together with any interest or any
penalty, addition to tax or additional amount (whether disputed
or not) imposed by any Governmental Authority responsible for
the imposition of any such tax (domestic or foreign) (each, a
Tax Authority), (b) any liability for
the payment of any amounts of the type described in
clause (a) of this sentence as a result of being a member
of an affiliated, consolidated, combined, unitary or aggregate
group for any Taxable period, and (c) any liability for the
payment of any amounts of the type described in clause (a)
or (b) of this sentence as a result of being a transferee
of or successor to any Person or as a result of any express or
implied obligation to assume such Taxes or to indemnify any
other Person.
Tax Return shall mean any return, statement,
report or form (including estimated Tax returns and reports,
withholding Tax returns and reports, any schedule or attachment,
and information returns and reports) required to be filed with
respect to Taxes.
Transaction Expenses means all costs and
expenses incurred in connection with the Merger and this
Agreement and the transactions contemplated hereby (including
any fees and expenses of legal counsel, financial advisors,
investment bankers and accountants).
Unvested Company Options means any Company
Options that may be forfeited to or repurchased by the Company
under the terms of any Contract with the Company (including,
without limitation, any stock option agreement, or stock option
exercise agreement, or restricted stock purchase agreement).
Unvested Company Shares means any Company
Common Stock that may be forfeited to or repurchased by the
Company under the terms of any Contract with the Company
(including, without limitation, any stock option agreement, or
stock option exercise agreement, or restricted stock purchase
agreement).
Other capitalized terms defined elsewhere in this Agreement and
not defined in this Article 1 shall have the
meanings assigned to such terms in this Agreement.
A-10
ARTICLE 2
The
Merger
2.1 Conversion of Shares.
(a) Conversion of Merger Sub Common
Stock. At the Effective Time, each share of
Merger Sub Common Stock that is issued and outstanding
immediately prior to the Effective Time shall be converted into
one validly issued, fully paid and nonassessable share of Common
Stock, $0.0001 par value per share, of the Surviving
Corporation, and the shares of the Surviving Corporation into
which the shares of Merger Sub Common Stock are so converted
shall be the only shares of Company Common Stock that are issued
and outstanding immediately after the Effective Time.
(b) Conversion or Assumption of Company
Securities.
(i) Company Common Stock. Subject
to the terms and conditions of this Agreement, at the Effective
Time, each share of Company Common Stock that is issued and
outstanding immediately prior to the Effective Time (other than
Dissenting Shares and shares to be canceled pursuant to
Section 2.1(c)) shall, by virtue of the Merger and
without the need for any further action on the part of the
holder thereof (except as expressly provided herein), be
converted into and represent the right to receive an amount of
cash, without interest, equal to the Cash Amount Per Share. The
amount of cash each Company Stockholder is entitled to receive
for the shares of Company Common Stock held by such Company
Stockholder shall be rounded to the nearest cent and computed
after aggregating cash amounts for all shares of Company Common
Stock held by such Company Stockholder.
(ii) Company Options. Subject to
the terms and conditions of this Agreement, at the Effective
Time, each Company Option that is issued and outstanding
immediately prior to the Effective Time, whether or not then
exercisable, will be assumed by Acquiror and converted into an
option to purchase Acquiror Common Stock (collectively,
Assumed Options). Each Company Option so
assumed and converted will continue to have, and be subject to,
the same terms and conditions, except that (A) each
converted Company Option shall be exercisable (or will become
exercisable in accordance with its terms) for that number of
whole shares of Acquiror Common Stock equal to the product of
the number of shares of Company Common Stock that were subject
to such Company Option immediately prior to the Effective Time
(whether vested or unvested) multiplied by the Exchange Ratio
(rounded down to the nearest whole share) and (B) the per
share exercise price for the shares of Acquiror Common Stock
issuable upon exercise of such converted Company Option shall be
equal to the quotient determined by dividing the exercise price
per share of Company Common Stock at which such Company Option
was exercisable immediately prior to the Effective Time by the
Exchange Ratio (rounded up to the nearest whole cent). The
conversion of Company Options provided for in this
Section 2.1(b)(ii) with respect to any Company
Options that are intended to be incentive stock
options (as defined in Section 422 of the Code) shall
be effected in a manner consistent with Section 424(a) of
the Code and otherwise in a manner designed to preserve
incentive stock option treatment to the extent permitted by
Applicable Law.
(iii) Company Restricted Stock
Units. Subject to the terms and conditions of
this Agreement, at the Effective Time, each Company Restricted
Stock Unit that is issued and outstanding immediately prior to
the Effective Time will be assumed by Acquiror and converted
into an Acquiror Restricted Stock Unit (collectively,
Assumed Restricted Stock Units). Each Company
Restricted Stock Unit so assumed and converted will continue to
have, and be subject to, the same terms and conditions, except
that each converted Company Restricted Stock Unit shall be for
that number of whole shares of Acquiror Common Stock equal to
the product of the number of shares of Company Common Stock that
were subject to the Company Restricted Stock Unit immediately
prior to the Effective Time multiplied by the Exchange Ratio
(rounded down to the nearest whole share).
(iv) Company Warrants. Subject to
the terms and conditions of this Agreement, at the Effective
Time, each Company Warrant that is issued and outstanding
immediately prior to the Effective Time shall, by virtue of the
Merger and without the need for any further action on the part
of the holder thereof (except as expressly provided herein), be
converted into and represent the right to receive an amount of
cash, without interest, equal
A-11
to the product of (A) the number of shares of Company
Common Stock subject to such Company Warrant immediately prior
to the Effective Time (whether vested or unvested) multiplied by
(B) the Cash Amount Per Share, less the exercise price per
share attributable to such Company Warrant; provided,
however, that the Surviving Corporation and Acquiror
shall be entitled to deduct and withhold from such payment made
to the holder of a Company Warrant the amount of withholding for
Taxes required to be deducted and withheld as a result of the
transactions contemplated by this
Section 2.1(b)(iv); provided further,
that the right of the Company Warrantholder to receive such cash
shall remain subject to the same terms and conditions set forth
in such Company Warrant. The amount of cash each Company
Warrantholder is entitled to receive for the Company Warrants
held by such Company Warrantholder shall be rounded to the
nearest cent and computed after aggregating cash amounts for all
Company Warrants held by such Company Warrantholder.
(c) Cancellation of Company-Owned
Stock. Notwithstanding
Section 2.1(b), each share of Company Capital Stock
held by the Company or any Company Subsidiaries immediately
prior to the Effective Time shall be canceled and extinguished
without any conversion thereof.
(d) Adjustments. In the event of
any stock split, reverse stock split, stock dividend (including
any dividend or distribution of securities convertible into
capital stock), reorganization, reclassification, combination,
recapitalization or other like change with respect to the
Company Capital Stock occurring after the Agreement Date and
prior to the Effective Time, all references in this Agreement to
specified numbers of shares of any class or series affected
thereby, and all calculations provided for that are based upon
numbers of shares of any class or series (or trading prices
therefor) affected thereby, shall be equitably adjusted to the
extent necessary to provide the parties the same economic effect
as contemplated by this Agreement prior to such stock split,
reverse stock split, stock dividend, reorganization,
reclassification, combination, recapitalization or other like
change.
(e) Continuation of Vesting and Repurchase
Rights. If there are any Unvested Company
Shares issued and outstanding immediately prior to the Effective
Time, then the right to recover or extinguish such Unvested
Company Shares under the terms of any Contract with the Company
shall be assigned to Acquiror and the cash payable upon
conversion of such Unvested Company Shares in the Merger (the
Unvested Cash) shall be, in place of such
Unvested Company Shares, equally subject to such right assigned
to Acquiror and shall be withheld by Acquiror and paid without
interest to the holders of such Unvested Company Shares if and
to the extent such assigned right expires unexercised by
Acquiror pursuant to the terms of the applicable Contract with
the Company; provided, however, that the Surviving
Corporation and Acquiror shall be entitled to deduct and
withhold from such payments the amount of withholding imposed
for Taxes as required by Applicable Law; provided
further, that a portion of such newly vested cash so
distributed may be treated as imputed interest and will be so
treated to the extent required under the Code and the
regulations promulgated thereunder; provided
further, that for administrative convenience, Acquiror
may in its discretion make all such required payments of newly
vested cash according to its normal payroll schedule following
the date within a month upon which such cash became vested.
Notwithstanding the foregoing, if any such holder paid for
Unvested Company Shares with promissory notes, Unvested Cash
which vests shall first be applied towards repayment of accrued
interest and then outstanding principal under such promissory
notes before being distributed to such holder. The Company shall
take all actions that may be reasonably necessary to ensure
that, from and after the Effective Time, Acquiror (or its
assignee) is entitled to exercise any such right assigned
hereunder, such that any Unvested Cash shall be returned to
Acquiror without payment to such holder (other than payment of
the original purchase price of any Unvested Company Shares
converted into Unvested Cash upon exercise of the applicable
right by Acquiror according to the terms of the Contract with
the Company governing such Unvested Company Shares as of
immediately prior to the Effective Time).
(f) Dissenting Shares. Dissenting
Shares shall not be converted into the right to receive the Cash
Amount Per Share, and the holders thereof shall be entitled to
only such rights as are granted by Section 262 of the
Delaware Law; provided, however, that if any such
Company Stockholder shall fail to perfect or shall effectively
waive, withdraw or lose such stockholders rights under
Section 262 of the Delaware Law, such stockholders
shares of Company Common Stock in respect of which such
stockholder would otherwise be entitled to receive fair value
under Section 262 of the Delaware Law shall thereupon be
deemed to have been converted, at the Effective Time, into the
right to receive the Cash Amount Per Share.
A-12
2.2 Effects of the
Merger. At and upon the Effective Time:
(a) the separate existence of Merger Sub shall cease and
Merger Sub shall be merged with and into the Company, and the
Company shall be the surviving corporation of the Merger
pursuant to the terms of this Agreement and the Certificate of
Merger;
(b) the Certificate of Incorporation of the Surviving
Corporation shall be amended in its entirety to read as set
forth in the Certificate of Merger, until thereafter amended as
provided by Delaware Law;
(c) the Bylaws of the Surviving Corporation shall be
amended in their entirety to read as the Bylaws of Merger Sub,
until thereafter amended as provided by Delaware Law;
(d) the officers of Merger Sub immediately prior to the
Effective Time shall be appointed as the officers of the
Surviving Corporation immediately after the Effective Time until
their respective successors are duly appointed;
(e) the members of the Board of Directors of Merger Sub
immediately prior to the Effective Time shall be appointed as
the members of the Board of Directors of the Surviving
Corporation immediately after the Effective Time until their
respective successors are duly elected or appointed and
qualified; and
(f) the Merger shall, from and after the Effective Time,
have all of the effects provided by Delaware Law.
2.3 Tax Consequences and Withholding.
(a) The parties intend that the Merger shall be treated as
a Taxable purchase of securities of the Company pursuant to the
Code. However, Acquiror makes no representations or warranties
to the Company or to any Company Securityholder regarding
(i) the Tax treatment of the Merger or (ii) any of the
Tax consequences to the Company or any Company Securityholder of
this Agreement, the Merger or any of the other transactions or
agreements contemplated hereby. The Company and, by virtue of
the Company Stockholders adopting this Agreement, the Company
Stockholders, acknowledge that the Company and the Company
Stockholders are relying solely on their own Tax advisors in
connection with the Merger, this Agreement and the other
transactions or agreements contemplated hereby.
(b) Acquiror or Acquirors agent shall be entitled to
deduct and withhold from the amounts payable pursuant to this
Agreement to any Company Securityholder, any amounts required to
be deducted and withheld under the Code, or any other provision
of Applicable Law, with respect to the making of such payment.
To the extent that amounts are so withheld, such withheld
amounts shall be treated for all purposes of this Agreement as
having been paid to the Company Securityholder in respect of
whom such deduction and withholding was made.
2.4 Further Assurances.
At and after the Effective Time, the officers and directors of
Acquiror and the Surviving Corporation will be authorized to
execute and deliver, in the name and on behalf of the Company
and Merger Sub, any deeds, bills of sale, assignments or
assurances and to take and do, in the name and on behalf of the
Company and Merger Sub, any other actions and things to vest,
perfect or confirm of record or otherwise in the Surviving
Corporation any and all right, title and interest in, to and
under any of the rights, properties or assets acquired or to be
acquired by the Surviving Corporation as a result of, or in
connection with, the Merger.
ARTICLE 3
Representations
and Warranties of the Company
Except as set forth in the disclosure letter of the Company
addressed to Acquiror, dated as of the Agreement Date and
delivered to Acquiror concurrently with the parties
execution of this Agreement (the Company Disclosure
Letter) referencing a representation or warranty
herein (it being understood that (i) the Company Disclosure
Letter shall be arranged in sections and subsections
corresponding to the sections and subsections contained in this
Article 3, (ii) the disclosures in any section
or subsection of the Company Disclosure Letter shall qualify the
applicable representations and warranties in the corresponding
section or subsection of this Article 3 and, in
addition, the representations and warranties in other sections
or subsections in this Article 3 to the extent it is
reasonably apparent on the face of such disclosures that such
disclosures are applicable to such other sections or
A-13
subsections, and (iii) such disclosures in the Company
Disclosure Letter relating to the representations and warranties
in this Article 3 shall also be deemed to be
representations and warranties made by the Company under this
Article 3), the Company represents and warrants to
Acquiror as follows:
3.1 Organization and Good
Standing. The Company is a corporation
duly organized, validly existing and in good standing under the
laws of the State of Delaware. The Company has the corporate
power and authority to own, operate and lease its properties and
to carry on the Company Business. The Company is duly qualified
or licensed to do business, and is in good standing (to the
extent that such concept is applicable), in each jurisdiction
where the character of the properties owned, leased or operated
by it or the nature of its activities makes such qualification
or licensing necessary, except where the failure to be so
qualified and in good standing, individually or in the aggregate
with any such other failures, would not reasonably be expected
to be material to the Company and the Company Subsidiaries,
taken as a whole; without limiting the foregoing, the Company is
so qualified or licensed and in good standing (to the extent
that such concept is applicable) in each jurisdiction listed on
Schedule 3.1 of the Company Disclosure Letter. The
Company has made available to Acquirors legal counsel true
and complete copies of the Company Charter Documents. The
Company is not in violation of the Company Charter Documents.
3.2 Company Subsidiaries.
(a) Organization and Good
Standing. Schedule 3.2(a) of the
Company Disclosure Letter sets forth a true, correct and
complete list of all Company Subsidiaries. Each Company
Subsidiary is a corporation duly organized, validly existing and
in good standing (to the extent that such concept is applicable)
under the laws of its jurisdiction of organization. Each Company
Subsidiary has the corporate power and authority to own, operate
and lease its properties and to carry on its business. Each
Company Subsidiary is duly qualified or licensed to do business,
and is in good standing, in each jurisdiction where the
character of the properties owned, leased or operated by it or
the nature of its activities makes such qualification or
licensing necessary, except where the failure to be so qualified
and in good standing, individually or in the aggregate with any
such other failures, would not reasonably be expected to be
material to the Company and the Company Subsidiaries, taken as a
whole; without limiting the foregoing, each respective Company
Subsidiary is so qualified or licensed and in good standing (to
the extent that such concept is applicable) in each jurisdiction
listed on Schedule 3.2(a) of the Company Disclosure
Letter. The Company has made available to Acquirors legal
counsel true and complete copies of the currently effective
Certificate of Incorporation and Bylaws (or other comparable
charter documents) of each Company Subsidiary, each as amended
to date. Each Company Subsidiary is not in violation of its
Certificate of Incorporation or Bylaws (or other comparable
charter documents), each as amended to date.
(b) Ownership. The Company is the
owner of all of the issued and outstanding shares of capital
stock of each Company Subsidiary and all such shares are duly
authorized, validly issued, fully paid and nonassessable. All of
the issued and outstanding shares of capital stock of each
Company Subsidiary are owned by the Company free and clear of
all Encumbrances (other than Permitted Encumbrances) and are not
subject to any preemptive right or right of first refusal
created by statute, the Certificate of Incorporation and Bylaws
(or other comparable charter documents), as applicable, of such
Company Subsidiary or any agreement to which such Company
Subsidiary is a party or by which it is bound. There are no
stock appreciation rights, options, warrants, calls, rights,
legally binding commitments, conversion privileges or preemptive
or other rights or agreements outstanding to purchase or
otherwise acquire any shares of capital stock of a Company
Subsidiary or any securities or debt convertible into or
exchangeable for capital stock of a Company Subsidiary or
obligating the Company or any Company Subsidiary to grant,
extend or enter into any such option, warrant, call, right,
legally binding commitment, conversion privilege or preemptive
or other right or agreement. Other than the Company Subsidiaries
set forth in Schedule 3.2(a) of the Company
Disclosure Letter, the Company does not have any Company
Subsidiary or any equity or ownership interest (or any interest
convertible or exchangeable or exercisable for, any equity or
ownership interest), whether direct or indirect, in any Person.
As of the Agreement Date, the Company is not contractually
obligated to make nor is it bound by any agreement or
contractual obligation to make any investment in or capital
contribution in or on behalf of any other Person.
3.3 Power, Authorization and Validity.
(a) Power and Authority. Subject
to adoption of this Agreement by holders of a majority of the
outstanding shares of Company Common Stock (the Company
Stockholder Approval), the Company has all requisite
A-14
corporate power and authority to enter into, execute, deliver
and perform its obligations under this Agreement and to
consummate the Merger and the other transactions contemplated
hereby. As of the Agreement Date, the Company Board, by
resolutions duly adopted (and not thereafter modified or
rescinded) by the unanimous vote of the full Company Board, has
(i) determined that this Agreement and the terms and
conditions of the Merger and this Agreement are fair to,
advisable and in the best interests of the Company and the
Company Stockholders, (ii) approved and adopted this
Agreement and the Merger, and (iii) directed that the
adoption of this Agreement be submitted to the Company
Stockholders for consideration and recommended that all of the
Company Stockholders adopt this Agreement. The Company
Stockholder Approval is the only vote of the holders of any
class or series of Company Capital Stock necessary to adopt this
Agreement and consummate the Merger and the other transactions
contemplated hereby under the Company Charter Documents and
Applicable Law.
(b) No Governmental Consents. No
consent, approval, order, authorization, release or waiver of,
or registration, declaration or filing with, any Governmental
Authority, is necessary or required to be made or obtained by
the Company to enable the Company to lawfully execute and
deliver, enter into, and perform its obligations under, this
Agreement or to consummate the Merger, except for (i) the
filing of the Certificate of Merger with the Delaware Secretary
of State and appropriate documents with the relevant authorities
of other states in which Company is qualified to do business,
(ii) such filings and notifications as may be required to
be made by the Company in connection with the Merger under the
HSR Act and other applicable Antitrust Laws and the expiration
or early termination of applicable waiting periods under the HSR
Act and such Antitrust Laws, (iii) the filing with the SEC
of the Proxy Statement and such reports and filings under the
Exchange Act and the rules and regulations thereunder as may be
required in connection with this Agreement and the transactions
contemplated hereby, (iv) such other filings and
notifications as may be required to be made by the Company under
federal, state or foreign securities laws or the rules and
regulations of NASDAQ, and (v) such other consents,
approvals, orders, authorizations, releases, waivers,
registrations, declarations or filings that if not made or
obtained would not, individually or in the aggregate, reasonably
be expected to have a material adverse effect on the ability of
the Company to consummate the Merger or have a Material Adverse
Effect on the Company.
(c) Enforceability. This Agreement
has been duly executed and delivered by the Company, and
assuming the due execution and delivery of this Agreement by
Acquiror and Merger Sub, constitutes the valid and binding
obligations of the Company, enforceable against the Company in
accordance with its terms, subject to the effect of
(i) applicable bankruptcy, insolvency, reorganization,
moratorium or other similar laws now or hereafter in effect
relating to rights of creditors generally and (ii) rules of
law and equity governing specific performance, injunctive relief
and other equitable remedies.
(d) Takeover Laws. Assuming the
truth of the representation and warranty contained in
Section 4.5, the adoption of this Agreement and the
approval of the Merger and the transactions contemplated hereby
by the Company Board referred to in Section 3.3(a)
constitute all of the approvals that are necessary to render
inapplicable to this Agreement, the Merger, and the transactions
contemplated hereby the provisions of Section 203 of
Delaware Law and represent the only actions necessary to ensure
that Section 203 of Delaware Law do not and will not apply
to the execution, delivery, or performance of this Agreement or
the consummation of the Merger or other transactions
contemplated hereby. To the knowledge of the Company, no other
state takeover or other similar statute or regulation is
applicable to this Agreement or the Merger.
3.4 Capital Structure of the Company.
(a) The authorized capital stock of the Company consists
solely of 100,000,000 shares of Company Common Stock, of
which 2,000,000 shares are designated as Class B
non-voting Common Stock, and 5,000,000 shares of Company
Preferred Stock. As of the close of business on January 24,
2007, a total of 29,386,546 shares of Company Common Stock,
no shares of Class B non-voting Common Stock and no shares
of Company Preferred Stock are issued and outstanding. The
Company has reserved (i) an aggregate of
5,798,098 shares of Company Common Stock for issuance
pursuant to the Company Option Plans (including shares subject
to outstanding Company Options) and (ii) an aggregate of
3,125,213 shares of Company Common Stock for issuance
pursuant to the Company ESPP. As of the close of business on
January 24, 2007, (i) a total of 2,300,853 shares
of Company Common Stock are subject to outstanding Company
Options, (ii) a total of 1,459,998 shares of Company
Common Stock are subject to outstanding Company Warrants,
(iii) a total of 1,490,289 shares of Company Common
Stock
A-15
are reserved for future grant and issuance under the Company
Option Plans (excluding shares subject to outstanding Company
Options), and (iv) a total of 2,454,329 shares of
Company Common Stock are reserved for future grant and issuance
under the Company ESPP. Except for Company Options and Company
Warrants, there are no stock appreciation rights, options,
warrants, calls, rights, legally binding commitments, conversion
privileges or preemptive or other rights or Contracts
outstanding to purchase or otherwise acquire any shares of
Company Capital Stock or Company Voting Debt or any securities
or debt convertible into or exchangeable for Company Capital
Stock or Company Voting Debt or obligating the Company to grant,
extend or enter into any such option, warrant, call, right,
legally binding commitment, conversion privilege or preemptive
or other right or Contract. In the period from January 24,
2007 through the Agreement Date, (i) the Company has not
issued shares of Company Capital Stock other than pursuant to
the exercise of Company Options or Company Warrants that were
issued and outstanding on January 24, 2007 and
(ii) the Company has not issued any Company Options or
Company Warrants.
(b) Schedule 3.4(b) of the Company Disclosure
Letter sets forth as of the close of business on
January 24, 2007, all holders of Unvested Company Shares,
and for each such Company Stockholder, (i) the number of
Unvested Company Shares held, (ii) the material terms of
the Companys rights to repurchase such Unvested Company
Shares, (iii) the schedule on which such rights lapse and
(iv) whether such repurchase rights lapse in full or in
part as a result of any of the transactions contemplated by this
Agreement or upon any other event or condition. All issued and
outstanding shares of Company Common Stock have been duly
authorized and validly issued, are fully paid and nonassessable,
were not issued in violation of and are not subject to any right
of rescission, right of first refusal or preemptive right, and
have been offered, issued, sold and delivered by the Company in
compliance with all requirements of Applicable Law and all
requirements set forth in applicable Contracts. There is no
Liability for dividends accrued and unpaid by the Company. As of
the Agreement Date, there are no shares of Company Common Stock
held in treasury by the Company or any Company Subsidiaries.
(c) Schedule 3.4(c)-1
of the Company Disclosure Letter sets forth as of the close of
business on January 24, 2007, for each Company Option,
(i) the name of the holder of such Company Option,
(ii) the exercise price per share of such Company Option,
(iii) each holder of outstanding Company Options that is
not an employee of the Company or any Subsidiary (including
non-employee directors, former employees, consultants, advisory
board members, vendors, service providers or other similar
persons), (iv) the number of shares covered by such Company
Option, (v) the term of such Company Option, (vi) the
vesting schedule for such Company Option and the extent such
Company Option is vested as of January 24, 2007,
(vii) whether such Company Option is an incentive stock
option under Section 422 of the Code, (viii) the terms
of any accelerated vesting or exercisability of any Company
Options, and (ix) which Company Option Plan (if any) such
Company Option was granted under. The terms of the Company
Option Plans permit the conversion of Company Options into cash
as provided in this Agreement, without the consent or approval
of the holders of such Company Options, the Company Stockholders
or otherwise and except as set forth in
Section 3.4(c) of the Company Disclosure Letter,
without acceleration of the exercise schedule or vesting
provisions in effect for such Company Options.
Schedule 3.4(c)-2
of the Company Disclosure Letter sets forth as of the close of
business on January 24, 2007, for each Company Warrant,
(i) the name of the holder of such Company Warrant,
(ii) the exercise price per share of such Company Warrant,
(iii) the number and kind of shares covered by such Company
Warrant, (iv) the vesting schedule for such Company
Warrant, (v) the extent such Company Warrant is vested as
of January 24, 2007, (vi) whether such Company Warrant
was issued in connection with the performance of services, and
(vii) whether the exercisability of such Company Warrant
shall be accelerated in any manner by any of the transactions
contemplated by this Agreement or upon any other event or
condition and the extent of acceleration, if any. All issued and
outstanding Company Options and Company Warrants were issued by
the Company in material compliance with all requirements of
Applicable Law and all requirements set forth in applicable
Contracts and were not issued in material violation of and are
not subject to any right of rescission, right of first refusal
or preemptive right. True and correct copies of the Company
Option Plans, the standard agreement under each Company Option
Plan, each agreement for each Company Option that does not
conform to the standard agreement under such Company Option Plan
and each Company Warrant have been made available by the Company
to Acquirors legal counsel, and such plans and agreements
have not been amended, modified or supplemented since being made
available, and there are no agreements, understandings or
commitments to amend, modify or supplement such plans or
agreements in any case from those made available.
A-16
(d) Company Debt. No bonds,
debentures, notes or other Debt of the Company or any Company
Subsidiaries (i) having the right to vote on any matters on
which stockholders may vote (or which is convertible into, or
exchangeable for, securities having such right) or (ii) the
value of which is any way based upon or derived from capital or
voting stock of the Company (collectively, Company
Voting Debt), is issued or outstanding as of the
Agreement Date. Schedule 3.4(d) to the Company
Disclosure Letter accurately lists all Debt of Company and
Company Subsidiaries, including, for each item of Debt, the
agreement governing the Debt and the interest rate, maturity
date and whether or not such Debt is secured. All Debt may be
prepaid at the Closing without penalty under the terms of the
agreements governing such Debt.
(e) No Other Rights. The Company
Charter Documents do not provide, and the Company is not a party
to or otherwise bound by any Contract providing, registration
rights, rights of first refusal, preemptive rights, co-sale
rights or other similar rights applicable to any securities of
the Company or any Company Subsidiary issued and outstanding as
of the Agreement Date. The Company is not a party to any
Contract regarding the voting of any outstanding securities of
the Company (other than the Voting Agreements).
3.5 No Conflict.
Neither the execution and delivery of this Agreement by the
Company, nor the consummation of the Merger or any other
transaction contemplated hereby: (a) conflicts with, or
(with or without notice or lapse of time, or both) results in a
termination, breach, impairment or violation of, or constitutes
a default under, or requires a consent, waiver or approval of
any Person under, (i) any provision of the Company Charter
Documents or other comparable charter documents of any Company
Subsidiary, each as currently in effect, (ii) subject to
compliance with the requirements described in
clauses (i)-(iv) of Section 3.3(b), in any
material respect, any Applicable Law applicable to the Company,
any Company Subsidiary or any of their respective assets or
properties, (iii) any Company Material Contract (as defined
in Section 3.12) to which the Company or any Company
Subsidiary is a party or by which the Company or any Company
Subsidiary or any of their respective assets or properties are
bound, or (iv) any privacy policy of the Company or any
Company Subsidiary (except in the cases of clause (iii) or
(iv), where such conflicts, terminations, breaches, impairments,
violations or defaults, or failures to obtain such consents,
waivers or approvals, individually or in the aggregate, would
not reasonably be expected to be material to the Company and the
Company Subsidiaries, taken as a whole); or (b) will result
in the creation of any material Encumbrance on any of the
material properties or assets of the Company and the Company
Subsidiaries, taken as a whole.
3.6 SEC Filings.
(a) SEC Reports. The Company has
filed with the SEC all registration statements, prospectuses,
reports, forms, statements, schedules, certifications and other
documents (including exhibits and all other items incorporated
by reference) required to be filed or furnished by the Company
since January 1, 2005 (all such required registration
statements, prospectuses, reports, forms, statements, schedules,
certifications and other documents, including those that the
Company may file subsequent to the Agreement Date, are referred
to herein as the Company SEC Documents), and,
to the Companys knowledge, all such Company SEC Documents
in the form filed with the SEC are available on the SECs
EDGAR website. As of their respective dates, the Company SEC
Documents (i) were prepared in accordance and complied in
all material respects with the requirements of the Securities
Act, the Exchange Act and the rules and regulations of the SEC
promulgated thereunder applicable to such Company SEC Documents
(ii) did not at the time they were filed (or if amended or
superseded by a filing prior to the Agreement Date, then on the
date of such filing) contain any untrue statement of a material
fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading, except to the extent corrected prior to the
Agreement Date by a subsequently filed Company SEC Document.
None of the Company Subsidiaries is required to file any forms,
reports or other documents with the SEC.
(b) Financial Statements. Each of
the consolidated financial statements (including, in each case,
any related notes thereto) contained in the Company SEC
Documents (the Company Financial Statements),
including each Company SEC Document filed after the Agreement
Date until the Closing, (i) was prepared in accordance with
GAAP (except in the case of unaudited interim financial
statements, as may be permitted by the SEC on
Form 10-Q
or
Form 8-K)
applied on a consistent basis throughout the periods involved
(except as may be indicated in the notes thereto), and
(ii) fairly presented, in all material respects, the
consolidated financial position of Company and the
A-17
Company Subsidiaries as at the respective dates thereof and the
consolidated results of Companys and the Company
Subsidiaries operations and cash flows for the periods
indicated (except that the unaudited interim financial
statements were subject to normal and recurring year-end and
quarter-end adjustments which were not material). Except as
reflected in the Company Balance Sheet (or described in the
notes thereto), neither the Company nor any of the Company
Subsidiaries has any Liabilities of any nature that would be
required by GAAP to be reflected on a consolidated balance sheet
of the Company and the Company Subsidiaries, or described in the
notes thereto, and that are, individually or in the aggregate,
material to the business, results of operations or financial
condition of the Company and its Subsidiaries taken as a whole,
except (i) Liabilities incurred since the Balance Sheet
Date in the ordinary course of business consistent with past
practice which are not material in nature or amount and do not
result from any breach of Contract, tort or violation of any
Applicable Law, (ii) Liabilities under the Company Material
Contracts (as defined in Section 3.12 below) set
forth on Schedule 3.6(b) of the Company Disclosure
Letter or under any Contracts entered into to by the Company or
any of the Company Subsidiaries subsequent to the Agreement Date
not in violation of Section 5.2(a) below,
(iii) Liabilities reserved against in the Company Balance
Sheet (but only to the extent of such reserves), and
(iv) Liabilities for Transaction Expenses. The books and
records of the Company and each Subsidiary have been, and are
being, maintained in all material respects in accordance with
applicable legal and accounting requirements and the Company
Financial Statements are consistent with such books and records.
(c) Sarbanes Act. The Company is in
compliance in all material respects with the applicable
provisions of the Sarbanes Act and the related rules and
regulations promulgated under such act or the Exchange Act, in
each case, as currently in effect. Since January 1, 2005,
no party has submitted any complaint to the Audit Committee of
the Company Board pursuant to the procedures established in
accordance with Section 10A(m)(4) of the Exchange Act. To
the Companys knowledge, there are no material violations
of the Companys code of conduct, adopted pursuant to
NASDAQ Rule 4350(n). As of the date hereof, no attorney
representing the Company or any of its Subsidiaries has reported
any material violation to the Companys chief legal
officer, chief executive officer, or any committee of the
Company Board, including any qualified legal compliance
committee, as contemplated by the rules set forth in 17 CFR
Part 205.
(d) Controls. The Company has
established and maintains a system of internal accounting
controls that complies with Section 13(b)(2)(B) of the
Exchange Act. There are no significant deficiencies
or material weaknesses (as defined by the Public
Company Accounting Oversight Board) in the design or operation
of the Companys internal controls and procedures which
could adversely affect the Companys ability to record,
process, summarize and report financial data. To the
Companys knowledge, there is no fraud, whether or not
material, that involves management or other current or former
employees of the Company or any of the Company Subsidiaries who
have a role in the Companys internal controls over
financial reporting. The Company has established and maintains
disclosure controls and procedures (as defined in
Rule 13a-15
promulgated under the Exchange Act), and such disclosure
controls and procedures are effective for the purpose for which
they were established. Each of the principal executive officer
of the Company and the principal financial officer of the
Company (or each former principal executive officer of the
Company and each former principal financial officer of the
Company, as applicable) has made all certifications required by
Sections 302 and 906 of the Sarbanes Act and the rules and
regulations promulgated thereunder with respect to the Company
SEC Reports. The Company has established and maintains
internal control over financial reporting (as
defined in
Rule 13a-15
promulgated under the Exchange Act) and such internal control
over financial reporting are effective in providing reasonable
assurance regarding the reliability of the Companys
financial reporting and the preparation of the Companys
financial statements in accordance with GAAP.
(e) Amendments. The Company has
heretofore made available to Acquiror a complete and correct
copy of any amendments or modifications, which have not yet been
filed with the SEC but which are required to be filed, to
agreements, documents or other instruments which previously had
been filed by the Company with the SEC pursuant to the
Securities Act or the Exchange Act. No material
contract (as such term is defined in Item 601(b)(10)
of
Regulation S-K
promulgated by the SEC) filed as an exhibit to the Company SEC
Documents has been amended or modified, except for amendments or
modifications so furnished or which have been filed as an
exhibit to a subsequently dated Company SEC Document. The
Company has heretofore made available to Acquiror a complete and
correct copy of any comment letters or similar correspondence
received by the Company from the
A-18
SEC for the Companys three prior fiscal years and current
fiscal year. The SEC has not provided comments to the Company in
connection with any Company SEC Documents that to the
Companys knowledge remain unresolved and are material. No
investigation by the SEC with respect to the Company or any of
the Company Subsidiaries is pending or, to the knowledge of the
Company, threatened.
(f) Proxy Statement. The
information supplied by the Company for inclusion in the Proxy
Statement shall not at the time the Proxy Statement is filed
with the SEC contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or
necessary in order to make the statements therein not
misleading. The information supplied by the Company for
inclusion or incorporation by reference in the Proxy Statement
shall not, on the date the Proxy Statement is mailed to Company
Stockholders, or at the time of the meeting of Company
Stockholders to consider the Company Stockholder Approval (the
Company Stockholders Meeting), contain
any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in
order to make the statements therein, in light of the
circumstances under which they are made, not false or
misleading, or omit to state any material fact necessary to
correct any statement in any earlier communication with respect
to the solicitation of proxies for the Company
Stockholders Meeting which has become false or misleading.
The Proxy Statement will comply as to form in all material
respects with the provisions of the Exchange Act and the rules
and regulations thereunder. Notwithstanding the foregoing, the
Company makes no representation or warranty with respect to any
information supplied by Acquiror or Merger Sub that is contained
in the Proxy Statement.
3.7 Litigation. (a) There
is no action, suit, arbitration, mediation, proceeding,
investigation or filed claim pending against the Company or any
Company Subsidiary or any of their respective assets or
properties (or to the knowledge of the Company, against any
executive officer, director or senior employee of the Company or
any Company Subsidiary in their capacity as such) before any
Governmental Authority, arbitrator or mediator, nor, to the
knowledge of the Company, has any such action, suit,
arbitration, mediation, proceeding, investigation or filed claim
been threatened, and (b) there is no judgment, decree,
injunction, rule or order of any Governmental Authority,
arbitrator or mediator outstanding against the Company or any
Company Subsidiary (or, to the knowledge of the Company, against
any executive officer, director or senior employee of the
Company or any Company Subsidiary in their capacity as such),
except in the case of clause (a) or (b), where such pending
or threatened actions, suits, arbitrations, mediations,
proceedings, claims or investigations, or any such judgments,
decrees, injunctions, rules or orders, individually or in the
aggregate, are not, and would not reasonably be expected to be,
material to the Company and the Company Subsidiaries, taken as a
whole. Neither the Company nor any Company Subsidiary has any
material action, suit, arbitration, mediation, proceeding,
investigation or filed claim pending against any Governmental
Authority or other Person. There has not been since
January 1, 2005, nor are there currently pending, any
material internal investigations or material inquiries being
conducted by the executive management of the Company or the
Company Board (or any committee thereof), or any third party at
the request of any of the foregoing, concerning any financial,
accounting, Tax, conflict of interest, illegal activity,
fraudulent or deceptive conduct or other misfeasance or
malfeasance issues.
3.8 Compliance with Laws.
(a) Applicable Laws. Neither the
Company nor any Company Subsidiary is in violation of or default
under, or has been in violation of or default under, any
Applicable Law in any material respect (which such violation or
default has not been fully remedied). Neither the Company nor
any of the Company Subsidiaries has received any written notice
or other written communication from any Governmental Authority
asserting that the Company or any of its Subsidiaries has failed
to comply, or is not in compliance, in any material respect,
with Applicable Law (which such failure to comply or
non-compliance has not been fully remedied) and to the
Companys knowledge, no investigation or review of the
Company or any of the Company Subsidiaries with respect to the
foregoing by any Governmental Authority is pending or threatened.
(b) Governmental Permits. The
Company and each Company Subsidiary holds all material permits,
licenses and approvals from, and has made all material filings
with, government (and quasi-governmental) agencies and
authorities, that are necessary
and/or
legally required to be held by it to conduct the Company
Business without any violation of Applicable Law
(Governmental Permits), the Company and each
Company Subsidiary has materially complied, and is now in
material compliance, with all Governmental Permits, and all such
Governmental
A-19
Permits are valid and in full force and effect. Neither the
Company nor any Company Subsidiary has received any written
notice or other written communication from any Governmental
Authority regarding (i) any actual or possible material
violation of any Governmental Permit or any failure to comply
with any material term or requirement of any Governmental Permit
(which such violation or failure to comply has not been fully
remedied) or (ii) any actual or possible revocation,
withdrawal, suspension, cancellation, termination or material
modification of any Governmental Permit.
(c) Unlawful Payments. Neither the
Company nor any Company Subsidiary nor the Companys
knowledge, any director, officer, agent or employee of the
Company or any Company Subsidiary, has, for or on behalf of the
Company or any Company Subsidiary, (i) used any funds for
unlawful contributions, gifts, entertainment or other unlawful
expenses relating to political activity or (ii) made any
unlawful payment to foreign or domestic government officials or
employees or to foreign or domestic political parties or
campaigns or violated any provision of the Foreign Corrupt
Practices Act of 1977, as amended.
(d) Export Control Laws. The
Company and each Company Subsidiary has conducted its export
transactions in accordance in all material respects with
applicable provisions of United States export control laws and
regulations, including but not limited to the Export
Administration Act and implementing Export Administration
Regulations. Without limiting the foregoing: (i) the
Company and each Company Subsidiary has obtained all export
licenses and other approvals required for exports by the Company
or such Company Subsidiary of products, software and
technologies from the United States; (ii) the Company and
each Company Subsidiary is in material compliance with the terms
of all export licenses or other approvals applicable to the
Company or such Company Subsidiary; (iii) there are no
pending or, to the knowledge of the Company, threatened claims
against the Company or any Company Subsidiary with respect to
such export licenses or other approvals; (iv) there are no
actions, conditions or circumstances pertaining to the
Companys or any Subsidiarys exports of products or
technology that would reasonably be expected to give rise to any
future claims; and (v) no consents or approvals for the
transfer of export licenses to Acquiror are required, except for
such consents and approvals that can be obtained expeditiously
without material cost.
(e) NASDAQ. The Company is in
material compliance with the applicable criteria for continued
listing of the Company Common Stock on NASDAQ, including all
applicable corporate governance rules and regulations.
3.9 Taxes.
(a) The Company and each Company Subsidiary (and any
consolidated, combined, unitary or aggregate group for Tax
purposes of which the Company or any Company Subsidiary is or
has been a member), have properly completed and timely filed all
material Tax Returns required to be filed by them and have
timely paid all material Taxes due and owing (whether or not
shown on any Tax Return). All such Tax Returns are complete and
accurate and were prepared in compliance with all Applicable Law
in all material respects. The Company has made available to
Acquiror correct and complete copies of all Tax Returns and
examination reports and statements of deficiencies assessed
against or agreed to by the Company or any of its Company
Subsidiaries.
(b) The Company and each Company Subsidiary has established
an adequate accrual or reserve in accordance with GAAP for the
payment of all income Taxes and all other material Taxes payable
in respect of the periods or portions thereof prior to the
Balance Sheet Date (which accrual or reserve as of the Balance
Sheet Date is fully reflected on the Company Balance Sheet), and
has no Liability for income Taxes or other material Taxes for
periods or portions of periods prior to the Balance Sheet Date
in excess of the accruals or reserves so established. Neither
the Company nor any Company Subsidiary has any Liability for
unpaid Taxes accruing after the Balance Sheet Date except for
Taxes arising in the ordinary course of business consistent with
past practice subsequent to the Balance Sheet Date. The
Companys Tax personnel have not made a determination and
do not have any current plan, intention, or expectation to
change the Companys Tax reserve as a result of the
Companys adoption of FASB Interpretation No. 48.
(c) No deficiencies for any Tax have been threatened,
claimed or proposed in writing or assessed against the Company
or any Company Subsidiary. Neither the Company nor any Company
Subsidiary has received any written notification from any Tax
Authority regarding any issues that (a) are currently
pending before such Tax Authority regarding the Company or any
Company Subsidiary, or (b) have been raised by such Tax
Authority and not yet
A-20
finally resolved. No Tax Return of the Company or any Company
Subsidiary is under audit by any Tax Authority. All past audits
(if any) have been completed and fully resolved to the
satisfaction of the applicable Tax Authority conducting such
audit and all Taxes determined by such audit to be due from the
Company or any Company Subsidiary have been paid in full to the
applicable Tax Authority. No Tax liens are currently in effect
against any of the assets of the Company or any Company
Subsidiary other than liens that arise by operation of
Applicable Law for Taxes not yet due and payable. There is not
in effect any waiver by the Company or any Company Subsidiary of
any statute of limitations with respect to any Taxes. Neither
the Company nor any Company Subsidiary has consented to extend
to a date later than the Agreement Date the period in which any
Tax may be assessed or collected by any Tax Authority.
(d) The Company and each Company Subsidiary have complied
(and until the Closing Date will comply) with all Applicable Law
relating to the payment and withholding of Taxes (including
withholding of Taxes pursuant to Sections 1441, 1442, 1445
and 1446 of the Code or similar provisions under any foreign
law), have, within the time and in the manner prescribed by law,
withheld from employee wages and paid over to the proper Tax
Authority (or are properly holding for such timely payment) all
amounts required to be so withheld and paid over under all
Applicable Law (including Federal Insurance Contribution Act,
Medicare Federal Unemployment Tax Act, federal and state income
Taxes and relevant state income and employment Tax withholding
laws), and has timely filed all withholding Tax Returns, for all
periods through and including the Closing Date.
(e) Neither the Company nor any Company Subsidiary has
filed any disclosures under Section 6662 of the Code or
comparable provisions of state, local or foreign law to prevent
the imposition of penalties with respect to any Tax reporting
position taken on any Tax Return.
(f) Neither the Company nor any Company Subsidiary has
consummated, has participated in, or is currently participating
in any transaction which was or is a Tax shelter
transaction as defined in Sections 6662 or 6111 of the Code
or the Treasury Regulations promulgated thereunder. Neither the
Company nor any Company Subsidiary has participated in, nor are
any of them currently participating in, a Listed
Transaction or a Reportable Transaction within
the meaning of Section 6707A(c) of the Code or Treasury
Regulation Section 1.6011-4(b),
or any transaction requiring disclosure under a corresponding or
similar provision of state, local, or foreign law.
(g) Neither the Company nor any Company Subsidiary has ever
been a member of a consolidated, combined, unitary or aggregate
group of which the Company was not the ultimate parent
corporation.
(h) Neither the Company nor any Company Subsidiary has any
Liability for the Taxes of any Person (other than the Company or
any Company Subsidiary) under
Section 1.1502-6
of the Treasury Regulations (or any similar provision of state,
local or foreign law) as a transferee or successor, by contract
or otherwise.
(i) The Company for itself and for each Company Subsidiary
has disclosed in Schedule 3.9(i) of the Company
Disclosure Letter the amount of any deferred gain or loss
arising out of any intercompany transaction within the meaning
of
Section 1.1502-13
of the Treasury Regulations.
(j) Neither the Company nor any Company Subsidiary will be
required to include any item of income in, or exclude any item
of deduction from, Taxable income for any Taxable period (or
portion thereof) ending after the Closing Date as a result of
any (i) change in method of accounting for a Taxable period
ending on or prior to the Closing Date; (ii) closing
agreement described in Section 7121 of the Code (or
any corresponding or similar provision of state, local, or
foreign Tax law); (iii) intercompany transactions or any
excess loss account described in Treasury Regulations under
Section 1502 of the Code (or any corresponding or similar
provision of state, local, or foreign Tax law);
(iv) installment sale or open transaction disposition made
on or prior to the Closing Date; or (v) prepaid amount
received or accrued on or prior to the Closing Date.
(k) Neither the Company nor any Company Subsidiary has
incurred a dual consolidated loss within the meaning of
Section 1503 of the Code.
(l) No claim has ever been made by a Governmental Authority
in a jurisdiction where the Company or any of its Company
Subsidiaries does not file Tax Returns that the Company or any
of its Subsidiaries is or may be subject to Taxation by that
jurisdiction. Neither the Company nor any of its Company
Subsidiaries has a permanent establishment in any country
outside of its country of incorporation.
A-21
(m) None of the Tax attributes (including net operating
loss carry forwards and general business Tax credits) of either
the Company or any Company Subsidiary is limited by
Sections 269, 382, 383, 384 or 1502 of the Code (or any
comparable provisions of foreign, state, local or municipal law).
(n) Each of the Company and each Company Subsidiary has in
its possession official foreign government receipts for any
Taxes paid by it to any foreign Tax Authorities.
(o) Schedule 3.9(o) of the Company Disclosure
Letter sets forth a complete and accurate list of all material
agreements, rulings, settlements or other Tax documents relating
to Tax incentives between Company or any Subsidiary and any
Governmental Authority. The Company and its Company Subsidiaries
are in compliance with the requirements for any applicable Tax
holidays or incentives and none of the Tax holidays or
incentives will be jeopardized by the transaction contemplated
in this Agreement.
(p) The Company has made available to Acquiror all
contemporaneous documentation prepared for Section 6662 of
the Code (or similar provision under foreign law) supporting the
transfer pricing with any of the foreign Company Subsidiaries
for the three most recent taxable years for which the Company
has filed income Tax Returns.
(q) Neither the Company nor any Company Subsidiary is a
party to or bound by any Tax sharing, Tax indemnity, or Tax
allocation agreement nor does the Company or any Company
Subsidiary have any Liability or potential Liability to another
party under any such agreement.
(r) Neither the Company nor any Company Subsidiary has
constituted either a distributing corporation or a
controlled corporation in a distribution of stock
qualifying for Tax-free treatment under Section 355 of the
Code (a) in the two years prior to the Agreement Date or
(b) in a distribution that could otherwise constitute part
of a plan or series of related
transactions (within the meaning of Section 355(e) of
the Code) in conjunction with the Merger.
(s) The Company has made available to Acquiror true,
correct and complete copies of all election statements under
Section 83(b) of the Code, together with evidence of timely
filing of such election statement with the appropriate Internal
Revenue Service Center, that are in the Companys (or any
Company Subsidiarys) possession or subject to the
Companys (or any Company Subsidiarys) control with
respect to any Unvested Company Shares or other property issued
by the Company to any of its (or any Company Subsidiarys)
employees, non-employee directors, consultants or other service
providers.
(t) To the Companys knowledge, each of the
Companys and its Subsidiaries nonqualified
deferred compensation plans within the meaning of Code
Section 409A (and associated United States Treasury
Department guidance) comply with or are exempt from Code
Section 409A (and associated United States Treasury
Department guidance); specifically each such nonqualified
deferred compensation plan that is subject to Code
Section 409A has been administered in good faith and
operated in compliance with Code Section 409A (and
associated Treasury Department guidance), and no such
nonqualified deferred compensation plan that is not
subject to Code Section 409A has been materially modified
within the meaning of Code Section 409A (and associated
Treasury Department guidance). No event has occurred that would
be treated by Section 409(A)(b) as a transfer of property
for purposes of Section 83 of the Code. Each Company Option
has been issued at not less than 100% of fair market value on
the date of grant. Schedule 3.9 of the Company
Disclosure Letter lists all nonqualified deferred
compensation plans (within the meaning of
Section 409A of the Code) to which the Company or any
Subsidiary is a party.
(u) There is no agreement, plan, arrangement or other
Contract covering any current or former employee or other
service provider of the Company or any Company Subsidiary or
ERISA Affiliate to which the Company
and/or any
Company Subsidiary is a party or by which the Company
and/or any
Company Subsidiary is bound that, considered individually or
considered collectively with any other such agreements, plans,
arrangements or other Contracts, will, or could reasonably be
expected to, as a result of the transactions contemplated hereby
(whether alone or upon the occurrence of any additional or
subsequent events), give rise directly or indirectly to the
payment of any amount that could reasonably be expected to be
non-deductible under Section 162 of the Code (or any
corresponding or similar provision of state, local or foreign
Tax law) or characterized as a parachute payment
within the meaning of Section 280G of the Code (or any
corresponding or similar provision of state, local or foreign
Tax law).
A-22
3.10 Title to Properties.
(a) The Company and each Company Subsidiary has good and
valid title to all of their respective assets and personal
properties (including those shown on the Company Balance Sheet,
except assets and personal properties sold or otherwise disposed
of since the date thereof in the ordinary course of business),
free and clear of all Encumbrances, except (a) Permitted
Encumbrances and (b) mortgages deeds of trust, security
interests or other encumbrances on title related to indebtedness
reflected on the consolidated financial statements of the
Company included in the Company SEC Documents. All properties
used in the operations of the Company Business are reflected on
the Company Balance Sheet to the extent required under GAAP to
be so reflected.
(b) Neither the Company nor any Company Subsidiary owns any
real property. Schedule 3.10(b) to the Company
Disclosure Letter is a complete and correct list of all material
real property and interests in real property leased by the
Company or any Company Subsidiary, excluding in all cases
premises involving payments of less than $250,000 per annum
(each such property or interest, a Leased Real
Property). With respect to Leased Real Property,
(i) the Company or the Company Subsidiary, as applicable,
has a valid leasehold interest in such Leased Real Property
which affords the Company or such Company Subsidiary peaceful
and undisturbed leasehold possession of the Leased Real Property
that is the subject of the lease, free and clear of all
Encumbrances other than Permitted Encumbrances, and
(ii) neither the Company nor any Company Subsidiary has
subleased, licensed or otherwise granted any Person the right to
use or occupy such Leased Real Property or any portion thereof.
The Company has made available to Acquiror true, correct and
complete copies of all leases, subleases and other Contracts
under which the Company
and/or any
Company Subsidiary uses or occupies or has the right to use or
occupy, now or in the future, any Leased Real Property,
including all modifications, amendments and supplements thereto.
The Company and the Company Subsidiaries have adequate rights of
ingress and egress into any real property used in the operation
of their respective businesses.
(c) The tangible personal property and equipment of each of
the Company and each Company Subsidiary that are used in the
operations of their respective businesses are
(i) reasonably suitable for the uses to which they are
currently employed, (ii) in working operating condition and
repair, subject to normal wear and tear, (iii) regularly
and properly maintained, (iv) not obsolete, dangerous or in
need of renewal or replacement, except for renewal or
replacement in the ordinary course of business, consistent with
past practice, (v) to the knowledge of the Company, free
from any material defects, and (vi) to the extent leased,
subject to a fully effective lease that affords the Company or
such Company Subsidiary peaceful and undisturbed leasehold
possession of the personal property that is the subject of the
lease.
(d) To the knowledge of the Company, the Company and the
Company Subsidiaries are not in violation of any zoning,
building, safety or environmental ordinance, regulation or
requirement applicable to the operation of the Leased Real
Properties, except for such violations that are not material to
the Company or any of the Company Subsidiaries, nor has the
Company or any of the Company Subsidiaries received any notice
of violation of any such ordinance, regulation or requirement
with which it has not complied.
(e) For the avoidance of doubt, the representations and
warranties set forth in this Section 3.10 do not
apply to Intellectual Property, which matters are specifically
addressed in Section 3.14.
3.11 Absence of Certain
Changes. Since the Balance Sheet Date to
and including the Agreement Date, the Company and the Company
Subsidiaries, taken as a whole, have operated their business in
the ordinary course consistent with its past practices, and
since such date there has not been any:
(a) Material Adverse Change or any change, event,
circumstance, condition or effect that would reasonably be
expected to result in a Material Adverse Change, in each case,
with respect to the Company;
(b) amendment or change in the Certificate of Incorporation
or Bylaws (or other comparable charter documents) of the Company
or any Company Subsidiary (except as required by Applicable Law
(as determined in good faith by the Company following
consultation with its outside legal counsel) and except for
immaterial amendments or changes to the charter documents of
Company Subsidiaries);
A-23
(c) incurrence, creation or assumption by the Company or
any Company Subsidiary of (i) any Encumbrance on any of its
assets or properties (other than Permitted Encumbrances) or
(ii) any Debt (other than permitted borrowing under a
Contract set forth on Schedule 3.12(g) of the
Company Disclosure Letter);
(d) except as set forth in Section 3.11(h) of
the Company Disclosure Letter, acceleration or release of any
vesting condition to the right to exercise any Company Option,
Company Warrant or other right to purchase or otherwise acquire
any shares of Company Capital Stock, or any acceleration or
release of any right to repurchase shares of Company Capital
Stock upon the stockholders termination of employment or
services with it or pursuant to any right of first refusal;
(e) purchase, sale, pledge, disposition of, transfer,
lease, license, or Encumbrance, or authorization of the
purchase, sale, pledge, disposition, transfer, lease, license,
or Encumbrance (other than a Permitted Encumbrance or pursuant
to transactions by or among the Company and the Company
Subsidiaries) of, any property or assets material to the Company
or any of the Company Subsidiaries taken as a whole, other than
the sale or non-exclusive license of its products or services to
its customers (including OEMs, distributors and resellers) in
the ordinary course of business consistent with past practice;
(f) damage, destruction or loss of any property or asset
material to the Company and the Company Subsidiaries taken as a
whole (normal wear and tear excluded), whether or not covered by
insurance (except where insurance proceeds fully covering such
damage, destruction or loss have been received);
(g) declaration, setting aside or payment of any dividend
on, or the making of any other distribution in respect of, the
Company Capital Stock, or any split, combination or
recapitalization of its capital stock or any direct or indirect
redemption, purchase or other acquisition of any of the Company
Capital Stock or any change in any rights, preferences,
privileges or restrictions of any of the Companys
outstanding securities (other than repurchases of stock in
accordance with the Company Option Plans or applicable Contracts
in connection with the termination of service of employees or
other service providers);
(h) (i) increase in the base salary, incentive
compensation (including stock awards, stock option grants or
stock appreciation rights), severance or retention benefits or
perquisites payable or to become payable to directors or
executive officers of the Company (other than increases pursuant
to the terms of an existing Contract set forth on
Schedule 3.12(a) of the Company Disclosure Letter or
increases not in excess of 10% of base salary granted pursuant
to performance reviews held in the ordinary course of business
consistent with past practice), and neither the Company nor any
Company Subsidiary has entered into any Contract to grant or
provide (nor has granted or provided) any severance,
acceleration of vesting or other similar benefits to any of such
persons (other than pursuant to the terms of an existing
Contract set forth on Schedule 3.12(a) of the
Company Disclosure Letter), (ii) increase in the
compensation or benefits payable to its other employees (other
than increases pursuant to the terms of an existing Contract or
increases not in excess of 10% of base salary granted pursuant
to performance reviews held in the ordinary course of business
consistent with past practice), (iii) amendment or entry
into of any employment or consulting Contract with any officer
or director (except in the ordinary course of business pursuant
to a standard offer letter with no severance, retention or
acceleration provisions), (iv) adoption of any plan or
arrangement to provide compensation or benefits to any
employees, directors or consultants, or amendment of any Company
Benefit Arrangements (except in each case as was required under
ERISA, or the Code, or Applicable Law), or (v) material
amendment to any deferred compensation plan within the meaning
of Section 409A of the Code and Internal Revenue Service
Notice
2005-1 or
Company Options, except to the extent as was necessary to meet
the good faith compliance requirements of such Section or Notice;
(i) change in the identity of the Chief Executive Officer
or any Vice President (who is an executive officer) of the
Company, any termination of employment of a material number of
employees of the Company and the Company Subsidiaries, or any
organized labor dispute or claim of unfair labor practices
involving the Company or the Company Subsidiaries;
(j) making by the Company or any Company Subsidiary of any
loan, advance or capital contribution to, or any investment in,
any of its executive officers, directors or 10% stockholders or
any firm or business enterprise in which the Company had
knowledge that any such Person had a direct or indirect material
interest
A-24
at the time of such loan, advance, capital contribution or
investment (other than reasonable and normal advances to
employees for bona fide expenses that are incurred in the
ordinary course of business consistent with the Companys
past practices);
(k) entering into, amendment of, relinquishment,
termination or nonrenewal by it of any Company Material Contract
other than in the ordinary course of its business consistent
with the Companys past practices;
(l) change in the manner in which it extends discounts,
credits or warranties to customers other than changes in the
ordinary course of business consistent with past practices,
which changes were immaterial to the Company Business, taken as
a whole;
(m) entering into by it of any transaction or Contract that
by its terms requires or contemplates a current
and/or
future financial commitment, expense (inclusive of overhead
expense) or obligation on its part that involves in excess of
$1,000,000 or that is not entered into in the ordinary course of
its business consistent with its past practices;
(n) making or entering into any Contract with respect to
any acquisition, sale or transfer of any material asset of the
Company and the Company Subsidiaries, taken as a whole (other
than such Contracts by or among the Company and the Company
Subsidiaries);
(o) any material change in accounting policies or
procedures, except as required by GAAP or IAS (including any
change in depreciation or amortization policies or rates or
revenue recognition policies), or any revaluation of any of its
material assets;
(p) any deferral of the payment of any accounts payable
other than in the ordinary course of business, consistent with
past practices, or in an amount in excess of $250,000;
(q) commencement or settlement (or agreement to settle) of
any litigation, action, suit, proceeding, claim, arbitration or
mediation (except where the amount in controversy did not exceed
$500,000 and did not involve injunctive or other equitable
relief);
(r) entry into any Contract that would be required to be
disclosed as an off-balance sheet arrangement under GAAP; or
(s) announcement of, or any entry into any Contract to do,
any of the things described in the preceding clauses (a)
through (r) (other than negotiations and agreements with
Acquiror and its representatives regarding the transactions
contemplated by this Agreement).
3.12 Contracts, Agreements, Arrangements,
Commitments and Undertakings.
Schedules 3.12(a)-(s) of the Company Disclosure Letter
set forth a list of each of the following Contracts to which the
Company or any Company Subsidiary is a party or to which the
Company or any Company Subsidiary or any of their respective
assets or properties is bound (each a Company Material
Contract):
(a) any Contract that is a material contract
(as such term is defined in Item 601(b)(10) of
Regulation S-K
promulgated by the SEC);
(b) any Contract (other than real and personal property
leases which are covered by subsection (p) below) that
requires by its terms payments (whether fixed, contingent or
otherwise) by it in an aggregate annual amount of $750,000 or
more;
(c) any dealer, distributor, OEM (original equipment
manufacturer), VAR (value added reseller), sales representative
or similar Contract (other than any Form Agreement or
Freely Terminable Agreement) under which any third party is
authorized to sell, sublicense, lease, distribute or market any
of its products, services or technology;
(d) any Contract providing for the development of any
software, content (including textual content and visual,
photographic or graphics content), technology or intellectual
property for (or for the benefit or use of) it, or providing for
the purchase by or license to (or for the benefit or use of) it
of any software, content (including textual content and visual,
photographic or graphics content), technology or intellectual
property, which
A-25
software, content, technology or intellectual property is in any
manner incorporated (or is contemplated by it to be
incorporated) into any product of it (other than software
generally available to the public at a per copy license fee of
less than $10,000);
(e) any joint venture or partnership Contract that involves
a sharing of revenues, profits, cash flows, expenses or losses
with any other party or a payment of royalties to any other
party in amounts in excess of $1,000,000 per annum (other
than Contracts which are covered under
subsection (c) above and Freely Terminable Agreements);
(f) (i) any Contract for or relating to the employment
by it of any director, officer, employee or consultant or any
other type of Contract with any of its officers, employees or
consultants that is not terminable by it on 30 days or less
notice without cost or other Liability, (ii) any Contract
requiring it to make a cash payment to any director, officer,
employee or consultant on account of the Merger, or
(iii) any Contract with any director, officer, employee or
consultant that is entered into in connection with this
Agreement;
(g) any indenture, mortgage, trust deed, promissory note,
loan agreement, security agreement, guarantee or other Contract
for or with respect to the borrowing of money, a line of credit,
any currency exchange, commodities or other hedging arrangement,
or a leasing transaction of a type required to be capitalized in
accordance with GAAP, in each case involving an aggregate
principal amount of underlying Debt, currency exchange, exposure
under commodities or hedging arrangements or capitalized lease,
as applicable, in excess of $1,000,000;
(h) any Contract that restricts it from (i) engaging
in any material aspect of its business, (ii) participating
or competing in any line of business or market,
(iii) freely setting prices for its products, services or
technologies (including most favored customer pricing
provisions), (iv) engaging in any business in any market or
geographic area or that grants any exclusive rights, rights of
refusal, rights of first negotiation or similar rights to any
party, or (v) soliciting current or potential suppliers or
customers (except in the case of clauses (iii) and
(iv) for such provisions contained in customer agreements
involving non-Significant Customers that, individually or in the
aggregate, are not material to the Company Business);
(i) any Contract still in effect relating to the sale,
issuance, grant, exercise, award, purchase, repurchase or
redemption of any shares of Company Capital Stock or any Company
Options, Company Warrants or other rights to purchase or
otherwise acquire any such shares of Company Capital Stock,
Company Options or Company Warrants, except for those Contracts
conforming in all material respects to the standard agreements
under such Company Option Plan;
(j) any Contract with any labor union or any collective
bargaining agreement or similar Contract with its employees;
(k) any Contract of guarantee, assumption or endorsement
of, or any similar commitment with respect to, the Debt or
performance obligations of any other Person;
(l) any Contract providing for indemnification of any
director or officer of the Company or any Company Subsidiary;
(m) any Contract (i) to the Companys knowledge,
in which its officers, directors or 10% stockholders is directly
or indirectly interested (whether as a party or otherwise)
(other than offer letters, stock option and restricted stock
purchase agreements, non-disclosure agreements or invention
assignment agreements entered into in the ordinary course of
business that are on the Companys standard forms (as made
available to Acquirors counsel) without material
modifications) or (ii) with any Person with whom it does
not deal at arms length;
(n) any Contract pursuant to which it has acquired a
business or entity, or all or substantially all of the assets of
a business or entity, whether by way of merger, consolidation,
purchase of stock, purchase of assets, license or otherwise,
which Contract is still in effect and has ongoing obligations on
the part of the parties thereto, or any Contract pursuant to
which it has any material ownership interest in any other Person
(other than the Company Subsidiaries);
A-26
(o) any Contract with a Governmental Authority (other than
customer agreements involving payments of less than
$100,000 per annum) or any material Governmental Permit;
(p) any Contract pursuant to which it has purchased any
real property, or any Contract pursuant to which it is a lessor
or lessee of any real property or personal property involving
payments in excess of $250,000 per annum;
(q) any Contract with any investment banker, broker,
advisor or similar party, or any accountant, legal counsel or
other Person retained by it in connection with this Agreement
and the transactions contemplated hereby;
(r) any settlement or litigation standstill
agreement, or any tolling agreement, in each case, which is
still in effect and has ongoing obligations on the party or the
parties thereto (other than settlement agreements entered into
in the ordinary course of business with employees upon the
termination of their employment where all material obligations
of the Company have been fully performed by the Company (it
being understood that anti-disparagement and confidentiality
provisions and mutual releases shall not be considered material
obligations of the Company for this purpose)); or
(s) any Contract under which the Companys entering
into this Agreement or the consummation of the Merger
(i) requires the procurement of any consent, waiver or
novation from a third party or (ii) grants a third party
termination rights or other material rights.
A true and complete copy of each agreement or document required
by these subsections (a)-(s) of this Section 3.12 to
be listed on Schedule 3.12 of the Company Disclosure
Letter has been made available to Acquirors legal counsel.
All Company Material Contracts are in written form.
3.13 No Default; No Restrictions.
(a) The Company or the applicable Company Subsidiary has
performed all of the material obligations required to be
performed by it under each Company Material Contract. Each of
the Company Material Contracts is in full force and effect.
There exists no default or event of default or event,
occurrence, condition or act, on the part of or attributable to
the Company or any Company Subsidiary or to the knowledge of the
Company, on the part of or attributable to any other contracting
party, which, with or without the giving of notice or the lapse
of time, would reasonably be expected to (i) become a
material default or event of default under any Company Material
Contract or (ii) give any third party (A) the right to
declare a material default or exercise any material remedy under
any Company Material Contract, (B) the right to a material
rebate or reimbursement under any Company Material Contract,
(C) the right to accelerate the maturity or performance of
any material obligation of the Company or any of the Company
Subsidiaries under any Company Material Contract, or
(D) the right to cancel, terminate or adversely modify any
Company Material Contract. To the knowledge of the Company,
neither the Company nor any Company Subsidiary has received any
written notice regarding any material violation or breach of or
default under, or intention to cancel or materially adversely
modify, any Company Material Contract where the subject matter
of such notice remains pending and unresolved.
(b) Except as listed in Schedule 3.12(h) of the
Company Disclosure Letter, neither the Company nor any Company
Subsidiary is a party to, and to the Companys knowledge,
no asset or property of the Company or any Subsidiary is bound
or affected by, any judgment, injunction, order, decree,
Contract (noncompete or otherwise) that restricts or prohibits,
or purports to restrict or prohibit, the Company or any Company
Subsidiary or, following the Effective Time, the Surviving
Corporation or Acquiror, from (i) engaging in any material
aspect of the Company Business, (ii) participating or
competing in any line of business or market, (iii) freely
setting prices for the products, services or technologies of the
Company and Company Subsidiaries (including most favored
customer pricing provisions), (iv) engaging in any business
in any market or geographic area or that grants any exclusive
rights, rights of refusal, rights of first negotiation or
similar rights to any party, or (v) soliciting current or
potential suppliers or customers (except in the case of
clauses (iii) and (iv) for such provisions contained
in customer agreements involving non-Significant Customers that,
individually or in the aggregate, are not material to the
Company Business).
A-27
3.14 Intellectual Property.
(a) To the Companys knowledge, the Company and each
Company Subsidiary (i) owns or (ii) has the valid
right or license to use, and, to the extent that it does any of
the following, to develop, make, have made, offer for sale,
sell, import, copy, modify, create derivative works of,
distribute, license,
and/or
dispose of all Intellectual Property used in the conduct of the
Company Business (such Intellectual Property being hereinafter
collectively referred to as the Company IP
Rights) and such Company IP Rights are sufficient for
such conduct of the Company Business. As used in this Agreement,
Company-Owned IP Rights means Company IP
Rights that are or are purportedly owned or exclusively licensed
to the Company or any Subsidiary; and Company-Licensed
IP Rights means Company IP Rights that are not
Company-Owned IP Rights.
(b) Neither the execution, delivery and performance of this
Agreement nor the consummation of the Merger and the other
transactions contemplated by this Agreement shall, in accordance
with their terms: (i) constitute a material breach of or
default under any instrument, license or other Contract
governing any Company IP Right (collectively, the
Company IP Rights Agreements) (except where
such breaches, individually or in the aggregate, would not
reasonably be expected to be material to the Company and the
Company Subsidiaries, taken as a whole); (ii) cause the
forfeiture or termination of, or give rise to a right of
forfeiture or termination of, any Company IP Right (except where
such forfeitures or terminations, individually or in the
aggregate, would not reasonably be expected to be material to
the Company and the Company Subsidiaries, taken as a whole); or
(iii) materially impair the right of the Company or the
Surviving Corporation or any Company Subsidiary to use, develop,
make, have made, offer for sale, sell, import, copy, modify,
create derivative works of, distribute, license,
and/or
dispose of any Company IP Right or portion thereof (except where
such impairments, individually or in the aggregate, would not
reasonably be expected to be material to the Company and the
Company Subsidiaries, taken as a whole). There are no royalties,
honoraria, fees or other payments (other than salaries payable
to employees and independent contractors not contingent on or
related to use of their work product) as a result of the use,
license-in, manufacture, sale, offering for sale, copying,
distribution, or disposition of any Company IP Rights that are
incorporated into, integrated or bundled with any of the Company
Products or Services by the Company or any Company Subsidiary
that shall become payable by the Company or any Company
Subsidiary as a result of the consummation of the transactions
contemplated by this Agreement. After the Closing, all
Company-Owned IP Rights will be fully transferable, alienable or
licensable by the Surviving Corporation and Acquiror without
restriction and without payment of any kind to any third party.
(c) Schedule 3.14(c) of the Company Disclosure
Letter sets forth a list (by name and version number) of each of
the products and services currently produced, manufactured,
marketed, licensed, sold, or distributed by the Company and the
Company Subsidiaries and each product and service currently
under development by the Company or any Company Subsidiary that
the Company intends to make generally commercially available
within six months after the Agreement Date (each a
Company Product or Service). To the
Companys knowledge, neither the operation of the Company
Business nor the use, development, manufacture, marketing,
licensing, sale, offering for sale, distribution, or intended
use of any Company Product or Service (i) violates (or will
violate) any license or other Contract between the Company or
such Company Subsidiary and any third party, or
(ii) infringes or misappropriates (or will infringe or
misappropriate) any Intellectual Property right of any other
party. There is no pending or threatened, claim or litigation
contesting the validity, ownership or right of the Company or
any Company Subsidiary to exercise any Company IP Right, nor is
there any legitimate basis for any such claim. Neither the
Company nor any Company Subsidiary has received any written
notice from a third party (or any other notice from a third
party of which the Companys internal legal department
personnel have actual knowledge) asserting that the operation of
the Company Business or the development, manufacture, marketing,
licensing, sale offering for sale, distribution or intended use
of the Company Products or Services conflicts with or infringes
(or will conflict with or infringe) the rights of any other
party, nor is there any legitimate basis for any such assertion.
Neither the Company nor any Company Subsidiary has received any
written notice from any third party offering a license under any
such third party patents. None of the Company-Owned IP Rights,
the Company Products or Services, the Company or any of the
Company Subsidiaries is subject to any proceeding or outstanding
order, contract or stipulation (i) restricting in any
manner the use, distribution, transfer, or licensing by the
Company or any Company Subsidiaries of any Company-Owned IP
Rights or any Company Product or Service (other than any pricing
restrictions), or which may affect the validity, use or
enforceability of any such Company-Owned IP Rights or
A-28
Company Product or Service, or (ii) restricting the conduct
of the Company Business in order to accommodate Intellectual
Property rights of a third party.
(d) To the Companys knowledge, no current or former
employee, consultant or independent contractor of the Company or
any Company Subsidiary: (i) is in material violation of any
term or covenant of any employment contract, patent disclosure
agreement, invention assignment agreement, nondisclosure
agreement, noncompetition agreement or any other Contract with
any other party by virtue of such employees,
consultants or independent contractors being
employed by, or performing services for, the Company or any
Company Subsidiary or using trade secrets or proprietary
information of others without permission; or (ii) has
developed any technology, software or other copyrightable,
patentable or otherwise proprietary work for the Company or any
Company Subsidiary that is subject to any Contract under which
such employee, consultant or independent contractor has assigned
or otherwise granted to any third party any rights (including
Intellectual Property) in or to such technology, software or
other copyrightable, patentable or otherwise proprietary work.
To the Companys knowledge, neither the employment of any
employee of the Company or any Company Subsidiary, nor the use
by the Company or any Company Subsidiary of the services of any
consultant or independent contractor subjects the Company or
such Company Subsidiary to any Liability to any third party for
improperly soliciting such employee, consultant or independent
contractor to work for the Company or such Company Subsidiary,
whether such Liability is based on contractual or other legal
obligations to such third party.
(e) The Company and each Company Subsidiary has taken all
commercially reasonable steps to protect, preserve and maintain
the secrecy and confidentiality of all confidential or
non-public information included in the Company IP Rights and to
preserve and maintain all the Companys and the Company
Subsidiaries interests, proprietary rights and trade
secrets in the Company IP Rights. All current and former
officers, employees, consultants and independent contractors of
the Company and any Company Subsidiary having access to material
proprietary information of the Company or such Company
Subsidiary, its customers or business partners and inventions
owned by the Company or such Company Subsidiary have executed
and delivered to the Company or such Company Subsidiary an
agreement regarding the protection of such proprietary
information and the assignment of inventions to the Company or
such Company Subsidiary (in the case of proprietary information
of the Companys or such Company Subsidiarys
customers and business partners, to the extent required by such
customers and business partners). The Company has secured valid
written assignments from all of the Companys and the
Company Subsidiaries current and former consultants,
independent contractors and employees who were involved in, or
who contributed to, the creation or development of any material
Company-Owned IP Rights, of the rights to such contributions
that may be owned by such persons or that the Company does not
already own by operation of law. No current or former employee,
officer, director, consultant or independent contractor of the
Company or any Company Subsidiary has any right, license, claim
or interest whatsoever in or with respect to any Company-Owned
IP Rights. Schedule 3.14(e) of the Company
Disclosure Letter sets forth a list and description of all
technology, software or Intellectual Property owned by a third
party (other than software generally available to the public at
a per copy license fee of less than $10,000) that is
incorporated into, integrated or bundled with any of the Company
Products or Services (including any patent licensed by a third
party to Company or any Company Subsidiary pursuant to a license
agreement which requires payment (solely for rights under such
patent) based upon the sale or distribution of any of the
Company Products or Services) (Third Party Product
Technology) and identifies each Contract pursuant to
which the Company licenses the Third Party Product Technology.
(f) Schedule 3.14(f) of the Company Disclosure
Letter contains a true and complete list of (i) all
registrations made throughout the world by or on behalf of the
Company or any Company Subsidiary of any patents, copyrights,
mask works, trademarks, service marks, Internet domain names or
Internet or World Wide Web URLs or addresses with any
Governmental Authority or quasi-governmental authority,
including Internet domain name registries, (ii) all
applications, registrations, filings and other formal written
governmental actions made or taken pursuant to Applicable Law by
the Company or any Company Subsidiary to secure, perfect or
protect its interest in the Company IP Rights, including all
patent applications (excluding unpublished patent applications),
copyright applications, mask work applications and applications
for registration of trademarks and service marks, including
intent-to-use
applications, and where applicable the jurisdiction in which
each of the items of the Company IP Rights has been applied for,
filed, issued or registered, and (iii) all inter parties
proceedings or actions before any court or tribunal (including
the United States Patent and Trademark Office) or equivalent
authority anywhere else in
A-29
the world) related to any of the Company IP Rights
(collectively, the Company Registered Intellectual
Property). All registered patents, trademarks, service
marks, Internet domain names, Internet or World Wide Web URLs or
addresses, copyrights and mask work rights held by the Company
or any Company Subsidiary are valid, enforceable and subsisting,
and the Company or such Company Subsidiary is the record owner
thereof. Schedule 3.14(f) of the Company Disclosure
Letter sets forth a list of all actions that are required to be
taken by the Company or its Subsidiaries within 120 days of
the Agreement Date with respect to any of the Company Registered
Intellectual Property in order to avoid prejudice to, impairment
or abandonment of such Company Registered Intellectual Property.
The Company and the Company Subsidiaries are the exclusive owner
of all trademarks and trade names used in connection with the
operation or conduct of the Company Business, including the
sale, licensing, distribution or provision of any Company
Products or Services by the Company or any of the Company
Subsidiaries. The Company owns exclusively, and has good title
to, all copyrighted works which the Company or any of the
Company Subsidiaries owns or purports to own.
(g) The Company and the Company Subsidiaries own all right,
title and interest in and to all Company-Owned IP Rights free
and clear of all liens, pledges and security interests (other
than Permitted Encumbrances).
(h) No license or other Contract to which the Company is a
party and pursuant to which any person is authorized to use any
Company-Owned IP Rights grants any third party exclusive rights
to or under any Company-Owned IP Rights or grants any third
party the right to sublicense any of such Company-Owned IP
Rights (provided that the right to resell a software
product, without the right to reproduce such product, shall not
be considered a sublicense right). Neither the Company nor any
of the Company Subsidiaries has transferred ownership of any
material Intellectual Property that is or was owned by the
Company or any of the Company Subsidiaries to any third party.
(i) Neither the Company nor any Company Subsidiary nor any
other party acting on its behalf has disclosed or made available
to any party, or permitted the disclosure or delivery to any
escrow agent or other party of, any Company Source Code (as
defined below). No event has occurred, and no circumstance or
condition exists, that (with or without notice or lapse of time,
or both) shall, or would reasonably be expected to, result in
the disclosure or delivery by the Company or any Company
Subsidiary or any other party acting on its behalf to any party
of any Company Source Code. Schedule 3.14(i) of the
Company Disclosure Letter identifies each Contract pursuant to
which the Company or any Company Subsidiary has deposited, or is
or may be required to deposit, with an escrow agent or other
party, any Company Source Code and further describes whether the
execution of this Agreement or the consummation of the Merger,
in and of itself, would reasonably be expected to result in the
release from escrow of any Company Source Code. As used in this
Section 3.14(i), Company Source
Code means, collectively, any human readable software
source code, or any material portion or aspect of the software
source code that constitutes a Company Product currently
marketed by the Company or any Company Subsidiary.
(j) To the Companys knowledge, there is no
unauthorized use, disclosure, infringement or misappropriation
of any Company IP Rights by any third party, including any
employee or former employee of the Company or any Company
Subsidiary.
(k) All Company Products or Services provided by or through
the Company or any Company Subsidiary to customers on or prior
to the Closing Date conform in all material respects (to the
extent required in Contracts with such customers) to applicable
contractual commitments, express warranties and representations
provided to customers in such Contracts, and neither Company nor
any Company Subsidiary has any material Liability (and, to the
knowledge of the Company or any Company Subsidiary, there is no
legitimate basis for any present or future action, suit,
proceeding, hearing, investigation, charge, complaint, claim or
demand against the Company or any Company Subsidiary giving rise
to any material Liability relating to the foregoing Contracts)
for replacement or repair thereof or other damages in connection
therewith in excess of any reserves therefor reflected on the
Company Balance Sheet. The Company has a policy and procedure
for tracking material bugs, errors and defects of which it
becomes aware in any Company Products or Services, and maintains
a database covering the foregoing. For all software used by the
Company and the Company Subsidiaries in providing Company
Products or Services, or in developing or making available any
of the Company Products or Services, the Company and the Company
Subsidiaries have used reasonable business judgment in
determining whether or not to implement security patches or
upgrades that are generally available for that software.
A-30
(l) No government funding or facilities of a university,
college, other educational institution or educational research
center was used in the development of the Company Products or
Services, computer software programs or applications owned by
the Company or any Company Subsidiary. To the Companys
knowledge, no current or former employee, consultant or
independent contractor of the Company or any Company Subsidiary
who was involved in, or who contributed to, the creation or
development of any Company IP Rights has performed services for
the government, for a university, college or other educational
institution or for an educational research center during a
period of time during which such employee, consultant or
independent contractor was also performing services for the
Company or any Company Subsidiary whereby the performance of
such services has caused such government, university, college,
educational institution or educational research center to obtain
rights to any material Company-Owned IP Rights.
(m) Schedule 3.14(m) lists all material Open
Source Materials incorporated or integrated by the Company or
any Company Subsidiary into any Company Product, and describes
the manner in which such material Open Source Materials were
incorporated or integrated into such Company Product (such
description shall include whether (and if so, how) the Open
Source Materials were modified or distributed by the Company or
any Company Subsidiary). As used in this
Section 3.14(m), Open Source
Materials means any software that (i) is
generally publicly distributed without charge, in source code
form, and under a license that authorizes each licensee to
modify and distribute such software and sublicense such rights
to other parties without charge (e.g., Linux). Open
Source Materials includes without limitation software licensed
under the GNUs General Public License (GPL) or
Lesser/Library GPL, the Mozilla Public License, the Netscape
Public License, the Sun Community Source License, the Sun
Industry Standards License, the BSD License, and the Apache
License. The Company is in material compliance with the terms
and conditions of all applicable licenses for such Open Source
Materials.
(n) With such exceptions as would not, individually or in
the aggregate, reasonably be expected to be material to the
Company and the Company Subsidiaries, taken as a whole, neither
the Company nor any Company Subsidiary has (i) incorporated
Open Source Materials into, or combined Open Source Materials
with, the Company Products; (ii) distributed Open Source
Materials in conjunction with any Company Products; or
(iii) used Open Source Materials, in such a way that, as a
result of (i), (ii), or (iii), grants, or purports to grant, to
any third party, any rights or immunities under any
Company-Owned Software (including using any Open Source
Materials in a manner that requires any Company-Owned Software
to be (A) disclosed or distributed in source code form,
(B) be licensed for the purpose of making derivative works,
or (C) be redistributable at no charge). As used in this
Section 3.14(n), Company-Owned
Software means any software included in any Company
Product that is constitutes Company-Owned IP Rights.
(o) Except as set forth in Section 3.14(o) of
the Company Disclosure Letter, neither the Company nor any
Subsidiary is now a member or promoter of, or a contributor to,
any industry standards body or any similar organization that
requires or obligates any of the Company or any Company
Subsidiary to grant or offer to any other Person any license or
right to any Company-Owned IP Rights.
3.15 Certain Transactions and
Agreements. Except as disclosed in the
Companys proxy statement for its 2006 Annual Meeting of
Stockholders as filed with the SEC on or about April 26,
2006 (the 2006 Proxy Statement), to the
knowledge of the Company, (a) none of the officers or
directors (or Immediate Family Members thereof) or 10%
stockholders of the Company has any direct or indirect ownership
interest in any firm or corporation that competes with, or does
business with, or has any material contractual arrangement with,
the Company or any Company Subsidiary (except with respect to
any interest in less than 5% of the stock of any corporation
whose stock is publicly traded), (b) none of the officers
or directors (or Immediate Family Members thereof) or 10%
stockholders of the Company a party to, or otherwise directly or
indirectly interested in, any Company Material Contract (except
for normal compensation for services as an officer or director
that have been disclosed to Acquiror in the Company Disclosure
Letter), and (c) none of the employees of the Company or
any Company Subsidiary otherwise has a conflict of interest in
violation of the Companys code of conduct.
3.16 Employees, ERISA and Other
Compliance.
(a) The Company and each Company Subsidiary is in
compliance in all material respects with Applicable Law and
Contracts relating to employment, discrimination in employment,
terms and conditions of employment, compensation matters, worker
classification (including the proper classification of employees
as exempt employees
A-31
and nonexempt employees under the Fair Labor Standards Act),
wages, hours and occupational safety and health and employment
practices, including the Immigration Reform and Control Act, and
is not engaged in any unfair labor practice. The Company has
withheld all amounts required by law or by agreement to be
withheld from the wages, salaries, and other payments to
employees; and is not liable for any material arrears of wages,
compensation, Taxes, penalties or other sums for failure to
comply with any of the foregoing. The Company has paid in full
to all employees, independent contractors and consultants all
wages, salaries, commissions, bonuses, material benefits and
other compensation due to or on behalf of such employees,
independent contractors and consultants, when such amounts
became due and payable. The Company is not liable for any
material payment to any trust or other fund or to any
Governmental Authority, with respect to unemployment
compensation benefits, social security or other benefits or
obligations for employees (other than routine payments to be
made in the normal course of business and consistently with past
practice). To the knowledge of the Company and each of its
Subsidiaries there are no material pending claims against the
Company or any of its Subsidiaries under any workers
compensation plan or policy or for long term disability. There
are no controversies pending or, to the knowledge of the
Company, threatened, between the Company and any of its
employees, which controversies have or would reasonably be
expected to result in an action, suit, proceeding, claim,
arbitration or investigation before any Governmental
Authority. A
complete list of all employees, officers and consultants of the
Company and the Company Subsidiaries and their current title,
compensation (base compensation and bonuses) is set forth on
Schedule 3.16(a) of the Company Disclosure Letter.
To the knowledge of the Company, all employees of the Company or
any of the Company Subsidiaries are legally permitted to be
employed by the Company or such Company Subsidiary in the
jurisdiction in which such employee is employed in their current
job capacities for the maximum period allowed under Applicable
Law. To the knowledge of the Company, all independent
contractors providing services to the Company or any of the
Company Subsidiaries have been properly classified as
independent contractors for purposes of federal and applicable
state Tax laws, laws applicable to employee benefits and other
Applicable Law. The Company and the Company Subsidiaries do not
have any employment or consulting Contracts currently in effect
that are not terminable at will (other than agreements with the
purpose of providing for the confidentiality of proprietary
information or assignment of inventions).
(b) Neither the Company nor any Company Subsidiary
(i) is now, or has ever been, subject to a union organizing
effort, (ii) is subject to any collective bargaining
agreement with respect to any of its employees, (iii) is
subject to any other Contract with any trade or labor union,
employees association or similar organization, and
(iv) has any current labor disputes. To the knowledge of
the Company, the Company and the Company Subsidiaries each has
good labor relations, and has no knowledge of any facts
indicating that the consummation of the Merger shall have a
material adverse effect on such labor relations, and has no
knowledge that any of its key employees intends to leave their
employ. There are no pending, or threatened, efforts to certify
any Person as the collective bargaining agent of all or some of
the employees of the Company or any Company Subsidiary.
(c) The Company has no Company Benefit Arrangement which
constitutes, or has since the enactment of ERISA, constituted,
(i) a multiemployer plan as defined in
Section 3(37) of ERISA, (ii) a multiple employer
plan as defined in ERISA or Code Section 413(c), or
(iii) a funded welfare plan within the meaning
of Code Section 419. No pension plan of the Company is
subject to Title IV of ERISA.
(d) (i) Schedule 3.16(d) of the Company
Disclosure Letter lists, with respect to the Company and any
trade or business (whether or not incorporated) which is treated
under Code Section 414(b) or (c) as a single employer
with the Company (an ERISA Affiliate) each
employment, consulting, severance or other similar Contract
(except offer letters providing for at-will employment which do
not provide for severance, acceleration, or post-termination
benefits except as required by Applicable Law), each
employee benefit plan as defined in
Section 3(3) of ERISA, each loan to an employee in excess
of $10,000 and each plan or arrangement providing for insurance
coverage (including any self-insured arrangements that are
clearly identified as such), workers benefits, vacation
benefits, severance benefits, retention, disability benefits,
death benefits, hospitalization benefits, relocation benefits,
cafeteria benefits, child care benefits, sabbatical, retirement
benefits, deferred compensation, profit-sharing, bonuses, stock
options, stock purchase, phantom stock, stock appreciation or
other forms of incentive compensation or post-retirement
insurance, compensation or benefits for employees, consultants
or directors that is currently in effect, maintained or
contributed to by the Company, any Company Subsidiary or any
ERISA Affiliate and which covers any employee or former employee
of the Company or any Company Subsidiary. Such Contracts, plans
and
A-32
arrangements as are described in this
Section 3.16(d) are hereinafter collectively
referred to as Company Benefit Arrangements.
(ii) Except, in each case, as would not individually or in
the aggregate result in a material liability to the Company and
the Company Subsidiaries, taken as a whole, each Company Benefit
Arrangement has been maintained in compliance in all material
respects with its terms and with the requirements prescribed by
any Applicable Law that is applicable to such Company Benefit
Arrangement. Unless otherwise indicated in
Schedule 3.16(d) of the Company Disclosure Letter,
with respect to each such Company Benefit Arrangement that is an
employee pension benefit plan as defined in
Section 3(2) of ERISA that is intended to qualify under
Section 401(a) of the Code, the Company has received a
favorable opinion, advisory, notification
and/or
determination letter, as applicable, that such plan satisfied
the requirements of the Uruguay Round Agreements Act, the
Uniformed Services Employment and Reemployment Rights Act of
1994, the Small Business Job Protection Act of 1996 and the
Taxpayer Relief Act of 1997 (collectively referred to as
GUST), the Tax Reform Act of 1986, the IRS
Restructuring and Reform Act of 1998 and the Community Renewal
Tax Relief Act of 2000 (a copy of which letter(s) have been made
available to Acquiror and its counsel), and nothing has occurred
since the issuance of such opinion, advisory, notification
and/or
determination letter, as applicable, which would reasonably be
expected to cause the loss of the Tax-qualified status of such
Company Benefit Arrangement. Each Company Benefit Arrangement
can be amended, terminated or otherwise discontinued after the
Effective Time in accordance with its terms, without liability
to Acquiror
and/or the
Merger Sub (other than ordinary administrative expenses
typically incurred in a termination event). No suit,
administrative proceeding, action or other litigation has been
brought, or to the knowledge of the Company, is threatened,
against or with respect to any such Company Benefit Arrangement,
including any audit or inquiry by the Internal Revenue Service
or United States Department of Labor. No Company Benefit
Arrangement is subject to any surrender fees or services fees
upon termination other than the normal and reasonable
administrative fees associated with the termination of benefit
plans. No Company Benefit Arrangement that is an employee
welfare benefit plan as defined in Section 3(1) of
ERISA is self-insured.
(iii) The Company has made available to Acquiror and its
legal counsel a complete and correct copy and description of
each Company Benefit Arrangement, including all plan documents,
adoption agreements, and amendments and restatements thereto
executed since inception of such Company Benefit Arrangement,
current trust documents, current financial statements, current
insurance policies, current vendor contracts, current employee
booklets, current summary plan descriptions, summary of material
modifications and other authorizing documents, and any material
employee communications relating thereto.
(iv) The Company has timely filed and made available to
Acquiror and its legal counsel the two most recent annual
reports (Form 5500) for each Company Benefit
Arrangement that is subject to ERISA and Code reporting
requirements, including all attachments, schedules, financial
statements and accountants opinions attached thereto.
(v) To the knowledge of the Company, no suit,
administrative proceeding, action or other litigation has been
brought, or to the knowledge of the Company or any Company
Subsidiary, is threatened against or with respect to any Company
Benefit Arrangement, including any audit or inquiry by the
Internal Revenue Service or the U.S. Department of Labor.
Neither the Company nor any Company Subsidiary has ever been a
participant in any prohibited transaction within the
meaning of Section 406 of ERISA with respect to any
employee pension benefit plan (as defined in Section 3(2)
of ERISA) that the Company or such Company Subsidiary sponsors
as employer or in which the Company or such Company Subsidiary
participates as an employer which was not otherwise exempt
pursuant to Section 408 of ERISA and regulatory guidance
thereunder (including any individual exemption granted under
Section 408(a) of ERISA) or that could result in an excise
Tax under the Code or the assessment of a civil penalty under
Section 502(i) of ERISA.
(vi) All contributions due from the Company with respect to
any of the Company Benefit Arrangements have been timely made
under the terms of the applicable Company Benefit Arrangement,
ERISA, the Code and any other Applicable Law, or there is a
period of time remaining for such contributions to be timely
made except to the extent failure to make such contributions
would result in a material liability to the Company.
(vii) No Company Benefit Arrangement (other than life
insurance arrangements) provides post-termination or retiree
welfare benefits to any person for any reason, except as may be
required by COBRA or other Applicable Law.
A-33
(e) To the knowledge of the Company each Company Benefit
Arrangement, to the extent applicable, is in compliance, in all
material respects, with the continuation coverage requirements
of Section 4980B of the Code, Sections 601 through 608
of ERISA, the applicable health care continuation and notice
provisions of COBRA and the regulations (including proposed
regulations) thereunder.
(f) Schedule 3.16(f) of the Company Disclosure
Letter lists each Person who the Company reasonably believes is,
with respect to the Company, any Subsidiary
and/or any
ERISA Affiliate, a disqualified individual (within
the meaning of Section 280G of the Code and the regulations
promulgated thereunder). No benefit payable or that may become
payable by the Company or any Company Subsidiary pursuant to any
Company Benefit Arrangement or as a result of, in connection
with or arising under this Agreement or the Agreement of Merger
shall constitute a parachute payment (as defined in
Section 280G(b)(2) of the Code) that is subject to the
imposition of an excise Tax under Section 4999 of the Code
or that would not be deductible by reason of Section 280G
of the Code. Unless otherwise indicated in
Schedule 3.16(f) of the Company Disclosure Letter,
neither the Company nor any Company Subsidiary is a party to
any: (i) Contract with any Person (A) the benefits of
which are contingent, or the terms of which are materially
altered, upon the occurrence of a transaction involving the
Company in the nature of the Merger, (B) providing any term
of employment or compensation guarantee, or (C) providing
severance benefits or other benefits after the termination of
employment of such employee regardless of the reason for such
termination of employment; or (ii) Company Benefit
Arrangement, any of the benefits of which shall be increased, or
the vesting of benefits of which shall be accelerated, by the
occurrence of the Merger, or any event subsequent to the Merger
such as the termination of employment of any person, or the
value of any of the benefits of which shall be calculated on the
basis of any of the transactions contemplated by this Agreement.
Neither the Company nor any of the Company Subsidiaries has any
obligation to pay any material amount or provide any material
benefit to any former employee or officer, other than
obligations (i) for which the Company has established a
reserve (or purchased an insurance policy listed in
Schedule 3.19 of the Company Disclosure Letter) for
such amount on the Company Balance Sheet and (ii) pursuant
to Contracts entered into after the Balance Sheet Date and
disclosed on Schedule 3.16(g) of the Company
Disclosure Letter.
(g) To the knowledge of the Company no employee or
consultant of the Company or any Company Subsidiary is in
material violation of (i) any Contract or (ii) any
restrictive covenant relating to the right of any such employee
or consultant to be employed by the Company or such Company
Subsidiary or to use trade secrets or proprietary information of
others.
(h) Each Company Benefit Arrangement that has been
established or maintained, or that is required to be maintained
or contributed to by the law or applicable custom or rule of the
relevant jurisdiction, outside of the United States (each such
Company Benefit Arrangement, a Foreign Plan)
is listed in Schedule 3.16(h) of the Company
Disclosure Letter. With respect to each Foreign Plan,
(i) to the knowledge of the Company, such Foreign Plan has
been administered in all material respects at all times in
accordance with its terms and Applicable Law and regulations,
(ii) to the knowledge of the Company, there are no pending
investigations by any governmental body involving such Foreign
Plan, and no pending claims (except for claims for benefits
payable in the normal operation of such Foreign Plan), suits or
proceedings against such Foreign Plan or asserting any rights or
claims to benefits under such Foreign Plan, (iii) to the
knowledge of the Company, the consummation of the transactions
contemplated by this Agreement will not by itself create or
otherwise result in any liability with respect to such Foreign
Plan other than the triggering of payment to participants, and
(iv) except as required by Applicable Law, no condition
exists that would prevent the Company or any of the Company
Subsidiaries from terminating or amending any Foreign Plan at
any time for any reason in accordance with the terms of each
such Foreign Plan (other than normal expenses typically incurred
in a termination event).
(i) In the past two years, there has been no mass
layoff, employment loss, or plant
closing as defined by the Workers Adjustment and
Retraining Notification Act (the WARN Act) in
respect of the Company.
(j) The Company has made available to Acquiror true and
complete copies of all election statements under
Section 83(b) of the Code that are in the Companys
possession or subject to its control with respect to any
unvested securities or other property issued by the Company or
any ERISA Affiliate to any of their respective employees,
non-employee directors, consultants and other service providers.
A-34
(k) Schedule 3.16(k) of the Company Disclosure
Letter lists as of the Agreement Date each employee of the
Company and any Company Subsidiary who is currently on leave
from the Company or a Company Subsidiary and the date that is
currently anticipated to be the date that they will return to
service.
3.17 Advisor Fees.
Except for fees payable to Goldman, Sachs & Co. as set
forth in engagement letter between the Company and Goldman,
Sachs & Co. dated August 8, 2006 (the
Engagement Letter), a true, correct and
complete version of which has been provided by the Company to
Acquiror, neither the Company nor any Affiliate of the Company
is obligated for the payment of any fees or expenses of any
investment banker, broker, advisor or similar party in
connection with the origin, negotiation or execution of this
Agreement or in connection with the Merger, and Acquiror will
not incur any liability to any such investment banker, broker,
advisor or similar party as a result of this Agreement, the
Merger or any act or omission of the Company.
3.18 Insurance. The
Company and the Company Subsidiaries maintain the policies of
insurance and bonds set forth in Schedule 3.18 of
the Company Disclosure Letter. Schedule 3.18 sets
forth the name of the insurer under each such policy and bond,
the type of policy or bond, the coverage amount and any
applicable deductible as of the Agreement Date. There is no
material claim pending under any of such policies or bonds as to
which coverage has been questioned, denied or disputed by the
underwriters of such policies or bonds. All premiums due and
payable under all such policies and bonds have been timely paid,
and the Company and each Company Subsidiary is otherwise in
compliance with the terms of such policies and bonds. All such
policies and bonds remain in full force and effect, and neither
the Company nor any Company Subsidiary has any knowledge of any
threatened termination of, or material premium increase with
respect to, any of such policies or bonds. Each of the Company
and each Company Subsidiary has made available to Acquiror
correct and complete copies of all such policies of insurance
and bonds.
3.19 Environmental Matters.
(a) The Company, each Company Subsidiary and their
respective predecessors and affiliates are in material
compliance with all applicable Environmental Laws (as defined
below), which compliance includes the possession by the Company
or such Company Subsidiary of all material permits and other
governmental authorizations required under applicable
Environmental Laws and compliance, in all material respects,
with the terms and conditions thereof. Neither the Company nor
any Company Subsidiary has received any written notice or other
communication, whether from a Governmental Authority, citizens
groups, employee or otherwise, that alleges that the Company or
such Company Subsidiary is not in compliance, in any material
respect, with any applicable Environmental Law. To the knowledge
of the Company, no current or prior owner of any property leased
or possessed by the Company or any Company Subsidiary has
received any written notice or other communication, whether from
a Governmental Authority, citizens group, employee or otherwise,
that alleges that such current or prior owner or the Company or
such Company Subsidiary is not in compliance, in any material
respect, with any applicable Environmental Law.
(b) For purposes of this Section 3.19:
(i) Environmental Law means any federal,
state or local statute, law, regulation or other legal
requirement relating to pollution, protection of the environment
(including ambient air, surface water, ground water, land
surface or subsurface strata) or exposure of any individual to
Materials of Environmental Concern, including any law or
regulation relating to emissions, discharges, releases or
threatened releases of Materials of Environmental Concern or
otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of
Materials of Environmental Concern; and
(ii) Materials of Environmental Concern
include chemicals, pollutants, contaminants, wastes, toxic
substances, petroleum and petroleum products and any other
substance that is currently regulated by an Environmental Law or
that is otherwise a danger to health, reproduction or the
environment.
3.20 Customers and Suppliers.
(a) As of the Agreement Date, neither the Company nor any
Company Subsidiary has any outstanding material disputes
concerning its products
and/or
services with any customer or distributor who, in the year ended
December 31, 2006, was one of the 20 largest sources of
revenues for the Company and the Company Subsidiaries, taken as
a whole, during such periods (each, a Significant
Customer) that would reasonably be expected to result
in a material deterioration in, or termination of, the
relationship between the Company or any Company Subsidiary
A-35
and such Significant Customer. Each Significant Customer is
listed on Schedule 3.20(a) of the Company Disclosure
Letter. As of the Agreement Date, neither the Company nor any of
the Company Subsidiaries has received any written notice from
any Significant Customer that such customer shall not continue
as a customer of the Company (or the Surviving Corporation or
Acquiror) after the Closing or that such customer intends to
terminate or materially adversely modify the existing Contracts
with the Company.
(b) As of the Agreement Date, neither the Company nor any
Company Subsidiary has any outstanding material dispute
concerning products
and/or
services provided by any supplier who, in the year ended
December 31, 2006, was one of the 10 largest suppliers of
products
and/or
services to the Company and the Company Subsidiaries, based on
amounts actually paid by the Company and the Company
Subsidiaries during such periods (each, a Significant
Supplier) that would reasonably be expected to result
in a material deterioration in, or termination of, the
relationship between the Company or any Company Subsidiary and
such Significant Supplier. Each Significant Supplier is listed
on Schedule 3.20(b) of the Company Disclosure
Letter. As of the Agreement Date, neither the Company nor any of
the Company Subsidiaries has received any written notice from
any Significant Supplier that such supplier shall not continue
as a supplier to the Company (or the Surviving Corporation or
Acquiror) after the Closing or that such supplier intends to
terminate or materially adversely modify the existing Contracts
with the Company.
3.21 Privacy. The
Company and each Company Subsidiary has complied with the
Companys privacy policies in effect as of the Agreement
Date and, to the Companys knowledge, the Company and each
Company Subsidiary have not failed to comply in all material
respects with all Applicable Law relating to (a) the
privacy of users of the Company Products or Services and all
Internet websites owned, maintained or operated by the Company
and the Company Subsidiaries (collectively, the Company
Websites), and (b) the collection, storage and
transfer of any personally identifiable information collected by
the Company and the Company Subsidiaries or by third parties
having authorized access to the Companys and the Company
Subsidiaries records. No material claims have been
asserted or, to the knowledge of the Company, are threatened,
against the Company or any of the Company Subsidiaries by any
person or entity alleging a violation of such persons or
entitys privacy, personal or confidentiality rights under
the privacy policies of the Company or the Company Subsidiaries.
3.22 Fairness Opinion.
The Company Board has received an opinion from Goldman,
Sachs & Co., dated as of the Agreement Date, to the
effect that, as of the Agreement Date and based on and subject
to the matters set forth in the opinion, the Cash Amount Per
Share to be received by the holders of Company Common Stock in
the Merger is fair, from a financial point of view, to such
holders.
ARTICLE 4
Representations
and Warranties of Acquiror
Acquiror represents and warrants to the Company as follows:
4.1 Organization and Good
Standing. Each of Acquiror and Merger
Sub is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware and has
the corporate power and authority to own, operate and lease its
properties and to carry on its business as now conducted and as
presently proposed to be conducted. Each of Acquiror and Merger
Sub is duly qualified or licensed to do business, and is in good
standing (to the extent that such concept is applicable), in
each jurisdiction where the character of the properties owned,
leased or operated by it or the nature of its activities makes
such qualification or licensing necessary, except where the
failure to be so qualified or licensed would not individually or
in the aggregate be material to Acquirors or Merger
Subs ability to consummate the Merger or to perform their
respective obligations under this Agreement. Acquiror has made
available to the Company true and complete copies of the
currently effective Certificate of Incorporation and Bylaws of
Acquiror and Merger Sub, each as amended to date. Neither
Acquiror nor Merger Sub is in violation of its Certificate of
Incorporation or Bylaws, each as amended to date.
4.2 Power, Authorization and Validity.
(a) Power and Authority. Acquiror
has all requisite corporate power and authority to enter into,
execute, deliver and perform its obligations under this
Agreement and to consummate the Merger and the other
transactions
A-36
contemplated hereby. The execution, delivery and performance by
Acquiror of this Agreement and all other agreements,
transactions and actions contemplated hereby have been duly and
validly approved and authorized by all necessary corporate
action on the part of Acquiror. Merger Sub has all requisite
corporate power and authority to enter into, execute, deliver
and perform its obligations under this Agreement and to
consummate the Merger and the other transactions contemplated
hereby. The execution, delivery and performance by Merger Sub of
this Agreement and all other agreements, transactions and
actions contemplated hereby have been duly and validly approved
and authorized by all necessary corporate action on the part of
Merger Sub.
(b) No Governmental Consents. No
consent, approval, order or authorization of, or registration,
declaration or filing with, any Governmental Authority, is
necessary or required to be made or obtained by Acquiror or
Merger Sub to enable Acquiror and Merger Sub to lawfully execute
and deliver, enter into, and perform their respective
obligations under this Agreement or to consummate the Merger,
except for (i) the filing of the Certificate of Merger with
the Delaware Secretary of State and appropriate documents with
the relevant authorities of other states in which Acquiror is
qualified to do business, (ii) such filings and
notifications as may be required to be made by Acquiror in
connection with the Merger under the HSR Act and other
applicable Antitrust Laws and the expiration or early
termination of applicable waiting periods under the HSR Act and
such Antitrust Laws, (iii) the filing with the SEC of such
reports and filings under the Exchange Act and the rules and
regulations thereunder as may be required in connection with
this Agreement and the transactions contemplated hereby,
(iv) such other filings and notifications as may be
required to be made by Acquiror or Merger Sub under federal,
state or foreign securities laws or the rules and regulations of
NASDAQ, and (v) such other consents, approvals, orders,
authorizations, releases, waivers, registrations, declarations
or filings that if not made or obtained would not, individually
or in the aggregate, reasonably be expected to materially affect
the ability of Acquiror or Merger Sub to consummate the Merger
or have a Material Adverse Effect on Acquiror.
(c) Enforceability. This Agreement
has been duly executed and delivered by Acquiror and Merger Sub,
and assuming the due execution and delivery of this Agreement by
the Company, constitutes the valid and binding obligations of
Acquiror, enforceable against Acquiror in accordance with its
terms, subject to the effect of (i) applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws now
or hereafter in effect relating to rights of creditors generally
and (ii) rules of law and equity governing specific
performance, injunctive relief and other equitable remedies.
This Agreement constitutes the valid and binding obligations of
Merger Sub, enforceable against Merger Sub in accordance with
its terms, subject to the effect of (i) applicable
bankruptcy, insolvency, reorganization, moratorium or other
similar laws now or hereafter in effect relating to rights of
creditors generally and (ii) rules of law and equity
governing specific performance, injunctive relief and other
equitable remedies.
4.3 No Conflict.
Neither the execution and delivery of this Agreement by Acquiror
or Merger Sub, nor the consummation of the Merger or any other
transaction contemplated hereby, conflicts with, or (with or
without notice or lapse of time, or both) results in a
termination, breach, impairment or violation of, or constitutes
a default under, or requires a consent, waiver or approval of
any Person under, (a) any provision of the Certificate of
Incorporation or Bylaws of Acquiror or Merger Sub, each as
currently in effect, (b) any Applicable Law applicable to
Acquiror, Merger Sub or any of their respective material assets
or properties, or (c) any Contract to which Acquiror or
Merger Sub is a party or by which Acquiror or Merger Sub or any
of their respective assets or properties are bound, except in
the cases of clauses (b) and (c) where such conflict,
termination, breach, impairment, violation or default, or
failure to obtain such consent, waiver or approval, would not be
material to Acquirors or Merger Subs ability to
consummate the Merger or to perform their respective obligations
under this Agreement.
4.4 Financing. Acquiror
has, and will have available to it upon the Effective Time,
sufficient funds to consummate the transactions contemplated by
this Agreement, including payment in full of the amounts payable
to the Company Securityholders under Article 2.
4.5 Stock Ownership. As
of the Agreement Date, neither Acquiror nor Merger Sub
beneficially own any shares of Company Capital Stock. Neither
Acquiror nor Merger Sub, nor any of their Affiliates
or Associates, has been an interested
stockholder of the Company at any time within three years
of the Agreement Date, as those terms are used in
Section 203 of the Delaware Law.
A-37
4.6 No Prior Merger Sub
Operations. Merger Sub was formed solely
for the purpose of effecting the Merger and has not engaged in
any business activities or conducted any operations other than
in connection with the transactions contemplated hereby.
4.7 Proxy Statement.
The information supplied by Acquiror for inclusion in the Proxy
Statement shall not at the time the Proxy Statement is filed
with the SEC contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or
necessary in order to make the statements therein not
misleading. The information supplied by Acquiror for inclusion
or incorporation by reference in the Proxy Statement shall not,
on the date the Proxy Statement is mailed to Company
Stockholders, or at the time of the Company Stockholders
Meeting, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they are made, not false or
misleading, or omit to state any material fact necessary to
correct any statement in any earlier communication with respect
to the solicitation of proxies for the Company
Stockholders Meeting which has become false or misleading.
Notwithstanding the foregoing, Acquiror makes no representation
or warranty with respect to any information supplied by the
Company that is contained in the Proxy Statement.
ARTICLE 5
Company
Covenants
During the time period from the Agreement Date until the earlier
to occur of (a) the Effective Time or (b) the
termination of this Agreement in accordance with the provisions
of Article 9, the Company covenants and agrees with
Acquiror as follows:
5.1 Preparation of SEC Documents; Company
Stockholders Meeting.
(a) Proxy Statement. As soon as
reasonably practicable following the Agreement Date, the Company
shall prepare and file with the SEC the Proxy Statement. No
filing of, or amendment or supplement to, the Proxy Statement
will be made by the Company without providing Acquiror and its
counsel a reasonable opportunity to review and comment thereon
and reflecting therein all reasonable comments proposed by
Acquiror and its counsel. The Company will promptly advise
Acquiror, of the time when the definitive form of the Proxy
Statement has been filed with the SEC or any supplement or
amendment has been filed, the issuance of any stop order, or any
oral or written request by the SEC for amendment of the Proxy
Statement or comments thereon and responses thereto or requests
by the SEC for additional information and will promptly provide
Acquiror with copies of any written communication from the SEC
or any state securities commission. The Company will respond in
good faith to any comments of the SEC and will cause the Proxy
Statement to be mailed to its stockholders as soon as reasonably
practicable. If at any time prior to the Effective Time any
event or information (including any Change in Recommendation)
relating to the Company, or any of its Affiliates, officers or
directors, should be discovered by Acquiror or the Company which
should be set forth in an amendment or supplement to the Proxy
Statement, so that such document would not include any
misstatement of a material fact or omit to state any material
fact necessary to make the statements therein not misleading,
the party which discovers such information shall promptly notify
the other parties hereto and an appropriate amendment or
supplement describing such information shall be promptly filed
with the SEC and, to the extent required by Applicable Law,
disseminated to the Company Stockholders.
(b) Company Stockholders
Meeting. The Company shall, as soon as
reasonably practicable following the Agreement Date, take all
action necessary in accordance with the Company Charter
Documents and Applicable Law to duly give notice of, convene and
hold the Company Stockholders Meeting. Unless there has
been a Change in Recommendation pursuant to
Section 5.2(d), the Company will use reasonable best
efforts to obtain the Company Stockholder Approval, including by
using reasonable best efforts to solicit from its stockholders
proxies in favor of the adoption of this Agreement.
Notwithstanding anything to the contrary contained in this
Agreement, the Company may adjourn or postpone the Company
Stockholders Meeting to the extent necessary to ensure
that any necessary supplement or amendment to the Proxy
Statement is provided to its stockholders in advance of a vote
on the adoption of this Agreement, or, if, as of the time for
which the Company Stockholders Meeting is originally
scheduled, there are insufficient shares of Company Common Stock
represented (either in person or by proxy) to
A-38
constitute a quorum necessary to conduct the business of such
meeting. The Company shall ensure that the Company
Stockholders Meeting is called, noticed, convened, held
and conducted, and that all proxies solicited by the Company in
connection with the Company Stockholders Meeting are
solicited in compliance with the Company Charter Documents and
Applicable Law. Without the prior written consent of Acquiror,
adoption of this Agreement (including adjournment of the Company
Stockholders Meeting, if necessary, if a quorum is
present, to solicit additional proxies if there are not
sufficient votes in favor of adoption of this Agreement), is the
only matter which the Company shall propose to be acted on by
the Company Stockholders at the Company Stockholders
Meeting. Notwithstanding anything to the contrary contained
herein, unless this Agreement has been terminated in accordance
with its terms, adoption of this Agreement shall be submitted by
the Company to the Company Stockholders at the Company
Stockholders Meeting.
(c) Board Recommendation. Except
to the extent expressly permitted by Section 5.2(d),
(i) the Company Board shall recommend that its stockholders
vote in favor of the adoption of this Agreement at the Company
Stockholders Meeting, (ii) the Proxy Statement shall
include a statement to the effect that the Company Board has
recommended that the Company Stockholders vote in favor of
adoption of this Agreement at the Company Stockholders
Meeting, and (iii) neither the Company Board nor any
committee thereof shall withdraw, amend or modify, or propose or
resolve to withdraw, amend or modify in a manner adverse to
Acquiror, the recommendation of the Company Board that the
Company Stockholders vote in favor of the adoption of this
Agreement.
5.2 No Solicitation.
(a) Alternative Transaction. The
Company shall not and will cause the Company Subsidiaries not
to, (i) permit any of its or its subsidiaries
officers, directors, attorneys or financial advisors (or its or
its subsidiaries other employees, agents or
representatives who have the authority to act on behalf of the
Company or the Company Subsidiaries regarding any Alternative
Transaction) (collectively, Representatives)
to, directly or indirectly, solicit, initiate, seek, endorse,
recommend or support, or knowingly encourage or facilitate, any
inquiry, proposal or offer from, furnish any non-public
information to, or participate in any discussions or
negotiations with, or enter into any agreement with, any party
or group regarding any Alternative Transaction (except to
disclose the existence of the provisions of this
Section 5.2), (ii) approve, endorse or
recommend any Alternative Transaction (except to the extent
specifically permitted by Section 5.2(d)), or
(iii) enter into any letter of intent or similar document
or any contract, agreement or commitment (whether binding or
not) contemplating or otherwise relating to any Alternative
Transaction Proposal. The Company will, and will cause its
Subsidiaries and Representatives to, immediately cease any and
all existing activities, discussions or negotiations with any
third parties conducted heretofore with respect to any
Alternative Transaction Proposal, and, upon Acquirors
request, shall request the prompt return or destruction of all
confidential information previously furnished to any Person with
which the Company, its Subsidiaries or Representatives have
engaged in any such activities within the
12-month
period preceding the Agreement Date. The Company will, and will
cause its Subsidiaries and Representatives to, use reasonable
best efforts to enforce (and will not waive any provisions of)
any confidentiality or standstill agreement (or any similar
agreement) to which the Company of any of its Subsidiaries is a
party relating to any such Alternative Transaction Proposal. Any
breach of the foregoing provisions of this subsection by any of
the Company Subsidiaries or Representatives shall be deemed to
be a breach by the Company.
(b) Notification. As promptly as
practicable (and in any event within 24 hours) after
receipt by the Company, any of its Subsidiaries or
Representative of any Alternative Transaction Proposal or any
request for non-public information relating in any way to any
Alternative Transaction Proposal, the Company shall provide
Acquiror with oral and written notice of the material terms and
conditions of such Alternative Transaction Proposal or request,
and the identity of the Person or Group making any such
Alternative Transaction Proposal or request and a copy of
material written materials provided to it in connection with
such Alternative Transaction Proposal. Thereafter, the Company
shall keep Acquiror informed on a current basis in all material
respects regarding the status and details of any such
Alternative Transaction Proposal or request (including
substantive modifications or proposed substantive
modifications), including by providing to Acquiror a copy of
material written materials setting forth such modifications or
proposed modifications. The Company shall provide Acquiror with
48 hours prior notice (or such lesser prior notice as is
provided to the Company Board) of any meeting of the Company
Board at which it is reasonably expected to consider any
Alternative Transaction Proposal or Alternative Transaction,
including to consider whether such Alternative Transaction
Proposal is a Superior Proposal.
A-39
(c) Superior
Proposal. Notwithstanding anything to the
contrary contained in the provisions of
Section 5.2(a), in the event that prior to the time
that Company Stockholder Approval has been obtained, the Company
receives a bona fide written Alternative Transaction
Proposal that was not solicited in, or submitted as a result of
a, violation of Section 5.2(a)(i) hereof that the
Company Board determines in good faith (after consultation with
its outside legal counsel and its financial advisor) is, or is
reasonably likely to become, a Superior Proposal, the Company or
the Company Board may then take the following actions, but only
if (i) (A) the Company Board determines in good faith,
after consultation with its outside legal counsel, that it is
required to do so to comply with its fiduciary obligations to
the Company Stockholders under Applicable Law, and (B) the
Company has given Acquiror prior written notice that the Company
Board has made the determination set forth in the immediately
preceding clause (A), and (ii) the Company shall have
provided to Acquiror the information regarding such Alternative
Transaction Proposal as set forth in the first two sentences of
Section 5.2(b).
(i) Furnish non-public information to the Person or Group
making such Alternative Transaction Proposal, provided that
(A) the Company first shall have received from such Person
an executed confidentiality agreement in substantially the same
form as the Confidentiality Agreement, which confidentiality
agreement shall not include any provision having the actual or
purported effect of restricting the Company from fulfilling its
obligations under this Agreement or the Confidentiality
Agreement and shall also require such Person to agree to
customary employee non-solicitation provisions covering at least
12 months from execution of such confidentiality agreement
and (B) contemporaneously with furnishing any such
non-public information to such Person or Group, it furnishes
such non-public information to Acquiror (to the extent such
non-public information has not been previously so furnished to
Acquiror); and
(ii) Engage in discussions or negotiations (including
negotiation of appropriate documentation) with such Person or
Group with respect to such Alternative Transaction Proposal.
(d) Change in
Recommendation. Solely in response to the
receipt of a bona fide written Alternative Transaction
Proposal that was not solicited in, or submitted as a result of
a, violation of Section 5.2(a)(i) hereof that the
Company Board determines in good faith, after consultation with
its outside legal counsel and financial advisors, to be a
Superior Proposal, the Company Board may make a Change in
Recommendation, if all of the following conditions in
clauses (i) through (vi) are met:
(i) the Superior Proposal has been made and has not been
withdrawn;
(ii) the Company Stockholder Approval has not yet been
obtained;
(iii) the Company has (A) provided to Acquiror three
Business Days prior written notice which shall state
expressly (1) that it has received a Superior Proposal,
(2) the material terms and conditions of the Superior
Proposal, a copy of all negotiated draft agreements relating
thereto, and the identity of the Person or Group of Persons
making the Superior Proposal, and (3) that it intends to
effect a Change in Recommendation and the manner in which it
intends to do so, (B) provided to Acquiror (to the extent
not previously provided) a copy of all non-public information
made available to the Person or Group making the Superior
Proposal in connection with such Superior Proposal, and
(C) during the aforementioned three Business Day period, if
requested by Acquiror, engaged in good faith negotiations with
Acquiror with respect to any amendments Acquiror proposes to
make to this Agreement such that the Superior Proposal would no
longer be a Superior Proposal;
(iv) Acquiror shall not have, within the aforementioned
three Business Day period, made, and not withdrawn, a bona
fide written offer that the Company Board has in good faith
determined (after consultation with its outside legal counsel
and its financial advisor) results in the Alternative
Transaction Proposal that had been determined to be a Superior
Proposal no longer being a Superior Proposal; and
(v) the Company Board has determined in good faith, after
consultation with its outside legal counsel, that, in light of
such Superior Proposal and the results of any negotiations with
Acquiror as contemplated by subsection (iii) above and any
bona fide written offer from Acquiror contemplated by
subsection (iv) above, the Company Board is required
to effect a Change in Recommendation to comply with its
fiduciary duties to the Company Stockholders under Applicable
Law.
A-40
(e) Tender Offer Rules. Nothing
contained in this Agreement shall prohibit the Company or the
Company Board from taking and disclosing to its stockholders a
position contemplated by
Rules 14d-9
and 14e-2(a)
promulgated under the Exchange Act; provided that the Company
shall not effect, or disclose pursuant to such rules or
otherwise a position which constitutes, a Change in
Recommendation unless specifically permitted pursuant to the
terms of Section 5.2(d).
5.3 Maintenance of Business.
(a) The Company shall, and shall cause each of the Company
Subsidiaries to, exercise reasonable best efforts to carry on
the Company Business in the ordinary course consistent with its
past practices, including with respect to the payment of debts,
Taxes, and other Liabilities when due (subject to good faith
disputes over such debts, Taxes or other Liabilities), and in
such regard shall provide the access to information contemplated
in Section 5.7 hereof.
(b) The Company shall, and shall cause each of the Company
Subsidiaries to, use its reasonably diligent efforts to assure
that each of its Contracts (other than with Acquiror) entered
into after the Agreement Date will not require the procurement
of any consent, waiver or novation in connection with, or
terminate as a result of, the consummation of, the Merger.
(c) The Company shall perform the additional covenants set
forth on Schedule 5.3(c) of the Company Disclosure
Letter.
5.4 Conduct of
Business. The Company shall not, and
shall not permit any of the Company Subsidiaries to, take any of
the following actions without Acquirors prior written
consent:
(a) (i) incur any indebtedness for borrowed money or
guarantee, assume or endorse such indebtedness of another
Person, except for (A) indebtedness for borrowed money
under or guarantees with respect to indebtedness under any
existing debt obligation or existing line of credit set forth in
Schedule 3.12(g) of the Company Disclosure Letter,
(B) indebtedness of, by and among the Company and any
direct or indirect wholly-owned Company Subsidiary, or
(C) guarantees of indebtedness under corporate credit cards
held by employees in the ordinary course of business, consistent
with past practices; or (ii) guarantee, assume or endorse
the performance obligations of another Person;
(b) (i) lend any money, other than reasonable and
normal advances to employees for bona fide expenses that are
incurred in the ordinary course of business consistent with its
past practices (provided that no proceeds of any such
advances are used directly or indirectly to purchase shares of
Company Capital Stock); (ii) make any material investments
in or material capital contributions to, any Person (other than
a direct or indirect wholly-owned Company Subsidiary);
(iii) forgive or discharge in whole or in part any
outstanding loans or advances; or (iv) prepay any
indebtedness except in the ordinary course of business
consistent with past practice;
(c) (i) other than the entry into Contracts providing
for commercial sales of (or OEM, distribution or reseller
arrangements with respect to) the Company Products or Services,
in each case in the ordinary course of business and consistent
with past practice, enter into any Company Material Contract
specified in subsections (a), (b), (c), (d), (e), (h), (j), (l),
(m), (o) or (q) of Section 3.12, or
(ii) materially breach, terminate (other than allowing
expiration according to its terms, including failure to renew),
materially and adversely amend, or otherwise materially and
adversely modify or waive any of the material terms of, any
Company Material Contract (it being understood that actions
otherwise permitted by the terms of the other subsections of
this Section 5.4 shall not be deemed to constitute a
violation of this clause (ii));
(d) purchase, sell, pledge, dispose of, transfer, lease,
license or encumber, or authorize the sale, pledge, disposition,
transfer, lease, license or Encumbrance (other than a Permitted
Encumbrance) of, any property or assets material to the Company
and the Company Subsidiaries, taken as a whole, other than the
sale or non-exclusive license of its products or services to its
customers (including OEMs, distributors and resellers) in the
ordinary course of business consistent with past practice;
(e) other than as expressly permitted by
subsection (i) of this Section 5.4,
(i) increase the base salary, incentive compensation
(including stock awards, stock option grants or stock
appreciation rights), severance or retention benefits or
perquisites payable, or to become payable, to directors or
executive officers of the
A-41
Company (other than increases pursuant to the terms of a
Contract in effect on the Agreement Date and set forth on
Schedule 3.12(a) of the Company Disclosure Letter or
increases not in excess of 10% of base salary granted pursuant
to performance reviews held in the ordinary course of business
consistent with past practice) nor enter into any Contract to
grant or provide (nor grant or provide) any severance,
acceleration of vesting or other similar benefits to any of such
persons (other than pursuant to the terms of an existing
Contract set forth on Schedule 3.12(a) of the
Company Disclosure Letter or as required by Applicable Law (as
determined by the Company in good faith after consultation with
its and Acquirors outside legal counsel)),
(ii) increase the compensation or benefits payable or to
become payable to its other employees (other than increases
pursuant to the terms of a Contract in effect on the Agreement
Date or increases not in excess of 10% of base salary granted
pursuant to performance reviews held in the ordinary course of
business consistent with past practice) nor enter into any
Contract to grant or provide (nor grant or provide) any
severance, acceleration of vesting or other similar benefits to
any of such persons (other than pursuant to the terms of an
existing Contract set forth on Schedule 5.4(e) of
the Company Disclosure Letter or as required by Applicable Law
(as determined by the Company in good faith after consultation
with its and Acquirors outside legal counsel)),
(iii) amend or enter into any employment or consulting
Contract with any officer or director (except in the ordinary
course of business pursuant to a standard offer letter with no
severance, retention or acceleration provisions),
(iv) adopt any plan or arrangement to provide compensation
or benefits to any employees, directors or consultants, or amend
any Company Benefit Arrangements (except in each case as
required under ERISA, or the Code, or Applicable Law), or
(v) materially amend any deferred compensation plan within
the meaning of Section 409A of the Code and Internal
Revenue Service Notice
2005-1 or
Company Options except to the extent necessary to meet the good
faith compliance requirements of such Section or Notice;
(f) make any material change in accounting policies or
procedures, except as required by GAAP or IAS;
(g) declare, set aside or pay any cash or stock dividend or
other distribution (whether in cash, stock or property) in
respect of its capital stock, or redeem, repurchase or otherwise
acquire any of its capital stock or other securities (except for
the repurchase of stock from its employees, directors,
consultants or contractors in connection with the termination of
their services in accordance with the terms of Contracts
granting such repurchase rights), or pay or distribute any cash
or property to any of its stockholders or securityholders or
make any other cash payment to any of its stockholders or
securityholders;
(h) terminate, waive or release any material right or
claim, other than any termination, waiver or release of any such
right or claim (i) under customer (including OEM,
distributor and reseller) Contracts with respect to Company
Products or Services that are immaterial to the Company Business
and (ii) that does not involve any Significant Customer;
(i) issue, sell, create or authorize any shares of its
capital stock of any class or series or any other of its
securities, or issue, grant or create any warrants, obligations,
subscriptions, options, convertible securities, or other
commitments to issue shares of its capital stock or any
securities that are potentially exchangeable for, or convertible
into, shares of its capital stock, other than (i) the
issuance of shares of Company Capital Stock pursuant to the
exercise of Company Options or Company Warrants outstanding on
the Agreement Date, and (ii) the issuance of Company
Options to newly hired employees in the ordinary course of
business, consistent with past practices (provided that
such Company Options (A) will have customary share amounts
and vesting terms, consistent with past practices, (B) will
not accelerate upon the occurrence of the Merger or any
subsequent event (provided, however, that should
the Merger not occur, such restriction on acceleration may cease
to apply), and (C) will have exercise prices equal to fair
market value on the date of grant).
(j) subdivide, split, combine or reverse split the
outstanding shares of its capital stock of any class or series
or enter into any recapitalization affecting the number of
outstanding shares of its capital stock of any class or series
or affecting any other of its securities;
(k) merge, consolidate or reorganize with, acquire, or
enter into any other business combination with any corporation,
partnership, limited liability company or any other entity
(other than Acquiror or Merger Sub), acquire a substantial
portion of the assets of any such entity, or enter into any
Contract for such purpose;
A-42
(l) amend its Certificate of Incorporation or Bylaws or
other comparable charter documents (except as required by
Applicable Law (as determined in good faith by the Company
following consultation with its and Acquirors outside
legal counsel) and except for immaterial amendments or changes
to the charter documents of Company Subsidiaries);
(m) (i) license any of its technology or Intellectual
Property (except for licenses made, and the entry into Contracts
providing for commercial sales of, and OEM, distribution and
reseller relationships with respect to, the Company Products or
Services, in each case, in the ordinary course of business
consistent with its past practices) or (ii) other than
licenses of software generally available to the public at a per
copy license fee of less than $10,000, enter into any Contract
to acquire or license Intellectual Property that (A) may
not be canceled without penalty by the Company or the Company
Subsidiaries upon notice of 30 days or less and
(B) requires by its terms payments by the Company or the
Company Subsidiaries in an amount in excess of
$1,000,000 per annum or involves terms which materially
restrict the Company or any of the Company Subsidiaries, or
(iii) transfer or provide a copy of any source code of the
Company to any Person other than (A) to employees or
consultants of the Company or any of its Subsidiaries who have a
reasonable need to access such source code in the course of
performance of their duties for the Company or any such
Subsidiary or (B) pursuant to pre-existing obligations
arising from existing customer agreements;
(n) materially change any insurance coverage;
(o) (i) agree to any audit assessment by any Tax
Authority with respect to income Taxes or any material audit
assessment with respect to other Taxes, (ii) file any
income Tax Return, any other material Tax Return or any
amendment to any income or other material Tax Return unless
copies of such Tax Return or amendment have first been delivered
to Acquiror for its review at a reasonable time prior to filing,
(iii) except as required by Applicable Law, make or change
any material election in respect of Taxes or adopt or change any
material accounting method in respect of Taxes, or
(iv) enter into any closing agreement, settle any claim or
assessment in respect of income Taxes or other material Taxes,
surrender any right to claim a refund of Taxes, or consent to
any extension or waiver of the limitation period applicable to
any claim or assessment in respect of income Taxes or other
material Taxes;
(p) except as set forth in Schedule 5.4(p) of
the Company Disclosure Letter, modify or change the exercise or
conversion rights or exercise or purchase prices of any of its
capital stock, any of its stock options, warrants or other
securities, or accelerate or otherwise modify (i) the right
to exercise any option, warrant or other right to purchase any
of its capital stock or other securities or (ii) the
vesting or release of any shares of its capital stock or other
securities from any repurchase options or rights of refusal held
by it or any other party or any other restrictions;
(q) (i) except as set forth in
Schedule 5.4(q) of the Company Disclosure Letter,
initiate any litigation, action, suit, proceeding, claim or
arbitration (other than (A) for the routine collection of
bills or to enforce its rights under this Agreement and
(B) to enforce Company-Owned IP Rights against current or
former employees or individual contractors/consultants), it
being understood that with respect to any litigation, action,
suit, proceeding, claim or arbitration for which the prior
written consent of Acquiror is required under this
clause (i), (x) such consent will not be unreasonably
withheld or delayed, (y) such consent will be granted or
denied within three Business Days following the receipt by
Acquiror from the Company of all information reasonably
necessary to make an informed decision on such consent, and
(z) Acquiror will exercise reasonable best efforts to make
available appropriate personnel to review such information as
quickly as reasonably practicable, or (ii) settle or agree
to settle any litigation, action, suit, proceeding, claim or
arbitration (except in either case where the amount in
controversy does not exceed $500,000 and does not involve
injunctive or other equitable relief);
(r) (i) pay, discharge or satisfy, in an amount in
excess of $500,000 in any one case or $1,000,000 in the
aggregate, any Liability arising otherwise than in the ordinary
course of business, other than (1) the payment, discharge
or satisfaction of Liabilities reflected or reserved against in
the Company Balance Sheet and (2) the payment, discharge or
satisfaction of Transaction Expenses, or (ii) make any
capital expenditures, capital additions or capital improvements
that, individually or in the aggregate, materially deviate from
those
A-43
scheduled to be made prior to the End Date under the
Companys capital expense budget for the 2007 fiscal year
attached as Schedule 5.4(r)(ii) to the Company
Disclosure Letter;
(s) materially change the manner in which it extends
warranties, discounts or credits to customers, other than
changes in the ordinary course of business consistent with past
practices, which changes are immaterial to the Company Business,
taken as a whole; or
(t) agree to do any of the things described in the
preceding clauses (a)-(s).
For purposes of this Section 5.4, Company
Material Contract includes any Contract arising subsequent
to the Agreement Date that would have been required to be listed
on the Company Disclosure Letter pursuant to
Section 3.12 had such Contract been in effect on the
Agreement Date.
5.5 Advice of Changes.
(a) Closing Conditions. The
Company shall promptly advise Acquiror in writing of
(i) any event occurring subsequent to the Agreement Date
that would render any representation or warranty of the Company
contained in Article 3 untrue or inaccurate such
that the condition set forth in Section 8.3(a) would
not be satisfied, (ii) any breach of any covenant or
obligation of the Company pursuant to this Agreement such that
the condition set forth in Section 8.3(b) would not
be satisfied, or (iii) any Material Adverse Change in the
Company; provided, however, that the delivery of
any notice pursuant to this Section 5.5 shall not be
deemed to (1) modify any representation or warranty
contained herein, (2) supplement or modify the Company
Disclosure Letter or (3) limit or otherwise affect the
remedies available hereunder to Acquiror or the conditions to
Acquirors obligation to consummate the Merger.
(b) Litigation. The Company shall
notify Acquiror in writing promptly after the Company Board or
any executive officer or senior legal department member of the
Company is notified in writing of any material claim, action,
suit, arbitration, mediation, proceeding or investigation by or
before any court, arbitrator or arbitration panel, board or
governmental agency, initiated by or against it, or known by the
Company to be threatened against the Company or any Company
Subsidiary.
5.6 Reasonable Best Efforts.
(a) Governmental and Third Party
Approvals. Upon the terms and subject to the
conditions set forth in this Agreement, the Company agrees to
use its reasonable best efforts to take, or cause to be taken,
all actions, and to do, or cause to be done, and to assist and
cooperate with the other parties in doing, all things necessary,
proper or advisable under Applicable Law to consummate and make
effective, in the most expeditious manner practicable, the
Merger, including using reasonable best efforts to (i) make
all required Antitrust Filings and, as reasonably requested by
Acquiror, obtain all other necessary actions or non-actions,
waivers, consents and approvals from Governmental Authorities,
make all necessary registrations and filings and take all
reasonable steps as may be necessary to obtain an approval or
waiver from, or to avoid an action or proceeding by, any
Governmental Authority, (ii) cooperate with Acquiror to
determine an appropriate process to identify any, and thereafter
seek to obtain any so identified, consents, approvals or waivers
from third parties necessary to consummate the Merger,
(iii) defend any lawsuits or other legal proceedings,
whether judicial or administrative, brought by third parties
(and not Governmental Authorities) challenging this Agreement or
the consummation of the Merger, including promptly seeking to
have reversed any stay or temporary restraining order resulting
from such lawsuits or proceedings entered by any court or other
Governmental Authority, and (iv) execute and deliver any
additional instruments necessary to consummate the Merger. In
furtherance and not in limitation of the foregoing, the Company
shall make an appropriate filing of a Notification and Report
Form pursuant to the HSR Act with respect to the transactions
contemplated hereby as promptly as practicable after the
Agreement Date and to supply as promptly as practicable any
additional information and documentary material that may be
requested pursuant to the HSR Act and to take all other actions
reasonably necessary to cause the expiration or termination of
the applicable waiting periods under the HSR Act, and under
comparable merger notification regulations of any foreign or
other Governmental Authority, as soon as practicable. Subject to
Applicable Law relating to the exchange of information, Acquiror
shall have the right to review in advance, and to the extent
reasonably practicable the Company will consult Acquiror on, all
the information relating to the Company and its Subsidiaries
that appears in any filing made with, or written materials
submitted to, any Governmental Authority or third party in
connection with the Merger and the other transactions
contemplated by this Agreement.
A-44
(b) Notification. The Company
shall keep Acquiror reasonably apprised of the status of matters
relating to the completion of the Merger and work cooperatively
in connection with obtaining all required approvals or consents
of any Governmental Authority (whether domestic, foreign or
supranational). In that regard, the Company shall without
limitation use its reasonable best efforts to (i) promptly
notify Acquiror of, and if in writing and requested by Acquiror,
furnish Acquiror with copies of (or, in the case of material
oral communications, advise the other orally of) any
communications or filings from or with any Governmental
Authority (whether domestic, foreign or supranational) with
respect to the Merger or any of the other transactions
contemplated by this Agreement, (ii) permit Acquiror to
review and discuss in advance, and consider in good faith the
views of Acquiror in connection with, any proposed written (or
any material proposed oral) communication with any such
Governmental Authority with respect to the Merger or any of the
other transactions contemplated by this Agreement, (iii) to
the extent practicable, not participate in any meeting with any
such Governmental Authority with respect to the Merger or any of
the other transactions contemplated by this Agreement unless it
consults with Acquiror in advance and to the extent permitted by
such Governmental Authority gives Acquiror the opportunity to
attend and participate thereat, and (iv) furnish Acquiror
with such necessary information and reasonable assistance as
Acquiror may reasonably request in connection with its
preparation of necessary filings or submissions of information
to any such Governmental Authority. The Company may, as it deems
advisable and necessary, reasonably designate any competitively
sensitive material provided to Acquiror under this
Section 5.6 as outside counsel only.
Such material and the information so designated and contained
therein shall be given only to the outside legal counsel of the
recipient and will not be disclosed by such outside counsel to
employees, officers, or directors of the recipient unless
express written consent is obtained in advance from the Company
or its legal counsel.
(c) State Takeover Statutes. In
connection with and without limiting the foregoing, the Company
shall (i) take all action reasonably necessary to ensure
that no state takeover statute or similar statute or regulation
is or becomes applicable to this Agreement or the Merger and
(ii) if any state takeover statute or similar statute or
regulation becomes applicable to this Agreement or the Merger,
take all action reasonably necessary to ensure that such
transactions may be consummated as promptly as practicable on
the terms required by, or provided for, in this Agreement and
otherwise to minimize the effect of such statute or regulation
on this Agreement or the Merger. Prior to the Effective Time,
the Company shall not take any action to render inapplicable or
to exempt any third Person from, any state takeover law or state
law that purports to limit or restrict business combinations or
the ability to acquire or vote shares of capital stock unless
(i) required to do so by order of a court of competent
jurisdiction or (ii) the Company Board has determined in
good faith, after consultation with its outside legal counsel,
that, in light of a Superior Proposal with respect to the
Company, it is required to take such action to comply with its
fiduciary duties to the Company Stockholders under Applicable
Law.
5.7 Access to
Information. Except as set forth in
Schedule 5.7 to the Company Disclosure Letter,
subject to the Confidentiality Agreement and Applicable Law, the
Company shall, and shall cause each of its Subsidiaries to,
afford to Acquiror and to the officers, employees, accountants,
counsel, financial advisors and other representatives of
Acquiror, reasonable access at all reasonable times on
reasonable notice during the period prior to the Effective Time
to all their properties, books, contracts, commitments,
personnel and records (provided, that such access shall
not unreasonably interfere with the business or operations of
the Company and its Subsidiaries) and, during such period and
subject to the Confidentiality Agreement and Applicable Law, the
Company shall, and shall cause each of its Subsidiaries to, make
available promptly to Acquiror (i) a copy of each report,
schedule, registration statement and other document filed by it
during such period pursuant to the requirements of federal or
state securities laws and (ii) all other information
concerning its business, properties and personnel as Acquiror
may reasonably request; provided, however, that
with respect to any documents or other information subject to
the attorney-client privilege, the Company shall reasonably
cooperate with Acquiror to develop procedures (such as a common
legal interest agreement) to allow such documents and
information to be shared with Acquiror and its advisors without
waiving such attorney-client privilege. No review pursuant to
this Section 5.7 shall affect or be deemed to modify
any representation or warranty contained herein, the covenants
or agreements of the parties hereto or the conditions to the
obligations of the parties hereto under this Agreement.
5.8 Confidentiality.
The Company will hold and keep confidential, and will cause its
officers and employees and will direct its accountants, counsel,
financial advisors and other authorized representatives and
A-45
Affiliates to hold and keep confidential, any non-public
information in accordance with the terms of the Confidentiality
Agreement, which Confidentiality Agreement will remain in full
force and effect.
5.9 Public
Announcements. The Company will use
reasonable best efforts to consult with Acquiror before issuing,
and will provide Acquiror the opportunity to review and comment
upon, and use reasonable best efforts to agree on, any press
release or other public statements to be made by the Company
with respect to the Merger, and shall not issue any such press
release or make any such public statement prior to such
consultation, except as the Company may reasonably determine is
required by Applicable Law, court process or by obligations
pursuant to any listing agreement with any national securities
exchange or stock market. In addition, except to the extent
disclosed in or consistent with the Proxy Statement in
accordance with the provisions of Section 5.1 or
prior communications consented to in accordance with this
Section 5.9, the Company shall not issue any press
release or otherwise make any public statement or disclosure
concerning Acquirors business, financial condition or
results of operations without the consent of Acquiror, which
consent shall not be unreasonably withheld or delayed, except as
the Company may reasonably determine is required by Applicable
Law, court process or by obligations pursuant to any listing
agreement with any national securities exchange or stock market.
Notwithstanding the foregoing, and for the avoidance of doubt,
it is not intended that this Section 5.9 shall apply
to the matters set forth in Section 5.1 and
Section 5.2 hereof (including with respect to a
Change in Recommendation), which shall be exclusively governed
thereby. The initial press release to be issued with respect to
the transactions contemplated by this Agreement shall be in the
form agreed to by the Company and Acquiror.
5.10 Employee Benefits.
(a) Termination of Benefit
Plans. To the extent requested in writing by
Acquiror no later than ten Business Days prior to the Closing
Date, the Company shall take (or cause to be taken) all actions
necessary to terminate, effective no later than the date
immediately preceding the Closing Date, any Company Benefit
Arrangement that contains a cash or deferred arrangement
intended to qualify under Section 401(k) of the Code (the
Company 401(k) Plans) in accordance with the
provisions of the Company 401(k) Plans and Applicable Law. If
Acquiror requests that the Company 401(k) Plans be terminated,
the Company Board shall adopt resolutions authorizing the
termination of the Company 401(k) Plans effective no later than
the day immediately preceding the Closing Date, such resolutions
to subject to the reasonable review and approval by
Acquirors counsel. Upon the request of Acquiror, the
Company shall terminate (or cause to be terminated) any and all
group severance, separation, retention and salary continuation
plans, programs, agreements or arrangements prior to the Closing
Date (other than agreements that by their terms cannot be
unilaterally terminated by Company and Contracts listed on
Schedule 5.10(a) of the Company Disclosure Letter).
(b) Company ESPP. The Company
shall terminate the Company ESPP prior to the Effective Time. To
the extent any offering period under the Company ESPP is in
progress prior to such termination, the Company shall ensure
that such offering period ends immediately prior to such
termination, and that each participants accumulated
contributions for such offering period are applied towards the
purchase of Company Common Stock immediately prior to such
termination unless the participant has previously withdrawn from
such offering period in accordance with the terms of such plan.
(c) The Company will consult with Acquiror (and consider in
good faith the advice of Acquiror) prior to sending any material
notices or other communication materials to its employees
regarding the matters described in this Section 5.10
and any other matters relative to the entry into the Agreement
or the effects of the Merger.
5.11 Section 16
Matters. Prior to the Effective Time,
the Company shall take all such steps as may be required (to the
extent permitted under Applicable Law) to cause any dispositions
of Company Common Stock (including derivative securities with
respect to Company Common Stock) resulting from the transactions
contemplated by this Agreement by each individual who is subject
to the reporting requirements of Section 16(a) of the
Exchange Act with respect to the Company to be exempt under
Rule 16b-3
promulgated under the Exchange Act. The Company acknowledges
that all such above reference dispositions are compensatory in
nature.
A-46
ARTICLE 6
Acquiror
Covenants
During the time period from the Agreement Date until the earlier
to occur of (a) the Effective Time or (b) the
termination of this Agreement in accordance with the provisions
of Article 9, Acquiror covenants and agrees with the
Company as follows:
6.1 Advice of Changes.
Acquiror shall promptly advise the Company in writing of
(a) any event occurring subsequent to the Agreement Date
that would render any representation or warranty of Acquiror or
Merger Sub contained in Article 4 untrue or
inaccurate such that the condition set forth in
Section 8.2(a) would not be satisfied and
(b) any breach of any covenant or obligation of Acquiror or
Merger Sub pursuant to this Agreement such that the condition
set forth in Section 8.2(b) would not be satisfied;
provided, however, that the delivery of any notice
pursuant to this Section 6.1 shall not be deemed to
(i) modify any representation or warranty contained herein
or (ii) limit or otherwise affect the remedies available
hereunder to the Company or the conditions to the Companys
obligation to consummate the Merger.
6.2 Reasonable Best Efforts.
(a) Governmental and Third Party
Approvals. Upon the terms and subject to the
conditions set forth in this Agreement, Acquiror agrees to use
its reasonable best efforts to take, or cause to be taken, all
actions, and to do, or cause to be done, and to assist and
cooperate with the other parties in doing, all things necessary,
proper or advisable under Applicable Law to consummate and make
effective, in the most expeditious manner practicable, the
Merger, including using reasonable best efforts to (i) make
all required Antitrust Filings and, as reasonably requested by
the Company, obtain all other necessary actions or non-actions,
waivers, consents and approvals from Governmental Authorities,
make all necessary registrations and filings and take all
reasonable steps as may be necessary to obtain an approval or
waiver from, or to avoid an action or proceeding by, any
Governmental Authority, (ii) cooperate with the Company to
determine an appropriate process to identify any consents,
approvals or waivers from third parties necessary to consummate
the Merger, (iii) subject to Section 6.2(d),
defend any lawsuits or other legal proceedings, whether judicial
or administrative, brought by third parties challenging this
Agreement or the consummation of the Merger, including promptly
seeking to have reversed any stay or temporary restraining order
resulting from such lawsuits or proceedings entered by any court
or other Governmental Authority, (iv) execute and deliver
any additional instruments necessary to consummate the Merger,
and (v) cooperate with the Company in the preparation of
the Proxy Statement, including the provision to the Company of
any information required under Applicable Law to be included in
such Proxy Statement. In furtherance and not in limitation of
the foregoing, Acquiror shall make an appropriate filing of a
Notification and Report Form pursuant to the HSR Act with
respect to the transactions contemplated hereby as promptly as
practicable after the Agreement Date and to supply as promptly
as practicable any additional information and documentary
material that may be requested pursuant to the HSR Act and to
take all other actions reasonably necessary to cause the
expiration or termination of the applicable waiting periods
under the HSR Act, and under comparable merger notification
regulations of any foreign or other Governmental Authority, as
soon as practicable. Subject to Applicable Law relating to the
exchange of information, the Company shall have the right to
review in advance, and to the extent reasonably practicable
Acquiror will consult the Company on, all the information
relating to Acquiror and its Subsidiaries that appears in any
filing made with, or written materials submitted to, any
Governmental Authority or third party in connection with the
Merger and the other transactions contemplated by this Agreement.
(b) Notification. Acquiror shall
keep the Company reasonably apprised of the status of matters
relating to the completion of the Merger and work cooperatively
in connection with obtaining all required approvals or consents
of any Governmental Authority (whether domestic, foreign or
supranational). In that regard, Acquiror shall without
limitation use its reasonable best efforts to (i) promptly
notify the Company of, and if in writing and requested by the
Company, furnish the Company with copies of (or, in the case of
material oral communications, advise the other orally of) any
communications or filings from or with any Governmental
Authority (whether domestic, foreign or supranational) with
respect to the Merger or any of the other transactions
contemplated by this Agreement, (ii) permit the Company to
review and discuss in advance, and consider in good faith the
views of Company in connection with, any proposed written (or
any material proposed oral) communication with any such
Governmental Authority with respect to the Merger or any of the
other transactions contemplated by this
A-47
Agreement, (iii) to the extent practicable, not participate
in any meeting with any such Governmental Authority with respect
to the Merger or any of the other transactions contemplated by
this Agreement unless it consults with the Company in advance
and to the extent permitted by such Governmental Authority gives
the Company the opportunity to attend and participate thereat,
and (iv) furnish the Company with such necessary
information and reasonable assistance as the Company may
reasonably request in connection with its preparation of
necessary filings or submissions of information to any such
Governmental Authority. Acquiror may, as it deems advisable and
necessary, reasonably designate any competitively sensitive
material provided to the Company under this
Section 6.2 as outside counsel only.
Such material and the information so designated and contained
therein shall be given only to the outside legal counsel of the
recipient and will not be disclosed by such outside counsel to
employees, officers, or directors of the recipient unless
express written consent is obtained in advance from Acquiror or
its legal counsel.
(c) State Takeover Statutes. In
connection with and without limiting the foregoing, Acquiror
shall (i) take all action reasonably necessary to ensure
that no state takeover statute or similar statute or regulation
is or becomes applicable to this Agreement or the Merger and
(ii) if any state takeover statute or similar statute or
regulation becomes applicable to this Agreement or the Merger,
take all action reasonably necessary to ensure that such
transactions may be consummated as promptly as practicable on
the terms required by, or provided for, in this Agreement and
otherwise to minimize the effect of such statute or regulation
on this Agreement or the Merger.
(d) Antitrust
Restraints. Notwithstanding anything in this
Agreement to the contrary, if any administrative or judicial
action or proceeding is instituted (or threatened to be
instituted) by any Governmental Authority challenging any
transaction contemplated by this Agreement as violative of any
Antitrust Laws, it is expressly understood and agreed that:
(i) Acquiror shall not have any obligation to litigate or
contest, or continue to litigate or contest, any administrative
or judicial action or proceeding brought by, or any decree,
judgment, injunction or other order, whether temporary,
preliminary or permanent issued in favor of, any Governmental
Authority asserting that the Merger, or any aspect thereof, is
in violation of any Antitrust Law; and (ii) Acquiror shall
be under no obligation to make proposals, execute or carry out
agreements, enter into consent decrees or submit to orders
providing for (A) the sale, divestiture, license or other
disposition or holding separate (through the establishment of a
trust or otherwise) of any assets or categories of assets of
Acquiror or any of its affiliates or the Company or the Company
Subsidiaries, (B) the imposition of any limitation or
regulation on the ability of Acquiror or any of its affiliates
to freely conduct their business or own such assets, or
(C) the holding separate of the shares of Company Capital
Stock or any limitation or regulation on the ability of Acquiror
or any of its affiliates to exercise full rights of ownership of
the shares of Company Capital Stock, to such extent as would be
reasonably likely to (1) adversely impact in any material
respect the benefits expected to be derived by Acquiror from the
Merger, including with respect to products, services or
technologies of the Company, Acquiror or their respective
Subsidiaries, including existing products, services or
technologies, or (2) otherwise adversely impact in any
material respect any business line of Acquiror or its
Subsidiaries (any of the foregoing, an Antitrust
Restraint).
6.3 Confidentiality.
Acquiror will hold and keep confidential, and will cause its
officers and employees and will direct its accountants, counsel,
financial advisors and other authorized representatives and
Affiliates to hold and keep confidential, any non-public
information in accordance with the terms of the Confidentiality
Agreement, which Confidentiality Agreement will remain in full
force and effect.
Acquiror also covenants and agrees with the Company as follows:
6.4 Employee Benefits.
As promptly as reasonably practicable after the Effective Time,
Acquiror shall enroll those persons who were employees of the
Company or its Subsidiaries immediately prior to the Effective
Time and who remain employees of the Surviving Corporation or
its Subsidiaries or become employees of Acquiror following the
Effective Time (Continuing Employees) in
Acquirors employee benefit plans for which such employees
are eligible (which could, in Acquirors sole discretion,
include Company Benefit Arrangements continued by Acquiror after
the Effective Time) (the Acquiror Plans),
including its medical plans, dental plans, life insurance plans
and disability plans, pursuant to the terms of the applicable
Acquiror Plans, on substantially similar terms applicable to
employees of Acquiror who are similarly situated based on levels
of responsibility. Without limiting the generality of the
foregoing, Acquiror shall recognize the prior service with the
Company of each of the Continuing Employees (i) for all
purposes in connection with Acquirors PTO policy,
severance policy,
A-48
401(k) plan, medical plans, dental plans, life insurance plans
and disability plans and (ii) for all purposes in
connection with all other Acquiror Plans (to the extent
permitted by the terms of the applicable Acquiror Plans); it is
understood that for purposes of the foregoing Acquiror Plans,
even in situations where the prior service with the Company is
so recognized by Acquiror, the benefit levels under such
Acquiror Plans may nevertheless depend in part on the grade or
position of the Continuing Employees with Acquiror, all as set
forth under the terms of the applicable Acquiror Plans.
Notwithstanding anything in this Section 6.4 to the
contrary, this Section 6.4 shall not operate to
(a) duplicate any benefit provided to any Continuing
Employee or to fund any such benefit not previously funded,
(b) require Acquiror to continue in effect any Company
Benefit Arrangement or any severance plan or other employee
benefit plan of Acquiror (or prevent the amendment, modification
or termination thereof) following the Effective Time for
Acquirors employees, including the Continuing Employees,
or (c) be construed to mean the employment of the
Continuing Employees is not terminable by Acquiror at will at
any time, with or without cause, for any reason or no reason.
Acquiror shall also perform the additional covenants set forth
on Schedule 6.4 hereto.
6.5 Indemnification of Company Directors and
Officers.
(a) If the Merger is consummated, then until the sixth
anniversary of the Effective Time, Acquiror shall, and shall
cause the Surviving Corporation to, fulfill and honor in all
respects the obligations of the Company to its directors and
officers as of immediately prior to the Effective Time (the
Company Indemnified Persons) pursuant to any
indemnification provisions under the Companys or any
Company Subsidiarys Certificate of Incorporation or Bylaws
as in effect on the Agreement Date and pursuant to the terms of
any indemnification agreements between the Company or such
Company Subsidiary on the one hand, and such Company Indemnified
Person on the other hand, in each case existing as of the
Agreement Date (the Company Indemnification
Provisions), with respect to claims arising out of
acts or omissions occurring at or prior to the Effective Time.
In connection therewith Acquiror shall advance expenses to the
Company Indemnified Persons as incurred to the fullest extent
provided for under the Company Indemnification Provisions,
provided the person to whom expenses are advanced provides an
undertaking to repay such advances if it is ultimately
determined that such person is not entitled to indemnification
pursuant to the terms of the Company Indemnification Provisions
or under Applicable Law. Any claims for indemnification made
under this Section 6.5(a) on or prior to the sixth
anniversary of the Effective Time shall survive such anniversary
until the final resolution thereof.
(b) For a period of six years from and after the Effective
Time, Acquiror shall, and shall cause the Surviving Corporation
to, maintain in effect, to the extent available, directors
and officers liability insurance covering those persons
who are currently covered by the Companys directors
and officers liability insurance policy in an amount and
on terms no less advantageous, when taken as a whole, to those
applicable to the current directors and officers of the Company;
provided, however, Acquiror may fulfill its
obligations under this Section 6.5(b) by purchasing
a policy of directors and officers insurance or a
tail policy under the Companys existing
directors and officers insurance policy, in either
case which (i) has an effective term of six years from the
Effective Time, (ii) covers only those persons who are
currently covered by the Companys directors and
officers insurance policy in effect as of the Agreement
Date and only for actions and omissions occurring on or prior to
the Effective Time, and (iii) contains terms and conditions
(including, without limitation, coverage amounts) that are no
less advantageous, when taken as a whole, to those applicable to
the current directors and officers of the Company, provided
further, that in no event shall Acquiror or the Surviving
Corporation be required to expend an annual premium for any such
coverage in excess of 200% of the annual premium currently paid
by the Company under its directors and officers
liability insurance policy in effect as of the Agreement Date,
and if the cost for any such coverage is in excess of such
amount, Acquiror or the Surviving Corporation shall only be
required to maintain such coverage as is available for such
amount.
(c) This Section 6.5 shall survive the
consummation of the Merger, is intended to benefit each Company
Indemnified Person, shall be binding on all successors and
assigns of the Surviving Corporation and Acquiror, and shall be
enforceable by the Company Indemnified Persons.
6.6 Assumption of Company Securities;
Form S-8.
Acquiror shall take such actions as are reasonably necessary for
the assumption of the Company Options and Company Restricted
Stock Units pursuant to
Section 2.1(b)(ii)-(iii),
including the reservation for issuance and authorization for
listing on NASDAQ of the shares of Acquiror Common Stock subject
to Assumed Options and Assumed Restricted Stock. Acquiror shall
file a
A-49
registration statement on
Form S-8
for the shares of Acquiror Common Stock issuable with respect to
Assumed Options and Assumed Restricted Stock Units eligible for
registration on such form as soon as reasonably practicable (and
no later than three Business Days) after the Effective Time and
shall exercise reasonable best efforts to maintain the
effectiveness of such registration statement for so long as any
of such Assumed Options or Assumed Restricted Stock Units
remains outstanding.
ARTICLE 7
Closing
Matters
7.1 The Closing.
Subject to termination of this Agreement as provided in
Article 9, the Closing shall take place at the
offices of Fenwick & West LLP, Silicon Valley Center,
801 California Street, Mountain View, California, on the Closing
Date. Concurrently with the Closing or at such later date and
time as may be mutually agreed in writing by the Company and
Acquiror, the Certificate of Merger shall be filed with the
Delaware Secretary of State in accordance with Delaware Law.
7.2 Exchange of Certificates.
(a) Exchange Fund. As soon as
reasonably practicable after the Effective Time, Acquiror shall
deposit with Computershare Trust Company, Inc. (the
Exchange Agent) the aggregate amount of cash
consideration, in immediately available funds, payable pursuant
to Section 2.1(b) (the Exchange
Fund). The Exchange Fund will be held by the Exchange
Agent in trust in a separate fund for the benefit of Company
Stockholders and will be distributed to Company Stockholders in
exchange for outstanding Company Common Stock in accordance with
Article 2 hereof, subject to the provisions of
Section 2.1(e) (regarding the continuation of
vesting and repurchase rights).
(b) Exchange Procedures. As soon
as reasonably practicable (and no later than two Business Days)
after the Effective Time, Acquiror shall instruct the Exchange
Agent to mail to each holder of record of certificates or
instruments evidencing the Company Common Stock that were
outstanding immediately prior to the Effective Time
(collectively, the Certificates) and which
were converted into the right to receive cash pursuant to
Section 2.1(b), (i) a letter of transmittal
(that shall specify that delivery shall be effected, and risk of
loss and title to the Certificates shall pass, only upon proper
delivery of the Certificates to the Exchange Agent) and
(ii) instructions for use in effecting the surrender of the
Certificates in exchange for cash, which letter of transmittal
and instructions shall be in the customary form used by Acquiror
and the Exchange Agent (provided that Acquiror will provide the
Company with a reasonable opportunity to review and comment
thereon). Upon surrender of Certificates for cancellation to the
Exchange Agent together with such letter of transmittal, duly
completed and validly executed in accordance with the
instructions thereto, and such other documents as may reasonably
be required by the Exchange Agent (including any required
Form W-9
or
Form W-8),
the holders of such Certificates shall be entitled to receive in
exchange therefor a check in the amount of U.S. dollars
that such holders have the right to receive pursuant to
Section 2.1(b) subject to the provisions of
Section 2.1(e) (regarding the continuation of
vesting and repurchase rights), and the Certificates so
surrendered shall forthwith be canceled. Until so surrendered,
outstanding Certificates will be deemed from and after the
Effective Time, for all corporate purposes, to evidence only the
right to receive upon surrender thereof a check in the amount of
U.S. dollars that the holders thereof have the right to
receive pursuant to Section 2.1(b) subject to the
provisions of Section 2.1(e) (regarding the
continuation of vesting and repurchase rights). No interest will
be paid or accrued on any cash payable to holders of
Certificates. In the event of a transfer of ownership of shares
of Company Common Stock that is not registered in the transfer
records of the Company, a check in the amount of
U.S. dollars that the holder thereof has the right to
receive pursuant to Section 2.1(b) subject to the
provisions of Section 2.1(e) (regarding the
continuation of vesting and repurchase rights), may be issued to
a transferee if the Certificate representing such shares of
Company Common Stock is presented to the Exchange Agent,
accompanied by all documents required to evidence and effect
such transfer and by evidence that any applicable stock transfer
Taxes have been paid.
(c) Lost, Stolen or Destroyed
Certificates. In the event that any
Certificates shall have been lost, stolen or destroyed, the
Exchange Agent shall issue and pay in exchange for such lost,
stolen or destroyed Certificates, upon the making of an
affidavit of that fact by the holder thereof, a check in the
amount of U.S. dollars into which the
A-50
Company Common Stock represented by such Certificates were
converted pursuant to Section 2.1(b) subject to the
provisions of Section 2.1(e) (regarding the
continuation of vesting and repurchase rights); provided,
however, that Acquiror or the Exchange Agent may, in its
discretion and as a condition precedent to the issuance of such
cash, require the owner of such lost, stolen or destroyed
Certificates to deliver a bond in such sum as it may reasonably
direct as indemnity against any claim that may be made against
Acquiror, the Surviving Corporation or the Exchange Agent with
respect to the Certificates alleged to have been lost, stolen or
destroyed.
(d) Termination of Exchange
Fund. Any portion of the Exchange Fund which
remains undistributed to the former holders of Company Common
Stock for six months after the Effective Time shall be delivered
to Acquiror, upon demand, and any such holders of Company Common
Stock who have not theretofore complied with the provisions of
this Section 7.2 shall thereafter look only to
Acquiror and the Surviving Corporation for the cash to which
they are entitled pursuant to Section 2.1(b) subject
to the provisions of Section 2.1(e) (regarding the
continuation of vesting and repurchase rights), without any
interest thereon.
(e) No Further Ownership Rights in Company
Securities. All cash paid in accordance with
the terms hereof with respect to Company Common Stock and
Company Warrants shall be deemed to have been paid in full
satisfaction of all rights pertaining to such Company Common
Stock and Company Warrants, and there shall be no further
registration of transfers on the records of the Surviving
Corporation of Company Common Stock
and/or
Company Warrants that were outstanding immediately prior to the
Effective Time. If after the Effective Time Certificates are
presented to the Surviving Corporation for any reason, they
shall be canceled and exchanged as provided in this
Article 7.
(f) No Liability. Notwithstanding
anything to the contrary in this Section 7.2,
neither the Exchange Agent, Acquiror, the Company, the Surviving
Corporation nor any party hereto shall be liable to a holder of
Company Common Stock, Company Options or Company Warrants for
any amount properly paid to a public official pursuant to any
applicable abandoned property, escheat or similar Applicable Law.
ARTICLE 8
Conditions
to Obligations of The Parties
8.1 Conditions to Each Partys Obligation
to Effect the Merger. The respective
obligations of each party to this Agreement to effect the Merger
shall be subject to the satisfaction at or prior to the Closing
of each of the following conditions:
(a) Company Stockholder
Approval. The Company Stockholder Approval
shall have been obtained, as required by Delaware Law and the
Companys Certificate of Incorporation and Bylaws, each as
in effect on the date of such approval.
(b) Antitrust
Compliance. (i) All applicable waiting
periods (and any extensions thereof) applicable to the Merger
under the HSR Act shall have expired or early termination of
such waiting periods shall have been granted and (ii) the
approvals under antitrust, competition or similar laws of
Germany shall have been obtained, in each case without any
condition or requirements requiring or calling for any Antitrust
Restraint.
(c) No Injunctions or
Restraints. No judgment, order, injunction,
decree, statute, law, ordinance, rule or regulation, or other
legal restraint or prohibition (whether temporary, preliminary
or permanent), entered, enacted, promulgated, enforced or issued
by any court or other Governmental Authority of competent
jurisdiction, shall be in effect which prohibits, makes illegal
or enjoins the consummation of the Merger.
8.2 Additional Conditions to Obligations of the
Company. The obligation of the Company
to effect the Merger shall be subject to the satisfaction at or
prior to the Closing of each of the following conditions, any of
which may be waived in writing by the Company:
(a) Accuracy of Representations and
Warranties.
(i) The representations and warranties of Acquiror set
forth herein (other than in Sections 4.2(a) and (c))
(A) that are qualified as to Material Adverse Effect shall
be true and correct and (B) that are not so qualified as to
Material Adverse Effect shall be true and correct, in each case
both when made and at and
A-51
as of the Closing Date, as if made at and as of such time
(except to the extent expressly made as of an earlier date, in
which case as of such date), except to the extent that the
failure of any such representations and warranties referred to
in clause (B) to be so true and correct does not have,
and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect on Acquiror or a
material adverse effect on Acquirors ability to consummate
the Merger. At the Closing, the Company shall have received a
certificate to such effect signed on behalf of Acquiror by a
duly authorized executive officer of Acquiror.
(ii) The representations and warranties of Acquiror set
forth in Sections 4.2(a) and (c) shall be true and
correct both when made and at and as of the Closing Date, as if
made at and as of such time (except to the extent expressly made
as of an earlier date, in which case as of such date). At the
Closing, the Company shall have received a certificate to such
effect signed on behalf of Acquiror by a duly authorized
executive officer of Acquiror.
(b) Covenants. Acquiror shall have
performed and complied in all material respects with its
covenants under this Agreement on or before the Closing (to the
extent that such covenants require performance by Acquiror on or
before the Closing). At the Closing, the Company shall have
received a certificate to such effect signed on behalf of
Acquiror by a duly authorized executive officer of Acquiror.
8.3 Additional Conditions to Obligations of
Acquiror and Merger Sub. The respective
obligations of Acquiror and Merger Sub to effect the Merger
shall be subject to the satisfaction at or prior to the Closing
of each of the following conditions, any of which may be waived
in writing by Acquiror and Merger Sub:
(a) Accuracy of Representations and
Warranties.
(i) The representations and warranties of the Company set
forth herein (other than in Sections 3.3(a),
(c) and (d) and Section 3.4(a))
(A) that are qualified as to Material Adverse Effect shall
be true and correct and (B) that are not so qualified as to
Material Adverse Effect shall be true and correct, in each case
both when made and at and as of the Closing Date, as if made at
and as of such time (except to the extent expressly made as of
an earlier date, in which case as of such date), except to the
extent that the failure of any such representations and
warranties referred to in clause (B) to be so true and
correct does not have, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse
Effect on the Company. At the Closing, Acquiror shall have
received a certificate to such effect signed on behalf of the
Company by a duly authorized executive officer of the Company.
(ii) The representations and warranties of the Company set
forth in Sections 3.3(a), (c) and (d) shall be
true and correct both when made and at and as of the Closing
Date, as if made at and as of such time (except to the extent
expressly made as of an earlier date, in which case as of such
date). The representations and warranties of the Company set
forth in Section 3.4(a) shall be true and correct
both when made and at and as of the Closing Date, as if made at
and as of such time (except to the extent expressly made as of
an earlier date, in which case as of such date), except with
respect to deviations in the Companys actual fully diluted
capitalization (including outstanding Company Capital Stock,
Company Options and Company Warrants) from the Companys
fully diluted capitalization as set forth in
Sections 3.4(a) by an amount that does not exceed
one percent of such fully diluted capitalization. At the
Closing, Acquiror shall have received a certificate to such
effect signed on behalf of the Company by a duly authorized
executive officer of the Company.
(b) Covenants. The Company shall
have performed and complied in all material respects with its
covenants under this Agreement at or before the Closing (to the
extent that such covenants require performance by the Company at
or before the Closing). At the Closing, Acquiror shall have
received a certificate to such effect signed on behalf of the
Company by a duly authorized executive officer of the Company.
(c) No Material Adverse
Change. There shall not be any Material
Adverse Change in the Company which is continuing, whether or
not resulting from a breach in any representation, warranty or
covenant in this Agreement. At the Closing Acquiror shall have
received a certificate to such effect signed on behalf of the
Company by a duly authorized executive officer of the Company.
A-52
(d) No Litigation. (A) No
suit, action, proceeding, application or counterclaim shall be
pending by any Governmental Authority wherein an unfavorable
injunction, judgment, order, decree, ruling or charge would
(i) prevent, restrain or prohibit the consummation of the
Merger, (ii) cause the Merger to be rescinded, or
(iii) result in any Antitrust Restraint, (B) no such
injunction, judgment, order, decree, ruling or charge shall be
in effect nor shall any Applicable Law have been enacted having
any such effect, and (C) no Governmental Authority shall
have notified the parties in writing of, and not withdrawn, any
intent on its part to seek such injunction, judgment, order,
decree, ruling or charge having any such effect.
ARTICLE 9
Termination,
Amendment and Waiver
9.1 Termination. This
Agreement may be terminated at any time prior to the Effective
Time by action taken or authorized by the Board of Directors of
the terminating party or parties, which action (A) in the
case of Section 9.1(a),
Section 9.1(b)(i), Section 9.1 (b)(ii),
Section 9.1(c) and Section 9.1(d), may
be taken or authorized before or after the Company Stockholder
Approval, (B) in the case of Section 9.1(e) and
Section 9.1(f), may be taken or authorized only
before the Company Stockholder Approval, and (C) in the
case of Section 9.1(b)(iii), may be taken or
authorized only after the Company Stockholders Meeting
where a vote was taken:
(a) by mutual written consent of the Company and Acquiror,
if the Board of Directors of each so determines;
(b) by written notice of either the Company or Acquiror (as
authorized by the Board of Directors of the Company or Acquiror,
as applicable) to the other party:
(i) if the Merger shall not have been consummated by
July 31, 2007 (the End Date);
provided, however, that if the Merger shall not
have been consummated by the End Date, but on such date, all of
the conditions to Closing set forth in Article 8
(other than conditions that by their nature are only to be
satisfied as of the Closing and other than the conditions set
forth in Section 8.1(b)) have been satisfied or
waived in writing, then the End Date shall be extended until
October 31, 2007; provided, further, that the
right to terminate this Agreement under this
Section 9.1(b)(i) shall not be available to any
party whose failure to comply with, or breach of, any provision
of this Agreement has been a proximate cause of, or resulted in,
the failure of the Merger to be consummated by such date;
(ii) if a Governmental Authority of competent jurisdiction
shall have issued an order, decree or ruling or taken any other
action (including the failure to have taken an action), in any
case having the effect of permanently restraining, enjoining or
otherwise prohibiting the consummation of the Merger, which
order, decree, ruling or other action is final and
nonappealable; or
(iii) if the Company Stockholder Approval shall not have
been obtained at the Company Stockholders Meeting, or at
any adjournment or postponement thereof, at which a vote thereon
was taken;
(c) by the Company (as authorized by the Company Board), by
written notice to Acquiror, following a breach of any
representation, warranty, covenant or agreement on the part of
Acquiror set forth in this Agreement, such that the conditions
set forth in Section 8.2(a) or
Section 8.2(b) would not be satisfied as of the time
of such breach and such breach shall be incapable of being cured
or shall not have been cured in all material respects within 20
Business Days after written notice thereof shall have been
received by Acquiror;
(d) by Acquiror (as authorized by its Board of Directors),
by written notice to the Company, following a breach of any
representation, warranty, covenant or agreement on the part of
the Company set forth in this Agreement, such that the
conditions set forth in Section 8.3(a) or
Section 8.3(b) would not be satisfied as of the time
of such breach and such breach shall be incapable of being cured
or shall not have been cured in all material respects within 20
Business Days after written notice thereof shall have been
received by the Company;
(e) by the Company (as authorized by its Board of
Directors), by written notice to the Acquiror, if (i) the
Company Board shall have effected a Change in Recommendation
pursuant to Section 5.2(d), (ii) the
A-53
Company shall have paid to Acquiror the Termination Fee
described in Section 9.3(a), and (iii) the
Company shall have publicly announced its intention to accept or
enter into the Superior Proposal which was the subject of such
Change in Recommendation; or
(f) by Acquiror (as authorized by its Board of Directors),
by written notice to the Company, if the Company, the Company
Board or any committee thereof, for any reason, shall have
(i) materially breached its obligation to give notice of,
convene and hold the Company Stockholders Meeting in
accordance with Section 5.1(b), (ii) failed to
include in the Proxy Statement distributed to the Company
Stockholders the recommendation of the Company Board that such
stockholders adopt this Agreement, (iii) effected a Change
in Recommendation, (iv) approved any Alternative
Transaction or recommended that the Company Stockholders approve
or accept any Alternative Transaction (without the prior written
consent of Acquiror), (v) the Company shall have entered
into a letter of intent in violation of this Agreement or any
Contract accepting any Alternative Transaction Proposal (without
the prior written consent of Acquiror), (vi) failed to
reconfirm the recommendation of the Company Board that Company
Stockholders adopt this Agreement within ten Business Days of
receipt of a written request from Acquiror to do so following
the occurrence of any Alternative Transaction Proposal, or
(vii) failed, within ten Business Days after any tender or
exchange offer relating to Company Common Stock commenced by any
third Person shall have been first published, sent or given, to
have sent to its security holders pursuant to
Rule 14e-2
promulgated under the Exchange Act a statement disclosing that
the Company Board recommends rejection of such tender offer or
exchange offer.
9.2 Effect of
Termination. In the event of termination
of this Agreement as provided in Section 9.1 hereof
and any payment of a Termination Fee, this Agreement shall
forthwith become void and there shall be no liability on the
part of any of the parties, except (a) as set forth in
Sections 5.8 and 6.3 (Confidentiality), this
Section 9.2 (Effect of Termination) and
Section 9.3 (Payments), as well as
Article 10 (Miscellaneous) (other than
Section 10.1) to the extent applicable to such
surviving sections, each of which shall survive termination of
this Agreement, and (b) that nothing herein shall relieve
any party from any further liability for any willful or
intentional breach of any representation or warranty of such
party contained herein or any breach of any covenant or
agreement of such party contained herein. No termination of this
Agreement shall affect the obligations of the parties contained
in the Confidentiality Agreement, all of which obligations shall
survive termination of this Agreement in accordance with their
terms. Payments made pursuant to Section 9.3
(Payments) shall be in addition to any other rights, remedies
and relief of the parties hereto or with respect to the subject
matter of this Agreement.
9.3 Payments.
(a) Payments by the Company.
(i) Termination Fee. In the event
that this Agreement is terminated by the Company pursuant to
Section 9.1(e), the Company shall pay Acquiror a fee
equal to $37,500,000 (the Termination Fee) as
provided in Section 9.1(e). In the event
that this Agreement is terminated by Acquiror pursuant to
Section 9.1(f), the Company shall promptly, but in
no event later than two Business Days after the date of such
termination, pay Acquiror the Termination Fee. In the event that
this Agreement is terminated pursuant to
Section 9.1(b)(iii), the Company shall pay Acquiror
the Termination Fee if (A) following the Agreement Date and
prior to such termination, an Alternative Transaction Proposal
with respect to the Company (1) shall have been publicly
announced by any Person, (2) shall have been made to the
Company Stockholders by any Person, or (3) shall have been
made to the Company by any Person and subsequently been publicly
announced or disclosed, and in each case such Alternative
Transaction Proposal shall not have been withdrawn, and
(B) within 12 months following termination of this
Agreement, any Company Acquisition with respect to the Company
is consummated or the Company enters into a Contract providing
for any Company Acquisition, in which case such fee payment is
to be made concurrently with the earlier of the consummation of
such Company Acquisition or the execution of such Contract, as
applicable.
(ii) Acquiror Expenses. In the
event that this Agreement is terminated pursuant to
Section 9.1(b)(iii), the Company shall promptly, but
in no event later than two days after the date of such
termination, reimburse Acquiror for its Transaction Expenses,
not to exceed $2,000,000. The amount of any Transaction Expenses
reimbursed by the Company to Acquiror shall be credited against
any subsequent payment required to be made by the Company to
Acquiror of the Termination Fee pursuant to
Section 9.3(a)(i) above.
A-54
(b) Interest and Costs. All
payments under this Section 9.3 shall be made by
wire transfer of immediately available funds to an account
designated by Acquiror. The Company acknowledges that the
agreements contained in this Section 9.3 are an
integral part of the transactions contemplated by this Agreement
and that, without these agreements, Acquiror would not enter
into this Agreement. Accordingly, if the Company fails to pay in
a timely manner the amounts due pursuant to this
Section 9.3 and, in order to obtain such payment,
Acquiror makes a claim that results in a judgment against the
Company, the Company shall pay to Acquiror its reasonable costs
and expenses (including reasonable attorneys fees and
expenses) in connection with such suit, together with interest
on the amounts set forth in this Section 9.3 at the
rate of interest per annum publicly announced by Bank of America
as its prime rate, as in effect on the date such payment was
required to be made. Payment of the fees described in this
Section 9.3 shall not be in lieu of damages incurred
in the event of breach of this Agreement, to the extent
permitted by Section 9.2.
9.4 Amendment. Subject
to compliance with Applicable Law, this Agreement may be amended
by the parties at any time before or after the Company
Stockholder Approval; provided, however, that
after the occurrence of either the Company Stockholder Approval
there may not be, without further approval of the stockholders
of the Company, any amendment of this Agreement that changes the
amount or the form of the consideration to be delivered to the
holders of Company Common Stock hereunder, or which by
Applicable Law otherwise expressly requires the further approval
of such stockholders. This Agreement may not be amended except
by an instrument in writing signed on behalf of each of the
parties hereto and duly approved by the parties respective
Boards of Directors or a duly designated committee thereof.
9.5 Extension; Waiver.
At any time prior to the Effective Time, a party may, subject to
the proviso of Section 9.4 (and for this purpose
treating any waiver referred to below as an amendment),
(a) extend the time for the performance of any of the
obligations or other acts of the other parties hereto,
(b) waive any inaccuracies in the representations and
warranties of the other parties contained in this Agreement or
in any document delivered pursuant to this Agreement or
(c) waive compliance by the other party hereto with any of
the agreements or conditions contained in this Agreement. Any
agreement on the part of a party to any such extension or waiver
shall be valid only if set forth in an instrument in writing
signed on behalf of such party. Any extension or waiver given in
compliance with this Section 9.5 or failure to
insist on strict compliance with an obligation, covenant,
agreement or condition shall not operate as a waiver of, or
estoppel with respect to, any subsequent or other failure.
ARTICLE 10
Miscellaneous
10.1 Expiration of Representations and
Warranties. None of the representations,
warranties, covenants and agreements in this Agreement or in any
instrument delivered pursuant to this Agreement, including any
rights arising out of any breach of such representations,
warranties, covenants and agreements, shall survive the
Effective Time.
10.2 Notices. All
notices and other communications hereunder shall be in writing
and shall be deemed given on (i) the date of delivery, if
delivered personally or by commercial delivery service, or
(ii) on the date of confirmation of receipt (or the next
Business Day, if the date of confirmation of receipt is not a
Business Day), if sent via facsimile (with confirmation of
receipt), to the parties hereto at the following address (or at
such other address for a party as shall be specified by like
notice):
If to Acquiror or Merger Sub:
Symantec Corporation
20330 Stevens Creek Blvd.
Cupertino, CA 95014
Attention: Arthur F. Courville, Sr. V.P., Corporate
Legal Affairs
Fax Number:
(408) 517-8121
A-55
with a copy to:
Fenwick & West LLP
Silicon Valley Center
801 California Street
Mountain View, CA 94041
Attention: Daniel J. Winnike, Esq.
Douglas
N. Cogen, Esq.
Andrew
Y. Luh, Esq.
Fax Number:
(650) 988-8500
If to the Company:
Altiris, Inc.
588 West 400 South
Lindon, UT 84042
Attention: Craig Christensen, Vice President and General
Counsel
Fax Number:
(801) 805-2589
with a copy to:
Wilson Sonsini Goodrich & Rosati, P.C.
2795 East Cottonwood Parkway
Suite 300
Salt Lake City, UT
84121-6928
Attention: Martin W. Korman, Esq.
Robert
G. OConnor, Esq.
Lawrence
M. Chu, Esq.
Fax Number:
(801) 993-6499
10.3 Governing Law.
This Agreement and any disputes arising out of or related to
this Agreement shall be governed by, and construed in accordance
with, the laws of the State of Delaware.
10.4 Jurisdiction. In
any action or proceeding between any of the parties arising out
of or relating to this Agreement or any of the transactions
contemplated by this Agreement, each of the parties hereto:
(a) irrevocably and unconditionally consents and submits,
for itself and its property, to the exclusive jurisdiction and
venue of any Delaware State court (or, in the case of any claim
as to which the federal courts have exclusive subject matter
jurisdiction, the Federal court of the United States of America,
sitting in Delaware); (b) agrees that all claims in respect
of such action or proceeding must be commenced, and may be heard
and determined, exclusively in such Delaware State court (or, if
applicable, such Federal court); (c) waives, to the fullest
extent it may legally and effectively do so, any objection which
it may now or hereafter have to the laying of venue of any such
action or proceeding in such Delaware State court (and, if
applicable, such Federal court); and (d) waives, to the
fullest extent permitted by law, the defense of an inconvenient
forum to the maintenance of such action or proceeding in such
Delaware State court (or, if applicable, such Federal court).
Each of the parties hereto agrees that a final judgment in any
such action or proceeding and may be enforced in other
jurisdictions by suit on the judgment or in any other manner
provided by law. Each party to this Agreement irrevocably
consents to service of process in the manner provided for
notices in Section 10.2. Nothing in this
Agreement shall affect the right of any party to this Agreement
to serve process in any other manner permitted by Applicable Law.
10.5 Entire Agreement.
This Agreement, together with the exhibits and schedules hereto,
constitutes the entire understanding and agreement of the
parties hereto with respect to the subject matter hereof and
supersedes all prior and contemporaneous agreements or
understandings, inducements or conditions, express or implied,
written or oral, between the parties with respect hereto other
than the Confidentiality Agreement. The express terms hereof
control and supersede any course of performance or usage of the
trade inconsistent with any of the terms hereof.
10.6 Third Party Beneficiary
Rights. No provisions of this Agreement
are intended, nor shall be interpreted, to provide or create any
third party beneficiary rights or any other rights of any kind
in any client, customer, employee, affiliate, stockholder,
partner or any party hereto or any other Person unless
specifically provided
A-56
otherwise herein and, except as so provided, all provisions
hereof shall be personal solely between the parties to this
Agreement; except that Section 6.5 is
intended to benefit the Company Indemnified Persons, who shall
be third party beneficiaries for purposes of such Section.
10.7 Assignment; Binding Upon Successors and
Assigns. This Agreement shall inure to
the benefit of any successor to, or assignee of, all or
substantially all of the business and assets of Acquiror. Except
as set forth in the preceding sentence, no party hereto may
assign any of its rights or obligations hereunder without the
prior written consent of the other parties hereto. This
Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and permitted
assigns. Any assignment in violation of this provision shall be
void.
10.8 Severability. If
any provision of this Agreement, or the application thereof,
shall for any reason and to any extent be invalid or
unenforceable, then the remainder of this Agreement and the
application of such provision to other persons or circumstances
shall be interpreted so as reasonably to effect the intent of
the parties hereto. The parties further agree to replace such
void or unenforceable provision of this Agreement with a valid
and enforceable provision that shall achieve, to the extent
possible, the economic, business and other purposes of the void
or unenforceable provision.
10.9 Remedies; Specific
Performance. Except as otherwise
expressly provided herein, any and all remedies herein expressly
conferred upon a party hereunder shall be deemed cumulative with
and not exclusive of any other remedy conferred hereby or by law
on such party, and the exercise of any one remedy shall not
preclude the exercise of any other. The parties agree that
irreparable damage would occur and that the parties would not
have any adequate remedy at law in the event that any of the
provisions of this Agreement were not performed in accordance
with their specific terms or were otherwise breached. It is
accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this
Agreement in the Court of Chancery of the State of Delaware,
this being in addition to any other remedy to which they are
entitled at law or in equity.
10.10 Interpretation; Rules of
Construction. When a reference is made
in this Agreement to Exhibits, such reference shall be to an
Exhibit to this Agreement unless otherwise indicated. When a
reference is made in this Agreement to Sections, such reference
shall be to a Section of this Agreement unless otherwise
indicated. When a reference is made in this Agreement to
Articles, such reference shall be to an Article of this
Agreement unless otherwise indicated. The words
include, includes and
including when used herein shall be deemed in each
case to be followed by the words without limitation.
The words hereof, herein and
hereunder and words of similar import when used in
this Agreement shall refer to this Agreement as a whole and not
to any particular provision of this Agreement. All terms defined
in this Agreement shall have the defined meanings when used in
any certificate or other document made or delivered pursuant
hereto unless otherwise defined therein. The definitions
contained in this Agreement are applicable to the singular as
well as the plural forms of such terms and to the masculine as
well as to the feminine and neuter genders of such term. The
headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or
interpretation of this Agreement. References to the Subsidiaries
of an entity shall be deemed to include all direct and indirect
Subsidiaries of such entity. References to a Person are also to
its permitted successors and assigns. Any agreement, instrument
or statute defined or referred to herein or in any agreement or
instrument that is referred to herein means such agreement,
instrument or statute as from time to time amended, modified or
supplemented, including (in the case of agreements or
instruments) by waiver or consent and (in the case of statutes)
by succession of comparable successor statutes and references to
all attachments thereto and instruments incorporated therein.
The parties hereto agree that they have been represented by
legal counsel during the negotiation and execution of this
Agreement and, therefore, waive the application of any law,
regulation, holding or rule of construction providing that
ambiguities in an agreement or other document shall be construed
against the party drafting such agreement or document. The one
percent threshold established by the parties with respect to the
Companys capitalization in Section 8.3(a)(ii)
hereof shall not, in and of itself, constitute an economic
benchmark for determining whether any Effect shall be deemed to
be material in relation to the Company or shall be deemed to
constitute a Material Adverse Effect on the Company.
10.11 Counterparts. This
Agreement may be executed in any number of counterparts, each of
which shall be an original as regards any party whose signature
appears thereon and all of which together shall constitute one
A-57
and the same instrument. This Agreement shall become binding
when one or more counterparts hereof, individually or taken
together, shall bear the signatures of all parties reflected
hereon as signatories.
10.12 Expenses. Whether
or not the Merger is successfully consummated, each party shall
bear its respective Transaction Expenses, unless otherwise
expressly provided herein.
10.13 Attorneys
Fees. Should suit be brought to enforce
or interpret any part of this Agreement, the prevailing party
shall be entitled to recover, as an element of the costs of suit
and not as damages, reasonable attorneys fees to be fixed
by the court (including costs, expenses and fees on any appeal).
The prevailing party shall be entitled to recover its costs of
suit, regardless of whether such suit proceeds to final judgment.
10.14 No Joint Venture.
Nothing contained in this Agreement shall be deemed or construed
as creating a joint venture or partnership between any of the
parties hereto. No party is by virtue of this Agreement
authorized as an agent, employee or legal representative of any
other party. No party shall have the power to control the
activities and operations of any other and their status is, and
at all times shall continue to be, that of independent
contractors with respect to each other. No party shall have any
power or authority to bind or commit any other party. No party
shall hold itself out as having any authority or relationship in
contravention of this Section 10.14.
10.15 Confidentiality.
The Company and Acquiror each confirm that they have entered
into the Confidentiality Agreement and that they are each bound
by, and shall abide by, the provisions of such Confidentiality
Agreement; provided, however, that Acquiror shall
not be bound by such Confidentiality Agreement after the
Closing. If this Agreement is terminated, the Confidentiality
Agreement shall remain in full force and effect, and all copies
of documents containing confidential information of a disclosing
party shall be returned by the receiving party to the disclosing
party or be destroyed, as provided in the Confidentiality
Agreement.
10.16 Waiver of Jury
Trial. EACH PARTY HERETO ACKNOWLEDGES
AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES,
AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND
UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE
TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY
CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) EACH
PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS
WAIVER, (III) EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND
(IV) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS SECTION 10.16.
[Signature Page Next]
A-58
IN WITNESS WHEREOF, the parties hereto have executed this
Agreement as of the date first above written.
|
|
|
Symantec
Corporation
|
|
Altiris,
Inc.
|
|
|
|
|
|
By: /s/ Gregory
S.
Butterfield
|
Name: John W. Thompson
|
|
Name: Gregory S. Butterfield
|
Title: Chairman
and Chief Executive Officer
|
|
Title: President
and Chief Executive Officer
|
Atlas Merger Corp.
|
|
|
By:
|
/s/ Arthur
F. Courville
|
|
Name: Arthur F. Courville
Title: President and Chief Executive Officer
[Signature Page to
Agreement and Plan of Merger]
A-59
ANNEX B
CONFIDENTIAL
January 26,
2007
Board of Directors
Altiris, Inc.
588 West 400 South
Lindon, UT 84042
Gentlemen:
You have requested our opinion as to the fairness from a
financial point of view to the holders of the outstanding shares
of common stock, par value $0.0001 per share (the
Shares), of Altiris, Inc. (the Company),
of the $33.00 per Share in cash to be received by such
holders pursuant to the Agreement and Plan of Merger, dated as
of January 26, 2007 (the Agreement), among
Symantec Corporation (Symantec), Atlas Merger Corp.,
a wholly owned subsidiary of Symantec, and the Company.
Goldman, Sachs & Co. and its affiliates, as part of
their investment banking business, are continually engaged in
performing financial analyses with respect to businesses and
their securities in connection with mergers and acquisitions,
negotiated underwritings, competitive biddings, secondary
distributions of listed and unlisted securities, private
placements and other transactions as well as for estate,
corporate and other purposes. We have acted as financial advisor
to the Company in connection with, and have participated in
certain of the negotiations leading to, the transaction
contemplated by the Agreement (the Transaction). We
expect to receive fees for our services in connection with the
Transaction, all of which are contingent upon consummation of
the Transaction, and the Company has agreed to reimburse our
expenses and indemnify us against certain liabilities arising
out of our engagement. In addition, we have provided certain
investment banking services to Symantec from time to time,
including having acted as an agent in connection with its share
repurchase program in March 2004. We also may provide investment
banking services to the Company and Symantec in the future. In
connection with the above-described investment banking services
we have received, and may receive, compensation.
Goldman, Sachs & Co. is a full service securities firm
engaged, either directly or through its affiliates, in
securities trading, investment management, financial planning
and benefits counseling, risk management, hedging, financing and
brokerage activities for both companies and individuals. In the
ordinary course of these activities, Goldman, Sachs &
Co. and its affiliates may provide such services to the Company,
Symantec and their respective affiliates, may actively trade the
debt and equity securities (or related derivative securities) of
the Company and Symantec for their own account and for the
accounts of their customers and may at any time hold long and
short positions of such securities.
In connection with this opinion, we have reviewed, among other
things, the Agreement; annual reports to stockholders and Annual
Reports on
Form 10-K
of the Company for the four years ended December 31, 2005;
certain interim reports to stockholders and Quarterly Reports on
Form 10-Q
of the Company; certain other communications from the Company to
its stockholders; and certain internal financial analyses and
forecasts for the Company prepared by its management. We also
have held discussions with members of the senior management of
the Company regarding its assessment of the past and current
business operations, financial condition and future prospects of
the Company. In addition, we have reviewed the reported price
and trading activity for the Shares, compared certain financial
and stock market information for the Company with similar
information for certain other companies the securities of which
are publicly traded, reviewed the financial terms of certain
recent business combinations in the software industry
specifically and in other industries generally and performed
such other studies and analyses, and considered such other
factors, as we considered appropriate.
We have relied upon the accuracy and completeness of all of the
financial, accounting, legal, tax and other information
discussed with or reviewed by us and have assumed such accuracy
and completeness for purposes of
B-1
Board of Directors
Altiris, Inc.
January 26, 2007
Page 2
rendering this opinion. In that regard, we have assumed with
your consent that the internal financial forecasts prepared by
the management of the Company have been reasonably prepared on a
basis reflecting the best currently available estimates and
judgments of the Company. In addition, we have not made an
independent evaluation or appraisal of the assets and
liabilities (including any contingent, derivative or
off-balance-sheet assets and liabilities) of the Company or any
of its subsidiaries and we have not been furnished with any such
evaluation or appraisal.
Our opinion does not address the underlying business decision of
the Company to engage in the Transaction. Our opinion is
necessarily based on economic, monetary, market and other
conditions as in effect on, and the information made available
to us as of, the date hereof. Our advisory services and the
opinion expressed herein are provided for the information and
assistance of the Board of Directors of the Company in
connection with its consideration of the Transaction and such
opinion does not constitute a recommendation as to how any
holder of Shares should vote with respect to such transaction.
Based upon and subject to the foregoing, it is our opinion that,
as of the date hereof, the $33.00 per Share in cash to be
received by the holders of Shares, pursuant to the Agreement is
fair from a financial point of view to such holders.
Very truly yours,
(GOLDMAN, SACHS & CO.)
B-2
ANNEX C
GENERAL
CORPORATION LAW OF THE STATE OF DELAWARE
§ 262. Appraisal
rights.
(a) Any stockholder of a corporation of this State who
holds shares of stock on the date of the making of a demand
pursuant to subsection (d) of this section with
respect to such shares, who continuously holds such shares
through the effective date of the merger or consolidation, who
has otherwise complied with subsection (d) of this
section and who has neither voted in favor of the merger or
consolidation nor consented thereto in writing pursuant to
§ 228 of this title shall be entitled to an appraisal
by the Court of Chancery of the fair value of the
stockholders shares of stock under the circumstances
described in subsections (b) and (c) of this section.
As used in this section, the word stockholder means
a holder of record of stock in a stock corporation and also a
member of record of a nonstock corporation; the words
stock and share mean and include what is
ordinarily meant by those words and also membership or
membership interest of a member of a nonstock corporation; and
the words depository receipt mean a receipt or other
instrument issued by a depository representing an interest in
one or more shares, or fractions thereof, solely of stock of a
corporation, which stock is deposited with the depository.
(b) Appraisal rights shall be available for the shares of
any class or series of stock of a constituent corporation in a
merger or consolidation to be effected pursuant to
§ 251 (other than a merger effected pursuant to
§ 251(g) of this title), § 252,
§ 254, § 257, § 258,
§ 263 or § 264 of this title:
(1) Provided, however, that no appraisal rights under this
section shall be available for the shares of any class or series
of stock, which stock, or depository receipts in respect
thereof, at the record date fixed to determine the stockholders
entitled to receive notice of and to vote at the meeting of
stockholders to act upon the agreement of merger or
consolidation, were either (i) listed on a national
securities exchange or designated as a national market system
security on an interdealer quotation system by the National
Association of Securities Dealers, Inc. or (ii) held of
record by more than 2,000 holders; and further provided that no
appraisal rights shall be available for any shares of stock of
the constituent corporation surviving a merger if the merger did
not require for its approval the vote of the stockholders of the
surviving corporation as provided in subsection (f) of
§ 251 of this title.
(2) Notwithstanding paragraph (1) of this
subsection, appraisal rights under this section shall be
available for the shares of any class or series of stock of a
constituent corporation if the holders thereof are required by
the terms of an agreement of merger or consolidation pursuant to
§§ 251, 252, 254, 257, 258, 263 and 264 of this
title to accept for such stock anything except:
a. Shares of stock of the corporation surviving or
resulting from such merger or consolidation, or depository
receipts in respect thereof;
b. Shares of stock of any other corporation, or depository
receipts in respect thereof, which shares of stock (or
depository receipts in respect thereof) or depository receipts
at the effective date of the merger or consolidation will be
either listed on a national securities exchange or designated as
a national market system security on an interdealer quotation
system by the National Association of Securities Dealers, Inc.
or held of record by more than 2,000 holders;
c. Cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.
and b. of this paragraph; or
d. Any combination of the shares of stock, depository
receipts and cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.,
b. and c. of this paragraph.
(3) In the event all of the stock of a subsidiary Delaware
corporation party to a merger effected under § 253 of
this title is not owned by the parent corporation immediately
prior to the merger, appraisal rights shall be available for the
shares of the subsidiary Delaware corporation.
(c) Any corporation may provide in its certificate of
incorporation that appraisal rights under this section shall be
available for the shares of any class or series of its stock as
a result of an amendment to its certificate of
C-1
incorporation, any merger or consolidation in which the
corporation is a constituent corporation or the sale of all or
substantially all of the assets of the corporation. If the
certificate of incorporation contains such a provision, the
procedures of this section, including those set forth in
subsections (d) and (e) of this section, shall apply
as nearly as is practicable.
(d) Appraisal rights shall be perfected as follows:
(1) If a proposed merger or consolidation for which
appraisal rights are provided under this section is to be
submitted for approval at a meeting of stockholders, the
corporation, not less than 20 days prior to the meeting,
shall notify each of its stockholders who was such on the record
date for such meeting with respect to shares for which appraisal
rights are available pursuant to subsection (b) or
(c) hereof that appraisal rights are available for any or
all of the shares of the constituent corporations, and shall
include in such notice a copy of this section. Each stockholder
electing to demand the appraisal of such stockholders
shares shall deliver to the corporation, before the taking of
the vote on the merger or consolidation, a written demand for
appraisal of such stockholders shares. Such demand will be
sufficient if it reasonably informs the corporation of the
identity of the stockholder and that the stockholder intends
thereby to demand the appraisal of such stockholders
shares. A proxy or vote against the merger or consolidation
shall not constitute such a demand. A stockholder electing to
take such action must do so by a separate written demand as
herein provided. Within 10 days after the effective date of
such merger or consolidation, the surviving or resulting
corporation shall notify each stockholder of each constituent
corporation who has complied with this subsection and has not
voted in favor of or consented to the merger or consolidation of
the date that the merger or consolidation has become
effective; or
(2) If the merger or consolidation was approved pursuant to
§ 228 or § 253 of this title, then either a
constituent corporation before the effective date of the merger
or consolidation or the surviving or resulting corporation
within 10 days thereafter shall notify each of the holders
of any class or series of stock of such constituent corporation
who are entitled to appraisal rights of the approval of the
merger or consolidation and that appraisal rights are available
for any or all shares of such class or series of stock of such
constituent corporation, and shall include in such notice a copy
of this section. Such notice may, and, if given on or after the
effective date of the merger or consolidation, shall, also
notify such stockholders of the effective date of the merger or
consolidation. Any stockholder entitled to appraisal rights may,
within 20 days after the date of mailing of such notice,
demand in writing from the surviving or resulting corporation
the appraisal of such holders shares. Such demand will be
sufficient if it reasonably informs the corporation of the
identity of the stockholder and that the stockholder intends
thereby to demand the appraisal of such holders shares. If
such notice did not notify stockholders of the effective date of
the merger or consolidation, either (i) each such
constituent corporation shall send a second notice before the
effective date of the merger or consolidation notifying each of
the holders of any class or series of stock of such constituent
corporation that are entitled to appraisal rights of the
effective date of the merger or consolidation or (ii) the
surviving or resulting corporation shall send such a second
notice to all such holders on or within 10 days after such
effective date; provided, however, that if such second notice is
sent more than 20 days following the sending of the first
notice, such second notice need only be sent to each stockholder
who is entitled to appraisal rights and who has demanded
appraisal of such holders shares in accordance with this
subsection. An affidavit of the secretary or assistant secretary
or of the transfer agent of the corporation that is required to
give either notice that such notice has been given shall, in the
absence of fraud, be prima facie evidence of the facts stated
therein. For purposes of determining the stockholders entitled
to receive either notice, each constituent corporation may fix,
in advance, a record date that shall be not more than
10 days prior to the date the notice is given, provided,
that if the notice is given on or after the effective date of
the merger or consolidation, the record date shall be such
effective date. If no record date is fixed and the notice is
given prior to the effective date, the record date shall be the
close of business on the day next preceding the day on which the
notice is given.
(e) Within 120 days after the effective date of the
merger or consolidation, the surviving or resulting corporation
or any stockholder who has complied with subsections
(a) and (d) hereof and who is otherwise entitled to
appraisal rights, may file a petition in the Court of Chancery
demanding a determination of the value of the stock of all such
stockholders. Notwithstanding the foregoing, at any time within
60 days after the effective date of the merger or
consolidation, any stockholder shall have the right to withdraw
such stockholders demand for appraisal
C-2
and to accept the terms offered upon the merger or
consolidation. Within 120 days after the effective date of
the merger or consolidation, any stockholder who has complied
with the requirements of subsections (a) and
(d) hereof, upon written request, shall be entitled to
receive from the corporation surviving the merger or resulting
from the consolidation a statement setting forth the aggregate
number of shares not voted in favor of the merger or
consolidation and with respect to which demands for appraisal
have been received and the aggregate number of holders of such
shares. Such written statement shall be mailed to the
stockholder within 10 days after such stockholders
written request for such a statement is received by the
surviving or resulting corporation or within 10 days after
expiration of the period for delivery of demands for appraisal
under subsection (d) hereof, whichever is later.
(f) Upon the filing of any such petition by a stockholder,
service of a copy thereof shall be made upon the surviving or
resulting corporation, which shall within 20 days after
such service file in the office of the Register in Chancery in
which the petition was filed a duly verified list containing the
names and addresses of all stockholders who have demanded
payment for their shares and with whom agreements as to the
value of their shares have not been reached by the surviving or
resulting corporation. If the petition shall be filed by the
surviving or resulting corporation, the petition shall be
accompanied by such a duly verified list. The Register in
Chancery, if so ordered by the Court, shall give notice of the
time and place fixed for the hearing of such petition by
registered or certified mail to the surviving or resulting
corporation and to the stockholders shown on the list at the
addresses therein stated. Such notice shall also be given by 1
or more publications at least 1 week before the day of the
hearing, in a newspaper of general circulation published in the
City of Wilmington, Delaware or such publication as the Court
deems advisable. The forms of the notices by mail and by
publication shall be approved by the Court, and the costs
thereof shall be borne by the surviving or resulting corporation.
(g) At the hearing on such petition, the Court shall
determine the stockholders who have complied with this section
and who have become entitled to appraisal rights. The Court may
require the stockholders who have demanded an appraisal for
their shares and who hold stock represented by certificates to
submit their certificates of stock to the Register in Chancery
for notation thereon of the pendency of the appraisal
proceedings; and if any stockholder fails to comply with such
direction, the Court may dismiss the proceedings as to such
stockholder.
(h) After determining the stockholders entitled to an
appraisal, the Court shall appraise the shares, determining
their fair value exclusive of any element of value arising from
the accomplishment or expectation of the merger or
consolidation, together with a fair rate of interest, if any, to
be paid upon the amount determined to be the fair value. In
determining such fair value, the Court shall take into account
all relevant factors. In determining the fair rate of interest,
the Court may consider all relevant factors, including the rate
of interest which the surviving or resulting corporation would
have had to pay to borrow money during the pendency of the
proceeding. Upon application by the surviving or resulting
corporation or by any stockholder entitled to participate in the
appraisal proceeding, the Court may, in its discretion, permit
discovery or other pretrial proceedings and may proceed to trial
upon the appraisal prior to the final determination of the
stockholder entitled to an appraisal. Any stockholder whose name
appears on the list filed by the surviving or resulting
corporation pursuant to subsection (f) of this section
and who has submitted such stockholders certificates of
stock to the Register in Chancery, if such is required, may
participate fully in all proceedings until it is finally
determined that such stockholder is not entitled to appraisal
rights under this section.
(i) The Court shall direct the payment of the fair value of
the shares, together with interest, if any, by the surviving or
resulting corporation to the stockholders entitled thereto.
Interest may be simple or compound, as the Court may direct.
Payment shall be so made to each such stockholder, in the case
of holders of uncertificated stock forthwith, and the case of
holders of shares represented by certificates upon the surrender
to the corporation of the certificates representing such stock.
The Courts decree may be enforced as other decrees in the
Court of Chancery may be enforced, whether such surviving or
resulting corporation be a corporation of this State or of any
state.
(j) The costs of the proceeding may be determined by the
Court and taxed upon the parties as the Court deems equitable in
the circumstances. Upon application of a stockholder, the Court
may order all or a portion of the expenses incurred by any
stockholder in connection with the appraisal proceeding,
including, without limitation, reasonable attorneys fees
and the fees and expenses of experts, to be charged pro rata
against the value of all the shares entitled to an appraisal.
C-3
(k) From and after the effective date of the merger or
consolidation, no stockholder who has demanded appraisal rights
as provided in subsection (d) of this section shall be
entitled to vote such stock for any purpose or to receive
payment of dividends or other distributions on the stock (except
dividends or other distributions payable to stockholders of
record at a date which is prior to the effective date of the
merger or consolidation); provided, however, that if no petition
for an appraisal shall be filed within the time provided in
subsection (e) of this section, or if such stockholder
shall deliver to the surviving or resulting corporation a
written withdrawal of such stockholders demand for an
appraisal and an acceptance of the merger or consolidation,
either within 60 days after the effective date of the
merger or consolidation as provided in
subsection (e) of this section or thereafter with the
written approval of the corporation, then the right of such
stockholder to an appraisal shall cease. Notwithstanding the
foregoing, no appraisal proceeding in the Court of Chancery
shall be dismissed as to any stockholder without the approval of
the Court, and such approval may be conditioned upon such terms
as the Court deems just.
(l) The shares of the surviving or resulting corporation to
which the shares of such objecting stockholders would have been
converted had they assented to the merger or consolidation shall
have the status of authorized and unissued shares of the
surviving or resulting corporation.
C-4